{
  "meningioma_cases": [
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increased difficulty concentrating at work on computer screens",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Reports feeling more fatigued than usual despite adequate sleep"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "HbA1c consistently maintained around 7.0%",
          "Hypertension diagnosed 5 years ago - controlled with Lisinopril 10mg daily",
          "History of migraine headaches since early 30s, but notes current headaches are different",
          "Laser eye surgery (LASIK) 10 years ago",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "Regular health screenings up to date",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-DS-B\nPrimary Diagnosis: Meningioma\n==================================\n\nINITIAL VISIT - September 15, 2018\n---------------------------------\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n\nASSESSMENT:\nGiven patient's occupation as a data scientist requiring high cognitive function, symptoms suggesting increased ICP, and imaging characteristics, immediate surgical intervention recommended. WHO Grade II suspected based on imaging features.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of diabetes management\n3. Neuropsychological evaluation baseline\nKPS: 80 ECOG: 1\n\nSURGICAL NOTE - October 1, 2018\n------------------------------\nPROCEDURE: Right frontal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minimal residual tumor at dural attachment\nPATHOLOGY: WHO Grade II (Atypical) Meningioma\nPLAN: \n- Post-op adjuvant radiation therapy\n- Follow-up MRI in 3 months\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - January 15, 2019\n---------------------------\nPost-radiation therapy assessment\nIMAGING: No evidence of residual/recurrent tumor\nSYMPTOMS: Improving cognitive function\nPLAN: Continue q3 month monitoring\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 20, 2019\n-------------------------\nIMAGING: Stable post-surgical changes\nSYMPTOMS: Returned to work full-time\nPLAN: Continue monitoring\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - October 15, 2020\n----------------------------------\nIMAGING: Small enhancement at surgical site\nSYMPTOMS: Mild intermittent headaches\nPLAN: Increase monitoring frequency\nKPS: 85 ECOG: 1\n\nURGENT VISIT - March 10, 2021\n----------------------------\nIMAGING: 1.5cm recurrence at original site\nSYMPTOMS: Return of visual symptoms\nPLAN: Second surgical intervention scheduled\nKPS: 75 ECOG: 1\n\nSURGICAL NOTE - March 25, 2021\n-----------------------------\nPROCEDURE: Repeat craniotomy\n- Simpson Grade I resection achieved\nPATHOLOGY: Confirmed WHO Grade II\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - September 30, 2021\n-----------------------------\nIMAGING: No evidence of recurrence\nSYMPTOMS: Good recovery, back to work\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - October 15, 2022\n----------------------------------\nIMAGING: Stable post-surgical changes\nSYMPTOMS: Maintaining normal function\nKPS: 90 ECOG: 0\n\nRECENT FOLLOW-UP - December 1, 2023\n----------------------------------\nIMAGING: No evidence of recurrence\nSYMPTOMS: Excellent functional status\nPLAN: Continue annual monitoring\nKPS: 95 ECOG: 0\n\nLATEST VISIT - March 15, 2024\n----------------------------\nIMAGING: Stable findings\nSYMPTOMS: Maintaining normal work/life balance\nPLAN: \n1. Annual MRI surveillance\n2. Continue diabetes management\n3. Return to clinic in 12 months\nCurrent KPS: 95 ECOG: 0\n\nKPS/ECOG SCORE PROGRESSION:\n- Lowest KPS: 65 (post-second surgery)\n- Highest KPS: 95 (current)\n- ECOG range: 0-2 throughout treatment course\n\nTreatment approach focused on aggressive intervention due to:\n1. Patient's young age\n2. Cognitive-demanding occupation\n3. WHO Grade II pathology\n4. Tumor size and location\n5. Progressive symptomatology",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-DS-B\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\nKPS: 90 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation as data scientist requiring significant screen time and cognitive function, recommending conservative management with close monitoring. Diabetes must be considered in treatment planning.\n\nRECOMMENDATIONS:\n1. Watchful waiting approach with serial imaging\n2. Medical management of symptoms\n- Dexamethasone 4mg BID for edema control\n- Prophylactic levetiracetam 500mg BID\n3. Diabetes management optimization\n4. Monthly neurology follow-up initially\n\n-------------------\n\nFOLLOW-UP - March 20, 2019\nStable symptoms. Minor improvement in headaches.\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 18, 2019\nReports improved concentration at work\nMRI: Stable lesion\nKPS: 90 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 22, 2020\nMRI shows minimal growth (0.2cm)\nIncreased headache frequency\nKPS: 80 | ECOG: 1\nPlan: Increase steroid dose temporarily\n\n-------------------\n\nFOLLOW-UP - March 18, 2021\nVision symptoms stable\nMRI: No further growth\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 21, 2021\nExperiencing increased work difficulties\nMRI: Stable\nKPS: 75 | ECOG: 2\nPlan: Occupational therapy referral\n\n-------------------\n\nFOLLOW-UP - March 15, 2022\nImproved work adaptation\nMRI: Stable\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2022\nMinor progression (0.3cm growth)\nKPS: 70 | ECOG: 2\nDiscussing potential radiation options\n\n-------------------\n\nFOLLOW-UP - March 16, 2023\nOpted to continue observation\nMRI: No further growth\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 19, 2023\nStable disease\nImproved symptom control\nKPS: 85 | ECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - March 12, 2024\nMRI: Stable disease\nWell-adapted to work modifications\nKPS: 90 | ECOG: 1\n\nCURRENT MANAGEMENT:\n- Continued observation\n- Ergonomic workplace modifications\n- Regular ophthalmology follow-up\n- Diabetes remains well-controlled\n- Quality of life preserved through conservative approach\n\nKPS Score Range (2018-2024): 70-90\nECOG Score Range (2018-2024): 1-2\n\nLONG-TERM PLAN:\n- Continue biannual MRI surveillance\n- Maintain current medical management\n- Monitor cognitive function\n- Regular diabetes optimization\n- Consider radiation therapy only if significant progression\n\nNote: Conservative management has proven successful in maintaining patient's quality of life and occupational function while avoiding surgical risks. Will continue close monitoring."
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding correct words",
          "Subtle right-sided weakness noticed when typing",
          "Balance difficulties when walking, particularly in dimly lit areas",
          "Personality changes noted by family - more irritable and withdrawn",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Mild hearing loss in left ear - diagnosed 5 years ago",
          "Surgical history: Appendectomy (1985)",
          "Previous head trauma from car accident (1992) - no lasting effects",
          "No history of cancer",
          "Family history: Mother had breast cancer",
          "No smoking history",
          "Occasional alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 67-year-old male software developer\nChief Complaint: Progressive neurological symptoms with right-sided predominance\n\nMRI FINDINGS:\n- 4.2 cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on motor cortex\n- Enhancement pattern suggestive of WHO Grade II\nKPS: 70 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven size, location, and symptomatic presentation, immediate surgical intervention recommended. Occupation requires fine motor skills and cognitive precision - delay could impact professional function.\n\nSURGICAL INTERVENTION - March 28, 2018\n- Simpson Grade II resection performed\n- Subtotal removal due to superior sagittal sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- Post-op KPS: 60 | ECOG: 2\n\nFOLLOW-UP - June 15, 2018\n- Improved right-sided weakness\n- Starting adjuvant radiation therapy\n- 54 Gy in 30 fractions planned\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - December 20, 2018\n- Post-radiation imaging shows no progression\n- Returned to work part-time\n- Mild fatigue persists\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - June 10, 2019\n- MRI shows small area of enhancement at resection margin\n- Watchful waiting approach\n- Working full-time\nKPS: 90 | ECOG: 0\n\nURGENT VISIT - March 5, 2020\n- New onset seizures\n- MRI shows tumor progression\n- Second surgery recommended\nKPS: 70 | ECOG: 1\n\nSECOND SURGERY - March 20, 2020\n- More aggressive resection achieved\n- Pathology shows transformation to WHO Grade III\n- Post-op complications with infection\nKPS: 50 | ECOG: 2\n\nFOLLOW-UP - September 15, 2020\n- Post-treatment MRI stable\n- Started on temozolomide\n- Limited work capacity\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - March 10, 2021\n- Disease progression despite treatment\n- Considering clinical trial options\nKPS: 40 | ECOG: 3\n\nFOLLOW-UP - September 2021 - December 2023\n- Multiple admissions for seizure management\n- Progressive decline in functional status\n- Palliative care involvement\nKPS: 30-40 | ECOG: 3-4\n\nFINAL NOTE - January 2024\n- Significant disease progression\n- Transitioned to hospice care\n- Family support engaged\nKPS: 20 | ECOG: 4\n\nTREATMENT SUMMARY:\n- Initial presentation \u2192 aggressive surgical approach\n- Disease progression required multimodal therapy\n- Course complicated by malignant transformation\n- Total duration of care: 5 years, 10 months\n\nKPS Score Range: 20-90 throughout course\nECOG Score Range: 0-4 throughout course\n\nOUTCOME:\nDespite aggressive initial intervention and multimodal therapy, patient experienced malignant transformation and progressive decline. Early intervention provided initial good outcome but disease biology ultimately determined prognosis.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 67-year-old male software developer\nWHO Grade: II (based on imaging characteristics)\nKPS: 80 | ECOG: 1\n\nIMAGING FINDINGS:\n- MRI reveals 3.2cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No significant calcification\n\nASSESSMENT & PLAN:\nGiven patient's occupation requiring cognitive precision and presenting symptoms, conservative management initially recommended with close monitoring. Will consider intervention if progression occurs.\n- Monthly neurology follow-up\n- Anti-epileptic: Levetiracetam 500mg BID\n- Dexamethasone 4mg BID with taper\n- Occupational therapy referral for typing difficulties\n- Monthly cognitive assessments\n\nFOLLOW-UP - June 20, 2018\nKPS: 85 | ECOG: 1\n- Headaches improved with steroids\n- Vision stabilized\n- Typing function improved with OT\n- Continue current management\n- Reduced dexamethasone to 2mg daily\n\nFOLLOW-UP - December 5, 2018\nKPS: 75 | ECOG: 1\n- Mild tumor growth (3.5cm)\n- Increased edema\n- Discussed surgical options but patient prefers conservative approach\n- Increased dexamethasone to 4mg daily\n- Consider radiation therapy if further progression\n\nFOLLOW-UP - June 15, 2019\nKPS: 70 | ECOG: 2\n- Further growth (3.8cm)\n- Worsening symptoms\n- Recommended fractionated RT\n- Started RT: 54 Gy in 30 fractions\n\nFOLLOW-UP - January 10, 2020\nKPS: 85 | ECOG: 1\n- Post-RT improvement\n- Tumor stable\n- Reduced steroid dependency\n- Returned to work part-time\n\nANNUAL FOLLOW-UP - February 2021\nKPS: 90 | ECOG: 0\n- Stable disease\n- Working full-time\n- Maintained on levetiracetam\n- No seizures\n\nANNUAL FOLLOW-UP - March 2022\nKPS: 85 | ECOG: 1\n- Stable imaging\n- Minor cognitive complaints\n- Continuing conservative management\n\nANNUAL FOLLOW-UP - April 2023\nKPS: 80 | ECOG: 1\n- No tumor progression\n- Managing work with accommodations\n- Continue current approach\n\nRECENT FOLLOW-UP - January 2024\nKPS: 85 | ECOG: 1\n- Stable disease\n- Well-maintained quality of life\n- Continue annual monitoring\n\nMANAGEMENT SUMMARY:\nConservative approach with radiation therapy when needed has maintained good functional status. Patient has successfully continued working with accommodations. Regular monitoring has allowed for timely interventions while minimizing invasive procedures.\n\nCURRENT KPS: 85 - Able to carry on normal activity with minor symptoms\nCURRENT ECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PLAN:\n- Annual MRI\n- Quarterly neurology visits\n- Bi-annual cognitive assessments\n- Regular occupational therapy evaluations\n- Monthly blood pressure monitoring\n- Continue current medications"
      }
    },
    {
      "demographics": {
        "age": 69,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion when writing financial reports",
          "Subtle personality changes noted by family - increased irritability",
          "Balance difficulties when walking, particularly noticeable during restaurant visits",
          "Intermittent right-sided facial numbness",
          "Mild nausea without vomiting",
          "Recent difficulty concentrating during food tastings"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Osteoporosis diagnosed 3 years ago - on calcium supplements",
          "Successful cataract surgery left eye (2019)",
          "History of migraine headaches in 40s-50s, resolved spontaneously",
          "Mild hearing loss in right ear - diagnosed 2 years ago",
          "No prior surgeries except cataract removal",
          "No history of cancer",
          "Family history significant for mother with breast cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 69, Female, Blood Type: A\nOccupation: Financial Analyst/Food Critic\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, cognitive changes affecting work performance, balance issues, right facial numbness. Symptoms significantly impacting both professional roles.\nMRI Findings: 4.2cm right sphenoid wing meningioma with significant mass effect and peritumoral edema. Evidence of compression of the optic nerve and cavernous sinus involvement.\nWHO Grade: II (atypical features noted)\nPlan: Recommend immediate surgical intervention given size, location, and progressive symptoms.\nKPS Score: 70\nECOG: 1\n\nSURGICAL INTERVENTION - April 2, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nOutcome: Simpson Grade II resection achieved\nPost-op Status: Stable\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - July 15, 2018 (3 months post-op)\nStatus: Improving. Visual symptoms partially resolved. Balance improving.\nMRI: No residual tumor\nTreatment: Started adjuvant radiotherapy (60 Gy/30 fractions)\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - January 10, 2019 (9 months post-op)\nStatus: Significant improvement. Returned to financial analysis work part-time.\nMRI: Stable post-surgical changes\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - July 2019\nStatus: Small recurrence noted\nPlan: Stereotactic radiosurgery scheduled\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - January 2020\nStatus: Post-SRS, stable disease\nSymptoms: Mild fatigue, otherwise well\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - July 2020\nStatus: Developed radiation necrosis\nTreatment: Started dexamethasone\nKPS Score: 65\nECOG: 2\n\nFOLLOW-UP - January 2021\nStatus: Radiation changes improving\nWork Status: Resumed both occupations fully\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - July 2021\nStatus: New small satellite lesion discovered\nPlan: Additional SRS treatment\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - January 2022\nStatus: Post-second SRS, stable\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - July 2022\nStatus: Progressive disease\nPlan: Consideration for systemic therapy\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - January 2023\nStatus: Started bevacizumab\nResponse: Partial improvement\nKPS Score: 70\nECOG: 1\n\nCURRENT VISIT - January 2024\nStatus: Stable disease, maintaining work with accommodations\nMRI: No new progression\nPlan: Continue current regimen with quarterly imaging\nKPS Score: 80\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Multiple interventions including surgery, radiation, and systemic therapy\n- KPS Score range: 60-90 throughout treatment course\n- Current status: Stable with ongoing monitoring\n- Occupational impact: Initially significant, now managed with accommodations\n\nMONITORING RECOMMENDATIONS:\n1. Quarterly MRI with contrast\n2. Monthly ophthalmological evaluations\n3. Cognitive function assessments every 3 months\n4. Quality of life assessments focusing on occupational performance\n\nFinal KPS Score: 80 - Able to perform normal activities with effort\nFinal ECOG Score: 1 - Restricted in physically strenuous activity but ambulatory",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 69-year-old female, Financial Analyst/Food Critic\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\n\nMRI Findings:\n- 2.1cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\n\nAssessment:\nGiven patient's age, tumor size <3cm, and occupation requiring cognitive precision, recommending conservative management initially. Symptoms warrant close monitoring but tumor characteristics favor watchful waiting.\n\nPlan:\n1. MRI surveillance every 6 months initially\n2. Neurocognitive testing baseline\n3. Ophthalmology referral for visual symptoms\n4. Dexamethasone 4mg daily for edema management\nKPS: 80 ECOG: 1\n\nFollow-up - September 20, 2018\nMinimal tumor growth (2.2cm)\nVisual symptoms stable with steroid adjustment\nContinuing conservative management\nKPS: 85 ECOG: 1\n\nAnnual Visit - March 12, 2019\nTumor stable at 2.2cm\nImproved headaches with medical management\nPatient maintaining work schedule with accommodations\nKPS: 90 ECOG: 0\n\nFollow-up - March 15, 2020\nSlight progression to 2.4cm\nCOVID-19 considerations discussed\nContinuing surveillance\nKPS: 85 ECOG: 1\n\nAnnual Visit - April 2, 2021\nTumor size 2.5cm\nIncreasing headache frequency\nDiscussing potential SRS as future option\nKPS: 75 ECOG: 1\n\nCritical Decision Point - May 15, 2022\nTumor growth to 2.8cm\nWorsening symptoms affecting work performance\nRecommending transition to SRS consideration\nKPS: 70 ECOG: 2\n\nPost-SRS Follow-up - December 10, 2022\nGood response to targeted radiation\nSymptom improvement\nReturning to work part-time\nKPS: 80 ECOG: 1\n\nAnnual Visit - January 20, 2023\nStable tumor size post-SRS\nQuality of life improved\nResumed food critic duties with modifications\nKPS: 85 ECOG: 1\n\nRecent Visit - February 15, 2024\nTumor stable at 2.6cm\nMaintaining good functional status\nContinuing annual surveillance\nKPS: 90 ECOG: 0\n\nTreatment Summary:\n- Conservative management 2018-2022\n- Transition to SRS in 2022 due to progression\n- Successful tumor control with radiation\n- Preserved cognitive function for work duties\n\nOverall KPS Range: 70-90\nOverall ECOG Range: 0-2\n\nNotes: Patient's occupation as financial analyst and food critic influenced treatment decisions, prioritizing cognitive preservation and quality of life. Conservative approach initially successful, with timely transition to SRS when needed. Patient maintains professional activities with appropriate modifications."
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly severe in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea and vomiting, initially attributed to pregnancy",
          "Increasing difficulty with balance while working in kitchen",
          "Recent personality changes noted by coworkers - more irritable and having trouble concentrating",
          "Two episodes of focal seizures affecting left hand in past month",
          "Occasional ringing in right ear"
        ],
        "medical_history": [
          "BMI 34.2 - Class I Obesity",
          "Currently 24 weeks pregnant (G2P1)",
          "Previous uncomplicated pregnancy 5 years ago",
          "History of migraine headaches, but notes current headaches are different",
          "Surgical history: Appendectomy (2005)",
          "No prior neurological conditions",
          "Family history significant for breast cancer in mother",
          "No history of radiation exposure",
          "Taking prenatal vitamins and occasional acetaminophen for headaches",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n53-year-old female, Blood Type O\nDiagnosis: Right Frontal Parasagittal Meningioma (WHO Grade II)\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, balance issues, focal seizures, pregnancy (24 weeks)\nImaging: MRI reveals 4.2cm right frontal parasagittal meningioma with significant peritumoral edema\nAssessment: Given pregnancy status, size of tumor, and progressive neurological symptoms, urgent intervention warranted\nPlan: \n- Neurosurgical intervention recommended post-delivery\n- High-dose dexamethasone initiated with close monitoring\n- Anti-epileptic medication (Levetiracetam)\nKPS: 70 ECOG: 1\n\nFOLLOW-UP - June 28, 2018\nStatus: Post-successful C-section delivery\nImaging: Follow-up MRI shows tumor growth to 4.5cm\nPlan: Schedule surgical resection\nKPS: 65 ECOG: 1\n\nSURGICAL NOTE - July 15, 2018\nProcedure: Simpson Grade II resection of right frontal parasagittal meningioma\nFindings: WHO Grade II meningioma with brain invasion\nPost-op course: Uncomplicated\nKPS: 60 ECOG: 2\n\nFOLLOW-UP - January 10, 2019\nStatus: Good recovery, minimal residual symptoms\nImaging: Post-op MRI shows small residual tumor\nPlan: Adjuvant radiotherapy initiated\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - July 2019\nStatus: Completed radiotherapy\nImaging: Stable residual disease\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - July 2020\nStatus: Working part-time as chef\nImaging: No progression\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 2021\nStatus: New onset headaches\nImaging: Small area of progression\nPlan: SRS to residual tumor\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - July 2021\nStatus: Post-SRS, improved symptoms\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - July 2022\nStatus: Stable, working full-time\nImaging: No progression\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 2023\nStatus: Mild fatigue, otherwise stable\nImaging: Stable disease\nKPS: 85 ECOG: 1\n\nCURRENT VISIT - January 2024\nStatus: Maintaining good functional status\nImaging: Stable disease\nPlan: Continue biannual MRI surveillance\nCurrent medications: Levetiracetam 1000mg BID\nKPS: 90 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection\n- Adjuvant radiotherapy\n- Salvage SRS for progression\n- Regular imaging surveillance\n\nKPS Score Range: 60-90 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT STATUS:\nPatient has maintained good functional status with successful tumor control. Continues to work as chef with modifications to schedule and duties. Regular monitoring continues due to WHO Grade II status and history of progression.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 53F, G2P1 at 24 weeks gestation\nChief Complaint: Progressive neurological symptoms with intracranial mass\n\nMRI Findings:\n- 2.8cm right frontal convexity meningioma\n- Moderate peritumoral edema\n- Mass effect on adjacent frontal lobe\n- WHO Grade I features radiologically\n\nAssessment:\nSymptomatic right frontal meningioma in pregnant patient requiring careful management consideration. Given pregnancy status and symptom severity, immediate intervention warranted but must balance fetal risks.\n\nPlan:\n1. Dexamethasone 4mg BID for edema management\n2. Anti-epileptic prophylaxis (Levetiracetam 500mg BID)\n3. Weekly neurological monitoring through pregnancy\n4. Coordinate with high-risk OB team\n5. Plan for definitive treatment post-delivery\nKPS: 70 ECOG: 2\n\nFollow-up - September 20, 2018 (Post-delivery)\nSuccessful C-section delivery at 38 weeks. Neurological symptoms stable on current management. Continue conservative approach with close monitoring.\nKPS: 75 ECOG: 1\n\nAnnual Follow-up - March 12, 2019\nImaging shows stable tumor size. Symptoms improved with medical management. Patient has returned to work with modifications.\nPlan: Continue current management\nKPS: 80 ECOG: 1\n\nFollow-up - March 10, 2020\nMinimal tumor growth (2.9cm). Headaches well-controlled. Working reduced hours as chef with accommodations.\nPlan: Maintain current approach\nKPS: 85 ECOG: 1\n\nFollow-up - April 15, 2021\nTumor stable. Patient adapted well to workplace modifications. Regular exercise program initiated for weight management.\nKPS: 90 ECOG: 0\n\nFollow-up - May 20, 2022\nSlight increase in tumor size (3.1cm). Mild symptom progression.\nPlan: Increase monitoring frequency to q6 months\nKPS: 80 ECOG: 1\n\nFollow-up - December 10, 2022\nFurther growth to 3.3cm. Discussing surgical options but patient prefers continued conservative management.\nPlan: Continue close monitoring\nKPS: 75 ECOG: 1\n\nFollow-up - June 15, 2023\nStable disease. Managing work duties with assistance. Quality of life maintained.\nKPS: 80 ECOG: 1\n\nRecent Visit - January 20, 2024\nTumor size 3.4cm. Patient maintaining good functional status despite moderate symptoms.\nPlan: \n1. Continue conservative management\n2. Monthly neurological assessments\n3. Consider SRS if symptoms worsen\n4. Maintain work modifications\n5. Regular lifestyle counseling\nKPS: 75 ECOG: 1\n\nOverall Disease Course Summary:\n- Successfully managed through pregnancy\n- Maintained employment with modifications\n- Avoided surgical intervention\n- Preserved quality of life\n- Slow progression over 6 years\n- Conservative management successful\n\nCurrent Status:\nKPS Range: 70-90 (Currently 75)\nECOG Range: 0-2 (Currently 1)\n\nManagement Strategy:\n- Regular imaging surveillance\n- Symptom management\n- Workplace adaptations\n- Lifestyle modifications\n- Close monitoring of neurological status"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": true
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of loss of balance during stage performances",
          "Intermittent right-sided facial numbness",
          "Increased difficulty memorizing performance lines over past 2 months",
          "Occasional nausea without vomiting', \"Reports 'ringing in right ear' starting 3 months ago\""
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "Mild hypertension managed with lifestyle modifications",
          "No history of cancer",
          "No significant head trauma",
          "No family history of brain tumors",
          "Regular vision checks due to profession, last exam 1 year ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly balance/coordination tests, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly balance/coordination tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 53\nGender: Female\nBlood Type: A\nOccupation: Stage Artist\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\n- Evidence of compression of superior sagittal sinus\n\nASSESSMENT:\nGiven patient's symptomatic presentation, tumor size >3cm, and occupation requiring high cognitive function, immediate surgical intervention recommended. WHO Grade II suspected based on imaging characteristics.\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative functional MRI for surgical mapping\n3. Steroid therapy (Dexamethasone 4mg QID) initiated\nKPS: 70\nECOG: 1\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\nKPS: 60\nECOG: 2\n\nFOLLOW-UP - June 15, 2018\n- Improved vision and balance\n- Residual mild headaches\n- Started adjuvant radiation therapy\n- 54 Gy in 30 fractions\nKPS: 80\nECOG: 1\n\nFOLLOW-UP - December 20, 2018\n- Complete radiation course completed\n- No evidence of recurrence\n- Returned to stage performance\nKPS: 90\nECOG: 0\n\nSURVEILLANCE - June 15, 2019\nMRI shows no recurrence\nMinor memory complaints\nKPS: 90\nECOG: 0\n\nSURVEILLANCE - December 10, 2019\nStable imaging\nFull return to work\nKPS: 95\nECOG: 0\n\nSURVEILLANCE - June 8, 2020\nSmall enhancement noted on MRI\nClose monitoring recommended\nKPS: 90\nECOG: 0\n\nURGENT VISIT - January 15, 2021\nNew onset seizures\nMRI shows tumor recurrence\nKPS: 70\nECOG: 1\n\nSECOND SURGERY - February 1, 2021\n- Gross total resection achieved\n- Pathology confirms WHO Grade II\nKPS: 60\nECOG: 2\n\nFOLLOW-UP - March 15, 2021\nStarted on anticonvulsants\nRehabilitation initiated\nKPS: 75\nECOG: 1\n\nSURVEILLANCE - September 20, 2021\nStable imaging\nReturn to modified work schedule\nKPS: 85\nECOG: 1\n\nANNUAL REVIEW - September 15, 2022\nNo evidence of recurrence\nFull work activities resumed\nKPS: 90\nECOG: 0\n\nSURVEILLANCE - March 10, 2023\nStable imaging\nMaintaining performance schedule\nKPS: 95\nECOG: 0\n\nCURRENT VISIT - January 15, 2024\nComplete remission maintained\nRegular monitoring continues\nKPS: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical resections (2018, 2021)\n- Complete course of radiation therapy\n- Successful return to performing arts\n- Current status: Stable with excellent functional status\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neurological assessment quarterly\n- Annual cognitive evaluation\n- Regular quality of life assessments\n\nCurrent KPS: 95/100\nCurrent ECOG: 0/5\n\nPROGNOSIS:\nFavorable with continued close monitoring. Patient has demonstrated excellent recovery and maintained high functional status despite aggressive treatment approach.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 53-year-old female stage artist\nChief Complaint: Progressive neurological symptoms\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. WHO Grade I characteristics. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nGiven patient's profession requiring fine motor control, balance, and cognitive function, symptoms are significantly impacting quality of life. However, tumor size and characteristics favor initial conservative management.\n\nPLAN:\n1. Close monitoring with 3-month follow-up MRI\n2. Neurology referral for headache management\n3. Vestibular therapy for balance issues\n4. Ophthalmology consultation\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2018\nMinimal tumor growth (2.9cm). Symptoms stable with medication adjustment.\nContinue conservative management.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - December 5, 2018\nMRI shows stable tumor size. Patient reports improved headache control.\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - December 12, 2019\nTumor stable at 2.9cm. Patient maintaining performance schedule with accommodations.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - January 15, 2021\nSlight tumor growth to 3.1cm. Increased headache frequency.\nDiscussed surgical options but patient prefers continued conservative management.\nStarted on dexamethasone for symptom control.\nKPS: 70 ECOG: 1\n\nFOLLOW-UP - July 20, 2021\nTumor stable. Symptoms improved with medical management.\nKPS: 80 ECOG: 1\n\nANNUAL FOLLOW-UP - August 5, 2022\nMRI shows minimal growth (3.2cm). Patient maintaining professional activities.\nAdjusted medication regimen.\nKPS: 75 ECOG: 1\n\nURGENT VISIT - March 10, 2023\nSignificant worsening of vision and balance. MRI shows tumor growth to 3.5cm with increased edema.\nRecommended surgical intervention due to progressive symptoms.\nKPS: 60 ECOG: 2\n\nPOST-SURGERY FOLLOW-UP - May 15, 2023\nSimpson Grade II resection performed. Pathology confirms WHO Grade I meningioma.\nPatient recovering well, beginning performance rehabilitation.\nKPS: 70 ECOG: 1\n\nRECENT FOLLOW-UP - January 10, 2024\nExcellent recovery. Returned to modified performance schedule.\nMRI shows no residual/recurrent tumor.\nKPS: 90 ECOG: 0\n\nTREATMENT SUMMARY:\nInitial conservative management maintained quality of life for 5 years before surgical intervention became necessary. Post-surgical outcome excellent with return to professional activities.\n\nFINAL STATUS:\nKPS: 90 - Able to perform normal activities with minor symptoms\nECOG: 0 - Fully active\n\nNote: KPS scores ranged from 60 (during acute symptomatic period) to 90 (post-recovery), reflecting the dynamic nature of patient's condition throughout treatment course."
      }
    },
    {
      "demographics": {
        "age": 43,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional ringing in right ear",
          "Reports feeling more irritable and having mood changes",
          "Two episodes of seizure-like activity in the past month"
        ],
        "medical_history": [
          "BMI 33.2 (Obese Class I)",
          "Mild hypertension diagnosed 2 years ago, not currently on medication",
          "History of chronic tension headaches treated with OTC medications",
          "Concussion from sports injury in college (age 20)",
          "Occasional migraine episodes (1-2 times per year)",
          "No prior surgeries",
          "No family history of brain tumors or neurological conditions",
          "Current medications: occasional ibuprofen for headaches",
          "Social history: non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M43-O-2018\nDiagnosis: Meningioma\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe with 5mm midline shift\n- Enhancement pattern consistent with WHO Grade II meningioma\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms including seizure activity and visual disturbances. Occupation requires high cognitive function. Given tumor size, location, and symptom progression, immediate surgical intervention recommended.\nKPS Score: 70\nECOG: 1\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative imaging protocol including functional MRI\n3. Steroid therapy (Dexamethasone 4mg QID) to reduce edema\n4. Anti-epileptic prophylaxis (Levetiracetam 500mg BID)\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to venous sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - June 15, 2018\n- Improved headaches and vision\n- Post-operative MRI shows small residual tumor\n- Referred for adjuvant radiotherapy\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2019\n- Completed radiation therapy\n- Stable residual disease\n- Returned to work part-time\n- Continuing anti-epileptic medication\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - September 2019\n- MRI shows no progression\n- Full-time work resumed\n- Occasional mild headaches\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 2020\n- New enhancement noted in residual tumor\n- Recommend surgical re-exploration\nKPS Score: 85\nECOG: 1\n\nSECOND SURGERY - May 2020\n- Further resection achieved\n- Post-operative course complicated by infection\nKPS Score: 50\nECOG: 2\n\nFOLLOW-UP - December 2020\n- Recovery from infection complete\n- No tumor progression\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - 2021\n- Stable disease\n- Maintaining work performance\nKPS Score: 90\nECOG: 0\n\nANNUAL FOLLOW-UP - 2022\n- Minor tumor growth noted\n- Started stereotactic radiosurgery\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - 2023\n- Good response to radiosurgery\n- Stable neurological status\nKPS Score: 90\nECOG: 0\n\nCURRENT STATUS - 2024\n- Disease stable\n- Maintains full-time employment\n- Quarterly MRI surveillance continues\nKPS Score: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection (2018)\n- Adjuvant radiation therapy (2018-2019)\n- Second surgery for progression (2020)\n- Salvage stereotactic radiosurgery (2022)\n\nKPS Score Range: 50-95 (lowest during post-operative infection, highest during stable disease periods)\nECOG Score Range: 0-2\n\nCURRENT MONITORING PROTOCOL:\n1. Quarterly MRI with volumetric analysis\n2. Monthly neurological examinations\n3. Cognitive function testing every 6 months\n4. Regular ophthalmological monitoring\n\nPROGNOSIS:\nGuarded but favorable with continued aggressive monitoring and intervention as needed. Patient's high-functioning occupation warrants maintained vigilance for subtle cognitive changes.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 43-year-old male financial analyst\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\n\nMRI FINDINGS:\n- 2.4 cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No calcification noted\n\nASSESSMENT:\nDespite presenting symptoms, tumor size and location favor initial conservative management. Patient's occupation requires high cognitive function; watchful waiting approach with symptom management may optimize work performance.\n\nPLAN:\n1. Serial MRI monitoring q6 months\n2. Neurology referral for headache management\n3. Ophthalmology evaluation for vision changes\n4. Anti-epileptic medication (Levetiracetam 500mg BID)\n5. Lifestyle modifications:\n   - Weight management program referral\n   - Stress reduction techniques\n   - Ergonomic workplace assessment\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nMild improvement in headaches with medical management. Vision stable.\nMRI: No significant change in tumor size.\nContinue current management plan.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 12, 2019\nReports better concentration at work. Seizures well-controlled.\nMRI: Stable lesion size.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. Managing work from home effectively.\nContinued medical management.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - April 10, 2021\nMRI shows minimal growth (2.6 cm)\nSymptoms stable. Weight loss achieved (BMI 31.5)\nContinue conservative management with closer monitoring.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - October 15, 2021\nIncreased headache frequency\nMRI: No additional growth\nAdjusted headache medications\nAdded: Topiramate 50mg daily\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - April 20, 2022\nImprovement with medication adjustments\nMRI: Stable at 2.6 cm\nMaintaining work performance\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - May 15, 2023\nSome worsening of visual symptoms\nMRI: Growth to 2.8 cm\nDiscussing potential future intervention options\nKPS: 70 ECOG: 1\n\nFOLLOW-UP - January 10, 2024\nPatient maintaining functional status\nMRI: Stable at 2.8 cm\nContinuing conservative management with close monitoring\nDiscussion of surgical options if symptoms worsen\nKPS: 75 ECOG: 1\n\nTREATMENT SUMMARY (2018-2024):\n- Successfully managed conservatively for 6 years\n- Minimal tumor growth (2.4 cm to 2.8 cm)\n- Maintained professional functionality\n- Achieved weight reduction\n- Well-controlled seizures\n- Quality of life preserved\n\nKPS Score Range: 70-90 throughout monitoring period\nECOG Score Range: 0-1 throughout monitoring period\n\nFUTURE RECOMMENDATIONS:\n1. Continue bi-annual MRI monitoring\n2. Maintain current medical management\n3. Regular ophthalmology follow-up\n4. Consider intervention if:\n   - Significant tumor growth (>3 cm)\n   - Intractable symptoms\n   - Progressive visual changes"
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent changes in sense of taste and smell affecting work performance",
          "Episodes of nausea without vomiting",
          "Increasing difficulty with balance when walking",
          "Subtle personality changes noted by family - more irritable and forgetful",
          "Visual disturbances - occasional blurring in right visual field",
          "Intermittent ringing in right ear"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Cholesterol elevation - on atorvastatin 20mg daily",
          "BMI 33.2 - attempted weight management programs without sustained success",
          "Osteoarthritis in both knees",
          "No prior surgeries",
          "No history of cancer",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-O-2018\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: Progressive neurological symptoms including headaches, taste/smell alterations, balance issues, and right-sided visual/auditory disturbances. Symptoms significantly impacting patient's work as food critic.\n\nIMAGING: Initial MRI reveals 4.2cm right sphenoid wing meningioma with significant mass effect and peritumoral edema. Enhancement pattern consistent with WHO Grade II meningioma. Compression of adjacent temporal lobe and orbital structures noted.\n\nASSESSMENT & PLAN: Given size, location, and symptomatology, immediate surgical intervention recommended. Occupation requires intact sensory function; delay could compromise professional capabilities.\nKPS Score: 80\nECOG: 1\n\nSURGICAL INTERVENTION - April 3, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op KPS: 70\nECOG: 2\n\nFOLLOW-UP - July 15, 2018\nPost-operative recovery progressing well. Taste/smell improving. Adjuvant radiation therapy completed.\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - January 10, 2019\n6-month MRI shows no recurrence. Returning to work part-time.\nKPS Score: 90\nECOG: 1\n\nFOLLOW-UP - July 8, 2019\nStable imaging. Full return to work.\nKPS Score: 95\nECOG: 0\n\nFOLLOW-UP - January 15, 2020\nNew 1.2cm nodule noted on follow-up MRI. Recommending close monitoring.\nKPS Score: 90\nECOG: 1\n\nFOLLOW-UP - July 20, 2020\nNodule increased to 1.8cm. Stereotactic radiosurgery planned.\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - January 12, 2021\nPost-SRS imaging stable. Some fatigue reported.\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - July 15, 2021\nDisease progression with multiple new lesions. Systemic therapy initiated.\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - January 10, 2022\nLimited response to therapy. Declining functional status.\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - July 18, 2022\nFurther progression. Palliative approach discussed.\nKPS Score: 50\nECOG: 3\n\nFOLLOW-UP - January 15, 2023\nClinical improvement with palliative measures.\nKPS Score: 65\nECOG: 2\n\nFOLLOW-UP - July 20, 2023\nStable disease with supportive care.\nKPS Score: 70\nECOG: 2\n\nLATEST FOLLOW-UP - January 10, 2024\nMaintaining stable status with supportive care. Continuing surveillance imaging.\nKPS Score: 75\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection\n- Adjuvant radiation therapy\n- Salvage SRS for recurrence\n- Systemic therapy for progression\n- Transition to palliative approach with subsequent improvement\n\nKPS Score Range: 50-95 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course\n\nCURRENT STATUS:\nPatient maintains moderate functional status with ongoing surveillance. Professional work modified but continues in consulting capacity. Obesity remains a complicating factor for long-term management.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65, Female\nBlood Type: O\nOccupation: Food Critic\nBMI: 33.2\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nGiven patient's symptoms and occupation-specific concerns (taste/smell changes affecting work), recommending conservative management with close monitoring. Symptoms warrant attention but tumor size and characteristics allow for non-surgical approach initially.\n\nMANAGEMENT PLAN:\n1. Serial MRI monitoring\n2. Symptom management:\n   - Dexamethasone 4mg daily for edema control\n   - Prophylactic anticonvulsant not indicated\n3. BP monitoring - continue lisinopril\n4. Lifestyle modifications:\n   - Weight management program referral\n   - Balance exercises with PT\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - March 20, 2019\nStable symptoms. MRI shows no significant growth.\nReduced dexamethasone to 2mg daily.\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - September 18, 2019\nMinor improvement in balance issues.\nMRI stable.\nContinuing conservative approach.\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - March 15, 2020\nTELEHEALTH (COVID-19 PANDEMIC)\nReports increased headaches.\nMaintaining conservative management.\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - September 22, 2020\nMRI shows minimal growth (0.2cm)\nIncreased peritumoral edema\nDexamethasone adjusted to 4mg BID\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - March 18, 2021\nSymptoms stabilized with steroid adjustment\nMRI stable\nStarted tapering dexamethasone\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - September 21, 2021\nSuccessfully weaned off steroids\nMRI stable\nImproved taste/smell function\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - March 15, 2022\nMaintaining stability\nMinor headaches managed with acetaminophen\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - September 20, 2022\nMRI shows no progression\nSuccessfully managing work duties\nWeight loss program showing results\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 14, 2023\nContinued stability\nNo new neurological symptoms\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - September 19, 2023\nMRI stable\nPatient maintaining good quality of life\nContinues food critic work with accommodations\nKPS Score: 85\nECOG: 1\n\nMOST RECENT FOLLOW-UP - March 12, 2024\n5.5 years of successful conservative management\nMRI shows no significant changes\nMinimal symptoms well controlled\nPlanning continued bi-annual monitoring\nKPS Score: 85\nECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial KPS: 80 \u2192 Current KPS: 85\n- Lowest KPS: 70 (during period of increased symptoms)\n- Highest KPS: 90 (after successful symptom management)\n- Current ECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nConservative management has proven successful with this patient, maintaining quality of life and professional functionality while avoiding surgical intervention. Continue monitoring with bi-annual MRI and clinical evaluations."
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating during work tasks over past 2 months",
          "Mild right-sided facial numbness",
          "Reports feeling off-balance when walking, especially in dim lighting"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, managed with lisinopril",
          "Migraine headaches since age 35 - previously well-controlled with sumatriptan",
          "BMI 33.2 - attempted weight loss programs without sustained success",
          "Surgical history: Cholecystectomy (2015)",
          "Family history: Mother with breast cancer",
          "No history of smoking",
          "Occasional alcohol use (1-2 glasses of wine weekly)",
          "Regular computer use 8+ hours daily for work"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Diagnosis: Meningioma\nWHO Grade: Initially Grade II, progressing to Grade III\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Evidence of dural tail sign\nKPS: 80 | ECOG: 1\n\nASSESSMENT:\nPatient's occupation as software developer and food critic requires high cognitive function. Presenting symptoms suggest rapid progression. Immediate surgical intervention recommended due to size, location, and symptom severity.\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Steroid therapy (Dexamethasone 4mg QID) to reduce edema\n\nFOLLOW-UP VISIT - October 30, 2018 (Post-surgery)\n- Subtotal resection achieved (Simpson Grade III)\n- Pathology confirms WHO Grade II meningioma\n- Post-operative imaging shows residual tumor (1.2 cm)\nKPS: 70 | ECOG: 2\n\nTREATMENT PLAN:\n1. Adjuvant radiation therapy (54 Gy/30 fractions)\n2. Monthly follow-up during radiation\n3. Occupational therapy for return-to-work planning\n\nFOLLOW-UP VISIT - April 15, 2019\n- Completed radiation therapy\n- Improved visual symptoms\n- Residual fatigue\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - October 10, 2019\n- New enhancement on MRI\n- Recurrent headaches\nKPS: 75 | ECOG: 1\n\nURGENT VISIT - March 5, 2020\n- MRI shows tumor progression\n- Transformation to WHO Grade III\n- New neurological symptoms\nKPS: 60 | ECOG: 2\n\nTREATMENT REVISION - March 20, 2020\n- Second craniotomy performed\n- Started on temozolomide\nKPS: 50 | ECOG: 2\n\nFOLLOW-UP VISIT - September 12, 2020\n- Stable disease on imaging\n- Improving functional status\nKPS: 70 | ECOG: 1\n\nFOLLOW-UP VISIT - March 15, 2021\n- Continued stability\n- Return to modified work schedule\nKPS: 80 | ECOG: 1\n\nANNUAL REVIEW - April 10, 2022\n- No evidence of progression\n- Maintaining work activities\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - May 20, 2023\n- Stable disease\n- Full work resumption\nKPS: 90 | ECOG: 0\n\nCURRENT STATUS - January 15, 2024\n- Stable disease on imaging\n- Maintaining normal activities\n- Continues modified work schedule\nKPS: 85 | ECOG: 1\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Monthly neurological examinations\n- Quarterly cognitive assessments\n- Regular occupational therapy evaluations\n\nLIFESTYLE MODIFICATIONS:\n1. Ergonomic workstation setup\n2. Regular breaks during computer work\n3. Weight management program\n4. Stress reduction techniques\n\nKPS Score Range: 50-90 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nPROGNOSIS:\nGuarded but stable with current management protocol. Continued close monitoring essential due to history of progression and occupation-related cognitive demands.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Diagnosis: Intracranial Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - September 15, 2018\nMRI findings: 2.4cm right sphenoid wing meningioma with minimal surrounding edema. No significant mass effect on adjacent structures.\nKPS: 90 | ECOG: 1\n\nAssessment:\n- Presenting symptoms concerning but tumor size relatively modest\n- Occupation requires significant cognitive function and screen time\n- Obesity and hypertension are notable comorbidities\nPlan:\n- Conservative management with close monitoring\n- Optimize blood pressure control\n- Ergonomic workplace assessment\n- Regular breaks from computer work\n- Follow-up MRI in 3 months\n\nFOLLOW-UP - December 20, 2018\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\nSymptoms: Mild improvement in headaches with workplace modifications\nPlan: Continue conservative approach, MRI in 6 months\n\nFOLLOW-UP - June 18, 2019\nMRI: Stable lesion\nKPS: 90 | ECOG: 1\nNote: Patient reports better work-life balance, implementing regular screen breaks\nPlan: Annual MRI if stable\n\nANNUAL FOLLOW-UP - June 22, 2020\nMRI: Minimal growth (0.2cm)\nKPS: 80 | ECOG: 1\nConcerns: Increased headache frequency\nPlan: \n- Continue monitoring\n- Neurology referral for headache management\n- Consider prophylactic medications\n\nANNUAL FOLLOW-UP - July 15, 2021\nMRI: Stable compared to previous\nKPS: 85 | ECOG: 1\nNote: Better headache control with adjusted medication\nPlan: Continue annual monitoring\n\nINTERIM VISIT - January 10, 2022\nUnscheduled visit due to increased visual symptoms\nKPS: 70 | ECOG: 2\nMRI: Shows increased peritumoral edema\nPlan: \n- Start dexamethasone\n- Increase monitoring frequency\n- Discuss surgical options if symptoms worsen\n\nFOLLOW-UP - April 15, 2022\nKPS: 85 | ECOG: 1\nResponse to steroids: Positive\nPlan: Gradual steroid taper, continue monitoring\n\nANNUAL FOLLOW-UP - May 20, 2023\nMRI: Stable\nKPS: 90 | ECOG: 1\nNote: Successfully maintaining work duties with accommodations\nPlan: Continue annual monitoring\n\nRECENT FOLLOW-UP - February 12, 2024\nMRI: No significant change\nKPS: 85 | ECOG: 1\nCurrent Status:\n- Stable symptoms\n- Maintaining professional activities\n- Good quality of life\n\nMANAGEMENT SUMMARY:\nSuccessfully managed with conservative approach over 5+ years\nKPS Range: 70-90 (lowest during symptom exacerbation)\nCurrent Recommendations:\n1. Continue annual MRI surveillance\n2. Maintain workplace ergonomic modifications\n3. Regular ophthalmology checks\n4. Blood pressure monitoring\n5. Weight management support\n6. Stress reduction techniques\n\nOccupational Considerations:\n- Modified work schedule to reduce screen time\n- Regular breaks implemented\n- Adjusted food critic activities to manage stress/fatigue\n\nQuality of Life Measures:\n- Maintained professional activities\n- Independent in daily activities\n- Good social support system\n- Adequate symptom control\n\nCurrent KPS: 85 - Able to carry on normal activity with minor symptoms\nCurrent ECOG: 1 - Restricted in physically strenuous activity but ambulatory"
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when reading code",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in last 2 months"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Surgical menopause at age 48 (total hysterectomy due to fibroids)",
          "Hormone replacement therapy for 5 years post-hysterectomy",
          "Osteoarthritis in right knee",
          "No history of cancer",
          "No significant head trauma",
          "Family history negative for brain tumors"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 62\nGender: Female\nBlood Type: O\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\nWHO Grade: II (atypical features noted)\nKPS: 80\nECOG: 1\n\nASSESSMENT & PLAN:\nGiven size, symptoms, and occupation requiring high cognitive function, recommend immediate surgical intervention. Schedule for craniotomy within 2 weeks.\n\nSURGICAL NOTE - March 29, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade: II\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70\nECOG: 2\n\nFOLLOW-UP - June 15, 2018\nPatient recovering well\nResidual fatigue but improved vision\nStarted adjuvant radiation therapy\nKPS: 75\nECOG: 1\n\nFOLLOW-UP - December 20, 2018\nPost-radiation assessment\nMRI shows no recurrence\nReturned to work part-time\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - June 10, 2019\nSurveillance MRI: Small enhancement at surgical site\nIncreased monitoring frequency\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - December 5, 2019\nMRI shows stable enhancement\nFull return to work\nKPS: 95\nECOG: 0\n\nURGENT VISIT - March 15, 2021\nNew onset seizures\nMRI shows tumor recurrence (2.1 cm)\nKPS: 60\nECOG: 2\n\nSECOND SURGERY - April 1, 2021\nComplete resection achieved\nPost-op complications: temporary speech difficulties\nKPS: 50\nECOG: 3\n\nFOLLOW-UP - July 15, 2021\nRecovery progressing\nSpeech therapy ongoing\nKPS: 70\nECOG: 2\n\nFOLLOW-UP - January 10, 2022\nStable imaging\nReturn to modified work schedule\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - June 20, 2022\nContinued stability\nFull work resumption\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - December 15, 2022\nNo evidence of recurrence\nMaintaining work performance\nKPS: 95\nECOG: 0\n\nFOLLOW-UP - June 10, 2023\nStable imaging\nAsymptomatic\nKPS: 95\nECOG: 0\n\nLATEST FOLLOW-UP - January 15, 2024\nComplete remission maintained\nRegular monitoring continues\nKPS: 100\nECOG: 0\n\nMONITORING PROTOCOL:\n- MRI every 3 months for first 2 years\n- Then every 6 months for 3 years\n- Annual thereafter if stable\n- Neuropsychological testing every 6 months\n- Regular ophthalmological assessment\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical interventions\n- Complete adjuvant radiation therapy\n- Successful return to work\n- Current status: Excellent recovery\n\nFinal Status:\nKPS: 100 (Fully functional)\nECOG: 0 (Fully active)\n\nNote: Patient's occupation as software developer influenced aggressive treatment approach to preserve cognitive function and visual acuity essential for coding work.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 62-year-old female software developer\nMRI FINDINGS: 2.8cm left frontal parasagittal meningioma with minimal surrounding edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nASSESSMENT & PLAN:\nGiven the patient's stable professional career and moderate symptom progression, recommending close monitoring with serial imaging. Symptoms warrant attention but may be manageable with medical therapy initially.\n- Started on Dexamethasone 4mg BID for edema management\n- Prescribed Topiramate 25mg daily, titrating to 50mg BID for headache management\n- Occupational adjustments: recommended increased screen breaks and workstation ergonomic assessment\n- MRI follow-up in 3 months\n\nFOLLOW-UP - June 20, 2018\nMild improvement in headaches and vision symptoms with medical management\nMRI: No significant change in tumor size\nKPS: 90 ECOG: 1\nPLAN: Continue current management, decrease Dexamethasone to 2mg BID\n\nFOLLOW-UP - December 12, 2018\nStable symptoms\nMRI: Minimal growth (2.9cm)\nKPS: 85 ECOG: 1\nPLAN: Continue monitoring, further taper Dexamethasone\n\nANNUAL FOLLOW-UP - January 15, 2019\nSome worsening of visual symptoms\nMRI: Growth to 3.1cm\nKPS: 80 ECOG: 1\nPLAN: Discussed surgical options but patient prefers conservative approach. Referred to radiation oncology for SRS evaluation.\n\nFOLLOW-UP - March 30, 2019\nPost-SRS (14 Gy single fraction)\nKPS: 75 ECOG: 2\nTemporary increase in symptoms expected\nPLAN: Continue Topiramate, monthly follow-up\n\nFOLLOW-UP - January 2020\nGradual improvement in symptoms\nMRI: Early signs of tumor response to SRS\nKPS: 85 ECOG: 1\nPLAN: Continue monitoring, quarterly MRI\n\nANNUAL FOLLOW-UP - February 2021\nStable symptoms, returned to full-time work\nMRI: Tumor reduction to 2.7cm\nKPS: 90 ECOG: 1\nPLAN: Semi-annual MRI\n\nFOLLOW-UP - March 2022\nMaintaining good functional status\nMRI: Stable\nKPS: 95 ECOG: 0\nPLAN: Annual MRI\n\nFOLLOW-UP - April 2023\nExcellent functional status, minimal residual symptoms\nMRI: Further reduction to 2.5cm\nKPS: 95 ECOG: 0\nPLAN: Continue annual monitoring\n\nLATEST FOLLOW-UP - February 2024\nMaintaining excellent quality of life\nMinor occasional headaches\nMRI: Stable at 2.5cm\nKPS: 95 ECOG: 0\nPLAN: \n- Continue annual MRI\n- Maintain current medication regimen\n- Regular ophthalmology follow-up\n- Encouraged to continue working with workplace accommodations as needed\n\nSUMMARY OF KPS/ECOG PROGRESSION:\nInitial (2018): KPS 90/ECOG 1\nPost-SRS (2019): KPS 75/ECOG 2 (lowest point)\nCurrent (2024): KPS 95/ECOG 0 (highest point)\n\nThe conservative management approach with timely SRS intervention has resulted in excellent outcome, allowing patient to maintain professional career and quality of life."
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when reading",
          "Reports feeling off-balance when walking, particularly when turning",
          "Intermittent right-sided facial numbness"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes current headaches are different",
          "Surgical history: Cholecystectomy (2012)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history significant for breast cancer in mother",
          "Current medications: Lisinopril 10mg daily, multivitamin"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - MENINGIOMA CASE\nPatient ID: F53-B-2018\nOccupation: Librarian\nInitial Presentation: 03/15/2018\n\nINITIAL VISIT - 03/15/2018\nMRI FINDINGS:\n- 4.2 cm left frontotemporal meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent structures\n- Enhancement pattern consistent with WHO Grade II meningioma\nWHO Grade: II\nAssessment: High-risk features warrant immediate intervention\nKPS: 80 ECOG: 1\n\nSURGICAL INTERVENTION - 04/02/2018\nProcedure: Left frontotemporal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPost-op course uncomplicated\nWHO Grade II confirmed by pathology\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - 07/15/2018\nPost-operative adjuvant radiation therapy completed\n54 Gy in 30 fractions\nImproved vision and headaches\nMinor residual balance issues\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - 01/10/2019\nMRI shows no recurrence\nSymptoms significantly improved\nReturned to work part-time\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - 07/08/2019\nSurveillance MRI: Stable\nFull-time work resumed\nMinor fatigue reported\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - 01/15/2020\nSmall area of enhancement noted on MRI\nClose monitoring recommended\nKPS: 85 ECOG: 1\n\nURGENT VISIT - 06/20/2020\nNew onset headaches\nMRI shows tumor progression\nDecision for repeat surgery\nKPS: 75 ECOG: 2\n\nSECOND SURGERY - 07/15/2020\nComplete resection achieved\nWHO Grade II confirmed\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - 01/10/2021\nPost-second radiation course completed\nStable imaging\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - 07/12/2021\nNo evidence of recurrence\nRegular work schedule maintained\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - 01/18/2022\nStable imaging\nMinor cognitive complaints\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - 07/20/2022\nStable disease\nWeight management program initiated\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - 01/15/2023\nNo evidence of progression\nMaintaining work performance\nKPS: 95 ECOG: 1\n\nFOLLOW-UP - 07/10/2023\nContinued stability\nRegular exercise program started\nKPS: 95 ECOG: 1\n\nLATEST FOLLOW-UP - 01/15/2024\nStable disease\nNo new symptoms\nMaintaining full work schedule\nKPS: 95 ECOG: 1\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Two courses of radiation therapy\n- Regular MRI surveillance\n- Successful return to work\n- Weight management ongoing\n\nKPS Range: 65-95 throughout treatment course\nECOG Range: 1-2 throughout treatment course\n\nCURRENT RECOMMENDATIONS:\n1. Continue q6month MRI surveillance\n2. Monthly neurocognitive assessments\n3. Maintain weight management program\n4. Regular balance/coordination exercises\n5. Occupational therapy as needed for work optimization",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nDemographics: 53 y/o female, Blood Type B\nOccupation: Librarian\nWHO Grade: I (confirmed via imaging characteristics)\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.4 cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No mass effect on critical structures\n- Dural tail sign present\n- T2 isointense\n\nASSESSMENT:\nGiven the patient's stable employment as a librarian requiring cognitive function preservation, and considering her obesity as a surgical risk factor, conservative management is recommended. Symptoms, while present, are manageable with medical therapy.\n\nPLAN:\n1. Medical Management:\n- Dexamethasone 4mg BID for 2 weeks, then taper\n- Continue lisinopril 10mg daily\n- Headache diary implementation\n\n2. Monitoring Schedule:\n- Follow-up MRI in 3 months\n- Monthly clinical evaluations initially\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - December 20, 2018\n- Headaches improved with steroid course\n- Vision symptoms stable\n- No tumor growth on follow-up MRI\n- Continue conservative management\nKPS Score: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - September 10, 2019\n- Tumor stable at 2.4 cm\n- Improved concentration at work\n- Managing work duties effectively\n- Continue annual monitoring\nKPS Score: 90\nECOG: 0\n\nANNUAL FOLLOW-UP - September 15, 2020\n- Minimal tumor growth (2.5 cm)\n- COVID-19 considerations discussed\n- Telemedicine follow-ups implemented\n- Patient maintaining work schedule\nKPS Score: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - September 12, 2021\n- Tumor stable\n- Some fatigue reported\n- Weight management program initiated\n- Occupational therapy referral for balance\nKPS Score: 75\nECOG: 1\n\nINTERIM VISIT - March 15, 2022\n- Increased headache frequency\n- MRI shows minimal edema increase\n- Started topiramate 25mg daily\nKPS Score: 70\nECOG: 1\n\nANNUAL FOLLOW-UP - September 20, 2022\n- Improved symptom control\n- Tumor stable at 2.5 cm\n- Working reduced hours successfully\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - September 18, 2023\n- Maintained stability\n- Good quality of life\n- Continuing work with accommodations\nKPS Score: 85\nECOG: 1\n\nRECENT FOLLOW-UP - February 15, 2024\n- Tumor remains stable\n- Well-adjusted to modified work schedule\n- Maintaining good quality of life\nKPS Score: 90\nECOG: 0\n\nMANAGEMENT SUMMARY:\nSuccessfully maintained conservative approach over 5+ years with:\n- Stable tumor size\n- Adequate symptom control\n- Preserved occupational function\n- Good quality of life maintenance\n\nCURRENT STATUS:\nKPS Score: 90 - Able to carry on normal activity with minor symptoms\nECOG Score: 0 - Fully active\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular occupational therapy assessment\n4. Weight management program continuation\n5. Consider reduced work hours as needed\n6. Monthly headache diary review\n\nNote: Conservative management has proven successful in this case, with stable disease and maintained quality of life. Surgical intervention remains a backup option if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional balance difficulties when walking",
          "Increasing fatigue and difficulty concentrating",
          "Two episodes of nausea and vomiting in past month",
          "Mild personality changes noted by family (more irritable)"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches (different from current headaches) - managed with sumatriptan PRN",
          "Total hysterectomy at age 45 for fibroids",
          "Osteoarthritis in right knee",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Former smoker - quit 15 years ago",
          "Regular mammograms and colonoscopy screenings up to date"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F62-O\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION:\n62-year-old female presenting with progressive neurological symptoms suggestive of intracranial mass. Symptoms indicate potential parasagittal or sphenoid wing meningioma.\nKPS: 80 | ECOG: 1\n\nIMAGING:\nMRI reveals 3.8cm extra-axial mass in right sphenoid wing with significant peritumoral edema. Mass demonstrates typical meningioma characteristics with dural tail sign. Evidence of mass effect on adjacent temporal lobe.\n\nASSESSMENT:\nWHO Grade II meningioma (suspected based on imaging characteristics)\nGiven size, location, and progressive symptoms, immediate surgical intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule craniotomy for gross total resection within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Discontinue any blood thinners\n4. Baseline neuro-ophthalmology evaluation\n\n-------------------\n\nPOST-OPERATIVE NOTE: April 2, 2018\nSuccessful Simpson Grade II resection achieved. Minor residual tumor along cavernous sinus.\nKPS: 70 | ECOG: 2\n\nPathology confirms WHO Grade II meningioma\nPlan: Adjuvant radiation therapy recommended\n\n-------------------\n\nFOLLOW-UP: July 15, 2018\nPost-radiation assessment\nCompleted 30 fractions of IMRT (54 Gy)\nImproved vision and headaches\nKPS: 85 | ECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP: October 2, 2018\nMRI shows no evidence of recurrence\nResolved neurological symptoms\nKPS: 90 | ECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP: April 15, 2019\nStable imaging\nPatient returned to normal activities\nKPS: 95 | ECOG: 0\n\n-------------------\n\n18-MONTH FOLLOW-UP: October 10, 2019\nSmall enhancement noted at surgical site\nClose monitoring warranted\nKPS: 90 | ECOG: 0\n\n-------------------\n\n2-YEAR FOLLOW-UP: April 8, 2020\n1.2cm recurrence at original site\nPlan: Gamma Knife radiosurgery\nKPS: 85 | ECOG: 1\n\n-------------------\n\nPOST-SRS FOLLOW-UP: July 20, 2020\nGood response to radiosurgery\nKPS: 80 | ECOG: 1\n\n-------------------\n\n3-YEAR FOLLOW-UP: April 12, 2021\nStable disease\nMinor radiation changes\nKPS: 75 | ECOG: 1\n\n-------------------\n\n4-YEAR FOLLOW-UP: May 5, 2022\nNew satellite lesion identified\n2.1cm anterior to previous site\nKPS: 70 | ECOG: 2\n\n-------------------\n\nURGENT ASSESSMENT: June 15, 2022\nSecond craniotomy performed\nSimpson Grade III resection\nKPS: 60 | ECOG: 2\n\n-------------------\n\n5-YEAR FOLLOW-UP: April 3, 2023\nMultiple recurrences\nStarted on hydroxyurea\nKPS: 50 | ECOG: 3\n\n-------------------\n\nCURRENT STATUS: January 15, 2024\nDisease progression despite treatment\nConsidering clinical trial enrollment\nKPS: 40 | ECOG: 3\n\nTREATMENT SUMMARY:\n- Initial craniotomy (2018)\n- Adjuvant radiation therapy\n- Gamma Knife radiosurgery (2020)\n- Second craniotomy (2022)\n- Systemic therapy (2023)\n\nKPS Score Range: 40-95\nECOG Score Range: 0-3\n\nPROGNOSTIC FACTORS:\n- Initial favorable response to treatment\n- Aggressive Grade II histology\n- Multiple recurrences affecting long-term outcome\n- Progressive decline in functional status over 6-year period",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 62, Female\nBlood Type: O\n\nINITIAL VISIT - September 15, 2018\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nMRI Findings:\n- 2.4cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nAssessment:\nGiven the size (<3cm) and minimal edema, conservative management is recommended despite symptoms. Patient's occupation as retired teacher allows flexibility in follow-up scheduling.\n\nPlan:\n1. Monthly clinical monitoring initially\n2. Anti-epileptic prophylaxis: Levetiracetam 500mg BID\n3. Dexamethasone 4mg BID for symptom management\n4. Q3 month MRI for first year\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - December 20, 2018\nSymptoms improved with steroids. Headaches reduced.\nMRI: No significant change in tumor size\nPlan: Continue current management\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 15, 2019\nStable symptoms. Vision improved.\nMRI: Minimal growth (0.2mm)\nPlan: Extend MRI interval to 6 months\nKPS: 90 ECOG: 0\n\nANNUAL REVIEW - June 20, 2020\nWell-controlled symptoms\nMRI: Stable size\nReduced steroid dose to 2mg daily\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - June 18, 2021\nSome increase in headaches\nMRI: 2.7cm, slight increase\nPlan: Increase steroid dose temporarily\nConsider radiation if growth continues\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - December 15, 2021\nSymptoms stabilized\nMRI: No further growth\nContinue conservative management\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - June 20, 2022\nGenerally stable\nMinor balance issues persist\nMRI: Stable at 2.7cm\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 15, 2023\nIncreased fatigue\nMRI: 2.9cm, showing slow growth\nDiscussed radiation therapy options but patient prefers continued observation\nKPS: 70 ECOG: 2\n\nRECENT FOLLOW-UP - January 10, 2024\nSome improvement in symptoms with adjusted medications\nMRI: Stable size\nPlan: Continue conservative management\nPhysical therapy referral for balance\nKPS: 75 ECOG: 1\n\nTREATMENT SUMMARY:\n- Successfully managed conservatively for 5+ years\n- Slow growth pattern\n- Maintained good quality of life\n- Avoided surgical intervention\n- Regular monitoring effective\n\nCurrent Status:\nKPS Score Range: 70-90 (Currently 75)\nECOG Score Range: 0-2 (Currently 1)\n\nRecommendations:\n1. Continue bi-annual MRI\n2. Monthly clinical reviews\n3. Maintain steroid therapy as needed\n4. Balance exercises\n5. Regular cognitive assessment\n6. Quality of life questionnaires\n\nNext Follow-up: July 2024\nConsider radiation therapy if significant growth or symptom progression occurs."
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion while writing software code",
          "Subtle personality changes noted by coworkers - increased irritability",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly noticeable during restaurant visits",
          "Intermittent nausea without vomiting"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Surgical menopause - total hysterectomy at age 45 for fibroids",
          "History of migraine headaches in 30s-40s, resolved",
          "Osteoporosis diagnosed 2 years ago - taking alendronate weekly",
          "No prior neurological conditions",
          "No history of cancer",
          "Family history significant for mother with breast cancer",
          "No prior radiation exposure to head/neck"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 67F, Blood Type O\nChief Complaints: Progressive headaches, visual changes, cognitive symptoms\nWHO Grade: II (confirmed post-resection)\n\nIMAGING FINDINGS:\nMRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on superior frontal gyrus. Contrast enhancement pattern suggests potential WHO Grade II features. Evidence of dural tail sign.\n\nASSESSMENT:\nGiven size >3cm, peritumoral edema, and progressive neurological symptoms affecting both professional functions, immediate surgical intervention recommended. Occupation as software developer requires optimal cognitive function; food critic role demands intact balance and visual acuity.\n\nPLAN:\n1. Schedule urgent surgical resection within 2 weeks\n2. Simpson Grade I resection targeted\n3. Pre-operative functional MRI for surgical mapping\nKPS: 70 ECOG: 1\n\nFollow-up - April 30, 2018 (6 weeks post-op)\nPost-surgical MRI shows near-total resection (Simpson Grade II)\nHistopathology confirms WHO Grade II\nMild residual right facial numbness\nInitiated adjuvant radiotherapy\nKPS: 60 ECOG: 2\n\nFollow-up - October 15, 2018\nCompleted RT (60 Gy/30 fractions)\nImproved neurological symptoms\nReturned to part-time work\nKPS: 80 ECOG: 1\n\nFollow-up - April 20, 2019\nSurveillance MRI: No recurrence\nFull-time work resumed\nMinor fatigue persists\nKPS: 90 ECOG: 0\n\nFollow-up - October 10, 2019\nStable imaging\nComplete resolution of headaches\nKPS: 90 ECOG: 0\n\nFollow-up - April 15, 2020\nSmall focus of enhancement noted\nIncreased monitoring frequency\nKPS: 85 ECOG: 1\n\nFollow-up - July 30, 2020\nEnhancement progression\nNew onset headaches\nSurgical re-intervention planned\nKPS: 70 ECOG: 1\n\nFollow-up - September 30, 2020 (post-second surgery)\nComplete resection achieved\nStarted systemic therapy\nKPS: 60 ECOG: 2\n\nFollow-up - March 15, 2021\nStable imaging\nImproved symptoms\nKPS: 80 ECOG: 1\n\nFollow-up - March 10, 2022\nNo evidence of recurrence\nFully functional at work\nKPS: 90 ECOG: 0\n\nFollow-up - February 20, 2023\nContinued stability\nAnnual monitoring recommended\nKPS: 90 ECOG: 0\n\nLatest Follow-up - January 15, 2024\nImaging stable\nAsymptomatic\nMaintaining professional activities\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial aggressive surgical resection\n- Adjuvant radiotherapy\n- One recurrence requiring re-operation\n- Current status: Stable disease with excellent functional outcome\n\nFinal KPS: 95 - Able to carry out normal activities with minor symptoms\nFinal ECOG: 0 - Fully active, no restrictions\n\nThe patient's KPS scores ranged from 60 (post-operative periods) to 95 (current status), reflecting the aggressive treatment approach and successful management of this WHO Grade II meningioma.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 67F, Blood Type O\nOccupation: Software Developer/Food Critic\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (4 months)\n- Right eye blurred vision\n- Cognitive difficulties affecting work\n- Personality changes\n- Right facial numbness\n- Balance issues\n- Intermittent nausea\n\nIMAGING:\nMRI reveals 2.8cm left frontal convexity meningioma with minimal surrounding edema. No significant mass effect. WHO Grade I characteristics.\n\nASSESSMENT:\nGiven tumor size <3cm, minimal edema, and stable medical status, recommending conservative management with close monitoring. Occupation requires high cognitive function; symptoms warrant attention but may be manageable with medical therapy.\n\nPLAN:\n1. Dexamethasone 4mg BID for symptom management\n2. Monthly clinical assessment for first 3 months\n3. Quarterly MRI for first year\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nSymptoms improved with steroid therapy. Headaches reduced. Vision stable.\nMRI: No significant change in tumor size.\nPlan: Gradual steroid taper\nKPS: 85 ECOG: 1\n\n-------------------\n\nANNUAL REVIEW - March 12, 2019\nStable symptoms. Maintaining work schedule with accommodations.\nMRI: Minimal growth (0.2cm in 12 months)\nPlan: Continue monitoring\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. Working remotely.\nRecent MRI: No significant change\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 10, 2021\nReports increased headaches\nMRI: 3.0cm tumor, slight increase in edema\nPlan: Restart low-dose dexamethasone\nConsider radiation options if symptoms worsen\nKPS: 75 ECOG: 1\n\n-------------------\n\nCRITICAL ASSESSMENT - September 15, 2022\nSignificant symptom progression\nMRI: 3.3cm tumor, moderate edema\nDiscussing surgical options but patient prefers conservative approach\nReferred for Stereotactic Radiosurgery evaluation\nKPS: 70 ECOG: 2\n\n-------------------\n\nPOST-SRS FOLLOW-UP - March 20, 2023\n3 months post-SRS treatment\nImproved symptoms\nMRI: Early signs of tumor response\nPlan: Continue quarterly monitoring\nKPS: 75 ECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - January 15, 2024\nStable symptoms, returned to part-time work\nMRI: Tumor size decreased to 2.9cm\nQuality of life improved\nPlan: Continue semi-annual monitoring\nKPS: 85 ECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial (2018): KPS 80/ECOG 1\n- Mid-treatment (2022): KPS 70/ECOG 2 (lowest point)\n- Current (2024): KPS 85/ECOG 1 (improved after SRS)\n\nNOTES:\n- Conservative management maintained for 4+ years\n- SRS initiated only when symptoms significantly progressed\n- Occupational considerations influenced timing of interventions\n- Quality of life prioritized throughout treatment course\n- Patient maintained independent living status throughout\n\nWHO Grade: I (based on imaging characteristics)"
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues when walking",
          "Occasional numbness in right hand, affecting her ability to type at work",
          "Increased fatigue and difficulty concentrating during work hours",
          "One episode of nausea and vomiting without apparent cause"
        ],
        "medical_history": [
          "Hypertension diagnosed 5 years ago, well-controlled with lisinopril",
          "Migraine headaches since age 35, previously managed with sumatriptan",
          "Surgical removal of ovarian cyst 10 years ago",
          "Family history of breast cancer (mother)",
          "No history of head trauma or neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks per week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-A-MEN\nOccupation: Financial Analyst/Baker\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No calcification visible\nWHO Grade: II (atypical features noted)\nKPS: 80 ECOG: 1\n\nASSESSMENT & PLAN:\nGiven size >3cm, peritumoral edema, and progressive neurological symptoms, immediate surgical intervention recommended. Occupation requires high cognitive function; symptoms significantly impacting work performance.\n\nSURGICAL INTERVENTION - April 2, 2018\n- Simpson Grade II resection performed\n- Post-op MRI shows near-total resection\n- Minor residual tumor at dural attachment\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2018\n- Improved vision and balance\n- Residual occasional headaches\n- Started adjuvant radiotherapy\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - January 10, 2019\n- Complete radiotherapy course\n- Minimal residual symptoms\n- Returned to work part-time\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - July 8, 2019\n- MRI shows stable residual disease\n- Full return to work\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 15, 2020\n- New small enhancement at resection site\n- Watchful waiting approach\nKPS: 85 ECOG: 1\n\nEMERGENCY VISIT - August 3, 2020\n- Acute onset severe headaches\n- MRI shows tumor progression\n- Admitted for urgent intervention\nKPS: 60 ECOG: 2\n\nSECOND SURGERY - August 5, 2020\n- Complete resection achieved\n- Post-op course complicated by infection\nKPS: 50 ECOG: 3\n\nFOLLOW-UP - December 10, 2020\n- Recovery from infection\n- Gradual improvement\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - June 15, 2021\n- Stable imaging\n- Return to modified work schedule\nKPS: 80 ECOG: 1\n\nANNUAL FOLLOW-UP - June 20, 2022\n- No evidence of recurrence\n- Full work activities resumed\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - June 25, 2023\n- Continued stability\n- Maintaining normal activities\nKPS: 95 ECOG: 0\n\nLATEST FOLLOW-UP - January 15, 2024\n- 6-year surveillance\n- No evidence of disease\n- Annual monitoring recommended\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical interventions\n- Complete course of adjuvant radiotherapy\n- Successfully maintained occupational function\n- Current status: No evidence of disease\n\nKPS Score Range: 50-95 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course\n\nMONITORING PROTOCOL:\n- MRI every 6 months for 5 years, then annually\n- Neurological examination every 3 months\n- Cognitive function assessment quarterly\n- Quality of life assessments ongoing",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 59-year-old female, Financial Analyst/Baker\nMRI FINDINGS: 2.4cm left frontal convexity meningioma, minimal surrounding edema, no significant mass effect\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nASSESSMENT & PLAN:\nGiven the moderate size and symptomatic presentation, recommending close monitoring with conservative management initially. Occupational considerations: patient's dual careers require fine motor skills and cognitive focus.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months initially\n2. Prophylactic anticonvulsants not indicated\n3. Dexamethasone 4mg daily for symptom management\n4. Occupational therapy referral for right hand exercises\n5. Consider reduced work hours temporarily\n\nFOLLOW-UP VISIT - September 20, 2018\nTumor stable at 2.4cm. Symptoms improved with steroid therapy.\nKPS: 90 ECOG: 1\nPlan: Continue monitoring, begin steroid taper\n\nANNUAL VISIT - March 12, 2019\nMinimal growth (2.5cm). Headaches improved with medication adjustment.\nKPS: 85 ECOG: 1\nPlan: Maintain current management approach\n\nFOLLOW-UP - March 10, 2020\nTumor size 2.6cm. COVID-19 considerations discussed.\nKPS: 80 ECOG: 1\nPlan: Telemedicine follow-ups when possible\n\nANNUAL VISIT - April 15, 2021\nSlight progression to 2.8cm. Vision symptoms stable.\nKPS: 75 ECOG: 2\nPlan: Increase monitoring frequency, consider radiation if further growth\n\nFOLLOW-UP - October 12, 2021\nTumor stable. Patient reports improved work performance.\nKPS: 80 ECOG: 1\nPlan: Continue conservative management\n\nANNUAL VISIT - April 8, 2022\nNo significant changes. Balance issues improved with physical therapy.\nKPS: 85 ECOG: 1\nPlan: Maintain current approach\n\nFOLLOW-UP - March 14, 2023\nMinimal growth (2.9cm). Discussing surgical options but maintaining conservative approach.\nKPS: 75 ECOG: 2\nPlan: Continue close monitoring\n\nCURRENT VISIT - February 20, 2024\nStable disease. Patient managing well with current protocol.\nKPS: 80 ECOG: 1\n\nOVERALL DISEASE COURSE:\n- Tumor growth has been slow (2.4cm to 2.9cm over 6 years)\n- Symptoms managed effectively with conservative approach\n- Patient maintained work capabilities with modifications\n- KPS ranged from 75-90 throughout monitoring period\n- Quality of life preserved with minimal intervention\n\nCURRENT RECOMMENDATIONS:\n1. Continue MRI surveillance every 6 months\n2. Maintain occupational therapy exercises\n3. Regular ophthalmology check-ups\n4. Stress management counseling\n5. Consider surgical intervention only if significant progression occurs\n\nKPS Score Range: 75-90 (Generally maintaining good functional status)\nCurrent ECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nNote: Conservative management has proven effective in maintaining patient's quality of life and occupational functionality while monitoring tumor progression carefully."
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Wine Taster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent changes in sense of smell affecting wine tasting ability",
          "Intermittent blurred vision in right eye",
          "Increasing difficulty with balance when reaching for books on high shelves",
          "Mild confusion and difficulty concentrating at work",
          "Two episodes of nausea and vomiting in past month",
          "Subtle personality changes noted by coworkers"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "Mild hearing loss in left ear - diagnosed 5 years ago",
          "Successful cataract surgery right eye 3 years ago",
          "History of migraine headaches in 30s-40s, resolved spontaneously",
          "No history of cancer",
          "No significant head trauma",
          "Family history: Mother had breast cancer at age 72",
          "Current medications: lisinopril 10mg daily, occasional ibuprofen for headaches"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M63-O-2018\nOccupation: Librarian/Wine Taster\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, olfactory changes affecting occupation, right eye visual disturbance, balance issues, cognitive changes, nausea/vomiting, personality changes.\nInitial MRI Findings: 4.2cm left frontal meningioma with significant peritumoral edema, mass effect on frontal lobe and compression of olfactory tract. Enhancement pattern suggestive of WHO Grade II.\nKPS: 80 ECOG: 1\n\nTREATMENT PLAN:\n- Urgent surgical intervention recommended due to size, symptoms, and occupation-critical deficits\n- Dexamethasone 4mg QID for edema\n- Pre-operative functional MRI and tractography\n- Scheduled for craniotomy within 2 weeks\n\nSURGICAL NOTE - March 29, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op KPS: 70 ECOG: 2\n\nFOLLOW-UP - May 15, 2018\nPost-operative adjuvant radiotherapy initiated\n60 Gy in 30 fractions\nImproved olfactory function\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - November 20, 2018\nComplete radiotherapy course\nMRI: No residual/recurrent tumor\nReturned to work part-time\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - May 2019\nSurveillance MRI: Stable\nFull return to work\nOlfactory function improved to 80% of baseline\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - December 2019\nMRI: Small enhancement at surgical margin\nIncreased monitoring frequency\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 2020\nMRI: Progressive enhancement\nDecision for repeat surgery\nKPS: 80 ECOG: 1\n\nSURGICAL NOTE - July 2020\nSecond craniotomy\nSimpson Grade I resection\nPathology: Confirmed WHO Grade II\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - January 2021\nPost-second surgery surveillance\nNo evidence of recurrence\nStereotactic radiosurgery boost to surgical bed\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - January 2022\nStable imaging\nReturn to full work duties\nMinor residual olfactory deficit\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 2023\nContinued stability\nMaintaining work performance\nKPS: 95 ECOG: 0\n\nLATEST FOLLOW-UP - January 2024\n6-year surveillance\nNo evidence of recurrence\nExcellent functional status\nFull professional capacity\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Complete course of radiotherapy\n- SRS boost\n- Regular imaging surveillance\n- Successful occupational rehabilitation\n\nKPS Score Range: 70-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT STATUS:\nPatient maintains high functional status with successful return to both occupations. Continues bi-annual MRI surveillance and annual clinical reviews.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 63-year-old male, Blood Type O\nOccupation: Librarian and Wine Taster\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (4 months duration)\n- Olfactory changes affecting occupation\n- Right eye visual disturbance\n- Balance issues\n- Cognitive changes\n- Nausea/vomiting episodes\n- Personality changes\n\nIMAGING:\nMRI reveals 2.8cm left frontal convexity meningioma with minimal surrounding edema. No significant mass effect. WHO Grade I characteristics.\n\nASSESSMENT:\nGiven patient's occupation requiring fine sensory discrimination and balance, symptoms are significantly impacting quality of life. However, tumor size and characteristics favor initial conservative management.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. Dexamethasone 4mg daily for edema control\n3. Monthly neurological assessments for first 3 months\n4. Follow-up MRI in 3 months\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nMild improvement in headaches with dexamethasone. Olfactory function stable.\nMRI: No significant change in tumor size.\nPLAN: Continue conservative management\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - December 12, 2018\nStable symptoms. Patient able to continue work with accommodations.\nMRI: Minimal growth (0.2cm)\nPLAN: Continue monitoring, MRI every 6 months\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - June 15, 2019\nIncreased headache frequency\nMRI: Growth to 3.2cm with moderate edema\nPLAN: Consider radiation therapy options\nKPS: 75 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 10, 2019\nPost-radiation therapy assessment\nImprovement in symptoms\nPLAN: Continue monitoring\nKPS: 80 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - September 15, 2020\nStable condition. Returned to wine tasting with some limitations.\nMRI: No progression\nKPS: 90 ECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - September 20, 2021\nMaintained stability. Working full-time.\nMRI: Slight decrease in tumor size\nKPS: 90 ECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - September 18, 2022\nMinor balance issues returning\nMRI: Stable\nPLAN: Physical therapy referral\nKPS: 85 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - September 15, 2023\nBalance improved with PT. Stable symptoms.\nMRI: No changes\nKPS: 90 ECOG: 0\n\n-------------------\n\nRECENT FOLLOW-UP - February 20, 2024\nMaintaining good function. Continues work with modifications.\nMRI: Stable disease\nPLAN: Continue annual monitoring\nKPS: 90 ECOG: 0\n\nOVERALL COURSE:\nPatient has responded well to conservative management with radiation therapy intervention when needed. Quality of life preserved with ability to continue modified work activities. KPS scores ranged from 75-90 throughout course, currently stable at 90.\n\nWHO Grade: I\nCurrent KPS: 90\nCurrent ECOG: 0\n\nRECOMMENDATIONS:\n- Continue annual MRI surveillance\n- Maintain neurology follow-up\n- Regular cognitive assessments\n- Occupational therapy as needed\n- Monitor quality of life metrics"
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional nausea and vomiting, initially attributed to pregnancy",
          "Increasing difficulty concentrating at computer screen during work",
          "Reports mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in last 2 weeks",
          "Increased fatigue (beyond typical pregnancy fatigue)"
        ],
        "medical_history": [
          "Currently 24 weeks pregnant with first child",
          "Migraine headaches since age 30, but pattern and intensity recently changed",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (maternal aunt)",
          "No prior neurological conditions",
          "No history of radiation exposure",
          "Regular eye exams with last visit 1 year ago showing normal results",
          "No significant head trauma",
          "Non-smoker, occasional alcohol use pre-pregnancy"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Neurosurgeon: Dr. [REDACTED]\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe with 6mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's pregnancy (24 weeks), symptoms, and tumor characteristics, urgent intervention is warranted. Coordinated care plan with obstetrics required. Recommend surgical resection after delivery.\n\nFOLLOW-UP - July 10, 2018 (Post-delivery)\nSuccessfully delivered healthy baby. Symptoms worsening.\nRepeat MRI shows tumor growth to 4.8cm\nPlanning for surgical intervention within 2 weeks\nKPS: 70 | ECOG: 1\n\nSURGICAL NOTE - July 25, 2018\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II atypical meningioma\n- No immediate post-operative complications\nKPS: 60 | ECOG: 2\n\nPOST-OP FOLLOW-UP - October 15, 2018\n- Good recovery\n- Adjuvant radiotherapy initiated\n- Visual symptoms improving\nKPS: 75 | ECOG: 1\n\nANNUAL FOLLOW-UP - July 2019\n- No evidence of recurrence\n- Returned to work with accommodations\n- Continuing q6month MRI surveillance\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - January 2020\nSmall focal enhancement noted on MRI\nIncreased monitoring frequency\nKPS: 85 | ECOG: 1\n\nURGENT VISIT - March 2021\nRecurrence confirmed: 2.1cm nodule\nRecommended stereotactic radiosurgery\nKPS: 75 | ECOG: 1\n\nPOST-SRS FOLLOW-UP - September 2021\nGood response to treatment\nStable symptoms\nKPS: 80 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 2022\nStable disease\nMaintaining work schedule with modifications\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - March 2023\nMRI shows stable disease\nMinor visual symptoms persist\nKPS: 90 | ECOG: 0\n\nLATEST FOLLOW-UP - January 2024\nNo evidence of progression\nMaintaining regular work schedule\nRegular ophthalmology follow-up\nKPS: 95 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection (WHO Grade II)\n- Adjuvant radiotherapy\n- Salvage SRS for focal recurrence\n- Regular MRI surveillance ongoing\n\nCURRENT STATUS:\nPatient maintains good functional status with minimal residual symptoms. Continues work as software developer with appropriate screen modifications. Regular monitoring continues due to WHO Grade II status.\n\nOverall KPS/ECOG Trend:\n- Lowest: KPS 60 (immediate post-op)\n- Highest: KPS 95 (current)\n- Current: KPS 95, ECOG 0",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F56-O\nChief Complaint: Progressive neurological symptoms during pregnancy\n\nIMAGING FINDINGS:\nMRI reveals 2.8cm left frontal convexity meningioma with moderate peritumoral edema. No significant mass effect on critical structures. WHO Grade I characteristics.\n\nASSESSMENT:\nComplex case given pregnancy status (24 weeks). Symptoms concerning but manageable. Conservative approach warranted due to pregnancy.\n\nPLAN:\n1. Close monitoring through pregnancy\n2. Dexamethasone 4mg BID for edema management\n3. Monthly clinical assessments\n4. Follow-up MRI post-delivery\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nPost-delivery assessment\nSymptoms slightly improved after delivery\nTumor stable on repeat MRI\nContinue conservative management\nKPS: 85 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2019\nHeadaches improved with medication management\nVision stable\nMRI shows no significant growth\nWorking full-time with accommodations\nKPS: 90 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - April 5, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nContinuing work-from-home\nRecommended ergonomic adjustments for computer work\nKPS: 90 ECOG: 0\n\n-------------------\n\nURGENT VISIT - November 10, 2021\nIncreased headaches and visual symptoms\nMRI shows 15% growth\nStarted on higher dose steroids\nDiscussing surgical options but patient prefers conservative approach\nKPS: 70 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2022\nResponse to medical management\nSymptoms stabilized\nMRI stable\nMaintaining work with modifications\nKPS: 75 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - April 20, 2023\nStable disease\nManaging work/life balance\nMinor visual symptoms\nContinue conservative approach\nKPS: 80 ECOG: 1\n\n-------------------\n\nRECENT VISIT - January 10, 2024\nSymptoms well-controlled\nMRI stable for past 18 months\nMaintaining quality of life\nContinues software development with accommodations\nRegular food critic activities resumed\nKPS: 85 ECOG: 1\n\nMANAGEMENT SUMMARY:\nSuccessfully managed with conservative approach for 6 years\nPeriodic symptom exacerbations controlled with medication\nOccupation-specific accommodations effective\nQuality of life maintained\nRegular monitoring continues\n\nKPS Range over 6 years: 70-90\nECOG Range: 0-1\n\nRECOMMENDATIONS:\n1. Continue biannual MRI\n2. Maintain current medication regimen\n3. Regular ophthalmology follow-up\n4. Ergonomic workplace assessment\n5. Stress management counseling\n6. Regular exercise program as tolerated\n\nWHO Grade: I (Stable)\nCurrent Status: Well-managed with conservative approach"
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work on computer screens",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in past 2 months"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Surgical history: Cholecystectomy (2010)",
          "Post-menopausal since age 51",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Mother with breast cancer",
          "Current medications: Lisinopril 10mg daily, Calcium + Vitamin D supplement"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 62-year-old female, Data Scientist\nMRI Findings: 4.2 cm left frontal convexity meningioma with significant peritumoral edema, mass effect on adjacent frontal lobe. Enhancement pattern consistent with WHO Grade II meningioma.\nSymptoms: Progressive headaches, visual disturbance, cognitive changes impacting work performance.\nAssessment: Given tumor size, symptom progression, and occupation requiring high cognitive function, recommend early surgical intervention.\nPlan: Schedule craniotomy within 2 weeks. Pre-operative imaging protocol initiated.\nKPS: 80 ECOG: 1\n\nSurgery Note - March 29, 2018\nProcedure: Left frontal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op Status: Stable, minimal residual edema\nPlan: Initiate adjuvant radiation therapy\nKPS: 70 ECOG: 2\n\nFollow-up - June 15, 2018\nStatus: Completed 6-week course of IMRT (60 Gy/30 fractions)\nSymptoms: Improving vision, headaches resolved\nMRI: Post-surgical changes, no residual tumor\nPlan: Q3 month MRI surveillance\nKPS: 85 ECOG: 1\n\n1-Year Follow-up - March 2019\nMRI: Small 8mm nodular enhancement at resection margin\nSymptoms: Asymptomatic\nPlan: Increased surveillance to q2 months, consider SRS for focal recurrence\nKPS: 90 ECOG: 0\n\n2-Year Follow-up - April 2020\nMRI: Progressive growth of recurrence (now 1.5cm)\nTreatment: Gamma Knife SRS delivered to recurrence (16 Gy)\nStatus: Maintaining full-time work\nKPS: 85 ECOG: 1\n\n3-Year Follow-up - May 2021\nMRI: Stable post-SRS changes\nSymptoms: Occasional mild headaches\nNeuropsychological testing: Normal cognitive function\nKPS: 90 ECOG: 0\n\n4-Year Follow-up - June 2022\nMRI: New satellite lesion (1.2cm) identified\nPlan: Second craniotomy scheduled\nStatus: Patient maintaining work with accommodations\nKPS: 75 ECOG: 1\n\nSecond Surgery - July 2022\nProcedure: Resection of recurrent tumor\nPathology: WHO Grade II, increased proliferation index\nPost-op Course: Complicated by temporary speech difficulties\nKPS: 60 ECOG: 2\n\n5-Year Follow-up - August 2023\nStatus: Recovery from second surgery complete\nMRI: Post-surgical changes, no new disease\nOccupational Status: Returned to work part-time\nPlan: Continue q3 month MRI surveillance\nKPS: 80 ECOG: 1\n\nCurrent Visit - January 2024\nMRI: Stable, no evidence of recurrence\nSymptoms: Fully functional, maintaining modified work schedule\nNeurocognitive Status: Normal\nPlan: Continue surveillance, consider extending to q4 months\nKPS: 90 ECOG: 0\n\nTreatment Summary (2018-2024):\n- Two craniotomies\n- One course of IMRT\n- One session of Gamma Knife SRS\n- Regular MRI surveillance\n- Successful maintenance of professional career with temporary accommodations\n\nCurrent Status:\nKPS Score: 90 - Able to carry on normal activity with minor symptoms\nECOG Score: 0 - Fully active, able to perform all pre-disease activities\n\nNote: Throughout treatment course, KPS scores ranged from 60 (post-second surgery) to 90 (current), reflecting the aggressive management approach and successful recovery periods.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 62-year-old female, Data Scientist\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal surrounding edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 80 ECOG: 1\n\nAssessment:\nPatient presents with progressive neurological symptoms affecting work performance. Imaging characteristics suggest WHO Grade I meningioma. Given size (<3cm) and patient's preference for conservative management, recommending close monitoring with consideration for intervention if symptoms worsen.\n\nPlan:\n1. MRI surveillance every 6 months initially\n2. Neurocognitive assessment baseline\n3. Ophthalmology referral for vision assessment\n4. Consider prophylactic anticonvulsants\n5. Ergonomic workplace assessment recommended\n6. Continue current medications\n\nFollow-up Visit - September 20, 2018\nMinimal tumor growth (2.9cm)\nVision stable after ophthalmology intervention\nKPS: 85 ECOG: 1\nPlan: Continue monitoring, provided workplace accommodations improving symptoms\n\nAnnual Visit - March 12, 2019\nTumor stable at 2.9cm\nHeadaches improved with ergonomic adjustments\nKPS: 90 ECOG: 0\nPlan: Extended MRI interval to annual\n\nAnnual Visit - March 15, 2020\nSlight growth to 3.1cm\nNew onset occasional seizures\nKPS: 70 ECOG: 1\nPlan: Started Levetiracetam 500mg BID, monthly neurology follow-up\n\nEmergency Visit - July 3, 2020\nPresented with increased headaches and vision changes\nKPS: 60 ECOG: 2\nPlan: Initiated dexamethasone 4mg QID, scheduled for Gamma Knife radiosurgery\n\nPost-radiation Follow-up - October 15, 2020\nGood response to radiation\nSymptoms improving\nKPS: 75 ECOG: 1\nPlan: Taper dexamethasone, continue anticonvulsants\n\nAnnual Visit - March 10, 2021\nTumor showing minor shrinkage (2.9cm)\nImproved symptoms\nKPS: 85 ECOG: 1\nPlan: Continue current management\n\nAnnual Visit - March 8, 2022\nStable disease\nWorking part-time with accommodations\nKPS: 90 ECOG: 0\nPlan: Maintain current approach\n\nAnnual Visit - March 14, 2023\nNo tumor growth\nWell-controlled symptoms\nKPS: 95 ECOG: 0\nPlan: Continue annual monitoring\n\nRecent Visit - February 20, 2024\nStable disease\nFully functioning at work with accommodations\nKPS: 95 ECOG: 0\nPlan: Continue annual imaging, consider biennial if stable next year\n\nOverall KPS Range: 60-95\nOverall ECOG Range: 0-2\n\nConservative management with targeted radiation intervention when needed has resulted in good outcome. Patient has maintained high functional status and continues her career with appropriate accommodations."
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Intermittent blurred vision in right eye",
          "Recent onset of clumsiness in left hand",
          "Difficulty concentrating at work, especially when reviewing spreadsheets",
          "Occasional nausea without vomiting",
          "Reports feeling more irritable and fatigued than usual",
          "Two episodes of focal seizures affecting left arm in past month"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2 years ago)",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "Regular mammograms, last one normal (6 months ago)",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-2018\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Evidence of compression of superior sagittal sinus\nWHO Grade: II (atypical features noted)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's age, occupation requiring cognitive precision, and progressive neurological symptoms, recommend aggressive surgical intervention. Schedule for craniotomy within 2 weeks.\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Minimal residual tumor at superior sagittal sinus\n- Post-op MRI shows >95% resection\nWHO Grade: II (confirmed by pathology)\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - June 15, 2018\n- Completed 6-week course of adjuvant radiotherapy (60 Gy/30fx)\n- Improvement in headaches and visual symptoms\n- Starting return-to-work protocol\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - December 20, 2018\n- MRI shows no recurrence\n- Returned to full-time work\n- Minor fatigue persists\nKPS: 90 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 2019\n- Stable imaging\n- Complete resolution of neurological symptoms\n- Maintaining work performance\nKPS: 95 | ECOG: 0\n\nFOLLOW-UP - September 2020\n- Small area of enhancement noted on MRI\n- Recommend increasing scan frequency\n- Prophylactic anticonvulsant adjustment\nKPS: 90 | ECOG: 1\n\nURGENT VISIT - February 2021\n- New onset seizures\n- MRI shows tumor recurrence (2.1cm)\n- Second surgery recommended\nKPS: 75 | ECOG: 2\n\nSURGICAL NOTE - March 2021\n- Complete resection achieved\n- Started on enhanced anti-epileptic regimen\nWHO Grade: II\nKPS: 65 | ECOG: 2\n\nFOLLOW-UP - September 2021\n- Post-radiation therapy course completed\n- No evidence of recurrence\n- Seizure-free for 4 months\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 2022\n- Stable imaging\n- Maintaining full work schedule\n- No neurological deficits\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - March 2023\n- Continued stability\n- Annual MRI negative for recurrence\n- Excellent functional status\nKPS: 95 | ECOG: 0\n\nLATEST FOLLOW-UP - January 2024\n- 6-year post-initial diagnosis\n- No evidence of disease\n- Maintained cognitive function\n- Continues high-level professional work\nKPS: 100 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Two surgical resections (2018, 2021)\n- Two courses of radiation therapy\n- Regular MRI surveillance\n- Successful maintenance of professional career\n- Excellent outcome with aggressive early intervention\n\nFinal Status:\nKPS: 100 - Fully functional with no evidence of disease\nECOG: 0 - Fully active, no restrictions\n\nMonitoring Plan:\n- Continue bi-annual MRI through 2025\n- Annual monitoring thereafter\n- Maintain anticonvulsant regimen\n- Regular cognitive assessments\n- Occupational performance monitoring",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-2016\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nASSESSMENT:\nDespite presenting symptoms, tumor size and location favor initial conservative management. Patient's cognitive demands at work require careful monitoring of neurological function.\n\nPLAN:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for 2 weeks, then taper\n3. Quarterly MRI surveillance\n4. Neuropsychological evaluation baseline\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2016\nImprovement in headaches and vision. Seizures controlled.\nMRI: Stable tumor size\nPLAN: Continue current management\nKPS: 85 ECOG: 1\n\nANNUAL VISIT - March 10, 2017\nStable symptoms. Successfully managing work duties.\nMRI: No growth\nPLAN: Extend to bi-annual MRI\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - September 15, 2018\nNew complaint of occasional memory lapses\nMRI: Minimal growth (0.2cm)\nPLAN: \n- Continue conservative management\n- Memory exercises recommended\n- Occupational therapy referral\nKPS: 85 ECOG: 1\n\nURGENT VISIT - February 3, 2019\nIncreased seizure frequency\nMRI: Tumor growth to 3.2cm, increased edema\nPLAN:\n- Increased Levetiracetam to 1000mg BID\n- Consider surgical intervention if symptoms worsen\nKPS: 70 ECOG: 2\n\nPOST-SURGICAL FOLLOW-UP - May 20, 2019\nSubtotal resection performed\nPathology: WHO Grade I meningioma\nPLAN: Quarterly MRI surveillance\nKPS: 60 ECOG: 2\n\nFOLLOW-UP - December 15, 2020\nGood recovery, returned to work\nMRI: Stable residual tumor\nPLAN: Continue surveillance\nKPS: 90 ECOG: 0\n\nANNUAL VISIT - January 10, 2022\nMaintaining good function\nMRI: No progression\nPLAN: Annual MRI\nKPS: 95 ECOG: 0\n\nFOLLOW-UP - January 15, 2023\nStable symptoms\nMRI: No changes\nPLAN: Continue annual monitoring\nKPS: 95 ECOG: 0\n\nRECENT VISIT - January 20, 2024\nFully functional, managing work well\nMRI: Stable disease\nPLAN: \n- Continue annual MRI\n- Consider extending to biennial if stable next year\nKPS: 100 ECOG: 0\n\nOVERALL PROGRESSION:\nKPS Score Range: 60-100\nECOG Score Range: 0-2\nPatient demonstrated excellent response to conservative management initially, required surgical intervention when symptoms worsened, and achieved optimal recovery with current stable disease status.\n\nOCCUPATIONAL CONSIDERATIONS:\n- Successfully maintained employment throughout treatment\n- Cognitive function preserved for analytical work\n- Ergonomic workplace modifications implemented\n- Stress management strategies incorporated"
      }
    },
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches for past 4 months, worse in morning",
          "Progressive blurred vision in right eye",
          "Recent onset of difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional episodes of nausea without vomiting",
          "Reports subtle personality changes noted by coworkers - more irritable than usual",
          "Mild right-sided facial numbness that developed gradually over 2 months",
          "Balance issues when walking, particularly noticeable when wearing heels at work"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "HbA1c consistently around 7.2%",
          "Hypertension diagnosed 5 years ago - controlled with Lisinopril 10mg daily",
          "Migraine headaches since early 30s - previously managed with sumatriptan PRN",
          "Laser eye surgery (LASIK) 10 years ago",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "Regular mammograms, last one 8 months ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-DM\nDiagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of optic nerve noted\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms indicating progressive disease. Occupation requires high cognitive function and visual acuity. Given size, location, and symptomatology, immediate surgical intervention recommended.\nWHO Grade: II (preliminary radiological assessment)\nKPS Score: 80\nECOG: 1\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of diabetes management\n3. Neurosurgical consultation with ophthalmology\n\nSURGICAL NOTE - March 30, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to cavernous sinus involvement\n- Minimal blood loss\n- No immediate complications\nPathology confirms WHO Grade II meningioma\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - June 15, 2018\nPost-operative MRI shows small residual tumor\nSymptoms improving\nInitiated adjuvant radiation therapy\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - December 20, 2018\nCompleted radiation therapy\nImproved visual symptoms\nReturn to work part-time\nKPS Score: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2019\nStable imaging\nFull return to work\nMinor residual facial numbness\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - September 2019\nMRI shows small area of enhancement\nClose monitoring warranted\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - March 2020\nTumor progression noted\nSecond surgery recommended\nKPS Score: 75\nECOG: 1\n\nSECOND SURGERY - April 2020\nComplete resection achieved\nKPS Score: 65\nECOG: 2\n\nFOLLOW-UP - October 2020\nPost-operative recovery satisfactory\nNo evidence of recurrence\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2021\nStable imaging\nReturn to full work duties\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 2022\nContinued stability\nAnnual monitoring recommended\nKPS Score: 95\nECOG: 0\n\nFOLLOW-UP - March 2023\nSmall area of enhancement noted\nIncreased monitoring frequency\nKPS Score: 85\nECOG: 1\n\nCURRENT VISIT - January 2024\nStable disease\nMaintaining work performance\nRegular monitoring continues\nKPS Score: 90\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation with WHO Grade II meningioma\n- Two surgical interventions (2018, 2020)\n- Complete course of radiation therapy\n- Current status: Stable disease with regular monitoring\n- Overall positive outcome with maintenance of professional function\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nMONITORING PLAN:\n- MRI every 6 months\n- Regular ophthalmological assessment\n- Diabetes management optimization\n- Cognitive function assessment quarterly\n- Continue current follow-up schedule",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-DM\nDiagnosis: Right Sphenoid Wing Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8 cm right sphenoid wing meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- Dural tail sign present\n\nASSESSMENT:\n46-year-old female financial analyst presenting with progressive neurological symptoms. Given tumor size and location, watchful waiting approach initially recommended with close monitoring.\n\nPLAN:\n1. MRI surveillance every 6 months\n2. Neurology referral for headache management\n3. Ophthalmology consultation for vision assessment\n4. Continue current medications\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nMinimal tumor growth (2.9 cm). Vision stable. Headaches improved with prophylactic therapy.\nPLAN: Continue surveillance\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 12, 2019\nTumor stable. Patient reports improved concentration with workplace accommodations (larger monitor, reduced screen time).\nPLAN: Continue monitoring\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - March 5, 2020\nSlight tumor growth (3.1 cm). Increased headache frequency.\nPLAN: \n- Increase monitoring frequency\n- Consider radiation therapy if symptoms worsen\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 15, 2020\nCOVID-19 Telehealth visit\nStable symptoms. Managing work remotely.\nPLAN: Continue current management\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 10, 2021\nTumor size 3.2 cm. Patient experiencing increased balance issues.\nPLAN: \n- Physical therapy referral\n- Discuss radiation therapy options\nKPS: 75 ECOG: 2\n\nFOLLOW-UP - September 22, 2021\nPost-radiation therapy assessment (completed fractionated RT)\nImproved symptoms, especially balance and headaches\nPLAN: Continue monitoring\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 15, 2022\nStable tumor size. Vision improved.\nPLAN: Annual MRI surveillance\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - March 20, 2023\nTumor slightly decreased (3.0 cm). Patient back to full-time work.\nPLAN: Continue annual monitoring\nKPS: 95 ECOG: 0\n\nFOLLOW-UP - February 15, 2024\nStable disease. Maintaining good quality of life.\nPLAN: \n- Continue annual MRI\n- Regular diabetes management\n- Maintain workplace accommodations\nKPS: 95 ECOG: 0\n\nWHO Grade: I (based on imaging characteristics)\n\nKPS Score Range Over Time: 75-95\nECOG Score Range Over Time: 0-2\n\nManagement Summary:\nConservative approach successful with radiation therapy intervention only when necessary. Patient maintained professional activities throughout treatment period with appropriate accommodations. Diabetes remained well-controlled, contributing to positive outcome.\n\nNext Follow-up: February 2025"
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, especially in morning; Right-sided facial numbness; Occasional balance issues when walking; Increasing difficulty concentrating at work; Recent onset of blurred vision in right eye; One episode of nausea and vomiting last week; Reports personality changes noted by family (more irritable)"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily; Underwent successful prostate cancer treatment 8 years ago (radiation therapy); Mild hearing loss in left ear; History of migraine headaches in 30s-40s but resolved; Appendectomy at age 23; Former smoker - quit 15 years ago; Family history of stroke (father); Regular health screenings up to date; No history of seizures or neurological disorders; Takes daily aspirin 81mg"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M67-DS-A\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms over 3 months\nMRI Findings:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Dural tail sign present\nWHO Grade: II (atypical features on imaging)\nKPS: 80\nECOG: 1\nPlan: Recommend immediate surgical intervention due to size, symptoms, and occupation requiring cognitive function.\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II\nComplications: None\nPost-op KPS: 70\nECOG: 2\nPathology confirms WHO Grade II meningioma\n\nFOLLOW-UP - May 15, 2018\nStatus: Improving\nSymptoms: Headaches resolved, facial numbness improving\nKPS: 85\nECOG: 1\nPlan: Begin adjuvant radiation therapy\n\nRADIATION ONCOLOGY NOTE - June-July 2018\nTreatment: 60 Gy in 30 fractions\nTolerance: Good\nPost-treatment KPS: 90\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 2018\nMRI: No residual/recurrent tumor\nKPS: 95\nECOG: 0\nReturn to work approved\n\nANNUAL FOLLOW-UP - April 2019\nStatus: Stable\nMRI: No recurrence\nKPS: 100\nECOG: 0\n\n18-MONTH FOLLOW-UP - October 2019\nNew symptoms: Mild right-sided headaches\nMRI: Small enhancement at surgical site\nKPS: 90\nECOG: 1\nPlan: Increased monitoring frequency\n\n2-YEAR FOLLOW-UP - April 2020\nMRI: 1.2cm recurrence at original site\nKPS: 85\nECOG: 1\nPlan: SRS recommended\n\nSRS TREATMENT - May 2020\nDose: 16 Gy single fraction\nPost-treatment KPS: 80\nECOG: 1\n\n3-YEAR FOLLOW-UP - April 2021\nStatus: Stable\nMRI: No progression\nKPS: 90\nECOG: 0\n\n4-YEAR FOLLOW-UP - April 2022\nStatus: Stable\nMRI: Stable post-treatment changes\nKPS: 95\nECOG: 0\n\n5-YEAR FOLLOW-UP - April 2023\nMinor balance issues reported\nMRI: Small area of enhancement (0.8cm)\nKPS: 85\nECOG: 1\nPlan: Continue close monitoring\n\nCURRENT VISIT - January 2024\nStatus: Stable with minor symptoms\nMRI: Stable enhancement\nKPS: 90\nECOG: 1\nPlan: Continue bi-annual MRI surveillance\n\nOverall KPS Range: 70-100\nOverall ECOG Range: 0-2\n\nTreatment Summary:\n- Initial surgical resection\n- Adjuvant radiation therapy\n- Salvage SRS for recurrence\n- Maintained high functional status throughout treatment course\n- Successfully managed WHO Grade II meningioma with aggressive multimodal approach\n\nOccupational Impact:\n- Brief work cessation during initial treatment\n- Successfully returned to Data Scientist role\n- Cognitive function preserved\n- Maintained professional productivity",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M67-DS-A\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4 cm right sphenoid wing meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I (likely)\nASSESSMENT:\nGiven tumor size <3cm, minimal edema, and stable presentation, recommending conservative management with close monitoring. Patient's cognitive demands as Data Scientist considered in management plan.\nPLAN:\n- Follow-up MRI in 3 months\n- Dexamethasone 4mg BID for symptom management\n- Neurocognitive assessment baseline\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2018\n- Mild improvement in headaches\n- Vision symptoms stable\n- MRI shows no tumor growth\n- Continuing conservative approach\nPLAN:\n- Reduce dexamethasone to 2mg BID\n- Next MRI in 6 months\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - December 12, 2018\n- Improved concentration at work\n- Balance issues resolved\n- MRI stable\nPLAN:\n- Further taper dexamethasone\n- Annual MRI if stable\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - December 10, 2019\n- Maintaining work performance\n- Minor right facial numbness persists\n- MRI shows minimal growth (0.2cm)\nPLAN:\n- Continue monitoring\n- Consider radiation if symptoms worsen\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - January 15, 2021\n- COVID-19 delayed previous visit\n- Working remotely successfully\n- MRI stable\n- Mild cognitive complaints\nPLAN:\n- Cognitive rehabilitation referral\n- Continue annual monitoring\nKPS: 85 ECOG: 1\n\nURGENT VISIT - July 30, 2021\n- Increased headaches\n- New onset seizure\n- MRI shows increased edema\nPLAN:\n- Start Levetiracetam 500mg BID\n- Increase steroid dose\n- Consider radiation therapy\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - October 15, 2021\n- Post-radiation therapy review\n- Improved symptoms\n- Working part-time\nPLAN:\n- Continue anticonvulsants\n- MRI in 3 months\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 20, 2022\n- Good response to radiation\n- Return to full-time work\n- MRI shows tumor shrinkage\nPLAN:\n- Continue current management\n- Annual MRI\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - April 5, 2023\n- Stable symptoms\n- Maintaining work performance\n- MRI stable\nPLAN:\n- Continue annual monitoring\n- Maintain current medications\nKPS: 90 ECOG: 0\n\nRECENT FOLLOW-UP - January 10, 2024\n- Excellent functional status\n- No new symptoms\n- MRI stable\nPLAN:\n- Continue annual monitoring\n- Consider extending to biennial MRI\nKPS: 95 ECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\nKPS scores ranged from 70 (during acute deterioration) to 95 (current status)\nECOG scores ranged from 0-2, currently at 0\n\nTreatment approach successfully preserved quality of life and cognitive function, essential for patient's work as Data Scientist. Conservative management with timely intervention (radiation) when needed proved effective."
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of unsteady gait and mild right-sided weakness",
          "Occasional nausea without vomiting",
          "Reports personality changes noted by family - increased irritability",
          "Difficulty concentrating at work for past 2-3 months"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Sleep apnea diagnosed 3 years ago, uses CPAP",
          "Hypercholesterolemia managed with atorvastatin",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Former smoker - quit 10 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M59-O-MEN\nInitial Visit: March 15, 2016\n\nINITIAL CONSULTATION\nChief Complaint: Progressive neurological symptoms with suspected meningioma\nPresent Illness: 59-year-old male presenting with progressive headaches, right-sided visual disturbance, and gait instability.\n\nIMAGING FINDINGS:\nMRI reveals a 4.2 cm left frontal parasagittal meningioma with significant peritumoral edema. Mass effect on superior sagittal sinus with early venous compression. T2 sequence shows hyperintense signal suggesting aggressive growth pattern.\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant peritumoral edema\n- Critical location near motor strip\n- History of radiation exposure\nWHO Grade: Likely Grade II (to be confirmed post-resection)\nKPS Score: 80\nECOG: 1\n\nPLAN:\nRecommend immediate surgical intervention given symptomatic presentation and high-risk features.\n\n-------------------\n\nSURGICAL NOTE - April 2, 2016\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2016\nPatient recovering well. Adjuvant radiation therapy completed (60 Gy/30 fractions)\nSymptoms improving\nKPS: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - January 10, 2017\n6-month MRI shows no recurrence\nNeurological symptoms resolved\nKPS: 90\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - July 2018\nMinor enhancement noted on follow-up MRI\nRecommend increased monitoring frequency\nKPS: 85\nECOG: 1\n\n-------------------\n\nURGENT VISIT - March 2020\nNew onset seizures\nMRI shows tumor recurrence (2.8 cm)\nKPS: 60\nECOG: 2\n\n-------------------\n\nSECOND SURGERY - April 2020\nRepeat resection with adjuvant chemotherapy\nPost-op complications with wound healing\nKPS: 50\nECOG: 3\n\n-------------------\n\nFOLLOW-UP - September 2020\nRecovery progressing slowly\nRehabilitation ongoing\nKPS: 70\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - March 2022\nStable disease on imaging\nImproved functional status\nKPS: 80\nECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - January 2024\nStable disease\nMaintaining good quality of life\nRegular CPAP use continues\nBlood pressure well-controlled\nKPS: 85\nECOG: 1\n\nTREATMENT SUMMARY:\n- Two surgical resections (2016, 2020)\n- Complete course of radiation therapy\n- Adjuvant chemotherapy\n- Regular imaging surveillance\n- Management of comorbidities\n\nKPS Score Range: 50-90 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course\n\nCURRENT STATUS:\nPatient maintains good functional status with stable disease. Continues regular monitoring with q6month MRI scans. Occupational status: Modified work schedule with accommodations for medical appointments.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 59-year-old male, blood type O\nChief Complaint: Progressive neurological symptoms\n\nMRI Findings:\n- 2.8cm left frontal parasagittal meningioma\n- Moderate peritumoral edema\n- No significant mass effect on critical structures\n- WHO Grade I (likely)\n\nAssessment:\nDespite symptomatic presentation, considering patient's history of radiation exposure and comorbidities, recommending initial conservative management with close monitoring. KPS: 80, ECOG: 1\n\nPlan:\n1. Anti-epileptic prophylaxis: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema management\n3. Monthly follow-up initially\n4. Occupational therapy evaluation\n5. Sleep study review for CPAP optimization\n\nFollow-up Visit - June 20, 2018\nSymptoms slightly improved with steroid therapy. Headaches decreased.\nMRI: Stable tumor size\nKPS: 85, ECOG: 1\nPlan: Continue current management, taper dexamethasone\n\nDecember 12, 2018\nPatient reports improved concentration\nMRI: No growth\nKPS: 90, ECOG: 0\nPlan: Extend follow-up to quarterly\n\nMarch 15, 2019\nMinor headache recurrence\nMRI: Minimal growth (0.2cm)\nKPS: 85, ECOG: 1\nPlan: Resume low-dose dexamethasone\n\nSeptember 20, 2020\nIncreased headache frequency\nMRI: Growth to 3.2cm\nKPS: 70, ECOG: 2\nPlan: Discuss radiation therapy options\n\nJanuary 15, 2021\nPost-radiation therapy (54 Gy/30 fractions)\nImproved symptoms\nKPS: 80, ECOG: 1\n\nJune 10, 2022\nStable symptoms\nMRI: Slight tumor shrinkage\nKPS: 85, ECOG: 1\n\nMarch 5, 2023\nWell-controlled symptoms\nMRI: Stable\nKPS: 90, ECOG: 0\n\nJanuary 20, 2024\nMaintaining good quality of life\nMRI: No progression\nKPS: 95, ECOG: 0\n\nCurrent Status:\nPatient has responded well to conservative management with radiation therapy. Maintaining good functional status and quality of life. Continue biannual monitoring.\n\nOverall KPS Range: 70-95\nOverall ECOG Range: 0-2\n\nTreatment Success Factors:\n1. Patient compliance with monitoring\n2. Effective symptom management\n3. Appropriate timing of radiation intervention\n4. Well-managed comorbidities\n\nLong-term Recommendations:\n1. Continue biannual MRI surveillance\n2. Regular blood pressure monitoring\n3. Weight management program\n4. Sleep apnea follow-up\n5. Quality of life assessments\n6. Cognitive function monitoring\n\nWHO Grade: I (Confirmed post-radiation)"
      }
    },
    {
      "demographics": {
        "age": 42,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Subtle right-sided facial numbness",
          "Reports increased clumsiness when handling kitchen utensils",
          "Occasional ringing in right ear",
          "Mild balance issues noted while standing for long periods in kitchen"
        ],
        "medical_history": [
          "Migraine headaches since age 35, previously well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2018)",
          "No history of radiation exposure",
          "No family history of brain tumors",
          "Regular eye exams, last one 2 years ago was normal",
          "No history of seizures",
          "No prior neurological conditions",
          "Currently taking oral contraceptives for past 8 years"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F42-O-2016\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nSymptomatic left frontal meningioma with concerning features warranting immediate intervention. Occupation requires high cognitive function and physical dexterity.\nPLAN:\n- Scheduled for surgical resection within 2 weeks\n- Pre-operative functional MRI and DTI\n- Steroid therapy initiated: Dexamethasone 4mg QID\nKPS: 70 ECOG: 1\n\nSURGICAL NOTE - March 30, 2016\n- Simpson Grade II resection achieved\n- Subtotal removal due to sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\nKPS: 60 ECOG: 2\n\nFOLLOW-UP - June 15, 2016\n- Post-operative adjuvant radiation therapy completed\n- Improved visual symptoms\n- Residual mild right facial numbness\n- Cleared to return to work with restrictions\nKPS: 80 ECOG: 1\n\nANNUAL FOLLOW-UP - March 2017\n- Stable residual tumor\n- No new symptoms\n- Returned to full work duties\nKPS: 90 ECOG: 0\n\n6-MONTH FOLLOW-UP - September 2018\n- MRI shows small area of recurrence\n- New onset headaches\n- Recommended repeat surgical intervention\nKPS: 75 ECOG: 1\n\nSECOND SURGERY - October 2018\n- Complete resection achieved\n- Pathology confirms WHO Grade II\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - April 2019\n- Post-operative course uncomplicated\n- Resumed work activities\n- No new neurological deficits\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 2020\n- Stable imaging\n- Maintaining work performance\nKPS: 90 ECOG: 0\n\n6-MONTH FOLLOW-UP - September 2021\n- Small recurrence noted\n- Gamma Knife radiosurgery performed\nKPS: 80 ECOG: 1\n\nANNUAL FOLLOW-UP - March 2022\n- Post-radiosurgery imaging stable\n- Maintaining normal activities\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 2023\n- No evidence of progression\n- Fully functional at work\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - January 2024\n- Stable disease\n- Maintaining normal lifestyle\n- Continue bi-annual MRI surveillance\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical resections (2016, 2018)\n- Adjuvant radiation therapy\n- Gamma Knife radiosurgery (2021)\n- Current status: Stable disease with excellent functional status\n\nCURRENT KPS: 95 - Able to carry out normal activities with minor symptoms\nCURRENT ECOG: 0 - Fully active, able to perform all pre-disease activities without restriction\n\nMONITORING PLAN:\n- Continue bi-annual MRI surveillance\n- Regular neurological assessments\n- Annual cognitive function testing\n- Occupational therapy evaluations as needed",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 42 | Sex: F | Blood Type: O\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\n\nSYMPTOMS/PRESENTATION:\n- Progressive headaches, worse in morning\n- Right eye blurred vision\n- Work-related concentration issues\n- Right-sided facial numbness\n- Balance/coordination issues affecting occupational activities\nKPS: 80 | ECOG: 1\n\nTREATMENT PLAN:\nGiven tumor size <3cm and minimal edema, recommending conservative management with close monitoring. Occupational considerations significant as patient requires fine motor skills for both professions.\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\n- Minimal tumor growth (2.5cm)\n- Headaches improved with prophylactic topiramate\n- Vision stable\n- Maintaining work activities with modifications\nKPS: 85 | ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2019\n- Stable tumor size\n- Improved symptom control\n- Added ergonomic workplace modifications\n- Continuing regular activities\nKPS: 90 | ECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - April 5, 2020\n- No tumor growth\n- Well-controlled symptoms\n- Discontinued oral contraceptives per recommendation\n- Maintaining full work schedule\nKPS: 90 | ECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - March 30, 2021\n- Slight increase in tumor size (2.7cm)\n- Mild increase in headache frequency\n- Added preventive migraine medication\n- Maintaining work with accommodations\nKPS: 75 | ECOG: 1\n\n-------------------\n\nINTERIM VISIT - September 15, 2021\n- Symptoms stabilized with medication adjustment\n- No further tumor growth\n- Discussing potential radiation options if growth continues\nKPS: 80 | ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 22, 2022\n- Stable tumor size\n- Well-controlled symptoms\n- Continuing conservative management\nKPS: 85 | ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - April 3, 2023\n- No tumor growth\n- Excellent symptom control\n- Maintaining full work activities\nKPS: 90 | ECOG: 0\n\n-------------------\n\nRECENT FOLLOW-UP - February 15, 2024\n- Stable disease (2.7cm)\n- Well-controlled symptoms\n- Continuing annual MRI surveillance\n- Patient satisfied with conservative approach\nKPS: 90 | ECOG: 0\n\nMANAGEMENT SUMMARY:\nSuccessfully managed with conservative approach over 6-year period. Patient maintained high functional status and quality of life. Periodic KPS fluctuations reflected symptom severity but overall remained stable with medical management.\n\nMONITORING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Quarterly neurological examinations\n3. Regular ophthalmology follow-up\n4. Ergonomic assessment updates as needed\n5. Continue headache prophylaxis\n\nOCCUPATIONAL CONSIDERATIONS:\n- Ergonomic modifications for computer work\n- Regular breaks during prolonged standing\n- Modified kitchen tools for safety\n- Reduced extended work hours when symptomatic\n\nKPS Range: 75-90 throughout monitoring period\nECOG Range: 0-1 throughout monitoring period"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": true
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 4 months, particularly in the morning; Recent onset of right-sided facial numbness; Increasing difficulty with balance during stage performances; Occasional episodes of nausea without vomiting; Reports subtle changes in hearing in right ear; Mild confusion and difficulty remembering lines during performances in the past 2 months"
        ],
        "medical_history": [
          "Hypertension diagnosed 3 years ago, well-controlled with lisinopril 10mg daily; Mild traumatic brain injury from stage accident 15 years ago with full recovery; History of migraine headaches in 20s and 30s that had resolved; Tinnitus in right ear diagnosed 2 years ago; No history of seizures; No prior cancers; Non-smoker; Occasional alcohol use; Family history significant for father with brain tumor (type unknown)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly balance/coordination tests, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly balance/coordination tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 53Y Male, Blood Type A\nChief Complaint: Progressive headaches, right facial numbness, balance issues\n\nIMAGING:\nInitial MRI reveals 4.2cm right petroclival meningioma with significant mass effect on brainstem and moderate peritumoral edema. Enhancement pattern suggests WHO Grade II. Evidence of compression of cranial nerves V, VII, and VIII.\n\nASSESSMENT:\nGiven tumor size, location, and symptomatic presentation, immediate surgical intervention recommended. Occupation as stage artist significantly impacted by current symptoms. WHO Grade II suspected.\nKPS: 80/100\nECOG: 1\n\nPLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Detailed neuropsychological evaluation\n4. Functional MRI for surgical planning\n\nSURGICAL NOTE - April 2, 2018\nPerformed right retrosigmoid approach for tumor resection. Simpson Grade II resection achieved. Intraoperative monitoring showed preservation of cranial nerve function.\nPost-op KPS: 70/100\nECOG: 2\n\nFOLLOW-UP - July 15, 2018\nPathology confirmed WHO Grade II meningioma\nPost-operative MRI shows small residual tumor (1.1cm)\nAdjuvant radiation therapy initiated\nKPS: 75/100\nECOG: 1\n\nFOLLOW-UP - January 10, 2019\nCompleted radiation therapy\nImprovement in balance and facial sensation\nReturn to modified performance schedule\nKPS: 85/100\nECOG: 1\n\nFOLLOW-UP - July 2019 - December 2023 (Bi-annual visits)\nRegular MRI surveillance showing stable residual disease\nGradual improvement in performance status\nReturn to full stage activities by 2020\nKPS ranging 90-95/100\nECOG: 0-1\n\nRECENT VISIT - January 15, 2024\nMRI shows small focus of enhancement suggesting possible recurrence\nNew onset occasional headaches\nPLAN: Increased monitoring frequency to every 3 months\nConsider repeat surgical intervention if progression confirmed\nKPS: 85/100\nECOG: 1\n\nTREATMENT SUMMARY (2018-2024):\n- Initial Simpson Grade II resection\n- Adjuvant radiation therapy\n- Regular imaging surveillance\n- Maintained performance career with brief interruption\n- Current status: Under close monitoring for possible recurrence\n\nKPS Score Timeline:\n2018 (Pre-op): 80/100\n2018 (Post-op): 70/100\n2018 (Post-radiation): 75/100\n2019-2023: 90-95/100\n2024: 85/100\n\nECOG Score Timeline:\n2018 (Pre-op): 1\n2018 (Post-op): 2\n2019-2023: 0-1\n2024: 1\n\nONGOING RECOMMENDATIONS:\n1. Quarterly MRI surveillance\n2. Monthly neurological examinations\n3. Consideration for repeat surgical intervention if progression confirmed\n4. Continued blood pressure monitoring\n5. Regular neuropsychological evaluations",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M53-2018\nBlood Type: A\nOccupation: Stage Artist\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right petroclival meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting professional performance. Given tumor location and size, conservative management initially recommended with close monitoring.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Symptomatic management:\n   - Dexamethasone 4mg BID for edema control\n   - Prophylactic anticonvulsant not indicated\n3. Monthly neurological evaluations\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nSymptoms partially improved with steroid therapy. Balance issues stabilized.\nMRI: No significant change in tumor size\nPLAN: Continue current management\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - March 12, 2019\nStable symptoms. Successfully modified performance routine to accommodate balance limitations.\nMRI: Minimal growth (0.2cm)\nPLAN: Continue monitoring\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 10, 2020\nCOVID-19 Telehealth Visit\nReports increased headaches\nPLAN: Adjusted dexamethasone dosing\nVirtual performance coaching recommended\nKPS: 75 ECOG: 1\n\nURGENT VISIT - September 5, 2020\nIncreased symptom severity\nMRI: Growth to 3.2cm with moderate edema\nPLAN: Radiation therapy consultation\nStarted on higher dose steroids\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - March 15, 2021\nPost-radiation therapy (54 Gy/30 fractions)\nImprovement in symptoms\nModified performance schedule implemented\nKPS: 80 ECOG: 1\n\nANNUAL REVIEW - March 10, 2022\nStable disease\nReturned to modified performance schedule\nMRI: Slight decrease in tumor size (2.9cm)\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 8, 2023\nMaintained stability\nMinor balance issues persist but manageable\nMRI: No change\nKPS: 90 ECOG: 0\n\nRECENT VISIT - February 15, 2024\nContinues stable course\nSuccessfully adapted performance techniques\nMRI: Stable disease\nPLAN: Continue annual monitoring\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\nConservative management with radiation therapy intervention when needed has provided good outcome. Patient has successfully adapted professional activities and maintains good quality of life.\n\nKPS Score Range: 70-95 (lowest during acute symptom exacerbation, highest after successful adaptation)\nECOG Score Range: 0-2 (currently 0)\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Quarterly neurological evaluations\n3. Continued performance modification strategies\n4. Stress management and lifestyle counseling\n5. Regular balance therapy sessions"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when cataloging books",
          "Occasional episodes of right-sided facial numbness",
          "Reports feeling more clumsy lately, dropping items with right hand"
        ],
        "medical_history": [
          "Hysterectomy at age 45 for uterine fibroids",
          "Migraine headaches since age 30, but pattern and intensity recently changed",
          "History of depression, managed with Sertraline 50mg daily",
          "Mild hypertension diagnosed 2 years ago, controlled with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-O-2016\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of compression of superior sagittal sinus\n\nASSESSMENT:\nSymptomatic left frontal meningioma with concerning features warranting immediate intervention. Symptoms significantly impacting quality of life and occupational function. WHO Grade II suspected.\nKPS: 70 ECOG: 1\n\nPLAN:\n1. Surgical resection recommended within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Detailed neuropsychological evaluation\n4. Discontinue Sertraline temporarily pre-surgery\n\nSURGICAL NOTE - March 30, 2016\n- Simpson Grade II resection achieved\n- Minimal blood loss\n- No immediate complications\n- Pathology confirms WHO Grade II meningioma\nKPS: 60 ECOG: 2\n\nPOST-OP FOLLOW-UP - May 15, 2016\n- Wound healing well\n- Adjuvant radiotherapy initiated\n- 54 Gy in 30 fractions\n- Improved right-sided symptoms\nKPS: 80 ECOG: 1\n\n6-MONTH FOLLOW-UP - September 30, 2016\n- MRI shows no residual tumor\n- Vision normalized\n- Headaches resolved\n- Returned to work part-time\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - March 2017\n- Stable MRI\n- Full-time work resumed\n- No neurological deficits\nKPS: 100 ECOG: 0\n\n18-MONTH FOLLOW-UP - September 2018\n- Small area of enhancement noted\n- Watch and wait approach\nKPS: 90 ECOG: 0\n\n2-YEAR FOLLOW-UP - March 2019\n- Enhancement increased\n- New symptoms: mild right hand weakness\n- Decision for repeat surgery\nKPS: 80 ECOG: 1\n\nSECOND SURGERY - April 2019\n- Complete resection achieved\n- Pathology confirms recurrent WHO Grade II\nKPS: 70 ECOG: 1\n\nPOST-SECOND SURGERY - June 2019\n- Stereotactic radiosurgery administered\n- 18 Gy single fraction\nKPS: 80 ECOG: 1\n\n3-YEAR FOLLOW-UP - March 2020\n- Stable imaging\n- Full functional recovery\nKPS: 90 ECOG: 0\n\n4-YEAR FOLLOW-UP - March 2021\n- No evidence of recurrence\n- Maintaining work schedule\nKPS: 100 ECOG: 0\n\n5-YEAR FOLLOW-UP - March 2022\n- Stable imaging\n- Annual monitoring continued\nKPS: 100 ECOG: 0\n\n6-YEAR FOLLOW-UP - March 2023\n- Small area of enhancement noted\n- Asymptomatic\n- Close monitoring implemented\nKPS: 90 ECOG: 0\n\nCURRENT STATUS - January 2024\n- Stable disease\n- Maintains full work capacity\n- Quarterly imaging scheduled\nKPS: 90 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical resections\n- One course conventional radiotherapy\n- One course stereotactic radiosurgery\n- Regular monitoring continues\n\nKPS Score Range: 60-100 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT MANAGEMENT:\n- Quarterly MRI surveillance\n- Regular neuropsychological assessment\n- Continued monitoring of occupational function\n- Hypertension management optimized",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 53-year-old female librarian\nMRI FINDINGS: 2.8cm left frontal convexity meningioma with minimal surrounding edema, WHO Grade I\nKPS: 90 | ECOG: 1\n\nASSESSMENT:\nGiven the patient's presenting symptoms and imaging characteristics, while the tumor is causing symptoms, its size and characteristics suggest potential for conservative management. Patient's occupation requires cognitive precision, making preservation of function paramount.\n\nPLAN:\n1. Conservative monitoring with serial MRIs\n2. Neuropsychological evaluation baseline\n3. Ophthalmology consultation for visual symptoms\n4. Headache management optimization\n5. Consider prophylactic anti-seizure medication\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nInterval MRI shows stable tumor size\nHeadaches improved with topiramate 50mg daily\nVisual symptoms stable\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nMinimal tumor growth (2.9cm)\nPatient reports improved concentration with medication adjustment\nWorking full-time with minor accommodations\nKPS: 90 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nTumor stable\nCOVID-19 discussion: telehealth monitoring implemented\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 2, 2021\nTumor growth to 3.2cm\nIncreased headache frequency\nDiscussing surgical options but patient prefers continued observation\nKPS: 75 | ECOG: 2\n\n-------------------\n\nFOLLOW-UP - October 15, 2021\nFurther growth to 3.4cm\nVisual symptoms worsening\nRecommended stereotactic radiosurgery (SRS)\nKPS: 70 | ECOG: 2\n\n-------------------\n\nPOST-SRS FOLLOW-UP - January 20, 2022\nCompleted SRS treatment\nInitial side effects well-managed\nKPS: 65 | ECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2022\nPost-SRS changes as expected\nSymptoms improving\nReturned to work part-time\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - January 10, 2023\nTumor showing minor shrinkage\nContinued improvement in symptoms\nWorking full-time again\nKPS: 90 | ECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - January 15, 2024\nStable tumor size with post-treatment changes\nMinimal symptoms\nMaintaining work schedule with minor accommodations\nKPS: 95 | ECOG: 0\n\nTREATMENT SUMMARY:\nConservative management was maintained for 3+ years before SRS became necessary. Patient's occupation and preference for non-surgical intervention guided treatment decisions. Quality of life was preserved throughout treatment course.\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular ophthalmology follow-up\n4. Consider reducing headache medication if stability continues\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course"
      }
    },
    {
      "demographics": {
        "age": 55,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty with balance when walking",
          "Subtle personality changes noted by family - more irritable and forgetful",
          "Occasional tingling sensation in right hand",
          "Reports difficulty focusing while reading books at work"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "HbA1c consistently around 7.2%",
          "Hypertension - controlled with Lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously well-controlled with sumatriptan PRN",
          "Laser eye surgery for myopia 12 years ago",
          "Cholecystectomy in 2015",
          "Family history of breast cancer (maternal aunt)",
          "No history of smoking or alcohol abuse"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F55-A-DM\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No calcification noted\nWHO Grade: II (atypical features noted)\nAssessment: Given size >3cm, peritumoral edema, and progressive neurological symptoms, immediate surgical intervention recommended.\nKPS: 80 ECOG: 1\n\nSURGICAL INTERVENTION - April 2, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade: II resection\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2018\nPost-operative adjuvant radiation therapy completed (60 Gy/30fx)\nSymptoms improving\nMRI: No residual tumor\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - January 10, 2019\nSurveillance MRI: No recurrence\nVision improved\nBalance issues resolved\nReturn to work part-time\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - July 8, 2019\nSurveillance MRI: Small enhancement at surgical site\nHeadaches returned\nNew cognitive complaints\nKPS: 75 ECOG: 1\n\nURGENT ASSESSMENT - October 15, 2019\nMRI shows tumor recurrence (2.1cm)\nSecond surgery recommended\nKPS: 70 ECOG: 2\n\nSECOND SURGERY - November 1, 2019\nComplete resection achieved\nPost-op KPS: 65 ECOG: 2\n\nFOLLOW-UP - May 20, 2020\nCOVID-19 Telehealth visit\nStable symptoms\nMRI deferred due to pandemic\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - December 5, 2020\nMRI: No recurrence\nReturned to full-time work\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - December 10, 2021\nStable MRI\nManaging diabetes well\nNo neurological symptoms\nKPS: 95 ECOG: 0\n\nFOLLOW-UP - June 15, 2022\nSmall area of enhancement on MRI\nAsymptomatic\nClose monitoring recommended\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - December 20, 2022\nEnhancement stable\nContinuing work without restrictions\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - January 15, 2024\nMRI stable\nNo new symptoms\nMaintaining regular work schedule\nRegular monitoring to continue\nCurrent KPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical resections\n- Complete course of radiation therapy\n- Regular imaging surveillance\n- Successful return to work\n- Well-controlled diabetes throughout treatment\n\nKPS Score Range: 65-95 (lowest post-second surgery, highest during stable periods)\nECOG Score Range: 0-2 (worst during immediate post-operative periods)\n\nCURRENT STATUS:\nPatient maintains excellent functional status with successful tumor control. Continues regular neurosurgical monitoring and diabetes management. Occupation as librarian successfully resumed with full cognitive function.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F55-A-DM\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (presumptive)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting daily function and work performance. Given tumor size and symptomatology, conservative management with close monitoring is recommended initially.\n\nPLAN:\n1. Serial MRI monitoring every 6 months\n2. Optimization of diabetes management - endocrinology referral\n3. Headache management protocol\n4. Occupational therapy evaluation for reading/vision compensation strategies\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nMinimal tumor growth (2.9cm)\nSymptoms stable with medication adjustment\nContinue conservative management\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 12, 2019\nTumor stable at 2.9cm\nVision symptoms improved with prescribed glasses\nWorking part-time with accommodations\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 5, 2020\nSlight tumor growth (3.1cm)\nIncreased headache frequency\nPLAN: Consider radiation therapy consultation\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - September 15, 2020\nPost-radiation therapy assessment\nTumor size stable\nSymptom improvement noted\nKPS: 75 ECOG: 1\n\nANNUAL FOLLOW-UP - September 10, 2021\nStable disease\nWorking full-time with accommodations\nDiabetes well-controlled\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - September 8, 2022\nNo tumor progression\nQuality of life improved\nMaintaining work schedule\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - September 14, 2023\nContinued stability\nMinor headaches managed with medication\nFull work capacity\nKPS: 90 ECOG: 0\n\nRECENT FOLLOW-UP - February 20, 2024\nStable disease condition\nWell-maintained diabetes control\nRegular work schedule\nConsider biennial MRI monitoring\nKPS: 95 ECOG: 0\n\nMANAGEMENT SUMMARY:\n- Successfully managed with conservative approach\n- Initial radiation therapy when needed\n- Maintained occupational function\n- Good quality of life preservation\n- Stable disease control\n\nCURRENT STATUS:\nKPS Score: 95 - Able to carry out normal activity with minor symptoms\nECOG Score: 0 - Fully active\n\nMONITORING RECOMMENDATIONS:\n1. Continue biennial MRI\n2. Annual neurological assessment\n3. Regular diabetes monitoring\n4. Vision checks every 6 months\n5. Quality of life assessments annually\n\nNote: KPS scores ranged from 70-95 throughout treatment period, reflecting initial challenges and subsequent improvement with conservative management."
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty with fine motor tasks while cooking",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Balance issues when turning quickly in kitchen"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches in 30s, resolved spontaneously",
          "Cholecystectomy 2015",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history: Mother had breast cancer at age 62",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F56-O-2016\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2016\nPRESENTING SYMPTOMS: Progressive neurological symptoms including headaches, right-sided visual disturbance, and balance issues. Occupational concerns due to fine motor deficits affecting patient's work as chef.\n\nIMAGING:\nInitial MRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on motor strip. Enhancement pattern suggestive of WHO Grade II.\n\nASSESSMENT & PLAN:\nGiven size, location, and symptomatic presentation, recommend immediate surgical intervention. Occupation requires fine motor skills - delay could impact livelihood.\nKPS Score: 80\nWHO Grade: II (preliminary)\n\nSURGICAL INTERVENTION - April 2, 2016\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70\n\nFOLLOW-UP - July 15, 2016\nImproved symptoms. Some residual right hand weakness.\nStarted adjuvant radiation therapy: 54 Gy in 30 fractions\nKPS Score: 75\n\nFOLLOW-UP - January 10, 2017\nComplete radiation course. Minimal side effects.\nMRI shows no recurrence\nReturn to work with modifications\nKPS Score: 85\n\nFOLLOW-UP - July 2017, January 2018, July 2018\nStable imaging\nGradual improvement in motor function\nKPS Scores: 90, 90, 95\n\nRECURRENCE - March 2019\nNew enhancement on MRI at resection margin\nSymptoms: mild headaches returning\nKPS Score: 85\nPlan: Gamma Knife radiosurgery\n\nFOLLOW-UP - September 2019\nPost-radiosurgery\nStable disease\nKPS Score: 90\n\nANNUAL FOLLOW-UPS 2020-2022\nStable imaging\nMaintained work status\nKPS Scores: 90-95\n\nCONCERNING CHANGES - June 2023\nNew satellite lesions identified\nIncreasing symptoms\nKPS Score: 75\nPlan: Second craniotomy with aggressive resection\n\nLATEST FOLLOW-UP - January 2024\nPost-second surgery\nStarted on hydroxyurea\nSome functional decline but maintaining independence\nKPS Score: 70\nECOG Score: 2\n\nTREATMENT SUMMARY:\n- Initial presentation 2016: WHO Grade II meningioma\n- Two surgical interventions (2016, 2023)\n- Radiation therapy and radiosurgery\n- Current status: Stable disease with ongoing monitoring\n\nKPS Score Range: 70-95 throughout course\nCurrent ECOG Score: 2\n\nMONITORING PLAN:\n- MRI every 3 months\n- Neurocognitive testing every 6 months\n- Occupational therapy ongoing\n- Consider additional systemic therapy if progression\n\nNote: Patient's occupation as chef and obesity considered in all treatment decisions. Aggressive monitoring due to WHO Grade II status and recurrence history.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 56 | Blood Type: O\nOccupation: Chef | BMI: 33.2\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting occupational function. Given tumor size <3cm and minimal edema, conservative management initially preferred. Symptoms warrant close monitoring.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Medical management of symptoms\n3. Occupational modifications recommended\n4. Follow-up in 3 months\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nSymptoms stable. Minor improvement in headaches with prescribed medications.\nMRI: No significant change in tumor size\nKPS: 80\nPlan: Continue conservative management\n\n-------------------\n\nFOLLOW-UP - December 12, 2018\nReports improved balance with prescribed physical therapy\nMRI: Stable lesion\nKPS: 85\nPlan: Extend monitoring interval to 6 months\n\n-------------------\n\nFOLLOW-UP - June 15, 2019\nNew complaint of increased right-sided facial numbness\nMRI: Minimal growth (2.6cm)\nKPS: 75\nPlan: Increase monitoring frequency; consider surgical options if symptoms worsen\n\n-------------------\n\nFOLLOW-UP - January 10, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nKPS: 80\nPlan: Continue monitoring\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nPost-vaccination follow-up\nMRI: Stable disease\nNotable improvement in occupational function\nKPS: 90\nPlan: Maintain current management\n\n-------------------\n\nFOLLOW-UP - April 20, 2022\nReports occasional headaches\nMRI: No progression\nKPS: 85\nPlan: Continue conservative approach\n\n-------------------\n\nFOLLOW-UP - May 15, 2023\nMinimal symptoms\nMRI: Stable disease\nSuccessfully managing work duties\nKPS: 90\nPlan: Annual monitoring\n\n-------------------\n\nCURRENT VISIT - February 10, 2024\nSix-year follow-up\nMRI: Stable disease (2.6cm)\nExcellent symptom control\nKPS: 95\nPlan: Continue annual monitoring\n\nFUNCTIONAL SCORES:\nKPS Score Timeline:\n- Initial (2018): 80\n- Lowest: 75 (2019)\n- Current: 95 (2024)\n\nECOG Score Timeline:\n- Initial (2018): 1\n- Highest: 2 (2019)\n- Current: 0 (2024)\n\nTREATMENT SUCCESS FACTORS:\n1. Patient's compliance with monitoring\n2. Successful adaptation of work environment\n3. Effective symptom management\n4. Stable tumor size\n5. Improved quality of life with conservative approach\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified kitchen workflow to minimize quick turning movements\n- Implemented regular breaks during long shifts\n- Ergonomic adjustments to workstation\n- Maintained professional capabilities with adaptations"
      }
    },
    {
      "demographics": {
        "age": 61,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by spouse - increased irritability",
          "Two episodes of stumbling/loss of balance in past month",
          "Mild right-sided facial numbness",
          "Increasing fatigue and difficulty concentrating at work"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Hypercholesterolemia - managed with atorvastatin 20mg daily",
          "Mild hearing loss in left ear diagnosed 3 years ago",
          "Appendectomy at age 23",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Mother with breast cancer, Father with hypertension",
          "Non-smoker, occasional alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M61-O-FA\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's cognitive-demanding occupation and progressive neurological symptoms, recommend aggressive surgical intervention. High-risk features include size >3cm, peritumoral edema, and proximity to eloquent areas.\n\nSURGICAL INTERVENTION - October 3, 2018\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- Post-op MRI shows small residual tumor (0.5cm)\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - December 15, 2018\n- Adjuvant radiotherapy completed (60 Gy/30 fractions)\n- Improvement in headaches and vision\n- Returning to work part-time\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - June 20, 2019\n- Stable imaging\n- Cognitive function improved\n- Full return to work\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - January 15, 2020\n- MRI shows small area of enhancement at resection site\n- Watchful waiting approach\nKPS: 90 | ECOG: 0\n\nURGENT VISIT - March 10, 2021\n- New onset seizures\n- MRI shows tumor progression\n- Second surgery recommended\nKPS: 70 | ECOG: 2\n\nSECOND SURGERY - April 5, 2021\n- Simpson Grade I resection achieved\n- Pathology confirms recurrent WHO Grade II\nKPS: 65 | ECOG: 2\n\nFOLLOW-UP - October 12, 2021\n- Post-radiation therapy course completed\n- Good recovery\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - April 15, 2022\n- Stable imaging\n- Returned to full work capacity\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - January 20, 2023\n- MRI stable\n- Maintaining cognitive function\nKPS: 95 | ECOG: 0\n\nRECENT FOLLOW-UP - March 1, 2024\n- Continued stability\n- Annual monitoring recommended\nKPS: 95 | ECOG: 0\n\nMONITORING PROTOCOL:\n- MRI every 6 months for 5 years\n- Neuropsychological testing annually\n- Regular ophthalmological assessment\n- Monthly blood pressure monitoring\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nTREATMENT SUMMARY:\nPatient demonstrated excellent response to aggressive multimodal treatment approach. Initial challenges with tumor recurrence were successfully addressed through prompt surgical intervention and targeted radiation therapy. Current status shows optimal functional recovery with return to high-level cognitive occupational demands.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n61-year-old male, Blood Type O\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\nKPS: 80 | ECOG: 1\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms but tumor characteristics favor initial conservative management. Occupation requires high cognitive function; symptoms affecting work performance.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. Medical management of symptoms:\n   - Dexamethasone 4mg daily for edema\n   - Prophylactic levetiracetam 500mg BID\n3. Monthly neurological assessments initially\n4. Follow-up MRI in 3 months\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nSymptoms slightly improved with medical management\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\n\nPLAN:\nContinue current management\nReduce dexamethasone to 2mg daily\nNext MRI in 6 months\n\n-------------------\n\nFOLLOW-UP - January 10, 2019\nReports improved concentration at work\nMRI: Stable\nKPS: 90 | ECOG: 0\n\nPLAN:\nMaintain current approach\nAnnual MRI if stable\n\n-------------------\n\nFOLLOW-UP - January 15, 2020\nMinor headache complaints\nMRI: Minimal growth (0.2cm)\nKPS: 85 | ECOG: 1\n\nPLAN:\nContinue observation\nOptimize headache management\n\n-------------------\n\nFOLLOW-UP - February 3, 2021\nCOVID-19 delayed follow-up\nSome cognitive decline noted\nMRI: Stable disease\nKPS: 70 | ECOG: 1\n\nPLAN:\nIncrease monitoring frequency\nConsider cognitive rehabilitation\n\n-------------------\n\nFOLLOW-UP - March 12, 2022\nImproved cognitive function\nWorking part-time\nMRI: No progression\nKPS: 80 | ECOG: 1\n\nPLAN:\nContinue conservative management\nOccupational therapy referral\n\n-------------------\n\nFOLLOW-UP - April 5, 2023\nManaging work well with accommodations\nMRI: Stable disease\nKPS: 85 | ECOG: 1\n\nPLAN:\nMaintain current approach\nAnnual imaging\n\n-------------------\n\nCURRENT VISIT - February 20, 2024\nWell-compensated with current management\nMRI: No significant change\nKPS: 90 | ECOG: 0\n\nTREATMENT SUMMARY:\nConservative management successful over 6-year period\nPatient maintained good functional status\nMinimal intervention required\nQuality of life preserved\nContinued occupational functionality\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medications\n3. Regular cognitive assessments\n4. Work modifications as needed\n\nKPS Range over monitoring period: 70-90\nECOG Range: 0-1\n\nThe conservative approach has proven successful, allowing patient to maintain professional activities while managing symptoms effectively. Regular monitoring has ensured safety while avoiding unnecessary surgical intervention."
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional episodes of nausea, subtle personality changes noted by spouse including increased irritability, recent difficulty concentrating at work, one episode of focal seizure affecting left hand 2 weeks ago"
        ],
        "medical_history": [
          "Migraine headaches diagnosed at age 35 but well-controlled with sumatriptan until recent changes in headache pattern, mild concussion from sports injury at age 22 with full recovery, family history negative for brain tumors, no prior radiation exposure, no history of cancer, generally healthy with normal annual physicals, takes occasional ibuprofen for tension headaches, no regular medications"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M40-A-2015\nOccupation: Researcher\n\nINITIAL VISIT - March 15, 2015\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, nausea, personality changes, concentration difficulties, recent left hand focal seizure.\nMRI Findings: 4.2cm right frontal convexity meningioma with significant peritumoral edema, mass effect on frontal lobe. Enhancement pattern consistent with WHO Grade II meningioma.\nKPS: 80/100\nECOG: 1\nPlan: Recommend immediate surgical intervention given size, symptoms, and occupation requiring cognitive function.\n\nSURGICAL NOTE - April 2, 2015\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II (Atypical) Meningioma\nPost-op KPS: 70/100\nECOG: 2\n\nFOLLOW-UP - July 15, 2015\nStatus: Improving neurological function\nImaging: Post-op MRI shows small residual tumor (0.8cm)\nAdjuvant Treatment: Initiated fractionated RT (60 Gy/30fx)\nKPS: 85/100\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 2, 2015\nStatus: Completed RT, improved symptoms\nImaging: Stable residual disease\nKPS: 90/100\nECOG: 1\n\nANNUAL FOLLOW-UP - April 15, 2016\nStatus: Working full-time, minimal symptoms\nImaging: No progression\nKPS: 95/100\nECOG: 0\n\n18-MONTH FOLLOW-UP - October 10, 2016\nNew symptoms: Mild headaches\nImaging: Small area of enhancement (1.2cm)\nKPS: 90/100\nECOG: 1\n\nURGENT VISIT - January 5, 2017\nStatus: Recurrent seizures\nImaging: Tumor progression (2.0cm)\nKPS: 70/100\nECOG: 2\nPlan: Second surgery scheduled\n\nSECOND SURGERY - January 20, 2017\nProcedure: Re-resection with improved margins\nPathology: Confirmed WHO Grade II\nKPS: 65/100\nECOG: 2\n\n2-YEAR FOLLOW-UP - April 2017 - April 2019\nQuarterly MRIs: Stable disease\nStatus: Returned to work part-time\nKPS: Ranging 80-90/100\nECOG: 1\n\n5-YEAR MARK - April 2020\nStatus: Stable, working full-time\nImaging: No recurrence\nKPS: 95/100\nECOG: 0\n\n7-YEAR FOLLOW-UP - March 2022\nStatus: Occasional headaches\nImaging: Small enhancement (0.5cm)\nKPS: 90/100\nECOG: 1\n\nLATEST FOLLOW-UP - January 2024\nStatus: Stable disease, fully functional\nImaging: No progression\nCurrent KPS: 95/100\nCurrent ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation with WHO Grade II meningioma\n- Two surgical interventions (2015, 2017)\n- Complete course of radiation therapy\n- Regular imaging surveillance\n- KPS range throughout treatment: 65-95\n- Current status: Excellent recovery, maintained cognitive function crucial for research work\n- Monitoring continues with bi-annual MRI\n\nCURRENT RECOMMENDATIONS:\n1. Continue bi-annual MRI surveillance\n2. Annual neuropsychological assessment\n3. Maintain anticonvulsant therapy\n4. Regular occupational health assessments\n5. Low threshold for intervention if new symptoms develop",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M40-A-2015\nOccupation: Researcher\n\nINITIAL VISIT - March 15, 2015\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, nausea, personality changes, concentration issues, recent left hand focal seizure.\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal peritumoral edema, no mass effect on critical structures.\nWHO Grade: I (presumptive based on imaging characteristics)\nManagement Plan: Given size <3cm and patient's cognitive demands as researcher, recommending close monitoring initially.\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1\n\nFOLLOW-UP - September 20, 2015\nSymptoms: Headaches improved with prophylactic topiramate\nMRI: Stable lesion size\nPlan: Continue monitoring, anticonvulsant therapy\nKPS: 90\n\nANNUAL FOLLOW-UP - March 12, 2016\nSymptoms: Well-controlled seizures, occasional headaches\nMRI: No growth\nOccupational Impact: Successfully managing research duties\nKPS: 95\n\nANNUAL FOLLOW-UP - March 18, 2017\nSymptoms: Stable\nMRI: Minimal growth (0.2cm), no new edema\nPlan: Continue conservative management\nKPS: 90\n\nINTERIM VISIT - August 30, 2018\nSymptoms: Increased headache frequency\nMRI: Growth to 3.2cm, moderate edema\nPlan: Discussing treatment options, started dexamethasone\nKPS: 80\n\nTREATMENT DECISION - October 15, 2018\nOpted for Gamma Knife radiosurgery given occupation requiring cognitive preservation\nKPS: 75 during treatment\n\nPOST-TREATMENT FOLLOW-UP - April 2019\nSymptoms: Improving\nMRI: Initial radiation changes, stable tumor size\nKPS: 85\n\nANNUAL FOLLOW-UP - March 2020\nSymptoms: Well-controlled\nMRI: Tumor shrinkage to 2.9cm\nNote: Successfully working remotely during COVID-19\nKPS: 90\n\nANNUAL FOLLOW-UP - March 2021\nSymptoms: Stable\nMRI: Continued response to radiosurgery\nKPS: 95\n\nANNUAL FOLLOW-UP - March 2022\nComplete symptom resolution\nMRI: Further tumor shrinkage to 2.5cm\nKPS: 100\n\nLATEST FOLLOW-UP - March 2024\nMaintaining excellent functional status\nMRI: Stable findings\nOccupational Status: Full research productivity maintained\nKPS: 100\nECOG: 0\n\nSummary of KPS/ECOG Progression:\n- Initial KPS: 90 (2015) - Minimal symptoms\n- Lowest KPS: 75 (During treatment 2018)\n- Current KPS: 100 (2024) - Normal function\n- Initial ECOG: 1 (2015)\n- Current ECOG: 0 (2024)\n\nManagement successfully preserved cognitive function critical for research career while achieving tumor control through minimal intervention approach."
      }
    },
    {
      "demographics": {
        "age": 43,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increased difficulty concentrating during work hours",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Reports mild balance issues when standing up quickly",
          "Intermittent ringing in right ear starting 2 months ago"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 2 years ago, not currently on medication",
          "Concussion from recreational soccer 8 years ago, fully recovered",
          "Occasional migraine headaches since age 30, managed with OTC medications",
          "No history of seizures",
          "No previous neurological conditions",
          "No family history of brain tumors",
          "Non-smoker",
          "Moderate alcohol consumption (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M43-O-2018\nOccupation: Software Developer/Coffee Roaster\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Compression of superior sagittal sinus\nWHO Grade: II (atypical features noted)\nKPS: 80 ECOG: 1\n\nASSESSMENT & PLAN:\nGiven size, symptoms, and occupation requiring cognitive focus, immediate surgical intervention recommended. Patient's work in software development demands optimal cognitive function. Headaches and visual symptoms suggest increasing ICP.\n\nSURGICAL INTERVENTION - April 3, 2018\n- Simpson Grade II resection performed\n- Post-op MRI shows near-total resection\n- Small residual along sagittal sinus\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2018\n- Adjuvant radiotherapy completed (60 Gy/30 fractions)\n- Improved vision and headaches\n- Returning to work part-time\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - January 10, 2019\n- Stable imaging\n- Full return to work\n- Minor fatigue reported\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - July 8, 2019\n- No evidence of recurrence\n- Cognitive function optimal\nKPS: 95 ECOG: 0\n\nFOLLOW-UP - January 15, 2020\nMRI shows small enhancement at resection site\n- Increased monitoring frequency recommended\nKPS: 90 ECOG: 0\n\nURGENT VISIT - August 20, 2020\n- New onset seizures\n- MRI shows tumor recurrence (2.1cm)\n- Second surgery recommended\nKPS: 75 ECOG: 1\n\nSECOND SURGERY - September 15, 2020\n- Complete resection achieved\n- WHO Grade II confirmed\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - March 10, 2021\n- Post-radiation recovery\n- Return to work planned\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 2021\n- Stable imaging\n- Full work resumption\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 2022\n- Continued stability\n- Annual monitoring recommended\nKPS: 95 ECOG: 0\n\nFOLLOW-UP - March 2023\n- No evidence of recurrence\n- Maintaining full work schedule\nKPS: 95 ECOG: 0\n\nLATEST FOLLOW-UP - February 2024\n- 6-year surveillance\n- Stable imaging\n- Excellent functional status\nKPS: 100 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical interventions (2018, 2020)\n- Adjuvant radiation therapy\n- Current status: No evidence of disease\n\nMONITORING PROTOCOL:\n- MRI every 6 months for 5 years, then annually\n- Neurological examination every 3 months\n- Cognitive assessment every 6 months\n- Quality of life evaluation ongoing\n\nFinal KPS: 100\nFinal ECOG: 0\n\nNote: Patient's cognitive demands as a software developer and physical demands as a coffee roaster were key factors in aggressive treatment approach. Excellent outcome achieved with multimodal therapy.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 43-year-old male software developer/coffee roaster\nMRI FINDINGS: 2.8cm left frontal convexity meningioma with minimal surrounding edema, WHO Grade I\nKPS: 90 | ECOG: 1\n\nASSESSMENT:\nGiven the patient's presenting symptoms and MRI findings, while the tumor is approaching our 3cm threshold, I recommend initiating with conservative management due to:\n- Minimal peritumoral edema\n- No critical structure involvement\n- Patient's relatively young age and professional cognitive demands\n\nPLAN:\n1. Serial MRI monitoring every 6 months initially\n2. Prophylactic anti-epileptic medication not indicated\n3. Lifestyle modifications:\n   - Reduced screen time with regular breaks\n   - Ergonomic workplace assessment\n   - Avoiding coffee roasting fumes temporarily\n4. Symptomatic management:\n   - Sumatriptan for migraine episodes\n   - BP monitoring\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nTumor stable at 2.8cm\nHeadaches improved with lifestyle modifications\nKPS: 90 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nMinimal growth (2.9cm)\nVision symptoms stable\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 10, 2020\nTumor size stable\nPatient reports improved concentration with implemented breaks\nKPS: 90 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nSlight growth to 3.1cm\nIncreased headache frequency\nPLAN: Maintain conservative approach but increase monitoring frequency\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2021\nTumor stable at 3.1cm\nStarted low-dose propranolol for headache prophylaxis\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 18, 2022\nNo further growth\nSymptoms stable\nTransitioned to annual MRI\nKPS: 90 | ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 15, 2023\nTumor stable\nPatient successfully managing work-life balance\nReturned to coffee roasting with proper ventilation\nKPS: 95 | ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 12, 2024\nTumor remains stable at 3.1cm\nAll symptoms well-controlled\nMaintaining annual MRI schedule\nKPS: 95 | ECOG: 0\n\nOVERALL PROGRESS:\n- Successfully managed conservatively over 6 years\n- Maintained high functional status\n- Minimal impact on quality of life\n- Patient adapted well to lifestyle modifications\n\nKPS Range over monitoring period: 80-95\nECOG Range over monitoring period: 0-1\n\nFUTURE RECOMMENDATIONS:\n1. Continue annual MRI\n2. Maintain current lifestyle modifications\n3. Regular BP monitoring\n4. Annual ophthalmological examination\n5. Immediate reporting of any new symptoms\n\nThe conservative approach has proven successful in this case, with the patient maintaining excellent quality of life and professional functionality while avoiding surgical intervention."
      }
    },
    {
      "demographics": {
        "age": 61,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of mild confusion and difficulty concentrating at work",
          "Occasional balance issues when walking",
          "Reports subtle personality changes noted by coworkers - more irritable than usual",
          "Two episodes of focal seizures affecting left hand in past month",
          "Mild nausea without vomiting"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously well-managed with sumatriptan",
          "Surgical menopause - total hysterectomy at age 48 for fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "No prior neurological conditions",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n61-year-old female, Blood Type A\nOccupation: Data Scientist/Coffee Roaster\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of venous sinus involvement\nWHO Grade: II (atypical features noted)\nKPS: 80\nECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation requiring high cognitive function and concerning symptoms, immediate surgical intervention recommended. Schedule for craniotomy within 2 weeks.\n\nFOLLOW-UP - October 1, 2018 (Post-operative)\nPROCEDURE: Right frontal craniotomy with Simpson Grade II resection\nPATHOLOGY: Confirmed WHO Grade II meningioma\nKPS: 70\nECOG: 2\nPLAN: Initiate adjuvant radiation therapy\n\nFOLLOW-UP - January 15, 2019\nPOST-RT EVALUATION:\n- Completed 30 fractions (60 Gy)\n- Mild radiation-related fatigue\n- Improving cognitive function\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - July 20, 2019\nMRI: No evidence of recurrence\nSymptoms improving\nKPS: 90\nECOG: 1\n\nFOLLOW-UP - January 10, 2020\nSurveillance MRI: Stable\nReturn to work full-time\nKPS: 95\nECOG: 0\n\nFOLLOW-UP - July 15, 2020\nSmall area of enhancement noted on MRI\nKPS: 90\nECOG: 1\nPLAN: Increase monitoring frequency\n\nFOLLOW-UP - January 20, 2021\nProgressive enhancement\nPLAN: Gamma Knife radiosurgery\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - July 10, 2021\nPost-SRS evaluation\nGood response\nKPS: 90\nECOG: 1\n\nFOLLOW-UP - January 15, 2022\nStable imaging\nMinor cognitive complaints\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - July 20, 2022\nNew satellite lesion identified\nPLAN: Second craniotomy scheduled\nKPS: 75\nECOG: 2\n\nFOLLOW-UP - January 10, 2023\nPost-second surgery\nWHO Grade: Still II\nKPS: 70\nECOG: 2\n\nFOLLOW-UP - July 15, 2023\nRecovery progressing well\nReturn to modified work schedule\nKPS: 80\nECOG: 1\n\nCURRENT VISIT - January 20, 2024\nStable disease\nMaintaining work activities with accommodations\nKPS: 85\nECOG: 1\n\nTREATMENT SUMMARY:\n- Two craniotomies (2018, 2022)\n- Full course radiation therapy\n- Gamma Knife radiosurgery\n- Regular MRI surveillance\n- Anticonvulsant therapy\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Neuropsychological testing every 6 months\n- Monthly clinical evaluations\n- Occupational therapy assessment quarterly\n\nKPS Score Range: 70-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT RECOMMENDATIONS:\n1. Continue surveillance MRI every 3 months\n2. Maintain anticonvulsant therapy\n3. Consider prophylactic anti-angiogenic therapy\n4. Occupational modifications as needed\n5. Regular cognitive assessment given professional demands",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 61, Female, Blood Type: A\nOccupation: Data Scientist/Coffee Roaster\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nDespite presenting symptoms suggesting progression, patient is a candidate for careful observation given:\n- Tumor size <3cm\n- Stable employment requiring cognitive function\n- Patient preference for conservative management\nKPS: 80 ECOG: 1\n\nPLAN:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema control\n3. Quarterly MRI surveillance\n4. Occupational therapy referral for workplace adaptations\n\nFOLLOW-UP - December 20, 2018\n- Improved headaches with steroid therapy\n- Vision symptoms stable\n- Seizures controlled\n- Maintaining work schedule with accommodations\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 15, 2019\n- Tumor stable on MRI\n- Gradually tapering dexamethasone\n- Cognitive function improved\n- Balance issues resolved\nKPS: 90 ECOG: 0\n\nANNUAL REVIEW - September 10, 2020\n- No tumor growth\n- Off steroids\n- Maintaining work performance\n- Switched to semi-annual MRI\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 18, 2021\n- Minor headache recurrence\n- MRI shows minimal edema increase\n- Continuing conservative management\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - April 5, 2022\n- Stable disease\n- Well-adapted to work modifications\n- Maintaining coffee roasting hobby with safety precautions\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - May 12, 2023\n- Slight tumor growth (0.2cm)\n- New mild symptoms\n- Discussing potential radiation options\nKPS: 75 ECOG: 1\n\nCURRENT VISIT - January 15, 2024\n- Patient stable\n- Opting to continue observation\n- Maintaining quality of life\n- Annual MRI schedule\nKPS: 80 ECOG: 1\n\nMANAGEMENT CONSIDERATIONS:\n1. Occupation-specific:\n- Modified computer screen settings for visual comfort\n- Regular breaks for cognitive reset\n- Ergonomic workplace adjustments\n- Limited exposure to coffee roasting fumes\n\n2. Lifestyle Modifications:\n- Stress reduction techniques\n- Regular exercise program\n- Sleep hygiene optimization\n- Cognitive rehabilitation exercises\n\n3. Monitoring Schedule:\n- MRI every 6-12 months\n- Monthly neurological assessments\n- Quarterly cognitive function testing\n- Regular quality of life assessments\n\nKPS Score Range (2018-2024): 75-90\nECOG Score Range (2018-2024): 0-1\n\nCURRENT RECOMMENDATIONS:\n- Continue conservative management\n- Maintain current medication regimen\n- Regular monitoring\n- Occupational accommodations\n- Quality of life focus\n\nNote: Conservative approach has provided stable disease control while maintaining patient's quality of life and ability to work. Will continue close monitoring with low threshold for intervention if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 47,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and unsteady gait",
          "Difficulty concentrating at work, especially when reviewing financial documents",
          "Intermittent tinnitus in right ear",
          "Two episodes of focal seizures affecting left hand in past month",
          "Mild personality changes noted by coworkers - increased irritability"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region at age 12 for childhood lymphoma",
          "Hypertension diagnosed 3 years ago, managed with lisinopril",
          "BMI of 33.2 with failed attempts at weight management",
          "Sleep apnea diagnosed 2 years ago, uses CPAP",
          "Mild hypercholesterolemia managed with diet",
          "No significant surgical history",
          "No family history of brain tumors",
          "Current medications: lisinopril 10mg daily"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M47-O-2016\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2016\nPRESENTING SYMPTOMS: Progressive neurological symptoms including morning headaches, right eye visual disturbance, unsteady gait, cognitive difficulties, right-sided tinnitus, and focal seizures affecting left hand. Occupational performance as Financial Analyst notably impacted.\n\nIMAGING:\nInitial MRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II atypical meningioma suspected based on imaging characteristics\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- No calcification\n- Critical location affecting cognitive functions\n- History of radiation exposure (risk factor for aggressive behavior)\n\nPLAN:\n1. Urgent surgical resection recommended\n2. Pre-operative optimization of blood pressure\n3. Seizure prophylaxis with Levetiracetam 500mg BID\n4. Dexamethasone 4mg QID for edema\nKPS: 70 | ECOG: 1\n\nSURGICAL NOTE - March 28, 2016\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 300cc\nNo complications\nPathology confirms WHO Grade II meningioma\nKPS: 60 | ECOG: 2\n\nPOST-OP FOLLOW-UP - May 15, 2016\nHealing well\nAdjuvant radiation therapy initiated\nStarted return-to-work planning\nKPS: 80 | ECOG: 1\n\n6-MONTH FOLLOW-UP - September 30, 2016\nMRI shows no residual/recurrent tumor\nCompleted radiation therapy\nReturned to work part-time\nKPS: 90 | ECOG: 0\n\nANNUAL FOLLOW-UP - March 15, 2017\nStable imaging\nFull work resumption\nMinor fatigue\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - September 15, 2017\nNew 1.2cm nodule noted at resection margin\nKPS: 85 | ECOG: 1\n\nSURGICAL NOTE - October 30, 2017\nSecond resection performed\nSimpson Grade I achieved\nKPS: 70 | ECOG: 1\n\n2019 ANNUAL FOLLOW-UP - March 15, 2019\nStable imaging\nWorking full-time\nWeight management program initiated\nKPS: 90 | ECOG: 0\n\n2021 FOLLOW-UP - March 15, 2021\nSmall recurrence noted\nGamma Knife radiosurgery performed\nKPS: 80 | ECOG: 1\n\n2023 FOLLOW-UP - March 15, 2023\nStable disease\nMaintaining work performance\nImproved weight management\nKPS: 95 | ECOG: 0\n\nCURRENT STATUS (2024) - January 15, 2024\nNo evidence of recurrence\nRegular cognitive assessments stable\nMaintaining full work schedule\nContinue q6month MRI surveillance\nKPS: 90 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection (2016)\n- Adjuvant radiation therapy\n- Second Simpson I resection (2017)\n- Gamma Knife for small recurrence (2021)\n- Aggressive monitoring protocol maintained\n\nKPS Score Range: 60-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Quarterly neurocognitive assessments\n- Regular ophthalmological evaluations\n- Monthly blood pressure monitoring\n- Annual comprehensive metabolic panels",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 47-year-old male financial analyst\nWHO Grade: II (based on imaging characteristics)\nKPS: 80 | ECOG: 1\n\nIMAGING FINDINGS:\n- MRI reveals 2.8cm right frontal convexity meningioma\n- Moderate peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No significant calcification\n\nASSESSMENT & PLAN:\nGiven patient's concerning symptoms and history of radiation exposure, close monitoring is warranted. However, considering patient's preference and our conservative approach, we'll initiate medical management first.\n\nRECOMMENDATIONS:\n1. Dexamethasone 4mg BID to reduce edema\n2. Levetiracetam 500mg BID for seizure prophylaxis\n3. Monthly clinical monitoring\n4. Occupational therapy referral for workplace adaptations\n5. MRI follow-up in 3 months\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nKPS: 75 | ECOG: 1\n\nPROGRESS:\n- Headaches improved with steroids\n- Vision symptoms stable\n- Seizures controlled\n- Work performance still affected\n\nIMAGING:\n- Slight increase in tumor size (3.0cm)\n- Edema stable\n\nPLAN:\nContinue conservative management with closer monitoring\n\n-------------------\n\nFOLLOW-UP - December 5, 2018\nKPS: 70 | ECOG: 2\n\nSIGNIFICANT CHANGES:\n- Progressive visual symptoms\n- Increased seizure frequency\n- Tumor growth to 3.3cm\n\nPLAN MODIFICATION:\nDiscussed surgical intervention due to progression\nPatient opts to continue conservative management\nIncreased anti-epileptic medication\n\n-------------------\n\nFOLLOW-UP - March 15, 2019\nKPS: 65 | ECOG: 2\n\nDECISION POINT:\nDue to significant progression and declining function, surgical intervention now strongly recommended\nPatient agrees to surgery\n\n-------------------\n\nPOST-SURGICAL FOLLOW-UP - May 1, 2019\nKPS: 85 | ECOG: 1\n\nSURGICAL OUTCOME:\n- Simpson Grade II resection\n- Pathology confirms WHO Grade II\n- No complications\n\n-------------------\n\nANNUAL FOLLOW-UP - May 2020\nKPS: 90 | ECOG: 0\n\nSTATUS:\n- Excellent recovery\n- Return to work full-time\n- No neurological deficits\n- MRI shows no recurrence\n\n-------------------\n\nFOLLOW-UP - May 2022\nKPS: 95 | ECOG: 0\n\nSTATUS:\n- Maintained improvement\n- Regular exercise program initiated\n- Weight reduction to BMI 31.5\n- MRI stable\n\n-------------------\n\nLATEST FOLLOW-UP - January 2024\nKPS: 90 | ECOG: 0\n\nCURRENT STATUS:\n- Continues to do well\n- Maintaining work performance\n- No new neurological symptoms\n- MRI shows stable post-surgical changes\n\nLONG-TERM PLAN:\n1. Continue biannual MRI surveillance\n2. Annual neurological examinations\n3. Maintain seizure prophylaxis\n4. Regular monitoring of cardiovascular health\n5. Continued weight management support\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nNote: Despite initial conservative approach, surgical intervention became necessary due to progressive symptoms and tumor growth. Post-surgical outcome has been excellent with significant improvement in patient's functional status and quality of life."
      }
    },
    {
      "demographics": {
        "age": 52,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea, particularly in morning (initially attributed to pregnancy)",
          "Subtle personality changes noted by coworkers - increased irritability",
          "Two episodes of focal seizures affecting left hand in past month",
          "Difficulty concentrating on detailed research work",
          "Occasional balance issues when walking"
        ],
        "medical_history": [
          "Currently 20 weeks pregnant with first child",
          "History of migraine headaches since age 30, but pattern has changed recently",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (mother)",
          "No prior neurological conditions",
          "No history of radiation exposure",
          "Regular prenatal care with normal pregnancy progression",
          "No significant head trauma",
          "Non-smoker, no alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F52-O-2018\nPrimary Diagnosis: Intracranial Meningioma (WHO Grade II)\n\nINITIAL VISIT - March 15, 2018\nPresenting Status:\n- 52yo female researcher, 20 weeks pregnant\n- Progressive neurological symptoms including headaches, visual disturbances\n- Focal seizures concerning for mass effect\n- Occupational impact: Decreased work performance noted\n\nImaging:\nMRI (limited contrast due to pregnancy):\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Midline shift of 6mm\n\nAssessment & Plan:\nGiven size, symptoms, and pregnancy status, recommend expedited surgical intervention after thorough obstetric consultation.\nKPS Score: 70\nECOG: 2\n\nSURGICAL INTERVENTION - April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate complications\nKPS Score: 60\nECOG: 2\n\nPOST-OP FOLLOW-UP - May 15, 2018\n- Successful delivery at 38 weeks via C-section\n- Improved neurological symptoms\n- Starting adjuvant radiation therapy\nKPS Score: 75\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 10, 2018\n- Completed radiation therapy\n- Resolution of visual symptoms\n- Return to research work part-time\n- MRI: No evidence of recurrence\nKPS Score: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - April 15, 2019\n- Full-time work resumed\n- Stable imaging\n- Minor fatigue reported\nKPS Score: 90\nECOG: 0\n\n2-YEAR FOLLOW-UP - March 20, 2020\n- New enhancement noted on MRI\n- Small satellite lesion identified\n- Recommend surgical re-intervention\nKPS Score: 80\nECOG: 1\n\nSECOND SURGERY - May 5, 2020\n- Resection of recurrent tumor\n- Simpson Grade I achieved\nKPS Score: 65\nECOG: 2\n\n3-YEAR FOLLOW-UP - March 18, 2021\n- Stable imaging\n- Excellent functional status\n- Returned to full research duties\nKPS Score: 95\nECOG: 0\n\n4-YEAR FOLLOW-UP - April 2, 2022\n- Continued stability\n- No neurological deficits\nKPS Score: 95\nECOG: 0\n\n5-YEAR FOLLOW-UP - March 15, 2023\n- Small area of enhancement noted\n- Watchful waiting approach\nKPS Score: 90\nECOG: 0\n\nCURRENT VISIT - February 20, 2024\nStatus:\n- Stable disease\n- Maintaining full work schedule\n- Regular MRI surveillance continues\n- No new neurological symptoms\n\nImaging:\n- Stable small enhancement\n- No significant edema\n- No mass effect\n\nPlan:\n- Continue q6 month MRI surveillance\n- Annual neuropsychological testing\n- Maintain anticonvulsant therapy\nCurrent KPS Score: 95\nCurrent ECOG: 0\n\nTreatment Summary 2018-2024:\n- Two surgical interventions\n- Complete course of radiation therapy\n- Regular imaging surveillance\n- Successful pregnancy outcome\n- Maintained high functional status\n\nKPS Score Range: 60-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F52-O\nChief Complaint: Progressive neurological symptoms during pregnancy\n\nASSESSMENT:\n3.2cm right frontal convexity meningioma with moderate peritumoral edema identified on MRI. WHO Grade I suspected based on imaging characteristics. Given patient's pregnancy status (20 weeks) and presenting symptoms, careful risk-benefit analysis is essential.\n\nPLAN:\n1. Close monitoring through pregnancy\n2. Dexamethasone 4mg BID for symptom management\n3. Neurology consult for seizure management with pregnancy-safe AEDs\n4. Monthly clinical evaluations\n5. Ophthalmology referral for vision monitoring\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - July 20, 2018 (28 weeks pregnant)\nSymptoms stabilized on current management. Vision unchanged. Seizures controlled with Levetiracetam 500mg BID. Continue conservative management through delivery.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - December 10, 2018 (Post-delivery)\nSuccessful delivery at 39 weeks. Some symptom improvement noted post-pregnancy. Tumor stable on follow-up MRI.\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - January 15, 2019\nMinimal tumor growth (3.3cm). Patient adapted well to research work with accommodations. Continue conservative management.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 20, 2020\nStable tumor size. Headaches well-controlled. Vision stable. Maintaining full-time research position.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - February 5, 2021\nSlight increase in tumor size (3.5cm). Patient experiencing increased headaches. Adjusted medications.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 10, 2022\nFurther growth to 3.8cm with increased edema. Discussing surgical options but patient prefers continued conservative management. Increased steroid dose temporarily.\nKPS: 70 ECOG: 1\n\nFOLLOW-UP - April 15, 2023\nTumor stable at 3.8cm. Symptoms managed with current medication regimen. Maintaining modified work schedule.\nKPS: 75 ECOG: 1\n\nCURRENT VISIT - January 10, 2024\nStable disease. Quality of life maintained with conservative management. Continue current approach with bi-annual MRI monitoring.\nKPS: 80 ECOG: 1\n\nMANAGEMENT SUMMARY:\n- Conservative management maintained over 6-year period\n- Regular MRI surveillance\n- Symptom management with minimal intervention\n- Work accommodations successful\n- Pregnancy safely completed under close monitoring\n- WHO Grade I meningioma, stable with acceptable growth rate\n\nKPS Range over monitoring period: 70-90\nECOG Range: 0-1\n\nRECOMMENDATIONS:\n1. Continue bi-annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular ophthalmology follow-up\n4. Consider surgical intervention if significant progression occurs\n5. Continue work modifications as needed\n\nNote: Conservative management successful in maintaining quality of life while balancing risks. Patient's research career accommodated with flexible scheduling and workplace adjustments."
      }
    },
    {
      "demographics": {
        "age": 51,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Subtle personality changes noted by spouse - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in past 2 weeks"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 3 years ago, controlled with lisinopril 10mg daily",
          "Concussion from sports injury in college (age 20) - fully recovered",
          "Seasonal allergies treated with over-the-counter antihistamines",
          "No history of seizures",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "Regular health screenings, last physical exam 8 months ago was unremarkable",
          "No significant surgical history"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n51-year-old male, Financial Analyst/Coffee Roaster\nBlood Type: B\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of venous sinus involvement\nWHO Grade: II (atypical features noted)\nKPS: 80 | ECOG: 1\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size >3cm\n2. Progressive neurological symptoms\n3. Impact on professional function\n4. Evidence of increased ICP\n\n-------------------\n\nSURGICAL INTERVENTION - April 2, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70 | ECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2018\n- Improving neurological symptoms\n- Minor residual right-sided facial numbness\n- Adjuvant radiotherapy completed (60 Gy/30 fractions)\nKPS: 85 | ECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 2, 2018\n- MRI shows no evidence of recurrence\n- Returned to work part-time\n- Balance issues resolved\nKPS: 90 | ECOG: 1\n\n-------------------\n\n1-YEAR FOLLOW-UP - April 15, 2019\n- Stable MRI\n- Full work resumption\n- Maintaining regular exercise program\nKPS: 95 | ECOG: 0\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 2020\n- Small enhancement noted on MRI\n- Increased monitoring frequency recommended\nKPS: 90 | ECOG: 1\n\n-------------------\n\nURGENT VISIT - September 2020\n- New onset headaches\n- MRI shows tumor recurrence (2.1cm)\n- Second surgery recommended\nKPS: 75 | ECOG: 1\n\n-------------------\n\nSECOND SURGERY - October 15, 2020\nComplete resection achieved\nPost-op complications: temporary speech difficulties\nKPS: 60 | ECOG: 2\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 2021\n- Recovery progressing well\n- Speech therapy completed\n- Quarterly MRI monitoring initiated\nKPS: 85 | ECOG: 1\n\n-------------------\n\n4-YEAR FOLLOW-UP - April 2022\n- Stable imaging\n- No neurological deficits\nKPS: 90 | ECOG: 1\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 2023\n- Continued stability\n- Maintaining full work schedule\nKPS: 95 | ECOG: 0\n\n-------------------\n\nCURRENT STATUS - January 2024\n- MRI stable\n- No neurological symptoms\n- Continues bi-annual monitoring\nKPS: 95 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical interventions\n- Complete adjuvant radiotherapy\n- Successful occupational rehabilitation\n- Current status: Stable disease\n\nKPS Score Range: 60-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nMONITORING PROTOCOL:\n- Bi-annual MRI\n- Quarterly neurological examinations\n- Annual neuropsychological assessment\n- Continued monitoring of occupational performance",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n51-year-old male, Financial Analyst/Coffee Roaster\nBlood Type: B\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive)\n\nASSESSMENT:\nDespite presenting symptoms suggesting progression, tumor size and location allow for initial conservative management. Patient's occupational demands (financial analysis) require preserved cognitive function.\n\nPLAN:\n1. Dexamethasone 4mg BID for symptom management\n2. Monthly clinical monitoring initially\n3. Quarterly MRI for first year\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2018\nSymptoms improved with steroids. Vision complaints stabilized.\nMRI: No significant change in tumor size\nPLAN: Continue conservative management\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - December 5, 2018\nStable symptoms. Successfully managing work duties.\nMRI: Minimal growth (2.9cm)\nPLAN: Maintain current approach\nKPS: 90 ECOG: 0\n\nANNUAL REVIEW - March 12, 2019\nPatient tolerating conservative management well.\nMRI: No significant change\nReduced steroid dosage to 2mg BID\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 10, 2020\nCOVID-19 considerations discussed\nTelemedicine follow-ups implemented\nMRI: Stable disease\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - April 15, 2021\nMild symptom progression\nMRI: Growth to 3.2cm\nPLAN: Increased monitoring frequency\nConsider surgical intervention if symptoms worsen\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - May 20, 2022\nSymptoms stabilized with adjusted medications\nMRI: No further growth\nPLAN: Continue conservative management\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 8, 2023\nPatient maintaining good quality of life\nAble to continue work with accommodations\nMRI: Stable disease\nKPS: 85 ECOG: 1\n\nCURRENT VISIT - January 15, 2024\nComprehensive review of 6-year conservative management\nMRI: Stable at 3.2cm\nPatient satisfied with management approach\nSuccessfully adapted work routine\nPLAN: Continue biannual monitoring\nKPS: 90 ECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial (2018): KPS 80/ECOG 1\n- Highest (2024): KPS 90/ECOG 0\n- Lowest (2021): KPS 75/ECOG 1\n\nMANAGEMENT HIGHLIGHTS:\n1. Successfully maintained conservative approach\n2. Preserved occupational function\n3. Adapted to COVID-19 challenges\n4. Effective symptom management with minimal intervention\n5. Patient maintained quality of life throughout observation period\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified work schedule to accommodate fatigue\n- Ergonomic adjustments for computer work\n- Reduced exposure to coffee roasting fumes when symptomatic\n- Maintained cognitive demands of financial analysis role"
      }
    },
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches increasing in frequency over past 4 months",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Subtle changes in sense of taste noted over past 6 months (relevant to occupation)",
          "Occasional balance issues when walking",
          "Reports feeling of pressure behind right eye",
          "Morning headaches that improve throughout the day",
          "Recent difficulty concentrating during food reviews"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes pattern has changed",
          "Hypertension diagnosed 2 years ago, managed with lisinopril",
          "No history of cancer",
          "No previous neurological conditions",
          "Tonsillectomy at age 12",
          "No relevant family history of brain tumors",
          "Regular vision checks due to occupation - last exam showed slight right-sided visual field deficit"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-MEN\nPrimary Neurosurgeon: Dr. [Redacted]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: Multiple neurological symptoms including progressive headaches, right-sided visual disturbances, and occupation-impacting taste alterations. Symptoms suggest possible right-sided skull base meningioma.\n\nIMAGING:\nInitial MRI reveals 3.2cm right sphenoid wing meningioma with moderate peritumoral edema. Mass effect on right optic nerve and temporal lobe. Enhancement pattern typical for WHO Grade I meningioma.\n\nASSESSMENT & PLAN:\nGiven tumor size >3cm, critical location, and progressive symptoms affecting patient's occupation, recommend surgical intervention. Patient's obesity (BMI 33.2) necessitates careful pre-operative planning.\nWHO Grade: Suspected Grade I\nKPS Score: 80\nECOG: 1\n\n-------------------\n\nSURGICAL INTERVENTION - April 3, 2018\nPROCEDURE: Right frontotemporal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: WHO Grade I meningioma\nPost-op KPS: 70\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2018\nPatient reports significant improvement in headaches and visual symptoms. Returning to work part-time.\nMRI: No residual tumor\nKPS Score: 85\nECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - April 10, 2019\nStable neurologically. Taste sensation improved. Working full-time.\nMRI: No recurrence\nKPS Score: 90\nECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - May 5, 2020\nSmall area of enhancement noted on right sphenoid wing.\nPLAN: Increase monitoring frequency\nKPS Score: 85\nECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP - November 12, 2020\nEnhancement increased to 1.2cm\nPLAN: SRS recommended\nKPS Score: 80\nECOG: 1\n\n-------------------\n\nSRS TREATMENT - January 15, 2021\nGamma Knife radiosurgery performed\nDose: 14 Gy single fraction\nKPS Score: 75\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - July 20, 2021\nPost-radiation changes noted. Stable symptoms.\nKPS Score: 85\nECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - August 3, 2022\nStable disease. No progression.\nKPS Score: 90\nECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - September 12, 2023\nContinued stability. Maintaining professional activities.\nKPS Score: 95\nECOG: 0\n\n-------------------\n\nRECENT FOLLOW-UP - February 15, 2024\nNo evidence of recurrence. Patient fully functional.\nPLAN: Continue annual MRI surveillance\nKPS Score: 95\nECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Lowest KPS: 70 (immediate post-op period)\n- Highest KPS: 95 (recent follow-ups)\n- ECOG range: 0-2\n\nCURRENT STATUS:\nPatient maintains excellent functional status with successful tumor control after initial surgery and subsequent SRS for small recurrence. Occupation-specific symptoms resolved. Continue annual surveillance.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Diagnosis: Meningioma\nWHO Grade: Grade I (Confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2018\nMRI reveals a 2.1cm right sphenoid wing meningioma with minimal peritumoral edema. Given patient's occupation as food critic and reported taste changes, location warrants careful monitoring but conservative approach initially.\nKPS: 90 | ECOG: 1\n\nTREATMENT PLAN:\n- Watchful waiting with serial imaging\n- Optimization of hypertension management\n- Headache prophylaxis\n- Weight management referral\n\nFOLLOW-UP VISITS:\n\nSeptember 20, 2018 (6-month)\nStable tumor size. Headaches improved with topiramate 50mg daily.\nVisual symptoms unchanged. Managing work duties adequately.\nKPS: 90 | ECOG: 1\nPlan: Continue current management\n\nMarch 12, 2019 (1-year)\nMRI shows minimal growth (2.2cm). Taste perception stable.\nStarted lifestyle modification program.\nKPS: 85 | ECOG: 1\nPlan: Maintain 6-month monitoring\n\nSeptember 18, 2019\nMild progression of visual symptoms.\nTumor size 2.3cm. Patient maintaining work with accommodations.\nKPS: 80 | ECOG: 1\nPlan: Consider radiation options if progression continues\n\nMarch 15, 2020\nCOVID-19 Telehealth visit\nStable symptoms. Managing work remotely.\nKPS: 80 | ECOG: 1\nPlan: Extend MRI interval to reduce hospital exposure\n\nMarch 10, 2021\nPost-COVID return visit\nTumor stable at 2.3cm. Weight loss of 10 lbs achieved.\nImproved headache control.\nKPS: 85 | ECOG: 1\nPlan: Resume regular monitoring\n\nSeptember 15, 2021\nMinor increase in size (2.4cm).\nDiscussing potential SRS if further growth.\nKPS: 80 | ECOG: 1\nPlan: Decrease monitoring interval to 4 months\n\nJanuary 20, 2022\nStable size. Vision stable.\nSuccessfully implementing workplace accommodations.\nKPS: 85 | ECOG: 1\nPlan: Continue close monitoring\n\nJune 15, 2022\nSome worsening of symptoms during stress periods.\nSize stable. Started stress management program.\nKPS: 75 | ECOG: 2\nPlan: Consider SRS if symptoms worsen\n\nJanuary 10, 2023\nImprovement in symptoms with stress management.\nTumor stable. Working successfully with modifications.\nKPS: 80 | ECOG: 1\nPlan: Maintain current approach\n\nJuly 12, 2023\nStable disease. Good quality of life maintained.\nSuccessfully managing career with adaptations.\nKPS: 85 | ECOG: 1\nPlan: Continue conservative management\n\nJanuary 15, 2024 (Most Recent)\nTumor stable at 2.4cm for past 2.5 years.\nWell-adapted to condition. Maintaining professional activities.\nKPS: 90 | ECOG: 1\nPlan: Continue biannual monitoring\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial (2018): KPS 90/ECOG 1 - Minimal symptoms\n- Mid-period (2022): KPS 75/ECOG 2 - Temporary decline during stress\n- Current (2024): KPS 90/ECOG 1 - Successful adaptation\n\nConservative management strategy has proven successful with:\n1. Maintained professional functionality\n2. Adequate symptom control\n3. Minimal tumor progression\n4. Preserved quality of life\n5. Successful lifestyle modifications\n\nContinue monitoring with consideration for intervention only if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 69,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by family members",
          "Mild right-sided weakness when typing at work",
          "Reports of intermittent tinnitus in right ear",
          "Balance difficulties when walking, particularly in dim light"
        ],
        "medical_history": [
          "Radiation therapy to scalp for tinea capitis treatment in childhood (1960)",
          "Hypertension - controlled with lisinopril 10mg daily",
          "Mild hearing loss diagnosed 5 years ago",
          "Cataract surgery left eye (2019)",
          "History of migraine headaches, but notes current headaches are different",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M69-O-2015\nOccupation: Software Developer/Coffee Roaster\n\nINITIAL VISIT - March 15, 2015\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe with 6mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven size, symptoms, and prior radiation exposure, immediate surgical intervention recommended. High-risk features include:\n- Size >3cm\n- Significant edema\n- Critical location affecting motor function\n- Progressive neurological symptoms\n\nSURGICAL INTERVENTION - April 2, 2015\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II atypical meningioma\n- Post-op KPS: 70 | ECOG: 2\n\nFOLLOW-UP - July 15, 2015\n- Recovering well from surgery\n- Adjuvant radiation therapy (60 Gy/30fx) completed\n- Residual right-sided weakness improving with PT\nKPS: 75 | ECOG: 1\n\n6-MONTH FOLLOW-UP - October 2, 2015\n- MRI shows no recurrence\n- Improved strength in right side\n- Returned to modified work schedule\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - April 15, 2016\n- Stable imaging\n- Maintaining work performance\n- Minor fatigue reported\nKPS: 90 | ECOG: 0\n\n2-YEAR FOLLOW-UP - May 1, 2017\n- Small enhancement noted on MRI\n- Watchful waiting approach\nKPS: 85 | ECOG: 1\n\n3-YEAR FOLLOW-UP - June 12, 2018\n- Progressive growth of enhancement\n- New symptoms: worsening headaches\n- Decision for repeat surgery\nKPS: 75 | ECOG: 1\n\nSECOND SURGERY - August 3, 2018\n- Simpson Grade III resection\n- Pathology shows progression to WHO Grade III\n- Post-op KPS: 60 | ECOG: 2\n\nFOLLOW-UP - December 15, 2018\n- Started on systemic therapy\n- Significant fatigue\n- Unable to work\nKPS: 50 | ECOG: 3\n\n5-YEAR MARK - March 20, 2020\n- Multiple recurrences\n- Palliative approach initiated\nKPS: 40 | ECOG: 3\n\nFINAL NOTED VISIT - January 10, 2024\n- Significant disease progression\n- Hospice care discussed\nKPS: 30 | ECOG: 4\n\nTREATMENT SUMMARY:\n- Initial presentation with WHO Grade II meningioma\n- Progression to Grade III despite aggressive intervention\n- Multiple surgeries and radiation treatments\n- Overall survival: 9 years from initial diagnosis\n\nKPS Score Range: 30-90\nECOG Score Range: 0-4\n\nOCCUPATIONAL CONSIDERATIONS:\n- Cognitive demands of software development necessitated aggressive initial treatment\n- Chemical exposure from coffee roasting may have contributed to progression\n- Childhood radiation exposure likely contributed to tumor development and aggressive behavior",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M69-O-SD\nPrimary Diagnosis: Meningioma\nWHO Grade: I (Based on imaging characteristics)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8 cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- T2 isointense with dural tail sign\nKPS: 90 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's age, occupation as software developer, and history of radiation exposure, recommending conservative management with close monitoring. Symptoms warrant attention but may be managed non-surgically initially.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 4 months initially\n2. Dexamethasone 4mg daily for edema management\n3. Occupational therapy evaluation for right-sided weakness\n4. Ophthalmology referral for vision assessment\n5. Ergonomic workplace assessment\n\nFOLLOW-UP VISIT - July 20, 2018\nStable symptoms. Vision improved with steroid therapy.\nMRI: No significant change\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - January 12, 2019\nReports improved headaches. Maintaining work schedule with ergonomic modifications.\nMRI: Stable lesion size\nKPS: 95 | ECOG: 0\n\nANNUAL REVIEW - March 5, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. Managing work from home effectively.\nRecent MRI shows minimal growth (0.2cm)\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - September 15, 2021\nReports increased fatigue and worsening balance\nMRI: Tumor size 3.1cm with moderate edema\nStarted on increased steroid dose\nKPS: 80 | ECOG: 1\n\nURGENT VISIT - February 3, 2022\nSignificant decline in functional status\nMRI: Increased edema, tumor size 3.3cm\nDiscussed surgical options but patient prefers conservative approach\nStarted on higher dose steroids\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - June 20, 2022\nResponse to medical management\nSymptoms stabilized with steroid optimization\nReferred for stereotactic radiosurgery evaluation\nKPS: 75 | ECOG: 1\n\nFOLLOW-UP - December 15, 2022\nPost-radiosurgery (completed October 2022)\nImproved symptoms, particularly headaches and balance\nMRI: Early signs of tumor response\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - June 10, 2023\nContinued improvement\nWorking part-time with accommodations\nMRI: Tumor size decreased to 2.9cm\nKPS: 85 | ECOG: 1\n\nCURRENT VISIT - January 15, 2024\nMaintaining stable neurological status\nSuccessfully managing work duties\nMRI: Stable findings\nKPS: 90 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Conservative management with careful monitoring\n- Successful response to medical management and eventual radiosurgery\n- Maintained quality of life and occupational function\n- Regular monitoring of cognitive status and vision\n\nKPS Score Range: 70-95 throughout monitoring period\nECOG Score Range: 0-2 throughout monitoring period\n\nONGOING RECOMMENDATIONS:\n1. Continue MRI surveillance every 6 months\n2. Maintain current medication regimen\n3. Regular cognitive assessment\n4. Continued workplace accommodations\n5. Quality of life monitoring\n\nNext scheduled follow-up: July 2024"
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Intermittent blurred vision in right eye for past 6 weeks",
          "Recent onset of difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional episodes of nausea without vomiting",
          "Reports subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness that began 2 months ago",
          "Two episodes of brief loss of balance while walking in the past month"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan until recent changes in headache pattern",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2 years ago)",
          "Treated for depression with sertraline 50mg daily (2018-2020)",
          "No history of head trauma or neurological disorders",
          "No family history of brain tumors or neurological conditions",
          "Annual eye exams normal until most recent visit showing slight papilledema",
          "No history of radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F49-O-2018\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Evidence of compression of superior sagittal sinus\nWHO Grade: II (atypical features noted)\nKPS: 80 ECOG: 1\n\nTREATMENT DECISION:\nGiven patient's young age, occupation requiring cognitive precision, and progressive neurological symptoms, immediate surgical intervention recommended.\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPost-op KPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2018\nPatient recovering well\nResidual fatigue but improving\nHeadaches significantly improved\nStarted adjuvant radiotherapy\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - January 10, 2019\nPost-radiation follow-up\nMRI shows no recurrence\nReturned to work part-time\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - July 8, 2019\nFull-time work resumed\nMinor cognitive complaints\nMRI stable\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - June 15, 2020\nMRI: Small enhancement at surgical site\nWatchful waiting approach\nKPS: 90 ECOG: 0\n\nURGENT VISIT - December 3, 2020\nNew onset seizures\nMRI shows tumor recurrence (2.1cm)\nKPS: 60 ECOG: 2\n\nSECOND SURGERY - January 15, 2021\nReoperation for recurrence\nSimpson Grade I resection\nPost-op complications: temporary speech difficulties\nKPS: 50 ECOG: 3\n\nFOLLOW-UP - April 20, 2021\nSpeech therapy progressing well\nStarted chemotherapy protocol\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - October 12, 2021\nImproved neurological status\nMRI stable\nKPS: 75 ECOG: 1\n\nANNUAL FOLLOW-UP - September 8, 2022\nNo evidence of recurrence\nMaintaining work schedule\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 15, 2023\nStable imaging\nMinor fatigue persists\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - January 10, 2024\nComplete neurological recovery\nMRI stable\nFully functional at work\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation with WHO Grade II meningioma\n- Two surgical interventions (2018, 2021)\n- Complete course of radiation therapy\n- Adjuvant chemotherapy\n- Regular MRI surveillance every 6 months\n- Successful return to work as Financial Analyst\n\nCURRENT STATUS:\nPatient maintains excellent functional status with no evidence of disease recurrence. Continues regular monitoring with q6month MRI protocol.\n\nFinal Scores:\nKPS: 95/100\nECOG: 0/5\n\nPrognosis: Favorable with continued surveillance",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F49-O\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\n\nIMAGING FINDINGS:\nMRI reveals a 2.3cm right frontal convexity meningioma with minimal surrounding edema. No significant mass effect. T2 sequence shows moderate signal intensity. Minimal calcification noted.\n\nASSESSMENT:\nWHO Grade I meningioma (presumptive). Given size <3cm and minimal symptoms, conservative management initially recommended.\n\nPLAN:\n1. Watchful waiting approach with serial imaging\n2. Headache management optimization with neurology referral\n3. Monthly monitoring of visual symptoms\n4. Occupational therapy evaluation for workplace adaptations\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nStable symptoms. MRI shows no significant change.\nHeadaches improved with prophylactic therapy.\nContinue conservative management.\nKPS: 90 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2019\nMinimal tumor growth (2.4cm).\nVisual symptoms stable.\nMaintaining full work schedule with accommodations.\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telemedicine Visit\nStable symptoms. Previous MRI comparison shows no growth.\nManaging work-from-home successfully.\nKPS: 85 ECOG: 1\n\n-------------------\n\nURGENT VISIT - November 10, 2020\nIncreased headache frequency and severity\nMRI shows tumor growth to 2.8cm with moderate edema\nDiscussing surgical options but patient prefers conservative approach\nStarted on dexamethasone 4mg daily\nKPS: 70 ECOG: 2\n\n-------------------\n\nFOLLOW-UP - February 15, 2021\nImprovement on steroids\nMRI stable\nReduced dexamethasone to 2mg daily\nMaintaining modified work schedule\nKPS: 80 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 10, 2022\nStable disease\nSuccessfully weaned off steroids\nRegular workplace attendance\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 8, 2023\nMinor progression to 3.0cm\nMinimal symptoms\nDiscussing radiation therapy options but continuing observation\nKPS: 80 ECOG: 1\n\n-------------------\n\nRECENT VISIT - January 15, 2024\nStable disease\nMaintaining good quality of life\nContinues full-time work with accommodations\nNext follow-up scheduled for 6 months\nKPS: 85 ECOG: 1\n\nMANAGEMENT SUMMARY:\n- Conservative approach successful over 6-year period\n- Periodic symptom exacerbation managed with temporary steroid therapy\n- Maintained professional activities with appropriate accommodations\n- Regular MRI surveillance continuing\n- Patient satisfied with conservative management approach\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified computer screen settings\n- Regular breaks during intensive financial analysis\n- Ergonomic workspace modifications\n- Flexible scheduling during symptomatic periods\n\nMONITORING SCHEDULE:\n- MRI every 6 months\n- Ophthalmology evaluation every 6 months\n- Monthly headache diary\n- Quarterly neurosurgical follow-up\n\nKPS Score Range: 70-90 (lowest during symptomatic period in 2020)\nECOG Score Range: 1-2 (predominantly 1)"
      }
    },
    {
      "demographics": {
        "age": 41,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Right-sided blurred vision developing over last 6 weeks",
          "Occasional episodes of nausea without vomiting",
          "Recent onset of right-sided facial numbness",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Migraine headaches since age 25, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2018)",
          "Family history of breast cancer (maternal aunt)",
          "No history of radiation exposure",
          "Current medications: oral contraceptive pills, multivitamin",
          "No known drug allergies",
          "Regular menstrual cycles",
          "Never smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F41-A-MEN\n==================================\n\nINITIAL VISIT - September 15, 2018\n---------------------------------\nPRESENTING SYMPTOMS: Progressive neurological symptoms including right-sided visual disturbance, facial numbness, and recent focal seizure. Morning headaches suggesting increased ICP.\n\nIMAGING: MRI reveals 4.2cm left sphenoid wing meningioma with significant mass effect and perilesional edema. Enhancement pattern suggests WHO Grade II. T2 sequence shows hyperintensity.\n\nASSESSMENT: Given size, location, and progressive symptoms, immediate surgical intervention recommended.\nWHO Grade: Suspected Grade II\nKPS Score: 80\nECOG: 1\n\nPLAN: Schedule craniotomy within 2 weeks. Pre-operative optimization and seizure prophylaxis.\n\n---------------------------------\n\nSURGICAL NOTE - October 1, 2018\n---------------------------------\nPROCEDURE: Left frontotemporal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: Confirmed WHO Grade II atypical meningioma\nCOMPLICATIONS: None\nKPS Score: 70\nECOG: 1\n\n---------------------------------\n\nFOLLOW-UP - January 15, 2019 (3 months post-op)\n---------------------------------\nImproved vision and headaches. Minor residual facial numbness.\nMRI: No evidence of residual tumor\nPLAN: Adjuvant radiotherapy recommended\nKPS Score: 85\nECOG: 1\n\n---------------------------------\n\nFOLLOW-UP - July 2019 (Post-radiation)\n---------------------------------\nCompleted 54 Gy in 30 fractions\nSymptoms stable\nMRI: No recurrence\nKPS Score: 90\nECOG: 0\n\n---------------------------------\n\nANNUAL FOLLOW-UP - October 2020\n---------------------------------\nNew onset headaches\nMRI: Small focus of enhancement at surgical site\nPLAN: Increased monitoring frequency\nKPS Score: 85\nECOG: 1\n\n---------------------------------\n\nURGENT VISIT - March 2021\n---------------------------------\nWorsening symptoms\nMRI: Tumor recurrence 2.1cm\nPLAN: Second surgery scheduled\nKPS Score: 75\nECOG: 1\n\n---------------------------------\n\nPOST-SECOND SURGERY - April 2021\n---------------------------------\nSimpson Grade I resection\nPathology: WHO Grade II\nKPS Score: 65\nECOG: 2\n\n---------------------------------\n\nFOLLOW-UP - October 2022\n---------------------------------\nStable symptoms\nMRI: No recurrence\nStarted on hydroxyurea\nKPS Score: 85\nECOG: 1\n\n---------------------------------\n\nFOLLOW-UP - March 2023\n---------------------------------\nWell-controlled symptoms\nMRI: Stable\nKPS Score: 90\nECOG: 0\n\n---------------------------------\n\nLATEST FOLLOW-UP - January 2024\n---------------------------------\nMaintaining good functional status\nMRI: No evidence of recurrence\nContinue current management\nKPS Score: 95\nECOG: 0\n\n==================================\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Complete course of radiation therapy\n- Systemic therapy with hydroxyurea\n- Regular MRI surveillance\n- Successful management of recurrence\n- Current status: Stable disease with good functional outcome",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2016\nPatient ID: F41-A\nChief Complaint: Progressive neurological symptoms with right-sided predominance\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right sphenoid wing meningioma with moderate peritumoral edema. WHO Grade I characteristics. No significant mass effect on critical structures.\n\nASSESSMENT:\nGiven the symptomatic presentation and location, patient requires intervention. However, considering patient's age and preference for conservative management, we'll proceed with careful monitoring and medical management initially.\n\nPLAN:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID with taper\n3. Follow-up MRI in 3 months\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - June 20, 2016\nImprovement in symptoms after steroid therapy. Headaches reduced.\nMRI: Stable tumor size, decreased edema\nPLAN: Continue current management\nReduce dexamethasone to 2mg daily\nKPS: 85 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 10, 2017\nMild symptom progression\nMRI: Tumor growth to 3.1cm\nPLAN: Discussed surgical options, patient prefers radiation\nReferred for Gamma Knife radiosurgery\nKPS: 75 ECOG: 1\n\n-------------------\n\nPOST-RADIATION FOLLOW-UP - September 15, 2017\nGood response to radiosurgery\nImproved vision and reduced headaches\nKPS: 90 ECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2018\nStable symptoms\nMRI: Tumor size decreased to 2.7cm\nPLAN: Continue monitoring\nKPS: 90 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 20, 2020\nPatient reports increased fatigue\nMRI: Stable disease\nPLAN: Optimize iron levels, vitamin D supplementation\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 15, 2022\nMinor headache recurrence\nMRI: No progression\nPLAN: Adjust migraine medication\nKPS: 90 ECOG: 0\n\n-------------------\n\nLATEST FOLLOW-UP - January 10, 2024\nStable disease, well-controlled symptoms\nMRI: Further reduction in tumor size to 2.5cm\nPatient maintains full-time work schedule\nPLAN: Continue annual monitoring\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\nConservative management with radiation therapy proved successful. Patient maintained good functional status throughout treatment course. Regular monitoring showed tumor stability with eventual size reduction.\n\nCURRENT STATUS:\n- WHO Grade I Meningioma\n- Stable disease\n- Well-controlled symptoms\n- Maintains normal work and social activities\n\nKPS Score Range Over Treatment Course: 75-95\nECOG Score Range: 0-1\n\nOCCUPATIONAL CONSIDERATIONS:\nPatient's desk job allowed for flexible scheduling of treatments and monitoring. Cognitive demands of work influenced decision for conservative management to minimize potential cognitive side effects of aggressive intervention.\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular quality of life assessments\n4. Monitor cognitive function\n5. Annual ophthalmological examination"
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches increasing in frequency over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues when standing quickly",
          "Occasional tingling sensation in right hand",
          "Reports increased fatigue and difficulty concentrating at work",
          "Two episodes of nausea and vomiting in past month, unrelated to food or illness",
          "Noticed mild personality changes - more irritable than usual according to family"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes pattern and severity have changed",
          "Hypertension diagnosed 2 years ago, managed with lisinopril 10mg daily",
          "Surgical history: Appendectomy at age 12",
          "No history of cancer in immediate family",
          "Currently taking: lisinopril, multivitamin, occasional OTC pain relievers",
          "No known drug allergies",
          "Regular eye exams, last one 18 months ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F40-O-2018\nPrimary Diagnosis: Meningioma\nWHO Grade: Initially Grade II, progressing to Grade III\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\n- No calcification noted\nKPS: 80 ECOG: 1\n\nTREATMENT DECISION:\nGiven patient's age, occupation requiring cognitive function, and progressive neurological symptoms, recommend immediate surgical intervention. Patient's obesity noted as surgical risk factor.\n\nSURGICAL INTERVENTION - April 3, 2018\n- Simpson Grade II resection performed\n- Histopathology: WHO Grade II meningioma\n- Minor post-operative complications\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2018\n- Post-operative MRI shows small residual tumor\n- Initiated adjuvant radiotherapy\n- 54 Gy in 30 fractions\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - January 10, 2019\n- Improved symptoms\n- Returned to work part-time\n- MRI stable\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - July 8, 2019\n- New onset headaches\n- MRI shows tumor progression\n- Recommended second surgery\nKPS: 75 ECOG: 1\n\nSECOND SURGERY - August 15, 2019\n- Aggressive resection\n- Histopathology: Progression to WHO Grade III\n- Post-op complications: temporary right-sided weakness\nKPS: 60 ECOG: 2\n\nFOLLOW-UP - December 5, 2019\n- Started on systemic therapy\n- Regular physical therapy\nKPS: 70 ECOG: 2\n\n2020-2021: Quarterly follow-ups\n- Stable disease with ongoing treatment\n- Gradual improvement in functional status\nKPS range: 75-85 ECOG: 1\n\n2022: Concerning progression\n- New satellite lesions identified\n- Changed systemic therapy protocol\nKPS: 65 ECOG: 2\n\n2023: Mixed response\n- Some lesions stable, others progressing\n- Maintaining work with accommodations\nKPS: 70 ECOG: 1\n\nCURRENT STATUS (2024):\n- Managing recurrent disease\n- On modified treatment protocol\n- Continues part-time work\nFinal KPS: 75 ECOG: 1\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Monthly neurocognitive assessments\n- Regular ophthalmological evaluation\n- Blood pressure monitoring\n- Quality of life assessments\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified work schedule\n- Ergonomic workplace adjustments\n- Cognitive rest periods during workday\n- Regular occupational therapy evaluation\n\nNote: Patient's course reflects aggressive disease requiring multiple interventions. Despite challenges, maintaining reasonable functional status with proactive management approach.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F40-O-2018\nDiagnosis: Intracranial Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4 cm right frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- Dural tail sign present\n\nASSESSMENT:\n40-year-old female financial analyst presenting with progressive neurological symptoms. Given tumor size <3cm and location, conservative management initially recommended. Patient's occupation requires cognitive focus; symptoms affecting work performance.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Medical management of symptoms\n3. Lifestyle modifications\n- Ergonomic workplace assessment\n- Stress reduction techniques\n- Weight management program referral\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nMild improvement in headaches with medical management. No tumor growth on follow-up MRI.\nPrescribed: Topiramate 25mg daily for headache prophylaxis\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 12, 2019\nStable symptoms. MRI shows no progression.\nPatient reports improved work performance with ergonomic adjustments.\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - March 15, 2020\nMinor tumor growth (0.2cm). Symptoms stable.\nContinue conservative management.\nKPS: 85 ECOG: 1\n\nINTERIM VISIT - September 30, 2020\nIncreased headache frequency\nMRI: No significant changes\nAdded: Propranolol 20mg daily\nKPS: 75 ECOG: 1\n\nANNUAL FOLLOW-UP - March 18, 2021\nTumor stable. Vision symptoms improved.\nPatient lost 10 lbs through lifestyle modifications.\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 22, 2022\nMRI: No growth\nSymptoms well-controlled\nContinuing current management\nKPS: 90 ECOG: 0\n\nURGENT VISIT - October 5, 2022\nAcute worsening of headaches\nMRI: Minimal increase in peritumoral edema\nAdded: Short course dexamethasone\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - January 15, 2023\nSymptoms improved post-steroid course\nMRI: Stable\nResumed conservative management\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 20, 2024\nSix-year follow-up\nMRI: Stable disease\nWell-adapted to current management strategy\nPatient maintains full-time work with accommodations\nKPS: 90 ECOG: 0\n\nCURRENT MANAGEMENT SUMMARY:\n- Annual MRI surveillance\n- Medical management of symptoms\n- Regular ophthalmology follow-up\n- Continued lifestyle modifications\n- Workplace accommodations maintained\n\nFINAL KPS/ECOG TREND:\nKPS range: 70-90 (Currently 90)\nECOG range: 0-2 (Currently 0)\n\nConservative management has proven successful with this patient, maintaining quality of life and occupational function while avoiding surgical intervention. Regular monitoring continues to be warranted."
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Intermittent blurred vision in right eye",
          "Recent onset of difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional episodes of nausea without vomiting",
          "Reports subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness that began 6 weeks ago",
          "Two episodes of loss of balance while walking in the past month"
        ],
        "medical_history": [
          "Migraine headaches since age 35, previously well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (ages 25-40)",
          "Treated for depression with sertraline 50mg daily (2018-2020)",
          "No history of head trauma or radiation exposure",
          "No family history of brain tumors or neurological conditions",
          "Regular mammograms, last one normal (6 months ago)",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F49-A-FA\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION:\n49-year-old female financial analyst presenting with progressive neurological symptoms suggesting space-occupying lesion. Symptoms significantly impact daily function and work performance.\n\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No calcification noted\nWHO Grade: II (atypical features on imaging)\nKPS: 80\nECOG: 1\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size >3cm\n2. Progressive symptoms\n3. Impact on cognitive function affecting work performance\n4. Location amenable to surgical approach\n\n-------------------\n\nSURGICAL NOTE: April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70\nECOG: 2\n\n-------------------\n\nFOLLOW-UP: July 15, 2018 (3 months post-op)\nPatient showing good recovery\nResidual fatigue but improving\nMRI: No evidence of residual tumor\nInitiated adjuvant radiotherapy\nKPS: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP: January 10, 2019 (9 months post-op)\nComplete radiotherapy course\nReturned to work part-time\nMinor headaches managed with medication\nKPS: 90\nECOG: 1\n\n-------------------\n\nFOLLOW-UP: July 8, 2019 (15 months post-op)\nFull return to work\nMRI: No recurrence\nCognitive function improved\nKPS: 95\nECOG: 0\n\n-------------------\n\nFOLLOW-UP: January 15, 2020\nRoutine surveillance MRI: Small enhancement noted\n2mm nodule at surgical margin\nClose monitoring warranted\nKPS: 90\nECOG: 1\n\n-------------------\n\nFOLLOW-UP: July 20, 2020\nNodule increased to 5mm\nRecommend gamma knife radiosurgery\nKPS: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP: January 12, 2021\nPost-gamma knife\nStable imaging\nNo new symptoms\nKPS: 90\nECOG: 1\n\n-------------------\n\nFOLLOW-UP: January 10, 2022\nMRI stable\nMaintaining work performance\nAnnual monitoring recommended\nKPS: 95\nECOG: 0\n\n-------------------\n\nFOLLOW-UP: March 15, 2023\nNew 1.2cm nodule identified\nDifferent location from original tumor\nRecommend surgical resection\nKPS: 85\nECOG: 1\n\n-------------------\n\nSURGICAL NOTE: April 20, 2023\nSecond craniotomy performed\nWHO Grade II confirmed\nSimpson Grade I resection\nKPS: 75\nECOG: 2\n\n-------------------\n\nLATEST FOLLOW-UP: January 15, 2024\nPost-second surgery recovery excellent\nNo evidence of recurrence\nMaintained cognitive function\nContinue surveillance imaging\nKPS: 90\nECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Highest KPS: 95 (during periods of stable disease)\n- Lowest KPS: 70 (immediate post-operative period)\n- Current KPS: 90\n- ECOG range: 0-2 (best during stable periods, worst post-operative)\n\nMONITORING PROTOCOL:\n- MRI every 3 months for first 2 years\n- Then every 6 months for 3 years\n- Annual thereafter if stable\n- Neuropsychological testing annually\n- Regular occupational therapy assessments",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F49-A-FA\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4 cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No mass effect on critical structures\n- T2 signal: moderately intense\nWHO Grade: I (presumptive, based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation requiring cognitive precision, recommending conservative management with close monitoring. Symptoms warrant attention but tumor size and location allow for non-surgical approach initially.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months initially\n2. Prophylactic anticonvulsants not indicated\n3. Dexamethasone 4mg daily for symptom management\n4. Occupational therapy referral for workplace adaptations\n5. Neurocognitive baseline assessment\n\nFOLLOW-UP VISIT - September 20, 2018\nTumor stable at 2.4 cm\nHeadaches improved with dexamethasone taper\nVisual symptoms stable\nKPS: 85 ECOG: 1\n\nFOLLOW-UP VISIT - March 12, 2019\nMinimal growth (2.5 cm)\nImplemented workplace modifications\nCognitive function stable\nKPS: 90 ECOG: 1\n\nFOLLOW-UP VISIT - March 15, 2020\nTumor size: 2.6 cm\nSome worsening of headaches\nStarted on topiramate for headache prophylaxis\nKPS: 80 ECOG: 1\n\nFOLLOW-UP VISIT - March 10, 2021\nTumor size stable\nImproved headache control\nMaintaining work performance\nKPS: 85 ECOG: 1\n\nFOLLOW-UP VISIT - April 5, 2022\nSlight growth to 2.8 cm\nIncreased edema noted\nStarted on higher dose dexamethasone\nDiscussing potential future intervention\nKPS: 75 ECOG: 2\n\nFOLLOW-UP VISIT - October 15, 2022\nTumor stable\nSymptoms managed with medication\nMaintaining independent function\nKPS: 80 ECOG: 1\n\nFOLLOW-UP VISIT - April 20, 2023\nGrowth to 3.0 cm\nIncreased visual symptoms\nDiscussing surgical options vs. radiation\nKPS: 70 ECOG: 2\n\nFOLLOW-UP VISIT - October 10, 2023\nOpted for stereotactic radiosurgery\nPost-treatment response favorable\nImproved symptoms\nKPS: 85 ECOG: 1\n\nCURRENT VISIT - March 1, 2024\nTumor showing slight regression (2.8 cm)\nImproved symptom control\nReturned to full work capacity\nKPS: 90 ECOG: 1\n\nTREATMENT SUMMARY:\n- Successfully managed conservatively for 5+ years\n- SRS implemented when growth exceeded 3 cm\n- Maintained high functional status throughout\n- Preserved occupational performance\n- Quality of life prioritized in management decisions\n\nFINAL KPS/ECOG TREND:\nKPS range: 70-90 (lowest during period of growth, highest during stable periods)\nECOG range: 1-2 (predominantly 1)\n\nONGOING PLAN:\n- Continue MRI surveillance every 6 months\n- Maintain workplace accommodations\n- Regular neurocognitive assessments\n- Quality of life monitoring\n- Headache management optimization"
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Intermittent blurred vision in right eye",
          "Recent onset of clumsiness in right hand, dropping objects occasionally",
          "Mild personality changes noted by family - increased irritability",
          "Episodes of nausea without vomiting",
          "Subtle hearing loss in right ear reported in last 2 months"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 2 years post-hysterectomy",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Well-controlled hypertension (diagnosed 3 years ago) on lisinopril 10mg daily",
          "No prior neurological conditions",
          "No history of head trauma or radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 49F, Blood Type B\nOccupation: Librarian\nKPS: 80 | ECOG: 1\n\nPRESENTING SYMPTOMS & ASSESSMENT:\nProgressive neurological symptoms highly concerning for space-occupying lesion. Symptom constellation suggests possible left-sided meningioma with mass effect. Occupational demands require high cognitive function and manual dexterity, both currently compromised.\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2 cm left frontotemporal meningioma\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Dural tail sign present\nWHO Grade: II (atypical features on imaging)\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention given:\n1. Size >3cm\n2. Progressive neurological symptoms\n3. Occupation requiring fine motor skills\n4. Evidence of mass effect\nSchedule for microsurgical resection within 2 weeks.\n\n-------------------\n\nPOST-OP FOLLOW-UP - April 12, 2018\nKPS: 70 | ECOG: 2\n\nGross total resection achieved. Pathology confirms WHO Grade II meningioma.\nPost-op course complicated by temporary right-sided weakness.\nInitiated physical therapy.\nPlan: Adjuvant radiotherapy recommended.\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 18, 2018\nKPS: 85 | ECOG: 1\n\nCompleted 60 Gy/30fx radiation therapy.\nImproved right-sided strength.\nReturned to work part-time.\nMRI: No evidence of recurrence.\n\n-------------------\n\nANNUAL FOLLOW-UP - April 15, 2019\nKPS: 90 | ECOG: 1\n\nWorking full-time.\nMinor fatigue persists.\nMRI: Stable post-surgical changes.\n\n-------------------\n\n18-MONTH FOLLOW-UP - October 20, 2019\nKPS: 95 | ECOG: 0\n\nComplete resolution of presenting symptoms.\nMRI: No evidence of recurrence.\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 18, 2020\nKPS: 60 | ECOG: 2\n\nNew enhancement noted on MRI suggesting local recurrence.\n2.1cm nodule adjacent to resection cavity.\nPlan: Stereotactic radiosurgery (SRS).\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 15, 2021\nKPS: 85 | ECOG: 1\n\nPost-SRS imaging shows good response.\nMaintained work schedule with accommodations.\n\n-------------------\n\n4-YEAR FOLLOW-UP - April 20, 2022\nKPS: 90 | ECOG: 1\n\nStable imaging.\nNo new neurological symptoms.\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 17, 2023\nKPS: 95 | ECOG: 0\n\nContinued stability on imaging.\nFull functional status.\nPlan: Continue biannual MRI surveillance.\n\n-------------------\n\n6-YEAR FOLLOW-UP - March 15, 2024\nKPS: 100 | ECOG: 0\n\nNo evidence of disease recurrence.\nFully functional at work and home.\nPlan: Annual MRI surveillance.\n\nOVERALL DISEASE COURSE:\nPatient demonstrated excellent response to aggressive initial intervention despite WHO Grade II status. Brief period of recurrence was successfully managed with SRS. Current status suggests favorable long-term prognosis with continued surveillance.\n\nKPS Score Range: 60-100 throughout course\nECOG Score Range: 0-2 throughout course",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F49-B-2016\nOccupation: Librarian\nWHO Grade: I (Confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 2.4 cm left petroclival meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- T2 signal: moderately hypointense\n- Calcification present on CT\n\nASSESSMENT:\nGiven the size (<3cm), calcification presence, and minimal edema, patient is a candidate for conservative management despite symptomatic presentation. Occupation requires cognitive precision but minimal physical exertion, supporting conservative approach.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Symptomatic management:\n   - Continue lisinopril 10mg daily\n   - Optimize headache management\n   - Prophylactic anticonvulsants not indicated\n3. Follow-up MRI in 3 months\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2016\nMinimal tumor growth (2.5 cm). Symptoms stable.\nPlan: Continue monitoring\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 10, 2017\nStable tumor size. Symptoms improved with medical management.\nPlan: Annual MRI\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - March 15, 2018\nNo growth. Patient adapted well to workplace accommodations.\nPlan: Continue annual monitoring\nKPS: 90 ECOG: 0\n\nINTERIM VISIT - September 30, 2019\nIncreased headaches, vision complaints\nMRI: Tumor size 2.7 cm\nPlan: Increase monitoring frequency to 6-monthly\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 20, 2020\nCOVID-19 Telehealth visit\nStable symptoms. No new neurological deficits.\nKPS: 80 ECOG: 1\n\nANNUAL FOLLOW-UP - March 15, 2021\nTumor stable at 2.7 cm\nVision symptoms improved with prescription adjustment\nPlan: Continue annual monitoring\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 10, 2022\nNo growth. Patient maintaining work schedule with accommodations.\nPlan: Continue conservative management\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - March 15, 2023\nStable disease. Quality of life well-maintained.\nPlan: Continue annual imaging\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - March 12, 2024\nEight-year follow-up shows successful conservative management.\nTumor stable at 2.7 cm\nSymptoms well-controlled\nPlan: Consider biennial imaging\nKPS: 95 ECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial presentation: KPS 80/ECOG 1\n- Lowest point (2019): KPS 75/ECOG 1\n- Current status: KPS 95/ECOG 0\n\nConservative management has proven successful with this patient, maintaining occupational function and quality of life while avoiding surgical risks. Regular monitoring has shown tumor stability, and symptom management has been effective."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Gradually worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of mild confusion and difficulty finding correct words while speaking",
          "Occasional balance issues when walking, particularly when turning corners",
          "Increasing fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting left hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously managed with sumatriptan PRN",
          "Total hysterectomy at age 45 for fibroids",
          "History of anxiety - managed with sertraline 50mg daily",
          "No prior neurological conditions",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "No prior radiation exposure",
          "Regular mammograms, last one normal 8 months ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F62-O-2016\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n\nASSESSMENT:\nSymptomatic right frontal meningioma with concerning features warranting immediate intervention. Symptoms significantly impacting daily function and work performance. Patient's role as librarian requires high cognitive function and visual acuity, both currently compromised.\nKPS: 70 | ECOG: 1\n\nPLAN:\n1. Surgical resection recommended within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Discontinue sertraline 1 week before surgery\n4. Complete neuropsychological evaluation\n\nSURGICAL NOTE - March 30, 2016\n- Simpson Grade II resection achieved\n- Minimal residual tumor at superior sagittal sinus\n- Pathology confirms WHO Grade II meningioma\n- No immediate complications\nKPS: 60 | ECOG: 2\n\nPOST-OP FOLLOW-UP - May 15, 2016\n- Healing well\n- Adjuvant radiotherapy initiated\n- 54 Gy in 30 fractions planned\nKPS: 80 | ECOG: 1\n\n6-MONTH FOLLOW-UP - September 30, 2016\n- Completed radiation therapy\n- Improved vision and balance\n- Returned to work part-time\n- MRI shows no recurrence\nKPS: 90 | ECOG: 0\n\nANNUAL FOLLOW-UP - March 15, 2017\n- Fully returned to work\n- Minor fatigue persists\n- MRI stable\nKPS: 90 | ECOG: 0\n\n2-YEAR FOLLOW-UP - March 20, 2018\n- New 1cm nodule at resection margin\n- Recommended SRS boost\n- Treatment completed May 2018\nKPS: 85 | ECOG: 1\n\n3-YEAR FOLLOW-UP - April 2, 2019\n- Stable imaging\n- Maintaining work schedule\n- No new neurological symptoms\nKPS: 90 | ECOG: 0\n\n4-YEAR FOLLOW-UP - March 25, 2020\n- MRI shows two new small nodules\n- Second surgery recommended and completed\n- Pathology confirms recurrent Grade II\nKPS: 70 | ECOG: 1\n\n5-YEAR FOLLOW-UP - April 10, 2021\n- Post-second surgery recovery optimal\n- Maintained on surveillance protocol\n- Working reduced hours\nKPS: 80 | ECOG: 1\n\n6-YEAR FOLLOW-UP - March 15, 2022\n- Stable disease\n- Regular cognitive assessments normal\n- Continuing work with accommodations\nKPS: 85 | ECOG: 1\n\n7-YEAR FOLLOW-UP - March 30, 2023\n- MRI stable\n- Maintaining good quality of life\n- Planning retirement next year\nKPS: 80 | ECOG: 1\n\nCURRENT VISIT - February 15, 2024\n- Stable disease\n- Retired from library work\n- Maintaining independent lifestyle\nKPS: 85 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection (2016)\n- Adjuvant radiotherapy completed (2016)\n- SRS boost for recurrence (2018)\n- Second surgery for new nodules (2020)\n- Maintained on surveillance protocol\n\nKPS Score Range: 60-90 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT STATUS:\nPatient maintains good functional status with stable disease after aggressive multimodal treatment approach. Continues regular monitoring with q6month MRI protocol.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 62-year-old female librarian\nMRI FINDINGS: 2.8cm right frontal convexity meningioma with minimal surrounding edema, WHO Grade I\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven the patient's presenting symptoms and MRI findings, while surgical intervention could be considered, I'm recommending a conservative initial approach with close monitoring. Patient's occupation requires cognitive clarity but allows for flexible adaptation of duties.\n\nRECOMMENDATIONS:\n1. Anti-epileptic: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID with taper over 2 weeks for edema\n3. Monthly neurological assessments for first 3 months\n4. Follow-up MRI in 3 months\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nTumor stable. Symptoms improved with medical management.\nKPS: 85 | ECOG: 1\nPlan: Continue current management, MRI in 6 months\n\n-------------------\n\nFOLLOW-UP - January 10, 2019\nMinimal tumor growth (0.2cm). Symptoms stable.\nKPS: 80 | ECOG: 1\nPlan: Maintain conservative approach, next MRI in 6 months\n\n-------------------\n\nFOLLOW-UP - July 15, 2019\nPatient reports increased headache frequency\nMRI shows slight increase in peritumoral edema\nKPS: 70 | ECOG: 2\nPlan: Increase dexamethasone temporarily, consider radiation therapy consultation\n\n-------------------\n\nFOLLOW-UP - January 20, 2020\nPost-radiation therapy assessment (completed fractionated RT)\nKPS: 75 | ECOG: 1\nTumor showing minor shrinkage\nPlan: Continue monitoring, MRI in 6 months\n\n-------------------\n\nFOLLOW-UP - August 5, 2020\nCOVID-19 Telehealth visit\nStable symptoms, managing work from home\nKPS: 80 | ECOG: 1\nPlan: Maintain current management\n\n-------------------\n\nFOLLOW-UP - February 12, 2021\nMRI stable, symptoms well-controlled\nKPS: 85 | ECOG: 1\nPlan: Annual MRI moving forward\n\n-------------------\n\nFOLLOW-UP - March 3, 2022\nStable disease, working part-time\nKPS: 90 | ECOG: 0\nPlan: Continue annual monitoring\n\n-------------------\n\nFOLLOW-UP - April 15, 2023\nMinor balance issues returned\nMRI shows small increase in edema\nKPS: 75 | ECOG: 1\nPlan: Short course of dexamethasone, continue monitoring\n\n-------------------\n\nLATEST FOLLOW-UP - January 10, 2024\nSymptoms stable, continuing part-time work\nMRI unchanged from previous\nKPS: 80 | ECOG: 1\nPlan: Continue annual MRI, maintain current management\n\nOVERALL DISEASE COURSE:\nPatient has maintained relatively stable disease with conservative management. KPS scores ranged from 70-90 throughout the course, with temporary declines during periods of symptom exacerbation. The conservative approach has allowed her to continue working, though with reduced hours. Quality of life has been preserved with minimal intervention.\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain anti-epileptic medication\n3. Regular cognitive assessments\n4. Occupational therapy as needed\n5. Consider full retirement if symptoms worsen\n\nFinal Status:\nKPS Range over course: 70-90 (Currently 80)\nECOG Range over course: 0-2 (Currently 1)"
      }
    },
    {
      "demographics": {
        "age": 48,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work on computer screens",
          "Subtle right-sided facial numbness noticed in past 2 months",
          "Reports feeling more fatigued than usual",
          "Mild balance issues when walking, especially in dimly lit areas"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2 years ago)",
          "No prior neurological conditions",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Regular eye exams, last one 1 year ago was normal",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n48-year-old Female, Blood Type O\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.2 cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Enhancement pattern consistent with WHO Grade II meningioma\nASSESSMENT:\nGiven patient's occupation requiring high cognitive function and progressive symptoms affecting work performance, recommend early surgical intervention. WHO Grade II suspected.\nPLAN:\n- Scheduled for surgical resection within 2 weeks\n- Pre-operative functional MRI and venography\nKPS Score: 80\nECOG: 1\n\nSURGICAL NOTE - March 30, 2018\nPROCEDURE: Left frontal craniotomy for tumor resection\nFINDINGS:\n- Simpson Grade II resection achieved\n- Tumor adherent to superior sagittal sinus\n- Pathology confirms WHO Grade II meningioma\nPOST-OP COURSE:\n- Uncomplicated recovery\n- Minimal residual tumor at sinus interface\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - September 15, 2018 (6 months post-op)\n- Improved headaches and vision\n- Return to work part-time\n- MRI shows no tumor progression\nPLAN:\n- Initiated adjuvant radiotherapy\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - March 20, 2019 (1 year post-op)\n- Complete resolution of visual symptoms\n- Full return to work\n- MRI stable\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 15, 2020 (2 years post-op)\nCONCERN:\n- Small enhancement at surgical site\nPLAN:\n- Increased monitoring frequency\n- Consider repeat surgical intervention if progression\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - September 20, 2020\n- Tumor progression confirmed\nPROCEDURE:\n- Second craniotomy performed\n- Simpson Grade I resection achieved\nKPS Score: 65\nECOG: 2\n\nFOLLOW-UP - March 15, 2021\n- Post-second surgery recovery\n- No evidence of recurrence\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - March 15, 2022\n- Stable imaging\n- Maintaining work schedule\n- Annual monitoring continued\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 15, 2023\n- Small area of enhancement noted\n- Asymptomatic\nPLAN:\n- Increased monitoring to q4 months\nKPS Score: 85\nECOG: 1\n\nCURRENT VISIT - February 20, 2024\n- Stable imaging\n- Fully functional at work\n- Maintaining regular follow-up\nPLAN:\n- Continue q4 month MRI surveillance\n- Annual neuropsychological testing\nKPS Score: 90\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation with WHO Grade II meningioma\n- Two surgical interventions (2018, 2020)\n- Complete adjuvant radiotherapy course\n- Current status: Stable disease with excellent functional status\n\nKPS Score Range Throughout Treatment: 65-90\nECOG Score Range: 0-2\n\nCURRENT PERFORMANCE STATUS:\nFinal KPS: 90 - Able to carry on normal activity, minor signs/symptoms\nFinal ECOG: 0 - Fully active, no restrictions",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 48-year-old female software developer\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\n\nMRI FINDINGS:\n- 2.4 cm left frontal parasagittal meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No calcification noted\n\nASSESSMENT:\nDespite symptomatic presentation, tumor size and location favor initial conservative management. Patient's occupation requires significant screen time and cognitive focus, which influences management strategy.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. Medical management of symptoms:\n   - Dexamethasone 4mg daily for edema\n   - Continue sumatriptan for migraines\n3. Quarterly MRI for first year\n4. Occupational recommendations:\n   - Blue light filters for computer screens\n   - Regular breaks using 20-20-20 rule\n   - Ergonomic workspace assessment\n\nKPS Score: 90\nECOG Score: 1\n\nFOLLOW-UP - June 20, 2018\nMild improvement in symptoms with steroid therapy. No tumor growth.\nPlan: Begin steroid taper.\nKPS Score: 90\nECOG Score: 1\n\nFOLLOW-UP - December 5, 2018\nStable symptoms, no tumor growth.\nPlan: Continue monitoring, extend MRI interval to 6 months.\nKPS Score: 95\nECOG Score: 0\n\nFOLLOW-UP - June 15, 2019\nMinor increase in headaches. MRI shows 2mm growth.\nPlan: Resume low-dose dexamethasone, continue monitoring.\nKPS Score: 85\nECOG Score: 1\n\nANNUAL REVIEW - March 10, 2020\nStable disease. Patient managing work with accommodations.\nPlan: Annual MRI if stable.\nKPS Score: 90\nECOG Score: 1\n\nFOLLOW-UP - March 22, 2021\nCOVID-19 delayed visit. Tumor stable. Patient reports increased screen time due to remote work.\nAdditional recommendations for workspace ergonomics.\nKPS Score: 85\nECOG Score: 1\n\nFOLLOW-UP - April 5, 2022\nMRI shows slow growth to 2.7cm. Increased headaches.\nPlan: Consider radiation therapy if symptoms worsen.\nKPS Score: 80\nECOG Score: 1\n\nFOLLOW-UP - May 12, 2023\nPatient experiencing increased visual symptoms.\nPlan: Referral to radiation oncology for consultation while maintaining conservative approach.\nKPS Score: 75\nECOG Score: 2\n\nCURRENT VISIT - January 15, 2024\nTumor now 3.0cm. Patient opted for fractionated RT.\nPlan: Begin RT schedule while maintaining work schedule.\nKPS Score: 70\nECOG Score: 2\n\nTREATMENT SUMMARY:\n- Conservative management maintained for 6 years\n- Successful symptom management through medical therapy\n- Quality of life preserved with occupational adjustments\n- Transition to RT only when necessary\n- Overall good outcome with minimal intervention\n\nFinal KPS Score: 70\nFinal ECOG Score: 2\n\nThe patient's KPS scores ranged from 95 (near normal function) to 70 (requires occasional assistance), reflecting the gradual progression of symptoms while maintaining independent function. ECOG scores remained relatively stable between 0-2, indicating preserved ability to work throughout most of the monitoring period."
      }
    },
    {
      "demographics": {
        "age": 60,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty concentrating at work",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly in dim lighting",
          "Increased irritability and personality changes noted by family",
          "Intermittent ringing in right ear"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches - previously well-controlled with sumatriptan PRN",
          "Mild hearing loss in right ear diagnosed 2 years ago",
          "No history of seizures",
          "No prior brain surgeries",
          "Family history negative for brain tumors",
          "Annual eye exams normal until recent changes",
          "No significant head trauma"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M60-DS-O\nPrimary Diagnosis: Meningioma\nTreatment Approach: Proactive Intervention Protocol\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\nKPS: 80 | ECOG: 1\n\nASSESSMENT:\nHigh-risk features noted:\n- Size >3cm\n- Critical location near cavernous sinus\n- Occupation requiring high cognitive function\n- History of radiation exposure\n- Multiple progressive neurological symptoms\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Progressive symptoms affecting work performance\n2. Size and location\n3. Risk of visual pathway compromise\nWHO Grade: II (confirmed post-surgery)\n\nFOLLOW-UP VISIT - June 20, 2018 (3 months post-op)\nPost-surgical MRI shows subtotal resection (Simpson Grade III)\nResidual tumor: 0.8cm near cavernous sinus\nRecommended adjuvant radiation therapy\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - December 15, 2018\nPost-radiation assessment\nStable residual disease\nImproved visual symptoms\nReturn to work part-time\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 10, 2019\nMRI: No progression\nMaintaining work schedule\nMinor fatigue\nKPS: 90 | ECOG: 1\n\nSURVEILLANCE - September 15, 2020\nMRI: Small area of enhancement (0.5cm growth)\nNew intermittent headaches\nKPS: 85 | ECOG: 1\n\nURGENT VISIT - February 20, 2021\nProgressive symptoms\nMRI: Tumor progression (1.2cm growth)\nDecision for second surgery\nKPS: 75 | ECOG: 2\n\nPOST-SECOND SURGERY - May 15, 2021\nComplete resection achieved\nStarted on targeted therapy\nKPS: 65 | ECOG: 2\n\nRECOVERY FOLLOW-UP - December 10, 2021\nExcellent recovery\nReturn to full-time work\nKPS: 90 | ECOG: 1\n\nSURVEILLANCE - June 15, 2022\nStable disease\nMaintaining normal activities\nKPS: 95 | ECOG: 0\n\nANNUAL FOLLOW-UP - March 20, 2023\nContinued stability\nNo new symptoms\nKPS: 95 | ECOG: 0\n\nRECENT FOLLOW-UP - January 10, 2024\nMRI: No recurrence\nFully functional at work\nMinor fatigue managed well\nKPS: 90 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II Meningioma\n- Two surgical interventions (2018, 2021)\n- Adjuvant radiation therapy\n- Regular MRI surveillance\n- Successful return to work as Data Scientist\n\nCURRENT STATUS:\n- Disease stable\n- Maintaining professional activities\n- Regular monitoring continues\n- Final KPS: 90 | ECOG: 1\n\nMONITORING PROTOCOL:\n- MRI every 4 months\n- Neurological assessment every 3 months\n- Cognitive function testing every 6 months\n- Visual field testing every 6 months\n\nKPS Score Range Over Treatment Period: 65-95\nECOG Score Range: 0-2",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\nPatient ID: [Redacted]\nBlood Type: O\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms concerning for meningioma. Given history of prior radiation exposure, conservative management initially preferred. Symptoms warrant close monitoring.\n\nPLAN:\n1. Serial MRI monitoring q3 months initially\n2. Dexamethasone 4mg BID for edema management\n3. Neurocognitive testing baseline\n4. Occupational therapy evaluation for work adaptations\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2018\nMild improvement in symptoms with steroid therapy. Vision stable.\nMRI: No significant change in tumor size\nPLAN: Continue current management\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - December 5, 2018\nSymptoms stable. Successfully implementing workplace accommodations.\nMRI: Minimal growth (2.9cm)\nPLAN: Continue monitoring, gradual steroid taper\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 15, 2019\nIncreased headaches following steroid taper\nMRI: Tumor now 3.1cm with increased edema\nPLAN: \n1. Restart dexamethasone 2mg BID\n2. Consider radiation therapy consultation\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - January 10, 2020\nPost-radiation therapy assessment (completed IMRT 54Gy/30fx)\nImprovement in symptoms\nMRI: Stable disease, decreased edema\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - July 2021\nMaintaining work schedule with accommodations\nMRI: No progression\nPLAN: Continue annual monitoring\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - August 2022\nMinor balance issues recurring\nMRI: Stable disease\nPLAN: Physical therapy referral\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - September 2023\nWell-controlled symptoms\nMRI: No progression\nPLAN: Continue annual monitoring\nKPS: 90 ECOG: 0\n\nCURRENT VISIT - February 2024\nMaintaining good quality of life, continues working\nMRI: Stable disease\nPLAN: Annual follow-up\nKPS: 90 ECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Lowest KPS: 75 (During peak symptoms pre-radiation)\n- Highest KPS: 90 (Post-treatment stability)\n- Current KPS: 90\n- ECOG range: 0-1\n\nMANAGEMENT HIGHLIGHTS:\n- Conservative approach prioritizing quality of life\n- Successful radiation therapy when needed\n- Maintained professional activity with accommodations\n- Regular monitoring showing disease stability\n- Effective symptom management through medical therapy"
      }
    },
    {
      "demographics": {
        "age": 50,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness; Occasional blurred vision in right eye; Balance difficulties when walking; Memory lapses and difficulty concentrating at work; One episode of seizure-like activity 2 weeks ago lasting approximately 2 minutes"
        ],
        "medical_history": [
          "Hypertension diagnosed 5 years ago, controlled with lisinopril 10mg daily; Migraine headaches since age 30, previously managed with sumatriptan PRN but current headaches differ in character; Mild traumatic brain injury from car accident 15 years ago with full recovery; No history of cancer; Family history significant for father with brain tumor (type unknown); Current medications: lisinopril 10mg daily, occasional ibuprofen for headaches; No known drug allergies; Social history: Former smoker (quit 10 years ago), occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 50-year-old male, Blood Type O\nChief Complaint: Progressive neurological symptoms with concerning MRI findings\n\nMRI FINDINGS:\n- 4.2 cm right frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Enhancement pattern suggestive of WHO Grade II\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven size >3cm, peritumoral edema, and progressive symptoms, immediate surgical intervention recommended. Schedule for craniotomy within 2 weeks.\n\nSURGICAL NOTE - March 29, 2018\nProcedure: Right frontal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minimal residual tumor at superior sagittal sinus\nPathology: WHO Grade II atypical meningioma\nPost-op KPS: 70 | ECOG: 2\n\nFOLLOW-UP - June 15, 2018\nPost-operative adjuvant radiotherapy completed (60 Gy/30 fractions)\nSymptoms improving\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - December 20, 2018\nMRI shows no recurrence\nHeadaches resolved\nReturn to work part-time\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - June 18, 2019\nSurveillance MRI: Small enhancement at surgical site\nProphylactic gamma knife radiosurgery recommended\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - January 10, 2020\nPost-radiosurgery MRI stable\nFull-time work resumed\nKPS: 95 | ECOG: 0\n\nURGENT VISIT - March 5, 2021\nNew onset seizures\nMRI shows tumor progression\nKPS: 60 | ECOG: 2\n\nSURGICAL NOTE - March 20, 2021\nSecond craniotomy performed\nPathology: Progression to WHO Grade III\nKPS: 50 | ECOG: 3\n\nFOLLOW-UP - September 15, 2021\nPost-op chemotherapy initiated\nLimited response\nKPS: 40 | ECOG: 3\n\nFOLLOW-UP - February 10, 2022\nDisease progression despite treatment\nPalliative care discussion\nKPS: 30 | ECOG: 4\n\nFOLLOW-UP - August 5, 2022\nClinical improvement with modified treatment protocol\nNew targeted therapy trial initiated\nKPS: 60 | ECOG: 2\n\nCURRENT STATUS - January 15, 2024\nStable disease\nMaintained on targeted therapy\nRegular seizure prophylaxis\nQuarterly MRI surveillance\nCurrent KPS: 75 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical interventions\n- Progression to Grade III\n- Multiple radiation treatments\n- Current status: Stable with ongoing targeted therapy\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Monthly neurology evaluations\n- Cognitive function testing every 6 months\n- Quality of life assessments\n- Seizure diary maintenance\n\nKPS Range Throughout Treatment: 30-95\nECOG Range Throughout Treatment: 0-4",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M50-O-MEN\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms but tumor size and location allow for initial conservative management. KPS: 80, ECOG: 1\n\nPLAN:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema management\n3. Monthly clinical monitoring\n4. Follow-up MRI in 3 months\n\nFOLLOW-UP - June 20, 2018\nSymptoms partially improved with medical management\nKPS: 85, ECOG: 1\nNo tumor growth on follow-up MRI\nContinue current medications with steroid taper\n\nFOLLOW-UP - December 15, 2018\nStable symptoms\nKPS: 90, ECOG: 0\nMRI shows no progression\nReduced steroid dose to 2mg daily\n\nANNUAL REVIEW - March 10, 2019\nMinor headaches persist but manageable\nKPS: 90, ECOG: 0\nStable tumor size\nMaintain current management\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nKPS: 85, ECOG: 1\nDeferred imaging due to pandemic\n\nFOLLOW-UP - September 20, 2020\nMRI shows minimal growth (0.2cm)\nNew onset occasional dizziness\nKPS: 75, ECOG: 1\nIncreased steroid dose temporarily\n\nANNUAL REVIEW - March 15, 2021\nSymptoms stable\nKPS: 85, ECOG: 1\nNo further growth\nContinued conservative management\n\nFOLLOW-UP - March 10, 2022\nIncreased headache frequency\nKPS: 70, ECOG: 2\nMRI shows minimal edema increase\nAdjusted anti-epileptic medication\n\nFOLLOW-UP - March 15, 2023\nImproved symptom control\nKPS: 80, ECOG: 1\nStable imaging\nMaintaining conservative approach\n\nRECENT FOLLOW-UP - January 10, 2024\nWell-controlled symptoms\nKPS: 85, ECOG: 1\nStable tumor size\nContinue current management\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively for 6 years\n- KPS range: 70-90\n- ECOG range: 0-2\n- Patient maintained employment with accommodations\n- Quality of life preserved through medical management\n- Regular monitoring continues to show stability\n\nCURRENT RECOMMENDATIONS:\n1. Continue bi-annual MRI surveillance\n2. Maintain current medications\n3. Monthly neurology checks\n4. Consider occupational therapy for balance support\n5. Regular cognitive assessments\n\nNote: Conservative management successful due to:\n- Stable tumor size\n- Well-controlled symptoms\n- Patient preference\n- Acceptable functional status\n- Regular monitoring compliance"
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Data generation failed"
        ],
        "medical_history": [
          "Data generation failed"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 66F, O+\nOccupation: Financial Analyst/Baker\nNotable: Diabetes, Currently pregnant (high-risk pregnancy)\n\nPRESENTING FINDINGS:\n- Incidental finding on MRI performed for unrelated headaches\n- Right frontal convexity meningioma, 2.8cm\n- Minimal peritumoral edema\n- WHO Grade I (presumptive)\n\nASSESSMENT & PLAN:\nGiven pregnancy status, immediate surgical intervention deferred until post-delivery. Close monitoring warranted.\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - September 20, 2018 (Post-delivery)\nTumor size increased to 3.2cm\nRecommend surgical resection given:\n- Growth during pregnancy\n- Occupation requires cognitive precision\n- Multiple risk factors (age, diabetes)\nSimpson Grade I resection planned\nKPS: 85 ECOG: 1\n\nSURGICAL NOTE - October 15, 2018\nComplete resection achieved\nPathology: WHO Grade I meningioma\nPost-op course uncomplicated\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - April 2019\nNo evidence of recurrence\nReturned to work part-time\nAnnual MRI scheduled\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - October 2020\nSmall recurrence (1.1cm) noted\nRecommend SRS given size\nKPS: 80 ECOG: 1\n\nPOST-SRS FOLLOW-UP - March 2021\nStable disease\nContinues work with accommodations\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - September 2022\nProgressive fatigue, intermittent headaches\nMRI stable\nDiabetes management optimized\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - March 2023\nStable imaging\nImproved symptoms\nMaintaining work schedule\nKPS: 80 ECOG: 1\n\nRECENT FOLLOW-UP - January 2024\nNo evidence of progression\nContinues regular monitoring\nAnnual MRI protocol maintained\nKPS: 85 ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial surgical resection\n- Subsequent SRS for small recurrence\n- Regular monitoring with stable disease\n- Overall good functional status maintained\n\nCurrent Status:\nKPS: 85/100\nECOG: 1/5\nWHO Grade: I\nMonitoring: Annual MRI\n\nNote: KPS scores fluctuated between 65-90 throughout treatment course, reflecting post-operative recovery periods and treatment responses. Current status shows good functional recovery and disease control.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\n66-year-old female, Blood Type O\nOccupation: Financial Analyst/Baker\nRelevant conditions: Diabetes, Pregnancy\n\nInitial Visit - March 15, 2015\nIncidental finding of right frontal convexity meningioma (2.1cm) on MRI performed for headache workup.\nWHO Grade I (presumptive, based on imaging characteristics)\nGiven pregnancy status, recommending conservative management with close monitoring.\nKPS: 90 ECOG: 1\n\nFollow-up - September 20, 2015\nPost-partum follow-up\nTumor stable at 2.1cm\nNo mass effect or significant edema\nContinuing watchful waiting approach\nKPS: 90 ECOG: 1\n\nAnnual Follow-up - March 18, 2016\nTumor stable\nPatient managing dual careers well\nDiabetes well-controlled\nRecommending annual MRI surveillance\nKPS: 90 ECOG: 1\n\nAnnual Follow-up - March 22, 2017\nMinimal growth (2.3cm)\nNo new symptoms\nContinuing conservative management\nRegular diabetes monitoring maintained\nKPS: 85 ECOG: 1\n\nAnnual Follow-up - April 5, 2018\nStable at 2.3cm\nPatient reports occasional mild headaches\nRecommended ergonomic workplace adjustments for financial analysis work\nKPS: 85 ECOG: 1\n\nAnnual Follow-up - March 30, 2019\nNo significant growth\nPatient managing work responsibilities well\nDiabetes remains controlled\nKPS: 80 ECOG: 1\n\nAnnual Follow-up - April 10, 2020\nSlight growth to 2.4cm\nSome fatigue reported, likely due to dual work responsibilities\nRecommended reduced hours at bakery\nKPS: 75 ECOG: 2\n\nAnnual Follow-up - March 25, 2021\nStable size\nPatient following modified work schedule\nQuality of life improved\nKPS: 80 ECOG: 1\n\nAnnual Follow-up - April 2, 2022\nNo significant changes\nWell-adapted to modified work routine\nMaintaining good diabetic control\nKPS: 85 ECOG: 1\n\nAnnual Follow-up - March 28, 2023\nStable disease\nPatient continues to manage well with conservative approach\nKPS: 85 ECOG: 1\n\nLatest Follow-up - February 15, 2024\nTumor stable at 2.4cm\nNo concerning symptoms\nContinuing annual surveillance\nPatient satisfied with conservative management approach\nKPS: 90 ECOG: 1\n\nManagement Summary:\n- Successfully maintained conservative management over 9-year period\n- Minimal tumor growth (0.3cm over 9 years)\n- Patient maintained good functional status\n- Work modifications successfully implemented\n- Diabetes remained controlled\n- Quality of life preserved\n\nKPS Range over monitoring period: 75-90\nECOG Range over monitoring period: 1-2\n\nRecommendations:\n- Continue annual MRI surveillance\n- Maintain current work-life balance\n- Regular diabetes monitoring\n- Return sooner if new symptoms develop"
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Reports mild balance issues when walking",
          "Two episodes of right-sided tinnitus in past month"
        ],
        "medical_history": [
          "Migraine headaches since age 30, managed with sumatriptan PRN",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2018)",
          "No prior neurological conditions",
          "No history of cancer",
          "No radiation exposure",
          "Family history negative for brain tumors",
          "Regular mammograms, last one normal (6 months ago)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-MEN\n==================================\n\nINITIAL VISIT - March 15, 2018\n------------------------------\nPRESENTING SYMPTOMS: Progressive neurological symptoms including right-sided visual disturbance, facial numbness, and morning headaches suggesting possible intracranial mass effect.\n\nIMAGING: Initial MRI reveals 3.8cm left frontal convexity meningioma with significant peritumoral edema. Mass demonstrates homogeneous enhancement with dural tail sign. Evidence of mass effect on adjacent frontal lobe with 4mm midline shift.\n\nASSESSMENT: WHO Grade II atypical meningioma (based on imaging characteristics)\nPLAN: Recommend urgent surgical intervention given size, symptoms, and location.\nKPS Score: 80\nECOG: 1\n\nSURGICAL NOTE - April 2, 2018\n----------------------------\nPROCEDURE: Left frontal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: Confirmed WHO Grade II atypical meningioma\nPOST-OP STATUS: Uncomplicated recovery\nKPS Score: 70\nECOG: 1\n\nFOLLOW-UP - July 15, 2018\n-------------------------\nSTATUS: Improving neurological symptoms\nIMAGING: Post-op MRI shows no residual tumor\nPLAN: Initiate adjuvant radiotherapy\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - January 10, 2019\n---------------------------\nSTATUS: Completed radiation therapy (60 Gy/30 fractions)\nIMAGING: Stable post-treatment changes\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - July 2019, January 2020, July 2020\n---------------------------------------------\nSTATUS: Stable, maintaining work schedule\nIMAGING: No evidence of recurrence\nKPS Score: 95\nECOG: 0\n\nURGENT VISIT - March 15, 2021\n----------------------------\nSYMPTOMS: New onset seizures\nIMAGING: Small focus of enhancement at resection margin\nPLAN: Surgical re-exploration\nKPS Score: 75\nECOG: 1\n\nSECOND SURGERY - April 1, 2021\n-----------------------------\nPROCEDURE: Repeat left frontal craniotomy\nFINDINGS: Local recurrence confirmed\nPATHOLOGY: WHO Grade III progression\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - July 2021\n--------------------\nSTATUS: Post-op complications including right-sided weakness\nPLAN: Intensive rehabilitation, consideration of systemic therapy\nKPS Score: 50\nECOG: 2\n\nFOLLOW-UP - January 2022\n-----------------------\nSTATUS: Improving with rehabilitation\nIMAGING: Stable post-treatment\nKPS Score: 70\nECOG: 1\n\nFOLLOW-UP - 2023-2024 (Quarterly visits)\n--------------------------------------\nSTATUS: Stable disease, maintained on anticonvulsants\nIMAGING: No new progression\nCURRENT KPS Score: 85\nCURRENT ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection\n- Adjuvant radiotherapy\n- Disease progression requiring second surgery\n- Current status: Stable disease with regular monitoring\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Monthly neurological examinations\n- Quarterly cognitive assessments\n- Regular quality of life evaluations\n\nKPS Score Range Throughout Treatment: 50-95\nECOG Score Range: 0-2\n\nFinal Recommendations:\nContinue close surveillance with quarterly MRI and monthly clinical assessments. Patient's occupation as an executive requires optimal cognitive function, supporting aggressive intervention strategy employed.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 45-year-old female, Blood Type O\nChief Complaint: Progressive neurological symptoms\n\nMRI FINDINGS:\n- 2.4 cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\n- T2 signal: Mildly hyperintense\n\nASSESSMENT:\nGiven the size <3cm and minimal edema, conservative management is warranted despite symptoms. Patient's occupation as an accountant requires sustained concentration, which is currently affected.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. MRI surveillance every 6 months initially\n3. Prophylactic anticonvulsants not indicated\n4. Dexamethasone 4mg BID for symptom management\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nTumor stable at 2.4 cm. Headaches improved with dexamethasone. Maintaining work schedule with accommodations.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 15, 2019\nMinimal growth (2.5 cm). Vision symptoms stable. Dexamethasone tapered to 2mg daily.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 10, 2020\nTumor size 2.6 cm. Patient reports increased headaches. COVID-19 considerations discussed for future appointments.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 5, 2021\nTumor size 2.7 cm. Balance issues resolved. Maintaining work from home successfully.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - February 28, 2022\nConcerning growth to 3.1 cm. Discussed treatment options including stereotactic radiosurgery (SRS).\nPatient prefers continued observation. Increased monitoring frequency.\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - August 15, 2022\nTumor stable at 3.1 cm. Symptoms managed with medication adjustments.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - February 20, 2023\nNo further growth. Quality of life improved with current management strategy.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - January 15, 2024\nTumor stable at 3.1 cm. Patient maintaining full-time work. Symptoms well-controlled.\nKPS: 90 ECOG: 0\n\nMANAGEMENT SUMMARY:\n- Successfully managed with conservative approach over 6-year period\n- Maintained employment and quality of life\n- Minimal intervention required\n- Regular imaging surveillance effective\n- Symptoms controlled with medical management\n\nCURRENT RECOMMENDATIONS:\n1. Continue MRI monitoring every 6 months\n2. Maintain current medication regimen\n3. Regular neurocognitive assessments\n4. Consider SRS if significant growth or symptom progression\n5. Continue workplace accommodations as needed\n\nFinal KPS: 90\nFinal ECOG: 0\n\nNote: KPS scores fluctuated between 70-90 throughout monitoring period, reflecting periods of symptom exacerbation and improvement. Conservative management strategy proved effective in maintaining patient's functional status and quality of life."
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work, especially when looking at computer screens",
          "Subtle personality changes noted by family - more irritable than usual",
          "Mild right-sided facial numbness that began 2 months ago",
          "Reports feeling more fatigued than usual despite adequate sleep"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "Hypertension - controlled with Lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously well-controlled with sumatriptan PRN",
          "Total hysterectomy at age 45 for fibroids",
          "Family history of breast cancer (maternal aunt)",
          "HbA1c consistently maintained between 6.5-7.0%",
          "No history of smoking or alcohol abuse",
          "Regular eye exams due to diabetes - last exam 1 year ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-DS-A\nPrimary Diagnosis: Meningioma\n==================================\n\nINITIAL VISIT - September 15, 2018\n---------------------------------\nPRESENTING SYMPTOMS: Progressive headaches, right eye visual disturbance, cognitive difficulties affecting work performance, facial numbness, fatigue. Symptoms significantly impacting patient's ability to perform data science work.\n\nIMAGING: Initial MRI reveals a 4.2cm right sphenoid wing meningioma with significant mass effect and perilesional edema. Enhancement pattern consistent with WHO Grade II meningioma. Compression of right optic nerve noted.\n\nASSESSMENT: Given size, location, and symptomatic presentation, immediate surgical intervention recommended. Occupation requires high cognitive function and visual acuity, making aggressive treatment crucial.\nKPS Score: 80\nECOG: 1\n\nPLAN: Scheduled for surgical resection within 2 weeks. Pre-operative optimization of diabetes management.\n\nSURGICAL NOTE - October 1, 2018\n------------------------------\nPROCEDURE: Right frontotemporal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: WHO Grade II meningioma confirmed\nPost-op KPS: 70\nECOG: 2\n\nFOLLOW-UP - December 15, 2018\n----------------------------\nPost-operative MRI shows small residual tumor (0.8cm)\nRecommended adjuvant radiation therapy\nPatient recovering well, some improvement in visual symptoms\nKPS Score: 85\nECOG: 1\n\nRADIATION ONCOLOGY - January-March 2019\n-------------------------------------\nCompleted fractionated RT: 54 Gy in 30 fractions\nWell-tolerated with minimal side effects\nKPS Score: 90\nECOG: 1\n\nFOLLOW-UP - September 2019\n-------------------------\n6-month post-RT MRI stable\nReturned to work part-time\nVisual symptoms improved\nKPS Score: 95\nECOG: 0\n\nANNUAL FOLLOW-UP - October 2020\n------------------------------\nMRI shows no progression\nWorking full-time\nDiabetes remains well-controlled\nKPS Score: 100\nECOG: 0\n\nFOLLOW-UP - April 2021\n----------------------\nNew 0.5cm nodule noted on surveillance MRI\nAsymptomatic but concerning for recurrence\nKPS Score: 95\nECOG: 0\n\nTREATMENT REVISION - May 2021\n----------------------------\nStereotactic radiosurgery to new nodule\n13 Gy single fraction\nKPS Score: 90\nECOG: 1\n\nFOLLOW-UP - November 2021\n------------------------\nPost-SRS MRI shows good response\nAll symptoms stable\nKPS Score: 95\nECOG: 0\n\nANNUAL FOLLOW-UP - October 2022\n------------------------------\nStable disease\nMaintaining work schedule\nRegular diabetes monitoring continues\nKPS Score: 95\nECOG: 0\n\nFOLLOW-UP - April 2023\n----------------------\nMinor enhancement changes on MRI\nClose monitoring recommended\nKPS Score: 90\nECOG: 1\n\nCURRENT STATUS - January 2024\n----------------------------\nStable disease with no progression\nMaintaining good functional status\nRegular monitoring continues\nKPS Score: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection\n- Adjuvant RT completed\n- Salvage SRS for small recurrence\n- Regular monitoring with q6month MRI\n- Diabetes management optimized throughout treatment\n\nCURRENT RECOMMENDATIONS:\n1. Continue q6month MRI surveillance\n2. Regular ophthalmological monitoring\n3. Maintain strict diabetes control\n4. Consider prophylactic anti-epileptic medication\n5. Cognitive function monitoring given occupation\n\nOverall KPS Range: 70-100 (lowest immediately post-op, highest during stable disease periods)\nOverall ECOG Range: 0-2 (highest during immediate post-op period)",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-DS-A\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- WHO Grade I (likely)\nKPS: 90 | ECOG: 1\n\nASSESSMENT:\n59-year-old female data scientist presenting with progressive neurological symptoms. Given tumor size (<3cm), location, and patient's comorbidities (T2DM), recommending conservative management with close monitoring.\n\nPLAN:\n1. Serial MRI monitoring every 6 months\n2. Ophthalmology referral for baseline assessment\n3. Continue current diabetes management\n4. Prescribe Dexamethasone 4mg BID for symptom management\n5. Ergonomic workplace assessment recommended\n\n-------------------\n\nFOLLOW-UP - March 20, 2019\nMinimal tumor growth (2.9cm)\nVisual symptoms stable\nKPS: 85 | ECOG: 1\n\nPLAN:\n- Continue monitoring\n- Reduced Dexamethasone to 2mg BID\n- Prescribed blue light filtering glasses for computer work\n\n-------------------\n\nFOLLOW-UP - September 18, 2019\nStable tumor size\nImproved headache control\nKPS: 90 | ECOG: 1\n\nPLAN:\n- Maintain current management\n- MRI interval extended to annual\n\n-------------------\n\nANNUAL REVIEW - September 22, 2020\nTumor stable at 2.9cm\nSome worsening of visual symptoms\nKPS: 80 | ECOG: 1\n\nPLAN:\n- Return to 6-monthly MRI monitoring\n- Increased Dexamethasone to 4mg BID\n- Occupational therapy referral\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nTumor growth to 3.2cm\nIncreased perilesional edema\nKPS: 70 | ECOG: 2\n\nPLAN:\n- Discussed treatment options including SRS\n- Patient prefers continued conservative management\n- Weekly neurology checks\n\n-------------------\n\nFOLLOW-UP - September 10, 2021\nStable tumor size\nImproved symptoms with medication adjustment\nKPS: 75 | ECOG: 1\n\nPLAN:\n- Continue current management\n- Regular diabetes monitoring\n- Modified work schedule implemented\n\n-------------------\n\nANNUAL REVIEW - September 20, 2022\nNo significant growth\nSymptoms well-controlled\nKPS: 85 | ECOG: 1\n\nPLAN:\n- Maintain current approach\n- Annual MRI resumed\n\n-------------------\n\nANNUAL REVIEW - September 18, 2023\nStable disease\nGood quality of life maintained\nKPS: 90 | ECOG: 1\n\nPLAN:\n- Continue annual monitoring\n- Gradual Dexamethasone taper\n- Maintain work modifications\n\n-------------------\n\nCURRENT VISIT - February 15, 2024\nTumor stable at 3.2cm\nWell-adapted to condition\nKPS: 85 | ECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Highest KPS: 90 (Initial visit, 2023)\n- Lowest KPS: 70 (March 2021)\n- Current KPS: 85\n- ECOG remained 1-2 throughout\n\nConservative management has proven successful with this patient, allowing her to maintain professional activities while managing symptoms effectively. Regular monitoring and symptom management have provided good quality of life preservation."
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work when cataloging books",
          "Mild right-sided facial numbness",
          "Reports feeling off-balance when reaching for high library shelves"
        ],
        "medical_history": [
          "Radiation therapy to scalp for severe tinea capitis at age 8",
          "Migraine headaches since age 30, managed with sumatriptan",
          "Hypertension diagnosed 2 years ago, controlled with lisinopril",
          "No history of seizures",
          "No previous neurological conditions",
          "No family history of brain tumors",
          "Regular eye exams, last one 6 months ago was normal",
          "No history of trauma"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-2016\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on superior frontal gyrus\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of dural tail sign\n\nASSESSMENT:\nGiven patient's history of radiation exposure, presenting symptoms, and tumor characteristics, immediate surgical intervention recommended. Location and size affecting daily function. WHO Grade II suspected.\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative functional MRI and DTI tractography\n3. Simpson Grade I resection goal\nKPS: 80 ECOG: 1\n\n-------------------\n\nPOST-OPERATIVE VISIT - April 12, 2016\nPROCEDURE: Left frontal craniotomy with gross total resection\nPATHOLOGY: Confirmed WHO Grade II atypical meningioma\nPOST-OP COURSE: Uncomplicated\nPLAN: \n- Adjuvant radiation therapy (60 Gy/30fx)\n- Follow-up MRI in 3 months\nKPS: 70 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - July 15, 2016\nPOST-RADIATION STATUS:\n- Completed RT with minimal side effects\n- Improved vision and balance\n- Returned to work part-time\nIMAGING: No evidence of residual/recurrence\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - January 10, 2017\nSTATUS: Working full-time\nIMAGING: Stable post-surgical changes\nPLAN: Continue q6month monitoring\nKPS: 90 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nCONCERN: New onset intermittent headaches\nMRI: Small enhancement along resection cavity\nPLAN: Increase monitoring frequency to q3months\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 15, 2018\nIMAGING: Progressive enhancement\nPLAN: Stereotactic radiosurgery to recurrent focus\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 10, 2019\nPOST-SRS STATUS: Good response\nIMAGING: Decreased enhancement\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - February 15, 2021\nSTATUS: Stable, working full-time\nIMAGING: No evidence of progression\nPLAN: Continue q6month monitoring\nKPS: 90 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 20, 2023\nCONCERN: New visual symptoms\nIMAGING: Multiple small recurrent nodules\nPLAN: \n1. Surgical re-exploration\n2. Consider systemic therapy\nKPS: 70 ECOG: 1\n\n-------------------\n\nCURRENT VISIT - January 10, 2024\nPOST-SECOND SURGERY STATUS:\n- Stable neurologically\n- Receiving bevacizumab\nIMAGING: Post-treatment changes, no new progression\nPLAN: Continue current regimen\nKPS: 80 ECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial: KPS 80/ECOG 1\n- Lowest: KPS 70/ECOG 1 (post-operative periods)\n- Highest: KPS 90/ECOG 0 (stable disease periods)\n- Current: KPS 80/ECOG 1\n\nTreatment approach reflected aggressive intervention due to:\n1. WHO Grade II status\n2. Prior radiation exposure history\n3. Occupation requiring cognitive clarity\n4. Progressive symptomatology\n5. Size and location of tumor",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-MEN\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms. Given size (<3cm) and patient's history of radiation exposure, recommending careful observation with serial imaging rather than immediate surgical intervention.\n\nPLAN:\n1. MRI surveillance every 4 months initially\n2. Prophylactic anticonvulsants not indicated\n3. Optimize headache management with neurology\n4. Occupational therapy evaluation for balance issues\n5. Regular ophthalmology follow-up\n\nFOLLOW-UP VISIT - July 20, 2018\nStable symptoms. MRI shows no growth.\nKPS: 90\nModified medication regimen for headaches.\nContinue monitoring schedule.\n\nFOLLOW-UP - November 12, 2018\nMinor improvement in headaches.\nMRI stable.\nKPS: 85\nAdded ergonomic workplace modifications.\n\nANNUAL REVIEW - March 5, 2019\nMRI: Minimal growth (0.2cm)\nKPS: 80\nIncreased frequency of headaches\nImplemented workplace accommodations\n\nFOLLOW-UP - September 15, 2019\nMRI: No further growth\nKPS: 85\nImproved symptom control\n\n2020 VISITS (During COVID-19 Pandemic):\nMarch 10, 2020 - Telemedicine\nKPS: 75 (COVID-related stress)\nContinue conservative management\n\nSeptember 8, 2020\nMRI: Stable\nKPS: 80\nAdded virtual vision therapy\n\n2021 ANNUAL REVIEW - March 15, 2021\nMRI: Minor growth (0.3cm total since initial)\nKPS: 70\nConsidering radiation therapy options\n\nDECISION POINT - September 20, 2021\nAfter tumor board review:\nInitiated stereotactic radiotherapy\nKPS: 65\n\n2022 FOLLOW-UP:\nMarch 10, 2022\nPost-radiation assessment\nKPS: 75\nImproved symptoms\n\nSeptember 15, 2022\nMRI: Tumor stabilization\nKPS: 80\nReturning to full work schedule\n\n2023 REVIEWS:\nMarch 12, 2023\nMRI: No progression\nKPS: 85\nMaintained improvement\n\nSeptember 18, 2023\nStable condition\nKPS: 90\nFull work capacity\n\nCURRENT STATUS (January 15, 2024):\nMRI: Stable disease\nKPS: 95\nExcellent functional status\nMinimal symptoms\n\nOVERALL SCORES:\nKPS Range: 65-95 (Current: 95)\nECOG Score: 1 (Fully ambulatory, can perform light work)\n\nMANAGEMENT SUMMARY:\nConservative approach successful with:\n- Regular MRI surveillance\n- Symptom management\n- Delayed radiation therapy\n- Workplace modifications\n- Quality of life preservation\n\nPatient maintains professional duties with accommodations. Conservative management with eventual targeted radiation therapy has provided good outcome while avoiding surgical risks."
      }
    },
    {
      "demographics": {
        "age": 54,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually over 2 months",
          "Reports of tinnitus in right ear"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "Mild hypertension diagnosed 2 years ago, managed with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Annual eye exams normal until 3 months ago",
          "No previous head trauma or neurological disorders"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F54-O-2016\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of optic nerve noted\n\nASSESSMENT:\nGiven patient's occupation requiring detailed visual work and cognitive function, symptoms significantly impact quality of life. Progressive neurological symptoms warrant immediate intervention.\nWHO Grade: II (preliminary)\nKPS Score: 80\nECOG: 1\n\nTREATMENT PLAN:\nRecommended aggressive surgical resection due to:\n1. Size >3cm\n2. Location affecting critical structures\n3. Progressive symptoms\n4. Impact on occupational function\n\n-------------------\n\nPOST-OPERATIVE FOLLOW-UP - April 2, 2016\nSurgical intervention performed March 25, 2016\n- Simpson Grade II resection achieved\n- Pathology confirmed WHO Grade II meningioma\n- Post-op MRI shows small residual tumor (0.5cm)\nKPS Score: 70\nECOG: 2\n\n-------------------\n\n3-MONTH FOLLOW-UP - July 15, 2016\n- Adjuvant radiation therapy completed (60 Gy/30fx)\n- Improvement in visual symptoms\n- Returning to work part-time\nKPS Score: 85\nECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP - September 30, 2016\n- MRI stable\n- Full return to work\n- Minimal residual symptoms\nKPS Score: 90\nECOG: 0\n\n-------------------\n\n1-YEAR FOLLOW-UP - March 20, 2017\n- MRI shows no progression\n- Maintaining work performance\nKPS Score: 95\nECOG: 0\n\n-------------------\n\n2-YEAR FOLLOW-UP - March 15, 2018\n- Small growth in residual tumor (0.8cm)\n- Recommend stereotactic radiosurgery\nKPS Score: 90\nECOG: 0\n\n-------------------\n\n3-YEAR FOLLOW-UP - March 20, 2019\nPost-SRS\n- Stable disease\n- No new symptoms\nKPS Score: 95\nECOG: 0\n\n-------------------\n\n5-YEAR FOLLOW-UP - March 18, 2021\n- MRI shows tumor progression (1.2cm)\n- New onset headaches\n- Recommend second surgical intervention\nKPS Score: 75\nECOG: 1\n\n-------------------\n\nPOST-SECOND SURGERY - May 1, 2021\n- Complete resection achieved\n- Pathology shows transformation to WHO Grade III\n- Initiated chemotherapy protocol\nKPS Score: 60\nECOG: 2\n\n-------------------\n\nCURRENT STATUS - January 15, 2024\n- Stable disease after aggressive treatment\n- Quarterly MRI surveillance\n- Maintained part-time work status\n- Well-managed symptoms\nKPS Score: 85\nECOG: 1\n\nTREATMENT SUMMARY:\n- Two surgical interventions (2016, 2021)\n- Radiation therapy\n- Stereotactic radiosurgery\n- Chemotherapy for Grade III progression\n\nKPS Score Range: 60-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nMONITORING PROTOCOL:\n- Quarterly MRI scans\n- Monthly neurological assessments\n- Visual field testing every 3 months\n- Cognitive function assessment every 6 months",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 54-year-old female software developer\nWHO Grade: I (based on imaging characteristics)\nMRI Findings: 2.4 cm left frontal convexity meningioma, minimal surrounding edema, no significant mass effect\n\nAssessment:\n- Symptomatic meningioma with progressive neurological symptoms\n- Occupation requires significant screen time and cognitive focus\n- Symptoms affecting work performance and quality of life\nKPS: 80 ECOG: 1\n\nPlan: Given size <3cm and patient preference, recommending close monitoring with consideration for intervention if progression occurs.\n\nFOLLOW-UP - September 20, 2018\nInterval MRI shows stable tumor size\nSymptoms: Moderate improvement with medical management\n- Started on Dexamethasone 4mg daily for edema\n- Prescribed blue light filtering glasses for screen work\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 12, 2019\nMRI: No significant change\nSymptoms: Stable with current management\nReduced Dexamethasone to 2mg daily\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 5, 2020\nMRI: Minimal growth (2.6 cm)\nSymptoms: Worsening headaches\nIncreased Dexamethasone to 4mg daily\nDiscussing surgical options but patient prefers conservative approach\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - September 15, 2020\nMRI: Stable at 2.6 cm\nSymptoms: Better controlled with medication adjustments\nModified work schedule implemented (regular breaks from screen)\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 10, 2021\nMRI: No change\nSymptoms: Well-controlled\nSuccessfully weaned off Dexamethasone\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 8, 2022\nMRI: Slight increase to 2.8 cm\nSymptoms: Stable\nDiscussing SRS as potential future option\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 14, 2023\nMRI: Stable at 2.8 cm\nSymptoms: Well-managed with current regimen\nContinuing conservative approach\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - February 20, 2024\nMRI: No significant change\nSymptoms: Stable\nMaintaining conservative management\nWorking successfully with accommodations\nKPS: 95 ECOG: 0\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively over 6-year period\n- Periodic MRI surveillance\n- Symptom management with medications as needed\n- Workplace accommodations implemented\n- Quality of life preserved with minimal intervention\n\nRECOMMENDATIONS:\n1. Continue biannual MRI surveillance\n2. Maintain ergonomic workplace modifications\n3. Regular ophthalmological follow-up\n4. Consider SRS if significant progression occurs\n\nFinal KPS: 95 - Able to carry on normal activity with minor symptoms\nFinal ECOG: 0 - Fully active, able to carry on all pre-disease performance without restriction"
      }
    },
    {
      "demographics": {
        "age": 51,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly in dim lighting",
          "Difficulty concentrating at work for past 2-3 months"
        ],
        "medical_history": [
          "Hypertension diagnosed 3 years ago - controlled with lisinopril 10mg daily",
          "Mild traumatic brain injury from car accident 15 years ago - full recovery",
          "Seasonal allergies - takes OTC antihistamines as needed",
          "Appendectomy at age 23",
          "No history of cancer",
          "No family history of brain tumors",
          "Non-smoker",
          "Social alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M51-A\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm parasagittal meningioma in right frontal region\n- Significant perilesional edema\n- Mass effect with 5mm midline shift\n- Enhancement pattern consistent with WHO Grade II meningioma\nWHO Grade: II\nKPS: 80\nECOG: 1\n\nTREATMENT DECISION:\nGiven size, location, and symptomatic presentation, immediate surgical intervention recommended.\n\nSURGICAL NOTE - April 3, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II\nComplications: None\nPost-op KPS: 70\nECOG: 2\n\nFOLLOW-UP - July 15, 2018\n- Improved headaches\n- Vision stabilized\n- Balance improving with PT\n- Started radiation therapy\nKPS: 75\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 3, 2018\nMRI: Small residual enhancement\nSymptoms: Significantly improved\nTreatment: Completed radiation therapy (60 Gy/30fx)\nKPS: 85\nECOG: 1\n\n1-YEAR FOLLOW-UP - April 15, 2019\nMRI: Stable residual disease\nReturned to work part-time\nKPS: 90\nECOG: 0\n\n2-YEAR FOLLOW-UP - May 2, 2020\nMRI: New nodular enhancement\nDecision: Second surgery recommended\nKPS: 85\nECOG: 1\n\nSECOND SURGERY - June 15, 2020\nProcedure: Revision craniotomy\nSimpson Grade: I\nPathology: WHO Grade II\nKPS: 65\nECOG: 2\n\n3-YEAR FOLLOW-UP - April 10, 2021\nMRI: No evidence of recurrence\nFull-time work resumed\nKPS: 95\nECOG: 0\n\n4-YEAR FOLLOW-UP - March 30, 2022\nMRI: Stable\nAsymptomatic\nKPS: 100\nECOG: 0\n\n5-YEAR FOLLOW-UP - April 5, 2023\nMRI: Small focus of enhancement\nRecommendation: Close monitoring\nKPS: 90\nECOG: 0\n\nRECENT FOLLOW-UP - February 12, 2024\nMRI: Stable disease\nMaintaining regular activities\nKPS: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial aggressive surgical resection\n- Adjuvant radiation therapy\n- One recurrence requiring revision surgery\n- Currently stable with excellent functional status\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neurological examination quarterly\n- Annual neuropsychological testing\n- Regular ophthalmological assessment\n\nKPS Range Throughout Treatment: 65-100\nECOG Range Throughout Treatment: 0-2\n\nFinal Status:\nKPS: 95 - Able to carry on normal activity; minor symptoms\nECOG: 0 - Fully active, able to carry on all pre-disease performance without restriction",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Male\nAge at Initial Presentation: 51\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No calcification noted\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms. Despite tumor size being <3cm, symptoms warrant close monitoring. Given patient's professional status and impact on work performance, conservative management with vigilant monitoring is recommended.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Neurology consult for headache management\n3. Ophthalmology referral for vision assessment\n4. Consider prophylactic anti-seizure medication\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - March 20, 2019\nTumor stable in size. Vision symptoms improved with prescribed glasses.\nHeadaches managed with:\n- Lifestyle modifications\n- Propranolol 40mg daily\nKPS Score: 85\nECOG: 1\n\nANNUAL REVIEW - February 12, 2020\nSlight tumor growth (0.2cm)\nSymptoms stable\nAdded: Dexamethasone 4mg daily for edema management\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - August 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nContinuing conservative management\nKPS Score: 75\nECOG: 1\n\nANNUAL REVIEW - January 30, 2021\nTumor size stable\nVision stable\nReduced dexamethasone to 2mg daily\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - February 5, 2022\nNotable increase in headache frequency\nMRI shows increased peritumoral edema\nIncreased dexamethasone to 4mg daily\nDiscussing surgical options but patient prefers conservative approach\nKPS Score: 70\nECOG: 2\n\nURGENT VISIT - July 12, 2022\nSignificant symptom progression\nMRI shows tumor growth to 3.2cm\nRecommended surgical intervention\nPatient still preferring conservative approach\nStarted on:\n- Higher dose dexamethasone (6mg daily)\n- Enhanced anti-seizure prophylaxis\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - January 15, 2023\nSome symptom improvement with medical management\nMaintaining conservative approach per patient preference\nRegular physical therapy for balance issues\nKPS Score: 65\nECOG: 2\n\nRECENT VISIT - December 5, 2023\nStable disease\nManaging symptoms effectively with:\n- Reduced dexamethasone (4mg daily)\n- Regular physical therapy\n- Occupational therapy for work adaptations\nKPS Score: 70\nECOG: 1\n\nLATEST VISIT - February 20, 2024\nStable disease status\nQuality of life improved\nContinuing conservative management\nMonthly neurology follow-up\nKPS Score: 75\nECOG: 1\n\nTREATMENT SUMMARY:\nConservative management maintained over 6-year period\nFocus on symptom management and quality of life\nRegular monitoring with MRI and clinical assessments\nMultidisciplinary approach including neurology, ophthalmology, and rehabilitation services\n\nKPS Score Range: 60-85 throughout monitoring period\nECOG Score Range: 1-2 throughout monitoring period\n\nRECOMMENDATIONS:\n1. Continue current management plan\n2. Monthly neurology follow-up\n3. MRI every 6 months\n4. Regular quality of life assessments\n5. Maintain work modifications\n6. Continue physical therapy\n\nNote: Conservative approach maintained per patient preference and relative stability of condition. Surgical option remains available if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional balance issues when walking, subtle personality changes noted by spouse including increased irritability, one episode of confusion while organizing library books, mild right-sided facial numbness"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily, surgical removal of gallbladder in 2012, mild hearing loss in left ear diagnosed 5 years ago, history of migraine headaches in 30s-40s that had resolved, occasional tension headaches treated with OTC medications, family history of father with stroke at age 72, no history of seizures or neurological disorders, no prior head trauma or radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 66-year-old male librarian, Blood Type O\nPresenting Symptoms: Progressive headaches (3 months), morning predominance, right eye visual disturbance, balance issues, personality changes, episodic confusion, right facial numbness\nKPS: 80/100 | ECOG: 1\n\nIMAGING:\nInitial MRI reveals 3.8cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe. T2 hyperintense with heterogeneous enhancement.\n\nASSESSMENT & PLAN:\nWHO Grade II meningioma suspected based on imaging characteristics. Given size >3cm, peritumoral edema, and progressive symptoms, recommend surgical resection. Occupation requires cognitive precision; symptoms affecting work performance.\n- Schedule craniotomy within 2 weeks\n- Start Dexamethasone 4mg QID\n- Pre-operative workup initiated\n\nSURGICAL NOTE - March 30, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II atypical meningioma\nPost-op imaging shows small residual tumor (0.5cm)\nKPS: 70/100 | ECOG: 2\n\nFOLLOW-UP - June 15, 2018\nPost-operative adjuvant radiation therapy completed (59.4 Gy in 33 fractions)\nSymptoms improving\nReturn to work part-time approved\nKPS: 85/100 | ECOG: 1\n\nFOLLOW-UP - December 20, 2018\n6-month MRI stable\nMinimal residual enhancement\nWorking full-time\nKPS: 90/100 | ECOG: 0\n\nFOLLOW-UP - June 18, 2019\nNew 1cm nodule at resection margin\nRecommend stereotactic radiosurgery\nKPS: 85/100 | ECOG: 1\n\nFOLLOW-UP - January 15, 2020\nPost-SRS imaging shows good response\nAnnual monitoring continued\nKPS: 90/100 | ECOG: 0\n\nFOLLOW-UP - March 10, 2021\nMRI shows stable disease\nNo new symptoms\nKPS: 90/100 | ECOG: 0\n\nFOLLOW-UP - April 5, 2022\nSmall progression noted (1.2cm new nodule)\nSecond SRS course recommended\nKPS: 80/100 | ECOG: 1\n\nFOLLOW-UP - May 12, 2023\nPost-second SRS imaging stable\nMild radiation changes noted\nKPS: 75/100 | ECOG: 1\n\nCURRENT VISIT - January 20, 2024\nMultiple new nodules noted\nConsidering systemic therapy options\nBevacizumab protocol discussed\nKPS: 60/100 | ECOG: 2\n\nTREATMENT SUMMARY:\n- Initial craniotomy (2018)\n- Adjuvant radiation therapy\n- Two courses of stereotactic radiosurgery\n- Regular MRI surveillance\n- Current consideration for systemic therapy\n\nKPS Score Range: 60-90/100\nECOG Score Range: 0-2\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Neurological examination every 6 weeks\n- Cognitive function testing quarterly\n- Quality of life assessments ongoing",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M66-O-2014\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches (3 months), morning predominance, right eye blurred vision, balance issues, personality changes, episodic confusion, right facial numbness.\nMRI Findings: 2.8cm left frontal parasagittal meningioma, minimal surrounding edema, no significant mass effect.\nWHO Grade: I (presumptive based on imaging characteristics)\nAssessment: Given size <3cm, minimal edema, and stable employment, conservative management initially recommended.\nPlan: \n- Dexamethasone 4mg BID for symptom management\n- Follow-up MRI in 3 months\n- Continue current medications\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2014\nSymptoms: Moderate improvement in headaches, vision stable\nMRI: No significant change in tumor size\nPlan: \n- Taper dexamethasone\n- Continue monitoring\n- Next MRI in 6 months\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - March 10, 2015\nSymptoms: Well-controlled headaches, maintaining work duties\nMRI: Stable lesion size, no new edema\nPlan: Annual MRI surveillance\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 15, 2016\nSymptoms: Mild fatigue, otherwise stable\nMRI: Minimal growth (0.2cm), no concerning features\nPlan: Continue annual monitoring\nKPS: 85 ECOG: 1\n\nURGENT VISIT - September 30, 2017\nSymptoms: Increased headaches, new onset dizziness\nMRI: Tumor growth to 3.2cm, moderate edema\nPlan: \n- Restart dexamethasone\n- Consider radiation therapy consultation\nKPS: 70 ECOG: 2\n\nFOLLOW-UP POST-RT - March 20, 2018\nTreatment: Completed fractionated RT (54 Gy/30 fractions)\nSymptoms: Improving\nMRI: Stable disease\nPlan: Continue monitoring every 6 months\nKPS: 75 ECOG: 1\n\nANNUAL REVIEW - March 15, 2020\nSymptoms: Well-controlled, working part-time\nMRI: Stable disease, decreased edema\nPlan: Return to annual monitoring\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 10, 2022\nSymptoms: Stable, maintaining quality of life\nMRI: No progression\nPlan: Continue annual surveillance\nKPS: 90 ECOG: 0\n\nRECENT VISIT - January 15, 2024\nAge: 76\nSymptoms: Stable neurologically, retired but active\nMRI: No tumor progression\nPlan: \n- Continue annual MRI\n- Monitor cognitive function\n- Quality of life maintenance\nKPS: 85 ECOG: 1\n\nMANAGEMENT SUMMARY:\nSuccessfully managed with conservative approach for 10 years. Initial watchful waiting progressed to RT when needed. Patient maintained good functional status and quality of life throughout, with KPS ranging from 70-90. Occupation as librarian allowed for cognitive monitoring through work performance. Treatment decisions prioritized functional preservation and minimal intervention when possible.\n\nKPS Range Over Time: 70-90\nECOG Range Over Time: 0-2"
      }
    },
    {
      "demographics": {
        "age": 44,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness and tingling; Occasional blurred vision in right eye; Balance difficulties when walking; Recent onset of nausea, particularly in mornings; Memory difficulties and trouble concentrating at work; One episode of seizure 2 weeks ago"
        ],
        "medical_history": [
          "BMI 34.2 (Obese Class I); Hypertension diagnosed 5 years ago, managed with lisinopril; Minor concussion from sports injury 15 years ago, fully recovered; Sleep apnea diagnosed 3 years ago, uses CPAP; Family history negative for brain tumors; No history of radiation exposure; Current medications: lisinopril 20mg daily; No known drug allergies; Social history: Former smoker (quit 8 years ago), occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 44-year-old male, Blood Type O\nChief Complaint: Progressive neurological symptoms with recent seizure\n\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nHigh-risk features warranting immediate intervention:\n- Size >3cm\n- Significant edema\n- Critical location\n- Progressive symptoms\n- Recent seizure\n\nPLAN:\n1. Surgical resection recommended within 2 weeks\n2. Pre-operative optimization of BMI and blood pressure\n3. Started on Dexamethasone 4mg QID\n4. Anti-epileptic (Levetiracetam 500mg BID)\nKPS: 70 | ECOG: 1\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Minimal residual tumor at superior sagittal sinus\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP - June 15, 2018\n- Improved neurological symptoms\n- Post-operative radiation therapy completed (60 Gy/30 fractions)\n- MRI shows minimal enhancement at resection site\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - December 20, 2018\n- Stable imaging\n- Improved cognitive function\n- Return to work part-time\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - June 18, 2019\n- New 1cm nodule at resection margin\n- Recommended stereotactic radiosurgery\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - January 15, 2020\n- Post-SRS imaging stable\n- Maintained neurological improvement\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - July 10, 2020\n- Multiple new nodules noted\n- Decline in functional status\n- Second surgery planned\nKPS: 60 | ECOG: 2\n\nSURGICAL NOTE - August 1, 2020\n- Gross total resection of recurrent tumors\n- Pathology shows progression to WHO Grade III\n- Initiated temozolomide chemotherapy\nKPS: 50 | ECOG: 2\n\nFOLLOW-UP - February 15, 2021\n- Partial response to chemotherapy\n- Improved functional status\nKPS: 70 | ECOG: 1\n\nFOLLOW-UP - August 20, 2021\n- Disease progression\n- Started bevacizumab\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - March 10, 2022\n- Stable disease\n- Improved quality of life\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - September 15, 2022\n- Continued stability\n- Maintained functional status\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - April 5, 2023\n- Minor progression\n- Continued bevacizumab\nKPS: 75 | ECOG: 1\n\nLATEST FOLLOW-UP - January 10, 2024\n- Stable disease\n- Well-maintained functional status\n- Continues regular monitoring\nKPS: 80 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Progression to Grade III\n- Multiple surgeries\n- Radiation and chemotherapy\n- Current status: Stable disease with good functional status\n\nKPS Range throughout treatment: 50-90\nECOG Range throughout treatment: 0-2",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M44-O-BMI34\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - September 15, 2016\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's age, obesity, and sleep apnea, recommending conservative management with close monitoring. Initiating anti-epileptic medication (Levetiracetam 500mg BID) due to recent seizure. Will monitor symptoms and tumor growth pattern before considering surgical intervention.\n\nFOLLOW-UP VISIT - March 20, 2017\nSymptoms stable. Headaches improved with medical management (Topiramate 50mg daily added). No new seizures.\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - February 12, 2018\nPatient reports improved sleep with consistent CPAP use. Maintaining employment with workplace accommodations.\nMRI: Minimal growth (0.2cm), stable edema\nKPS: 90 | ECOG: 0\n\nANNUAL FOLLOW-UP - March 5, 2019\nMinor increase in morning headaches. Adjusted medications.\nMRI: Tumor size 3.1cm, slight increase in edema\nKPS: 80 | ECOG: 1\nPlan: Increased monitoring frequency to 6-monthly\n\nINTERIM VISIT - September 10, 2019\nSymptoms stable with medication adjustment\nMRI: No significant change\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth visit\nPatient stable. Managing work from home effectively.\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - April 2, 2021\nReports increased fatigue and headaches\nMRI: Tumor size 3.3cm, moderate edema\nKPS: 70 | ECOG: 2\nPlan: Initiated dexamethasone for edema management\n\nFOLLOW-UP - October 12, 2021\nImproved symptoms with steroid therapy\nMRI: Stable, slight decrease in edema\nKPS: 80 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 8, 2022\nMaintaining stable symptoms. Successfully weaned off steroids.\nMRI: No significant change\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - February 14, 2023\nWell-controlled symptoms. Continues regular exercise program.\nMRI: Stable disease\nKPS: 90 | ECOG: 0\n\nRECENT FOLLOW-UP - January 10, 2024\nPatient maintaining good quality of life. Working full-time.\nMRI: No significant change since 2021\nKPS: 90 | ECOG: 0\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively for 8 years\n- Regular MRI surveillance\n- Symptom management with medications\n- Lifestyle modifications: weight management program, sleep hygiene\n- Maintained employment with accommodations\n- No surgical intervention required\n\nKPS Score Range: 70-90 (Lowest during steroid requirement period, highest during stable periods)\nECOG Score Range: 0-2 (Correlating with KPS fluctuations)\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular CPAP compliance\n4. Continue weight management program\n5. Annual neuropsychological assessment\n6. Regular blood pressure monitoring"
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness for past 2 months",
          "Balance difficulties when walking, particularly in dim lighting",
          "Recent memory issues affecting work performance"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, well-controlled on lisinopril 10mg daily",
          "Mild hearing loss in left ear - diagnosed 3 years ago",
          "Surgical history: Appendectomy (1985)",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Father had stroke at age 72",
          "Current medications: Lisinopril 10mg daily, occasional ibuprofen for headaches",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 56-year-old male, Blood Type A\nChief Complaint: Progressive neurological symptoms\n\nMRI Findings:\n- 4.2 cm right frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- WHO Grade II features suspected\n\nAssessment:\nSymptomatic right frontal meningioma with concerning features warranting immediate intervention. KPS: 80, ECOG: 1\n\nPlan:\n- Scheduled for surgical resection within 2 weeks\n- Preoperative imaging protocol: MRI with contrast, MR venography\n- Neurocognitive testing baseline established\n\nSurgical Note - March 30, 2018\nProcedure: Right frontal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minimal residual tumor at sinus interface\n- Pathology confirms WHO Grade II meningioma\nKPS: 70, ECOG: 2\n\nFollow-up - June 15, 2018\n- Improved vision and headaches\n- Starting adjuvant radiation therapy\n- 54 Gy in 30 fractions planned\nKPS: 75, ECOG: 1\n\nDecember 10, 2018\n- Post-radiation MRI shows no progression\n- Mild radiation-related fatigue\n- Cleared to return to work part-time\nKPS: 85, ECOG: 1\n\nJune 20, 2019\n- Surveillance MRI stable\n- Full work resumption\n- Minor right facial numbness persists\nKPS: 90, ECOG: 0\n\nJanuary 15, 2020\n- Small area of enhancement noted on MRI\n- Close monitoring recommended\n- Increased scan frequency\nKPS: 85, ECOG: 1\n\nJuly 30, 2020\n- Progressive enhancement\n- Decision for repeat surgery\nKPS: 80, ECOG: 1\n\nSurgical Note - August 15, 2020\nSecond resection performed\n- Simpson Grade III achieved\n- Pathology confirms recurrent WHO Grade II\nKPS: 65, ECOG: 2\n\nFebruary 10, 2021\n- Post-operative recovery satisfactory\n- Starting stereotactic radiosurgery\nKPS: 75, ECOG: 1\n\nJanuary 20, 2022\n- Stable imaging\n- Improved neurological status\nKPS: 85, ECOG: 1\n\nMarch 15, 2023\n- Small area of recurrence noted\n- Monitoring closely\nKPS: 80, ECOG: 1\n\nJanuary 10, 2024\n- Latest MRI shows stable disease\n- Maintaining work schedule\n- Quarterly imaging continues\nKPS: 85, ECOG: 1\n\nSummary of KPS/ECOG Progression:\n- Highest KPS: 90 (Full recovery period)\n- Lowest KPS: 65 (Post-second surgery)\n- Current KPS: 85\n- ECOG range: 0-2\n- Current ECOG: 1\n\nTreatment approach has been appropriately aggressive given:\n1. WHO Grade II status\n2. Patient's relatively young age\n3. Professional demands\n4. Progressive symptomatology\n5. Tumor location and size\n\nContinuing with quarterly MRI surveillance and biannual clinical assessments.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M56-A\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.4cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\nKPS: 90 | ECOG: 1\n\nASSESSMENT:\n56-year-old male executive presenting with progressive neurological symptoms. Given tumor size <3cm and stable employment requiring cognitive function, recommending conservative management initially.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Dexamethasone 4mg daily for symptom management\n3. Quarterly follow-up\n4. Occupational therapy referral for balance assessment\n\nFOLLOW-UP - December 10, 2018\nSymptoms slightly improved with steroids\nMRI: No significant change\nKPS: 90 | ECOG: 1\nPlan: Continue current management\n\nFOLLOW-UP - June 18, 2019\nReports improved headaches\nMRI: Stable lesion size\nKPS: 95 | ECOG: 0\nPlan: Reduce steroid dose gradually\n\nANNUAL REVIEW - September 20, 2020\nMinimal symptom progression\nMRI: 2.5cm, minimal growth\nKPS: 85 | ECOG: 1\nPlan: Continue monitoring, maintain reduced steroid dose\n\nFOLLOW-UP - March 15, 2021\nReports increased fatigue\nMRI: 2.7cm, slight progression\nKPS: 80 | ECOG: 1\nPlan: Increase steroid dose temporarily\n\nANNUAL REVIEW - September 10, 2022\nVision symptoms worsening\nMRI: 3.0cm, moderate growth\nKPS: 70 | ECOG: 2\nPlan: Discuss surgical options but continue conservative management per patient preference\n\nFOLLOW-UP - March 5, 2023\nSignificant symptom progression\nMRI: 3.2cm with increased edema\nKPS: 60 | ECOG: 2\nPlan: Recommend considering stereotactic radiosurgery\n\nCURRENT VISIT - January 15, 2024\nPost-radiation follow-up\nMRI: Stable disease, reduced edema\nKPS: 80 | ECOG: 1\n\nMANAGEMENT SUMMARY:\n- Successfully maintained conservative approach for 5+ years\n- Delayed surgical intervention through careful monitoring\n- Quality of life preserved through symptom management\n- Eventually required radiation therapy but avoided open surgery\n- Patient maintained employment throughout treatment period\n\nCURRENT STATUS:\nKPS Score: 80 - Able to perform normal activity with effort\nECOG Score: 1 - Restricted in physically strenuous activity\n\nMONITORING RECOMMENDATIONS:\n1. Continue MRI every 6 months\n2. Monthly neurological assessments\n3. Regular cognitive function testing\n4. Quality of life questionnaires\n5. Balance and vision evaluations quarterly\n\nNON-SURGICAL INTERVENTIONS:\n1. Steroid management as needed\n2. Physical therapy for balance\n3. Occupational therapy for work adaptation\n4. Cognitive rehabilitation exercises\n5. Stress management techniques"
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": true
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness during stage performances",
          "Occasional nausea without vomiting",
          "Subtle personality changes noted by coworkers - increased irritability",
          "Difficulty maintaining balance during dance routines",
          "Recent problems with memorizing new performance scripts"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 5 years ago - managed with Metformin",
          "HbA1c consistently around 7.2%",
          "Mild hypertension - not currently on medication",
          "History of migraine headaches since age 30, but notes current headaches are different",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "No history of radiation exposure",
          "Regular performer in theater productions for 15 years",
          "No significant head injuries"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly balance/coordination tests, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly balance/coordination tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M40-A-DM\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION\nChief Complaint: Progressive neurological symptoms affecting performance career\nAssessment: 40yo male performer presents with concerning neurological symptoms suggesting possible space-occupying lesion.\n\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- No calcification noted\nWHO Grade: II (atypical features on imaging)\nKPS: 80\nECOG: 1\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size >3cm\n2. Occupation requiring high cognitive/physical performance\n3. Progressive symptoms affecting quality of life\n4. Evidence of mass effect\n\n-------------------\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II resection\nFindings: Adherent to superior sagittal sinus\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 70\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2018 (3 months post-op)\nPatient reports:\n- Improved headaches\n- Vision normalized\n- Starting physical therapy\n- Planning return to stage work\nMRI: No residual tumor\nKPS: 90\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - January 10, 2019 (9 months post-op)\nSuccessfully returned to performing\nAdjuvant radiotherapy completed\nMRI: Stable\nKPS: 95\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - July 8, 2019\nRoutine surveillance\nMRI: No recurrence\nKPS: 100\nECOG: 0\n\n-------------------\n\nURGENT VISIT - March 3, 2020\nNew onset seizures\nMRI: Small recurrence at surgical site\nKPS: 60\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - April 15, 2020\nStarted anticonvulsants\nPlanning second surgery\nKPS: 70\nECOG: 1\n\n-------------------\n\nSURGICAL NOTE - May 1, 2020\nSecond resection performed\nSimpson Grade III\nKPS: 65\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - December 10, 2020\nPost-radiation therapy\nStable disease\nReturned to modified performance schedule\nKPS: 85\nECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - December 5, 2021\nStable disease\nFull performance schedule resumed\nKPS: 90\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - June 15, 2022\nRoutine surveillance\nMRI: Stable\nKPS: 95\nECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - June 20, 2023\nContinues performing\nNo new symptoms\nMRI: Stable\nKPS: 95\nECOG: 0\n\n-------------------\n\nRECENT FOLLOW-UP - January 15, 2024\n5.5 years post initial diagnosis\nStable disease\nRegular performance schedule maintained\nMRI: No evidence of recurrence\nKPS: 100\nECOG: 0\n\nMONITORING PLAN:\n- Continue q6month MRI surveillance\n- Regular neurological assessments\n- Monitor diabetes management\n- Annual neuropsychological testing\n- Occupational therapy as needed\n\nKPS Score Range: 60-100 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 40-year-old male, blood type A\nChief Complaint: Progressive headaches, visual changes, balance issues\n\nMRI Findings:\n- 2.1cm left frontal parasagittal meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\n\nAssessment:\nGiven patient's occupation as stage performer and well-controlled diabetes (HbA1c 7.2%), recommending conservative management initially. Symptoms warrant monitoring but tumor size and location allow for non-surgical approach.\n\nPlan:\n1. MRI surveillance every 4 months initially\n2. Dexamethasone 4mg daily for symptom management\n3. Referral to neuro-ophthalmology\n4. Consider temporary work modification\nKPS: 80 ECOG: 1\n\nFollow-up - July 20, 2018\nSymptoms slightly improved with steroids\nMRI: No significant change\nPlan: Continue current management\nKPS: 85 ECOG: 1\n\nJanuary 12, 2019\nPatient reports better balance, continuing performances\nMRI: Stable\nReduced dexamethasone to 2mg daily\nKPS: 90 ECOG: 0\n\nAugust 30, 2019\nMild headache recurrence\nMRI: Minimal growth (2.3cm)\nAdded prophylactic migraine medication\nKPS: 85 ECOG: 1\n\nMarch 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nMaintaining performance schedule with modifications\nKPS: 80 ECOG: 1\n\nSeptember 10, 2020\nMRI: 2.4cm, slight progression\nDiscussed surgical options but patient prefers conservative approach\nKPS: 75 ECOG: 1\n\nApril 5, 2021\nIncreasing headaches\nMRI: 2.6cm with moderate edema\nStarted higher dose steroids\nConsidering radiation therapy\nKPS: 70 ECOG: 2\n\nOctober 15, 2021\nDecision made for fractionated RT\n54 Gy in 30 fractions planned\nKPS: 65 ECOG: 2\n\nMarch 20, 2022\nPost-RT follow-up\nImproved symptoms\nMRI: Slight decrease in tumor size\nKPS: 75 ECOG: 1\n\nSeptember 30, 2022\nStable condition\nReturned to modified performance schedule\nKPS: 85 ECOG: 1\n\nApril 15, 2023\nMaintaining stability\nMRI: No progression\nReduced follow-up to annual\nKPS: 90 ECOG: 0\n\nJanuary 10, 2024\nLatest follow-up\nStable symptoms and imaging\nFully returned to performance work\nKPS: 95 ECOG: 0\n\nTreatment Summary:\nConservative management successfully maintained patient's quality of life and professional career. Initial watchful waiting approach followed by targeted RT when progression occurred. Patient maintained good functional status throughout treatment course with current KPS 95.\n\nFinal KPS: 95\nFinal ECOG: 0\n\nNote: KPS scores reflected patient's functional status, ranging from lowest 65 (during pre-RT period) to current 95 (stable disease with full functional recovery)."
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues",
          "Occasional nausea without vomiting",
          "Reports feeling increased pressure in head when bending over",
          "Subtle personality changes noted by family - increased irritability",
          "Right-sided facial numbness that developed gradually over 2 months"
        ],
        "medical_history": [
          "Hypertension - diagnosed 6 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraines in 30s that resolved spontaneously",
          "Surgical history: Cholecystectomy (2012)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history: Mother had breast cancer",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F58-A-MEN\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\nKPS: 80 | ECOG: 1\n\nASSESSMENT:\nGiven size, location, and symptomatic presentation, immediate surgical intervention recommended. Patient's obesity and hypertension noted as surgical risk factors.\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Neuropsychological evaluation\n4. Ophthalmological consultation for vision changes\n\nSURGICAL NOTE - April 2, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to cavernous sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - July 15, 2018\n- Residual tumor stable\n- Vision improving\n- Headaches resolved\n- Started adjuvant radiation therapy\nKPS: 75 | ECOG: 1\n\nFOLLOW-UP - January 10, 2019\n- Post-radiation MRI shows no progression\n- Minor radiation-related fatigue\n- Continuing rehabilitation\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 20, 2020\n- MRI shows small area of enhancement at surgical site\n- No new symptoms\n- Weight loss program initiated\nKPS: 90 | ECOG: 0\n\nURGENT VISIT - September 15, 2021\n- New onset seizures\n- MRI shows tumor progression\n- Second surgery recommended\nKPS: 60 | ECOG: 2\n\nSECOND SURGERY - October 1, 2021\n- More aggressive resection achieved\n- Pathology shows transformation to WHO Grade III\n- Post-op complications: temporary speech difficulties\nKPS: 50 | ECOG: 3\n\nFOLLOW-UP - January 15, 2022\n- Started on temozolomide\n- Speech therapy showing good progress\n- Monthly MRI surveillance initiated\nKPS: 65 | ECOG: 2\n\nFOLLOW-UP - June 20, 2023\n- Stable disease on imaging\n- Improved functional status\n- Continuing chemotherapy\nKPS: 75 | ECOG: 1\n\nLATEST FOLLOW-UP - January 10, 2024\n- No evidence of progression\n- Maintaining good quality of life\n- Continue surveillance protocol\nKPS: 80 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical interventions\n- Progression to Grade III\n- Current status: Stable disease on chemotherapy\n- Overall survival: 5+ years with maintained functionality\n\nCURRENT MONITORING PLAN:\n1. Quarterly MRI scans\n2. Monthly clinical evaluations\n3. Regular neuropsychological assessments\n4. Ongoing chemotherapy monitoring\n\nKPS Score Range: 50-90 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course\n\nPROGNOSIS:\nGuarded but stable with current treatment regimen. Continued close monitoring essential due to high-grade transformation history.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Female\nAge: 58\nInitial Consultation: March 15, 2018\n\nINITIAL VISIT - 03/15/2018\nPresenting Symptoms: Progressive headaches, right-sided visual disturbance, dizziness, facial numbness\nMRI Findings: 2.8cm right sphenoid wing meningioma with minimal perilesional edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 80 ECOG: 1\n\nAssessment & Plan:\nGiven tumor size <3cm and patient's comorbidities (obesity, hypertension), recommending conservative management with close monitoring. Will obtain baseline neurocognitive testing.\n- MRI surveillance every 6 months initially\n- Optimize blood pressure control\n- Dexamethasone 4mg daily for symptom management\n- Neurology referral for headache management\n\nFOLLOW-UP - 09/20/2018\nSymptoms slightly improved with steroid therapy\nMRI: No significant change in tumor size\nKPS: 85 ECOG: 1\nPlan: Begin steroid taper, continue monitoring\n\nFOLLOW-UP - 03/15/2019\nReports improved headaches\nMRI: Stable lesion size\nKPS: 90 ECOG: 0\nPlan: Extended MRI interval to annual\n\nANNUAL FOLLOW-UP - 03/20/2020\nMinimal symptoms\nMRI: No growth\nKPS: 90 ECOG: 0\nPlan: Continue annual surveillance\n\nANNUAL FOLLOW-UP - 04/10/2021\nNew complaint of worsening right-sided facial numbness\nMRI: 1mm growth noted\nKPS: 75 ECOG: 1\nPlan: Return to 6-month surveillance interval\n\nFOLLOW-UP - 10/15/2021\nSymptoms stable\nMRI: No additional growth\nKPS: 80 ECOG: 1\nPlan: Continue surveillance\n\nANNUAL FOLLOW-UP - 10/20/2022\nWell-controlled symptoms\nMRI: Stable\nKPS: 85 ECOG: 1\nPlan: Maintain current management approach\n\nANNUAL FOLLOW-UP - 11/05/2023\nMinor headache complaints\nMRI: No progression\nKPS: 90 ECOG: 0\nPlan: Continue annual imaging\n\nCURRENT VISIT - 02/15/2024\nStable symptoms\nMRI: No significant change over 6 years\nKPS: 90 ECOG: 0\n\nSUMMARY OF MANAGEMENT APPROACH:\n- Successfully managed conservatively for 6 years\n- Maintained quality of life through non-surgical intervention\n- Patient able to continue working as accountant (desk job compatible with condition)\n- Lifestyle modifications implemented: weight management program, stress reduction\n- Regular monitoring has shown tumor stability\n\nKPS Score Range Over Time: 75-90\nECOG Score Range Over Time: 0-1\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain BP control\n3. Regular ophthalmology checks\n4. Weight management program\n5. Consider occupational therapy if balance issues worsen\n6. Monthly headache diary maintenance\n\nThis conservative approach has proven successful with stable disease and good quality of life maintenance."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding right words",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, especially in dim lighting",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Surgical removal of benign breast lump in 2010",
          "Osteoarthritis in both knees - managed with NSAIDs",
          "Family history of breast cancer (mother)",
          "No history of smoking",
          "Regular mammograms, last one normal 8 months ago",
          "Post-menopausal since age 52"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-B-SD\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 4.2 cm left frontotemporal meningioma\n- Significant peritumoral edema\n- Mass effect with 5mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\n- Compression of left optic tract\n\nASSESSMENT:\nSymptomatic WHO Grade II meningioma requiring urgent intervention. Patient's cognitive symptoms affecting work performance as software developer. High-risk features present.\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Seizure prophylaxis with levetiracetam 500mg BID\nKPS: 70 | ECOG: 1\n\n-------------------\n\nPOST-OPERATIVE VISIT - April 12, 2016\nPROCEDURE:\nLeft frontotemporal craniotomy with Simpson Grade II resection\nPATHOLOGY: WHO Grade II atypical meningioma\nCOMPLICATIONS: None\n\nPLAN:\n1. Adjuvant radiation therapy (60 Gy/30 fractions)\n2. Monthly follow-up\nKPS: 60 | ECOG: 2\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 15, 2016\nIMAGING:\nNo evidence of residual/recurrent tumor\nResolving post-operative changes\n\nSYMPTOMS:\n- Improved vision\n- Resolved headaches\n- Mild word-finding difficulties persist\n\nPLAN:\n1. Continue q3month MRI surveillance\n2. Speech therapy referral\nKPS: 80 | ECOG: 1\n\n-------------------\n\n2-YEAR FOLLOW-UP - March 20, 2018\nIMAGING:\n2cm recurrence at original site\nNew satellite lesion (1.1cm)\n\nPLAN:\n1. Stereotactic radiosurgery to both lesions\n2. Increase surveillance frequency\nKPS: 75 | ECOG: 1\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 15, 2019\nIMAGING:\nStable post-radiation changes\nNo new lesions\n\nSYMPTOMS:\n- Working part-time\n- Manageable fatigue\n- No seizures\n\nPLAN:\nContinue q4month surveillance\nKPS: 85 | ECOG: 1\n\n-------------------\n\n5-YEAR FOLLOW-UP - March 10, 2021\nIMAGING:\nMultiple new lesions (largest 2.8cm)\nIncreasing edema\n\nSYMPTOMS:\nRecurrent headaches\nWorsening cognitive function\n\nPLAN:\n1. Second craniotomy for largest lesion\n2. Consider systemic therapy\nKPS: 50 | ECOG: 2\n\n-------------------\n\n7-YEAR FOLLOW-UP - May 15, 2023\nIMAGING:\nProgressive disease despite treatment\nSignificant mass effect\n\nSYMPTOMS:\n- Severely impaired cognition\n- Unable to work\n- Dependent for ADLs\n\nPLAN:\n1. Palliative care consultation\n2. Hospice discussion\nKPS: 40 | ECOG: 3\n\n-------------------\n\nFINAL VISIT - January 10, 2024\nStatus: Progressive neurological decline\nTransitioned to hospice care\nKPS: 30 | ECOG: 4\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection (2016)\n- Adjuvant radiation therapy\n- Stereotactic radiosurgery (2018)\n- Second craniotomy (2021)\n- Multiple courses of systemic therapy\n\nKPS Score Range: 30-85\nECOG Score Range: 1-4\n\nNote: Aggressive treatment approach was initially successful but disease progression ultimately led to declining functional status. Patient's occupation as software developer influenced early intervention decisions due to cognitive demands of work.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65\nGender: Female\nBlood Type: B\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive)\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms including progressive headaches, visual changes, and recent focal seizure. Given tumor size and symptom progression, conservative intervention is warranted.\n\nPLAN:\n1. Start Dexamethasone 4mg BID for edema\n2. Levetiracetam 500mg BID for seizure prophylaxis\n3. Monthly clinical monitoring\n4. Repeat MRI in 3 months\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2018\nSymptoms partially improved with medical management. Visual symptoms stable.\nMRI shows stable tumor size.\nReduced Dexamethasone to 2mg BID.\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - March 12, 2019\nStable symptoms. Maintaining work with accommodations.\nMRI: No tumor growth\nContinued conservative management\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 10, 2020\nCOVID-19 Telehealth Visit\nStable condition. Remote work beneficial for symptom management.\nContinue current medications\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - April 15, 2021\nMinor headache progression\nMRI: Minimal growth (3.0cm)\nAdjusted anti-seizure medication\nRecommended reduced screen time at work\nKPS: 75 ECOG: 1\n\nURGENT VISIT - September 30, 2021\nIncreased confusion episodes\nMRI: Increased edema\nIncreased Dexamethasone temporarily\nDiscussed potential radiation therapy\nKPS: 60 ECOG: 2\n\nFOLLOW-UP - March 20, 2022\nPost-radiation therapy assessment\nSymptoms improving\nMRI: Reduced edema\nKPS: 70 ECOG: 1\n\nANNUAL REVIEW - March 15, 2023\nStable condition\nWorking part-time with accommodations\nMRI: No progression\nKPS: 80 ECOG: 1\n\nRECENT FOLLOW-UP - January 10, 2024\nWell-maintained on current regimen\nMinor balance issues persist\nContinuing conservative management\nMRI: Stable\nKPS: 85 ECOG: 1\n\nCURRENT MANAGEMENT:\n- Levetiracetam 500mg BID\n- Dexamethasone 1mg daily\n- Regular ophthalmology follow-up\n- Occupational therapy for balance\n- Ergonomic workplace modifications\n- Quarterly clinical reviews\n- Annual MRI\n\nOVERALL PROGRESS:\nPatient has maintained relatively stable condition with conservative management. Occupation-specific accommodations have helped maintain quality of life. KPS scores ranged from 60-90 throughout treatment period, currently stable at 85.\n\nRECOMMENDATIONS:\n1. Continue current medication regimen\n2. Maintain reduced work hours\n3. Regular exercise program\n4. Cognitive rehabilitation exercises\n5. Next MRI scheduled for July 2024\n\nFinal Status:\nKPS: 85/100\nECOG: 1/5"
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty concentrating at work",
          "Occasional balance issues when walking",
          "Mild right-sided facial numbness that developed over last 2 months",
          "Reports increased irritability noticed by family members",
          "Two episodes of nausea and vomiting in past month, unrelated to food"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Mild sleep apnea diagnosed 3 years ago, uses CPAP",
          "History of migraine headaches in 30s, resolved spontaneously",
          "Underwent surgery for herniated disc L4-L5 in 2015",
          "Family history of cardiovascular disease",
          "No history of cancer",
          "No significant head trauma",
          "Current medications: lisinopril 20mg daily, multivitamin"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M62-DS-O\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2018\nInitial MRI reveals a 4.2 cm parasagittal meningioma with significant peritumoral edema in the right frontal region. Mass effect on adjacent structures with 5mm midline shift. Enhancement pattern suggestive of WHO Grade II meningioma.\nKPS: 80 | ECOG: 1\n\nTreatment Plan:\n- Urgent surgical intervention recommended due to size, symptoms, and occupation requiring cognitive function\n- Preoperative optimization of hypertension\n- CPAP compliance assessment\n- Dexamethasone 4mg QID for edema management\n\nSURGICAL INTERVENTION - October 3, 2018\nSimpson Grade II resection performed. Subtotal resection due to venous sinus involvement.\nPathology: WHO Grade II (Atypical) Meningioma\nPost-op KPS: 70 | ECOG: 2\n\nFOLLOW-UP - December 15, 2018\nPost-operative adjuvant radiation therapy (60 Gy/30 fractions) completed.\nImprovement in headaches and visual symptoms.\nKPS: 85 | ECOG: 1\n\n6-MONTH FOLLOW-UP - April 3, 2019\nMRI shows no evidence of progression. Minor residual enhancement at surgical site.\nPatient has returned to work part-time.\nKPS: 90 | ECOG: 1\n\n1-YEAR FOLLOW-UP - October 10, 2019\nStable imaging. Cognitive function improved.\nFull return to work as Data Scientist.\nKPS: 95 | ECOG: 0\n\n2-YEAR FOLLOW-UP - October 15, 2020\nSmall area of enhancement noted on MRI. Close monitoring warranted.\nKPS: 90 | ECOG: 1\n\n3-YEAR FOLLOW-UP - October 12, 2021\nProgressive enhancement on MRI. New symptoms of intermittent headaches.\nDecision for gamma knife radiosurgery to residual tumor.\nKPS: 85 | ECOG: 1\n\n4-YEAR FOLLOW-UP - September 30, 2022\nPost-radiosurgery imaging shows good response.\nStable neurological examination.\nKPS: 90 | ECOG: 1\n\n5-YEAR FOLLOW-UP - October 5, 2023\nStable disease. Maintaining work performance.\nRegular exercise program initiated for weight management.\nKPS: 95 | ECOG: 0\n\nCURRENT VISIT - March 15, 2024\nLong-term stability achieved. Continuing q6month MRI surveillance.\nBMI improved to 31.5 with lifestyle modifications.\nKPS: 100 | ECOG: 0\n\nTreatment Summary:\n- Initial surgical resection\n- Adjuvant radiation therapy\n- Subsequent gamma knife for residual disease\n- Aggressive monitoring protocol maintained\n- Successful return to cognitive-demanding occupation\n\nKPS Score Range: 70-100 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nRecommendations:\n1. Continue q6month MRI surveillance\n2. Maintain hypertension control\n3. Regular cognitive function assessment\n4. Weight management program\n5. Annual neuropsychological evaluation given occupation\n\nNext Follow-up: September 2024",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\nPatient ID: M62-DS-O\nPrimary: Dr. [Name]\n===============================\n\nINITIAL VISIT - March 15, 2018\n------------------------------\nPRESENTING SYMPTOMS: Progressive headaches, right-sided visual disturbance, cognitive issues, balance problems, facial numbness, and recent episodes of nausea/vomiting. Symptoms significantly impacting work performance as Data Scientist.\n\nIMAGING: MRI reveals 2.8cm left frontal convexity meningioma with minimal surrounding edema. No significant mass effect. WHO Grade I characteristics.\n\nASSESSMENT: Given patient's occupation requiring cognitive precision, symptoms warrant attention but tumor size and characteristics allow for initial conservative approach.\n\nPLAN: \n- Watchful waiting with close monitoring\n- Dexamethasone 4mg BID for symptom management\n- Continue lisinopril; optimize blood pressure control\n- CPAP compliance essential for intracranial pressure management\n- Weight management referral\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - September 20, 2018\n-----------------------------\nMild improvement in headaches with steroid therapy. Vision stable. Continuing work with accommodations.\nMRI: No significant change in tumor size.\nPLAN: Continue conservative management, taper dexamethasone.\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 12, 2019\n--------------------------------\nSymptoms stable. Successfully implementing workplace ergonomic modifications.\nMRI: Minimal growth (0.2cm), no new edema.\nPLAN: Maintain observation protocol.\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - March 10, 2020\n--------------------------\nReports increased headache frequency during COVID-19 remote work.\nMRI: Stable compared to previous.\nPLAN: Ergonomic assessment for home office, stress management strategies.\nKPS: 85 | ECOG: 1\n\nURGENT VISIT - November 5, 2020\n------------------------------\nAcute worsening of vision and balance.\nMRI: Increased peritumoral edema, tumor growth to 3.2cm\nPLAN: Consider surgical intervention vs. radiation therapy. Patient opts for SRS.\nKPS: 70 | ECOG: 2\n\nPOST-SRS FOLLOW-UP - February 15, 2021\n-------------------------------------\nCompleted SRS treatment. Gradual improvement in symptoms.\nMRI: Expected post-radiation changes.\nPLAN: Quarterly monitoring\nKPS: 75 | ECOG: 1\n\nANNUAL FOLLOW-UP - February 10, 2022\n-----------------------------------\nStable symptoms. Returned to full-time work.\nMRI: Tumor stability with minimal radiation changes.\nPLAN: Continue annual monitoring\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - February 8, 2023\n---------------------------\nMaintaining stable condition. Good work-life balance.\nMRI: No progression, some tumor shrinkage noted.\nPLAN: Maintain annual imaging\nKPS: 90 | ECOG: 0\n\nRECENT FOLLOW-UP - January 15, 2024\n----------------------------------\nExcellent functional status. Minor occasional headaches.\nMRI: Continued stability with slight reduction in tumor size.\nPLAN: Continue annual monitoring. Consider biennial imaging if stable next year.\nKPS: 95 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Conservative management initially successful\n- SRS required after progression in 2020\n- Current status: Stable disease with good quality of life\n- Occupational adaptations successful\n- Weight management ongoing challenge but stable\n\nKPS Range: 70-95 throughout treatment course\nECOG Range: 0-2 throughout treatment course"
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by spouse - increased irritability",
          "Balance difficulties when walking, particularly in dim lighting",
          "Mild right-sided facial numbness",
          "Two episodes of nausea and vomiting in past month, unrelated to food"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Hypercholesterolemia - managed with atorvastatin 20mg daily",
          "Mild hearing loss in left ear - diagnosed 3 years ago",
          "Appendectomy (1985)",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Father had stroke at age 72",
          "Non-smoker, occasional alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M66-A-FA\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION:\n66-year-old right-handed male financial analyst presenting with progressive neurological symptoms. Given occupation requiring high cognitive function, aggressive management approach warranted.\n\nMRI FINDINGS:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Compression of superior sagittal sinus\nWHO Grade: II (atypical features noted)\nKPS: 80\nECOG: 1\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention given size, symptoms, and occupation requiring cognitive precision.\n\n-------------------\n\nPOST-OPERATIVE FOLLOW-UP: April 2, 2018\nSimpson Grade II resection completed\nPathology confirmed WHO Grade II meningioma\nPost-op MRI shows small residual tumor (0.5cm)\nKPS: 70\nECOG: 2\nPlan: Adjuvant radiotherapy recommended\n\n-------------------\n\n6-MONTH FOLLOW-UP: October 15, 2018\nPost-radiation assessment\nImproved symptoms\nNo evidence of progression\nKPS: 85\nECOG: 1\nPlan: Continue q3 month MRI surveillance\n\n-------------------\n\nANNUAL FOLLOW-UP: March 20, 2019\nStable imaging\nReturned to work full-time\nMinor residual facial numbness\nKPS: 90\nECOG: 0\n\n-------------------\n\n18-MONTH FOLLOW-UP: September 12, 2019\nSmall focus of enhancement noted\nRecommend increased surveillance\nKPS: 85\nECOG: 1\n\n-------------------\n\n2-YEAR FOLLOW-UP: March 18, 2020\nProgressive growth of residual tumor\nNew onset headaches\nKPS: 75\nECOG: 1\nPlan: Second surgery scheduled\n\n-------------------\n\nPOST-SECOND SURGERY: May 5, 2020\nGross total resection achieved\nKPS: 65\nECOG: 2\n\n-------------------\n\n3-YEAR FOLLOW-UP: March 15, 2021\nStable imaging\nImproved symptoms\nKPS: 85\nECOG: 1\n\n-------------------\n\n4-YEAR FOLLOW-UP: March 10, 2022\nNo evidence of recurrence\nMaintaining work schedule\nKPS: 90\nECOG: 0\n\n-------------------\n\n5-YEAR FOLLOW-UP: March 16, 2023\nSmall area of enhancement noted\nAsymptomatic\nKPS: 85\nECOG: 1\nPlan: Increased monitoring frequency\n\n-------------------\n\nCURRENT VISIT: March 14, 2024\nStable imaging\nMaintaining full cognitive function\nWorking full-time\nKPS: 90\nECOG: 0\nPlan: Continue biannual MRI surveillance\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Lowest KPS: 65 (post-second surgery)\n- Highest KPS: 90 (current)\n- ECOG range: 0-2\n\nTREATMENT OUTCOMES:\n- Successfully managed WHO Grade II meningioma\n- Maintained cognitive function crucial for occupation\n- Currently stable with excellent functional status\n- Regular monitoring continues due to atypical histology",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 66-year-old male, Financial Analyst\nWHO Grade: II Meningioma\nLocation: Right frontal parasagittal region, 2.8cm x 2.5cm\n\nPresenting Symptoms: Progressive headaches, visual disturbances, cognitive changes, and balance issues suggest mass effect. Symptoms align with tumor location.\n\nInitial MRI Findings:\n- Extra-axial mass with dural tail sign\n- Moderate peritumoral edema\n- Mass effect on superior sagittal sinus\n- No significant calcification\n\nAssessment & Plan:\nGiven patient's professional role requiring cognitive function, recommending close monitoring over immediate surgical intervention. Will initiate dexamethasone 4mg BID for edema management.\nKPS: 80 ECOG: 1\n\nFollow-up: 3 months\n\n-------------------\n\nFollow-up Visit - June 20, 2018\nSymptoms partially improved with steroid therapy. Headaches reduced.\nMRI: Stable tumor size\nPlan: Gradual steroid taper\nKPS: 85 ECOG: 1\n\n-------------------\n\nAnnual Review - March 12, 2019\nMild symptom progression\nMRI: Minimal growth (3.0cm x 2.6cm)\nDiscussing radiation therapy options\nKPS: 75 ECOG: 1\n\n-------------------\n\nFollow-up - September 15, 2019\nStarted fractionated RT: 54 Gy/30 fractions\nTolerating treatment well\nKPS: 70 ECOG: 2\n\n-------------------\n\nPost-RT Review - March 20, 2020\nImproved symptoms\nMRI: Tumor stability with reduced edema\nKPS: 80 ECOG: 1\n\n-------------------\n\nAnnual Review - April 10, 2021\nMaintained improvement\nWorking part-time\nMRI: No progression\nKPS: 85 ECOG: 1\n\n-------------------\n\nFollow-up - May 15, 2022\nMinor balance issues persist\nCognitive function stable\nMRI: Stable disease\nKPS: 80 ECOG: 1\n\n-------------------\n\nAnnual Review - June 8, 2023\nSome fatigue reported\nMRI: No progression\nMaintaining conservative approach\nKPS: 75 ECOG: 1\n\n-------------------\n\nRecent Visit - January 15, 2024\nStatus: Stable disease\nWorking reduced hours\nQuality of life maintained\nMRI: No significant changes\nKPS: 80 ECOG: 1\n\nTreatment Summary:\n- Conservative management successful\n- RT effectively controlled tumor growth\n- Maintained functional independence\n- Regular monitoring continues\n\nOverall KPS Range: 70-85\nOverall ECOG Range: 1-2\n\nRecommendations:\n1. Continue biannual MRI surveillance\n2. Maintain current medications\n3. Regular cognitive assessments\n4. Balance therapy as needed\n5. Work modifications as required"
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional balance difficulties when walking",
          "Mild personality changes noted by spouse - increased irritability",
          "Two episodes of nausea and vomiting in past month, unrelated to food"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, controlled with lisinopril",
          "Mild concussion from sports injury 15 years ago, fully recovered",
          "Appendectomy at age 23",
          "No history of cancer",
          "No seizures",
          "Family history: Mother had breast cancer at age 65",
          "Non-smoker",
          "Social alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M49-O\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\nWHO Grade: II\nKPS: 80\nECOG: 1\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size >3cm\n2. Progressive neurological symptoms\n3. Evidence of mass effect\n4. Patient's young age and otherwise good health status\n\n-------------------\n\nPRE-OPERATIVE VISIT - October 1, 2018\nAdditional imaging completed:\n- CT angiogram shows significant tumor vascularity\n- Pre-operative embolization scheduled\nKPS: 75\nECOG: 1\n\n-------------------\n\nSURGICAL NOTE - October 8, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 400cc\nComplications: None\nWHO Grade: II confirmed by pathology\nKPS: 60\nECOG: 2\n\n-------------------\n\nPOST-OP FOLLOW-UP - December 15, 2018\nPatient recovering well\nAdjuvant radiation therapy initiated\nResidual symptoms improving\nKPS: 70\nECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP - April 10, 2019\nMRI shows no recurrence\nCompleted radiation therapy\nSymptoms resolved except mild occasional headaches\nKPS: 90\nECOG: 0\n\n-------------------\n\nANNUAL FOLLOW-UP - October 15, 2019\nStable imaging\nNo new symptoms\nReturn to work full-time\nKPS: 95\nECOG: 0\n\n-------------------\n\n18-MONTH FOLLOW-UP - April 12, 2020\nSmall enhancement noted on MRI\nWatch and wait approach\nKPS: 90\nECOG: 0\n\n-------------------\n\n2-YEAR FOLLOW-UP - October 18, 2020\nProgressive enhancement\nNew symptoms: occasional right-sided numbness\nDecision for re-operation\nKPS: 85\nECOG: 1\n\n-------------------\n\nSECOND SURGERY - December 5, 2020\nComplete resection achieved\nWHO Grade: II\nKPS: 65\nECOG: 2\n\n-------------------\n\n3-YEAR FOLLOW-UP - October 15, 2021\nStable imaging\nNo new symptoms\nKPS: 90\nECOG: 0\n\n-------------------\n\n4-YEAR FOLLOW-UP - October 20, 2022\nContinued stability\nAnnual MRI surveillance recommended\nKPS: 95\nECOG: 0\n\n-------------------\n\n5-YEAR FOLLOW-UP - October 15, 2023\nNo evidence of recurrence\nMaintained neurological improvement\nKPS: 100\nECOG: 0\n\n-------------------\n\nCURRENT VISIT - March 1, 2024\nComplete neurological examination normal\nImaging stable\nContinue annual surveillance\nKPS: 100\nECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Lowest KPS: 60 (immediate post-op period)\n- Highest KPS: 100 (current)\n- ECOG range: 0-2\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain regular neurosurgical follow-up\n3. Monitor for any new neurological symptoms\n4. Regular cognitive assessment\n5. Quality of life monitoring",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 49-year-old male, Blood Type O\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nIMAGING:\nInitial MRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nGiven the location and symptomatology, patient requires intervention, but favoring conservative approach initially. KPS 80, ECOG 1.\n\nPLAN:\n1. Start Dexamethasone 4mg BID for symptom management\n2. Monthly clinical monitoring\n3. Follow-up MRI in 3 months\n4. Lifestyle modifications discussed - stress reduction, adequate sleep\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nImprovement in headaches and vision with steroid therapy. Tumor stable on imaging.\nKPS 85, ECOG 1\nPLAN: Gradual steroid taper, continue monitoring\n\n-------------------\n\nANNUAL REVIEW - March 12, 2019\nStable symptoms. MRI shows no progression.\nKPS 90, ECOG 0\nPLAN: Continue conservative management, MRI every 6 months\n\n-------------------\n\nURGENT VISIT - September 30, 2020\nIncreased headache severity, new onset diplopia\nMRI shows 15% growth\nKPS 70, ECOG 2\nPLAN: Radiation therapy consultation initiated\n\n-------------------\n\nPOST-RADIATION FOLLOW-UP - March 15, 2021\nCompleted fractionated RT (54 Gy/30 fractions)\nImprovement in symptoms\nKPS 75, ECOG 1\n\n-------------------\n\nANNUAL REVIEW - March 10, 2022\nStable disease post-radiation\nMinor residual facial numbness\nKPS 85, ECOG 1\nPLAN: Annual MRI surveillance\n\n-------------------\n\nFOLLOW-UP - March 8, 2023\nNo progression on imaging\nWell-controlled symptoms\nKPS 90, ECOG 0\nPLAN: Continue annual surveillance\n\n-------------------\n\nRECENT FOLLOW-UP - February 15, 2024\nMaintained clinical stability\nMRI shows slight tumor shrinkage post-radiation\nKPS 95, ECOG 0\n\nOCCUPATIONAL CONSIDERATIONS:\n- Patient works as accountant - minimal physical demands\n- Recommended ergonomic workspace modifications\n- Flexible scheduling during treatment periods\n\nQUALITY OF LIFE MEASURES:\n- Maintained employment throughout treatment\n- Regular exercise program established\n- Good social support system\n\nCURRENT STATUS:\nPatient has responded well to conservative management approach with radiation therapy when needed. Continues to work full-time with good functional status.\n\nFinal Scores:\nKPS Range during treatment: 70-95 (Currently 95)\nECOG Range during treatment: 0-2 (Currently 0)"
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "AB",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues",
          "Occasional nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Right-sided facial numbness that developed gradually over 2 months",
          "Difficulty concentrating at work, especially when reading"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "Migraine headaches since age 35, but pattern has changed recently",
          "BMI 33.2 - Class I Obesity",
          "Surgical history: Cholecystectomy (2012)",
          "Family history: Mother had breast cancer",
          "No history of head trauma or radiation exposure",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No smoking history",
          "Regular mammograms, last one normal 8 months ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F58-AB\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nSymptomatic right frontal meningioma with concerning features warranting immediate intervention. High-risk features include size >3cm, peritumoral edema, and proximity to critical structures.\nKPS: 80\nECOG: 1\n\nPLAN:\n1. Surgical resection recommended within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Occupational considerations: Visual/cognitive demands of librarian role affected\n4. Weekly neurological monitoring until surgery\n\nSURGICAL NOTE - April 2, 2018\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate complications\nKPS: 70\nECOG: 1\n\nPOST-OP FOLLOW-UP - May 15, 2018\n- Adjuvant radiotherapy initiated\n- 54 Gy in 30 fractions\n- Improvement in headaches and vision\nKPS: 75\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 2, 2018\n- MRI shows no residual tumor\n- Returned to work part-time\n- Continuing rehabilitation\nKPS: 85\nECOG: 1\n\n1-YEAR FOLLOW-UP - April 5, 2019\n- Stable imaging\n- Full return to work\n- Minor residual right facial numbness\nKPS: 90\nECOG: 0\n\n2-YEAR FOLLOW-UP - April 10, 2020\n- Small focus of enhancement noted\n- Close monitoring recommended\n- Increased scan frequency\nKPS: 85\nECOG: 1\n\n3-YEAR FOLLOW-UP - March 30, 2021\n- Progressive enhancement\n- New symptoms: headaches returning\n- Decision for repeat surgery\nKPS: 75\nECOG: 1\n\nSECOND SURGERY - May 15, 2021\n- Simpson Grade I resection\n- Pathology confirms recurrent WHO Grade II\nKPS: 65\nECOG: 2\n\nPOST-SECOND SURGERY - June 2021\n- Stereotactic radiosurgery boost\n- 18 Gy single fraction\nKPS: 70\nECOG: 1\n\n4-YEAR FOLLOW-UP - April 2022\n- Stable imaging\n- Improved symptoms\n- Weight management program initiated\nKPS: 80\nECOG: 1\n\n5-YEAR FOLLOW-UP - March 2023\n- No evidence of recurrence\n- Maintaining work schedule\n- BP well-controlled\nKPS: 85\nECOG: 1\n\nCURRENT STATUS - February 2024\n- Stable disease\n- Quarterly MRI surveillance\n- Managing occupational demands well\nKPS: 90\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical resections\n- Adjuvant radiation and radiosurgery\n- Successful return to work\n- Current status: Stable disease\n\nKPS Range Throughout Treatment: 65-90\nECOG Range: 0-2\n\nMONITORING PROTOCOL:\n- Quarterly MRI for first two years post-recurrence\n- Biannual neuropsychological testing\n- Monthly blood pressure monitoring\n- Regular occupational therapy assessments",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F58-AB\nOccupation: Librarian\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2016\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- WHO Grade I (presumptive)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms. Despite symptomatic presentation, given tumor size <3cm and patient's preference, recommending close monitoring with consideration for intervention if symptoms worsen.\n\nPLAN:\n1. MRI surveillance every 4 months initially\n2. Ophthalmology referral for visual symptoms\n3. Consider prophylactic anticonvulsants\n4. BP monitoring - continue lisinopril\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - January 12, 2017\nMinimal tumor growth (2.9cm). Visual symptoms stable with prescribed glasses. Headaches improved with prophylactic medication.\nPLAN: Continue monitoring\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - August 24, 2017\nStable tumor size. Patient adapted work routine - increased breaks, better lighting.\nPLAN: Extend MRI interval to 6 months\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 15, 2018\nMinor growth (3.0cm). Symptoms stable.\nPLAN: Continue monitoring, discuss surgical options as contingency\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - February 20, 2019\nTumor stable. Patient managing well with workplace accommodations.\nPLAN: Annual MRI if stable\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 5, 2020\nNo growth. COVID-19 considerations discussed.\nPLAN: Telemedicine follow-up\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - April 12, 2021\nSlight increase in size (3.2cm). New headache pattern.\nPLAN: Increase monitoring frequency, optimize headache management\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - October 8, 2022\nStable size. Quality of life improved with medication adjustments.\nPLAN: Continue current management\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 30, 2023\nMinor progression (3.3cm). Discussing surgical options but patient prefers conservative approach.\nPLAN: More frequent monitoring, optimize symptoms\nKPS: 70 ECOG: 2\n\nCURRENT VISIT - January 15, 2024\nSize stable. Managing work with accommodations.\nPLAN: Continue monitoring, maintain conservative approach\nKPS: 75 ECOG: 1\n\nMANAGEMENT SUMMARY:\n- Conservative approach successful over 8-year period\n- Workplace adaptations beneficial\n- Quality of life maintained despite some symptom progression\n- Patient preference for non-surgical management respected\n\nCURRENT STATUS:\nKPS Score Range: 70-90 (Currently 75)\nECOG Score Range: 0-2 (Currently 1)\n\nRECOMMENDATIONS:\n1. Continue regular MRI surveillance\n2. Maintain workplace accommodations\n3. Regular ophthalmology follow-up\n4. BP monitoring\n5. Quality of life assessments\n6. Consider intervention if significant progression"
      }
    },
    {
      "demographics": {
        "age": 57,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually over 2 months",
          "Reports feeling unsteady when walking, particularly in dim lighting"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, controlled with lisinopril",
          "Migraine headaches since age 35, but notes current headaches are different",
          "BMI 33.2 - Class I Obesity",
          "Surgical history: Cholecystectomy (2012)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history significant for breast cancer in mother",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F57-O-2018\nPrimary Diagnosis: Meningioma\nWHO Grade: Initially Grade II, progressing to Grade III\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm parasagittal meningioma in right frontal region\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Enhancement pattern suggesting possible Grade II\nKPS: 80 | ECOG: 1\n\nTREATMENT PLANNING - March 20, 2018\nGiven patient's occupation requiring cognitive precision and concerning symptoms, recommend aggressive surgical intervention. Patient's obesity noted as surgical risk factor.\nPlan: Gross total resection with intraoperative monitoring\nKPS: 80 | ECOG: 1\n\nSURGICAL INTERVENTION - April 3, 2018\nProcedure: Right frontal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II meningioma\nPost-op KPS: 70 | ECOG: 2\n\nFOLLOW-UP - July 15, 2018\nPost-operative adjuvant radiation therapy completed\nSymptoms improving\nReturn to work planned with modifications\nKPS: 85 | ECOG: 1\n\nSURVEILLANCE - January 10, 2019\nMRI shows no recurrence\nPatient back at work full-time\nMild residual right facial numbness\nKPS: 90 | ECOG: 0\n\nANNUAL FOLLOW-UP - March 5, 2020\nSmall focus of enhancement noted on MRI\nClose monitoring warranted\nKPS: 85 | ECOG: 1\n\nURGENT VISIT - September 15, 2020\nNew onset seizures\nMRI shows tumor recurrence\nPlan: Second surgery scheduled\nKPS: 70 | ECOG: 2\n\nSECOND SURGERY - October 1, 2020\nFindings: Progression to WHO Grade III\nPost-op treatment: High-dose radiation and chemotherapy initiated\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - March 2021\nCompleting aggressive treatment protocol\nLimited work capacity\nKPS: 50 | ECOG: 3\n\nRECOVERY PHASE - September 2021\nImproving functional status\nPartial return to work\nKPS: 70 | ECOG: 2\n\nSURVEILLANCE - March 2022\nStable imaging\nContinuing modified work schedule\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - September 2022\nNo evidence of recurrence\nMaintaining work performance\nKPS: 85 | ECOG: 1\n\nCURRENT STATUS - January 2024\nStable disease control\nRegular monitoring continues\nFull-time work resumed with accommodations\nKPS: 90 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation \u2192 WHO Grade II\n- Progression to Grade III in 2020\n- Two surgical interventions\n- Multiple courses of radiation therapy\n- Aggressive monitoring protocol maintained\n\nKPS Score Range: 50-90 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course\n\nMONITORING PROTOCOL:\n- MRI every 3 months for first 2 years after Grade III diagnosis\n- Quarterly neurocognitive assessments\n- Monthly blood work\n- Occupational therapy support for work optimization",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nDemographics: 57-year-old female, Blood Type O\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4 cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No mass effect on critical structures\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nGiven the patient's stable neurological status and tumor characteristics, recommending conservative management with close monitoring. Occupation requires significant screen time, which may exacerbate symptoms.\n\nPLAN:\n1. Serial MRI monitoring\n2. Ergonomic workplace assessment\n3. Ophthalmology referral for vision assessment\n4. Headache management protocol\n5. BP monitoring\n\nFOLLOW-UP VISIT - September 20, 2018\nStable symptoms. Vision improved with computer glasses and workstation modifications.\nMRI: No significant change in tumor size\nKPS: 90\nWHO Grade: I\n\nFOLLOW-UP - March 12, 2019\nMinor headache improvement with prophylactic treatment.\nMRI: Stable\nKPS: 85\nContinuing conservative management\n\nFOLLOW-UP - February 15, 2020\nCOVID-19 telework transition beneficial for symptom management.\nMRI: Minimal growth (0.2cm)\nKPS: 80\nAdded: Virtual PT for balance exercises\n\nFOLLOW-UP - March 10, 2021\nSome worsening of symptoms during prolonged screen time\nMRI: Stable from previous\nKPS: 75\nModified work schedule implemented\n\nFOLLOW-UP - April 5, 2022\nIncreased headache frequency\nMRI: Growth to 2.8cm\nKPS: 70\nDiscussed surgical options but patient prefers continued observation\n\nFOLLOW-UP - May 15, 2023\nAdaptation to symptoms with lifestyle modifications\nMRI: Stable\nKPS: 75\nMaintaining conservative approach\n\nCURRENT VISIT - January 10, 2024\nStable symptoms with occasional exacerbations\nMRI: No significant change\nKPS: 80\nECOG: 1\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively for 6 years\n- Regular MRI surveillance\n- Lifestyle and workplace modifications\n- Symptom management through non-surgical interventions\n\nKPS SCORE TIMELINE:\n2018: 90 (Fully active)\n2019: 85 (Minor symptoms)\n2020: 80 (Some symptoms)\n2021: 75 (Required assistance)\n2022: 70 (Self-care but unable to work)\n2023: 75 (Improvement with adaptations)\n2024: 80 (Return to better function)\n\nECOG SCORE: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nRECOMMENDATIONS:\n1. Continue 6-monthly MRI surveillance\n2. Maintain ergonomic workplace modifications\n3. Regular ophthalmology follow-up\n4. Consider radiation therapy only if significant progression\n5. Continue balance exercises and physical therapy\n6. Regular BP monitoring\n7. Stress management techniques\n\nThe conservative approach has proven effective, with stable disease and manageable symptoms through non-surgical interventions. Patient's quality of life has been maintained with appropriate workplace and lifestyle modifications."
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea, particularly in morning (initially attributed to pregnancy)",
          "Subtle personality changes noted by family - increased irritability",
          "Right-sided facial numbness developing over past 6 weeks",
          "Balance difficulties when walking, particularly in dimly lit areas",
          "Occasional tinnitus in right ear"
        ],
        "medical_history": [
          "BMI 33.2 (Class I Obesity)",
          "Currently 24 weeks pregnant with second child",
          "History of migraine headaches, but notes current headaches are different",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (maternal aunt)",
          "Previous pregnancy without complications 4 years ago",
          "No history of radiation exposure",
          "Taking prenatal vitamins and occasional acetaminophen for headaches",
          "No prior neurological conditions"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nFemale, 56 years old, Blood Type: B\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION (03/15/2018)\nPresenting Symptoms: Progressive neurological symptoms during pregnancy (24 weeks gestation). Concerning constellation of symptoms including progressive headaches, right-sided visual disturbance, and facial numbness.\n\nMRI FINDINGS:\n- 4.2cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II\nKPS: 80 ECOG: 1\n\nTREATMENT PLAN:\nGiven size, location, and pregnancy status, recommend:\n1. Immediate high-dose dexamethasone for edema management\n2. Obstetric consultation for pregnancy management\n3. Schedule surgical resection post-delivery\n4. Weekly neurological monitoring\n\nFOLLOW-UP VISIT (06/20/2018)\n- Successful C-section delivery at 38 weeks\n- Tumor stable on repeat imaging\n- Planning surgical intervention\nKPS: 75 ECOG: 1\n\nSURGICAL NOTE (07/15/2018)\nProcedure: Right frontotemporal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate complications\nKPS: 60 ECOG: 2\n\nPOST-OP FOLLOW-UP (08/30/2018)\n- Good recovery from surgery\n- Residual facial numbness improving\n- Starting adjuvant radiation therapy\nKPS: 70 ECOG: 1\n\nRADIATION ONCOLOGY NOTE (12/15/2018)\nCompleted 54 Gy in 30 fractions\n- Well-tolerated\n- Minor fatigue reported\nKPS: 80 ECOG: 1\n\nANNUAL FOLLOW-UP (07/15/2019)\n- MRI shows no recurrence\n- Resolved headaches\n- Return to work full-time\nKPS: 90 ECOG: 0\n\nFOLLOW-UP (01/15/2020)\n- Stable imaging\n- No new symptoms\nKPS: 90 ECOG: 0\n\nURGENT VISIT (03/20/2021)\n- New onset headaches\n- MRI shows small recurrence at surgical margin\n- Plan for stereotactic radiosurgery\nKPS: 75 ECOG: 1\n\nPOST-SRS FOLLOW-UP (09/15/2021)\n- Good response to treatment\n- Symptoms improving\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP (09/15/2022)\n- Stable disease\n- Maintaining regular activities\nKPS: 90 ECOG: 0\n\nFOLLOW-UP (03/15/2023)\n- MRI stable\n- No new symptoms\nKPS: 95 ECOG: 0\n\nRECENT FOLLOW-UP (01/15/2024)\n- Continued stability\n- Regular monitoring to continue\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation during pregnancy\n- Post-delivery surgical resection\n- Adjuvant radiation therapy\n- Single recurrence treated with SRS\n- Current status: Stable disease with excellent functional status\n\nKPS Score Range: 60-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT MONITORING PLAN:\n1. Biannual MRI surveillance\n2. Quarterly neurological examinations\n3. Annual neuropsychological testing\n4. Continue regular follow-up with radiation oncology",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F56-B\nWHO Grade: I (Suspected based on imaging)\n\nPRESENTING EVALUATION:\n56-year-old female, 24 weeks pregnant, presenting with progressive neurological symptoms. MRI reveals a 2.8cm right-sided petroclival meningioma with minimal peritumoral edema.\n\nASSESSMENT:\nComplex case requiring careful consideration due to:\n- Ongoing pregnancy (24 weeks)\n- Class I obesity (BMI 33.2)\n- Progressive symptomatology\n- Location near critical structures\n\nMANAGEMENT PLAN:\nGiven pregnancy status, recommending conservative management until post-delivery:\n1. Weekly neurological monitoring\n2. Coordination with obstetrics\n3. Acetaminophen for headache management (pregnancy-safe)\n4. Monthly ophthalmological evaluations\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018 (Post-delivery)\nSuccessful delivery at 39 weeks. Tumor stable in size.\nContinuing conservative management with:\n- Quarterly MRI monitoring\n- Vision assessment every 2 months\n- Balance therapy referral\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - March 15, 2019\nMinimal tumor growth (0.2cm in 12 months)\nSymptoms stabilized with:\n- Improved headache control\n- Persistent but stable facial numbness\n- Vision stable\nMaintaining conservative approach\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 10, 2020\nCOVID-19 considerations implemented\nTelemedicine follow-up\nSymptoms stable\nNo imaging changes\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - April 5, 2021\nNoted slight increase in headache frequency\nMRI shows minimal edema increase\nInitiated:\n- Low-dose dexamethasone\n- Enhanced headache protocol\nKPS: 75 ECOG: 1\n\nCRITICAL ASSESSMENT - September 15, 2022\nTumor growth to 3.2cm\nIncreasing symptoms\nDiscussing surgical options but patient prefers conservative approach\nModified management:\n- Monthly MRI monitoring\n- Increased steroid dosage\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - March 20, 2023\nStabilization achieved with medical management\nContinuing conservative approach with:\n- Quarterly MRI\n- Regular balance therapy\n- Medication optimization\nKPS: 80 ECOG: 1\n\nCURRENT STATUS - January 15, 2024\nTumor stable at 3.2cm\nSymptoms well-managed with:\n- Controlled headaches\n- Adapted lifestyle modifications\n- Regular physical therapy\nMaintaining conservative approach\nKPS: 85 ECOG: 1\n\nTREATMENT SUMMARY (2018-2024):\nSuccessfully managed through conservative approach prioritizing:\n1. Quality of life preservation\n2. Pregnancy safety (initial period)\n3. Symptom management\n4. Regular monitoring\n5. Patient preference for non-surgical intervention\n\nKPS Score Range: 70-90 (Lowest during 2022 symptom progression, highest during stable periods)\nECOG Score Range: 0-2 (Primarily maintained at 1)\n\nRECOMMENDATIONS:\nContinue current conservative management with:\n- Quarterly MRI monitoring\n- Regular neurological assessments\n- Lifestyle modifications\n- Weight management program\n- Balance therapy continuation\n\nNote: Patient's occupation as a remote software developer allows flexibility for medical appointments and symptom management. Conservative approach aligns well with her lifestyle and preferences."
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing fatigue and difficulty concentrating at work",
          "Reports subtle changes in sense of smell over past 6 months",
          "Occasional episodes of right-sided facial numbness",
          "Mild balance issues when climbing library ladders"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 25, but notes pattern has changed recently",
          "Hypertension diagnosed 2 years ago, managed with lisinopril 10mg daily",
          "No history of head trauma or neurological conditions",
          "No family history of brain tumors",
          "Past surgical history: Cholecystectomy (2018)",
          "Regular exposure to coffee roasting fumes in current job",
          "No significant radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 40, Female, Blood Type: A\nOccupation: Librarian/Coffee Roaster\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\n- Proximity to superior sagittal sinus noted\n\nASSESSMENT:\nSymptomatic meningioma with concerning features warranting immediate intervention. Occupational exposure to coffee roasting fumes and obesity may complicate perioperative course.\nKPS Score: 80\nECOG: 1\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization of hypertension\n3. Comprehensive neuropsychological testing\n4. Occupational exposure cessation recommended\n\nSURGICAL NOTE - April 1, 2016\n- Simpson Grade II resection achieved\n- Subtotal removal due to venous sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - October 15, 2016\n- Post-operative radiation therapy completed (54 Gy/30 fractions)\n- Improved vision and headaches\n- Return to modified work duties\nKPS Score: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - April 2017\n- Stable imaging\n- Minor residual facial numbness\n- Successfully transitioned to full-time library work only\nKPS Score: 90\nECOG: 1\n\nFOLLOW-UP - October 2018\n- New 1cm growth in residual tumor\n- Decision for stereotactic radiosurgery\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - April 2019\n- Post-SRS imaging shows tumor control\n- Maintained neurological status\nKPS Score: 90\nECOG: 1\n\nEMERGENCY VISIT - January 2020\n- Acute onset seizures\n- MRI shows radiation necrosis\n- Admitted for management\nKPS Score: 60\nECOG: 2\n\nFOLLOW-UP - July 2020\n- Successfully managed with steroids\n- Seizure-free on levetiracetam\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - April 2021\n- Stable imaging\n- Weight reduction program initiated\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - April 2022\n- Continued stability\n- BMI improved to 31.5\nKPS Score: 90\nECOG: 1\n\nFOLLOW-UP - April 2023\n- Small area of enhancement noted\n- Close monitoring recommended\nKPS Score: 85\nECOG: 1\n\nCURRENT VISIT - February 2024\n- Stable disease\n- Maintaining good functional status\n- Continues library work exclusively\nKPS Score: 90\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection\n- Adjuvant radiation therapy\n- Salvage SRS for recurrence\n- Successfully managed complications\n- Currently stable with good functional status\n\nKPS Score Range: 60-90 throughout treatment course\nECOG Score Range: 1-2 throughout treatment course\n\nONGOING RECOMMENDATIONS:\n1. Continued bi-annual MRI surveillance\n2. Maintain healthy lifestyle modifications\n3. Regular neuropsychological assessments\n4. Seizure prophylaxis continuation\n5. Occupational therapy as needed",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nOccupation: Librarian/Coffee Roaster\nAge: 40, Female\n\nINITIAL VISIT - September 15, 2016\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms including progressive headaches, visual changes, and balance issues. Given tumor size and symptomatology, conservative management with close monitoring is recommended initially.\n\nPLAN:\n1. Serial MRI monitoring every 6 months\n2. Lifestyle modifications:\n   - Recommend reduced exposure to coffee roasting fumes\n   - Weight management program referral\n3. Headache management protocol\n4. BP monitoring\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - March 20, 2017\nTumor stable in size. Symptoms partially improved with medical management.\nModified work environment - reduced roasting exposure.\nContinue current management plan.\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - September 18, 2017\nSlight tumor growth (0.2cm). Symptoms stable.\nDiscussing surgical options but patient prefers conservative approach.\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - March 15, 2018\nTumor stable. Patient reports improved headache control.\nWeight loss of 10 lbs noted.\nKPS Score: 90\nECOG: 0\n\nANNUAL REVIEW - March 20, 2019\nNo significant tumor progression.\nPatient maintaining modified work duties.\nContinue annual monitoring.\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 25, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. No new neurological concerns.\nKPS Score: 85\nECOG: 1\n\nANNUAL REVIEW - April 2, 2021\nMinimal tumor growth (0.3cm over 5 years).\nPatient managing well with conservative approach.\nSome fatigue reported.\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - April 15, 2022\nIncreased headache frequency.\nMRI shows slight increase in peritumoral edema.\nStarted on low-dose dexamethasone.\nKPS Score: 70\nECOG: 2\n\nANNUAL REVIEW - May 1, 2023\nStable disease with medical management.\nPatient transitioned to part-time work.\nConsider radiation therapy if symptoms worsen.\nKPS Score: 75\nECOG: 1\n\nRECENT FOLLOW-UP - February 15, 2024\nTumor showing slow growth pattern (now 3.3cm).\nDiscussing potential for SRS vs. continued observation.\nPatient still favoring conservative approach.\nKPS Score: 80\nECOG: 1\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively for 8 years\n- Slow growth pattern\n- Modified lifestyle factors contributing to stability\n- Regular monitoring allowing for timely intervention if needed\n\nCURRENT STATUS:\nKPS Score Range: 70-90 (Currently 80)\nECOG Score Range: 0-2 (Currently 1)\n\nRECOMMENDATIONS:\n1. Continue regular MRI monitoring\n2. Maintain modified work environment\n3. Regular BP and weight management\n4. Consider SRS if significant progression occurs\n5. Maintain quality of life focus with current conservative approach"
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding right words",
          "Subtle weakness in left hand, noticed while typing at work",
          "Increased fatigue and difficulty concentrating during work hours",
          "Two episodes of loss of balance in past month",
          "Mild nausea without vomiting"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "BMI 33.2 - Class I Obesity",
          "Osteoarthritis in right knee",
          "Hormone replacement therapy for 5 years post-menopause (ages 52-57)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history: Mother had breast cancer at age 70"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n66-year-old female software developer with meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\nKPS: 80 | ECOG: 1\n\nASSESSMENT:\nHigh-risk features warranting immediate intervention:\n- Size >3cm\n- Significant edema\n- Neurological symptoms affecting work performance\n- Location near eloquent cortex\n\nPLAN:\n1. Surgical resection recommended within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Dexamethasone 4mg QID for edema\n4. Occupational considerations: cognitive demands of software development\n\n-------------------\n\nPOST-OPERATIVE NOTE - April 2, 2018\nPROCEDURE: Right frontal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minimal residual tumor at dural attachment\nPATHOLOGY: WHO Grade II (Atypical) Meningioma\nKPS: 70 | ECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2018\n- Recovering well\n- Mild residual left hand weakness\n- Started adjuvant radiation therapy\nKPS: 75 | ECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 2, 2018\n- Completed radiation therapy\n- Improved hand function\n- Returned to work part-time\nMRI: No evidence of progression\nKPS: 85 | ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - April 15, 2019\n- Full-time work resumed\n- Minor fatigue\nMRI: Stable\nKPS: 90 | ECOG: 0\n\n-------------------\n\n18-MONTH FOLLOW-UP - October 10, 2019\nCONCERN: New right-sided headaches\nMRI: Small enhancement at resection site\nKPS: 80 | ECOG: 1\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 8, 2020\n- Tumor recurrence noted\n- 1.5 cm nodule at original site\nPLAN: Stereotactic radiosurgery\nKPS: 75 | ECOG: 1\n\n-------------------\n\nPOST-SRS FOLLOW-UP - October 2020\n- Good response to treatment\n- Headaches improved\nKPS: 85 | ECOG: 1\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 2021\nMRI: Stable disease\n- Maintaining work schedule\n- Weight loss program initiated\nKPS: 90 | ECOG: 0\n\n-------------------\n\n4-YEAR FOLLOW-UP - April 2022\n- Stable imaging\n- No new symptoms\nKPS: 95 | ECOG: 0\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 2023\nCONCERN: New cognitive symptoms\nMRI: Multiple small recurrent nodules\nKPS: 70 | ECOG: 2\nPLAN: Consider systemic therapy\n\n-------------------\n\nCURRENT VISIT - February 2024\n- Progressive disease\n- Switched to part-time work\n- Started bevacizumab\nKPS: 60 | ECOG: 2\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection\n- Adjuvant radiation\n- Salvage SRS\n- Current systemic therapy\n\nKPS Range: 60-95 throughout treatment course\nECOG Range: 0-2 throughout treatment course\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Neurocognitive testing every 6 months\n- Quality of life assessments\n- Occupational therapy for hand function\n- Regular BP monitoring",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n66-year-old female software developer with meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's stable neurological status despite symptoms, recommending conservative management with close monitoring. Occupational considerations (computer work) warrant careful attention to visual and cognitive symptoms.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months initially\n2. Ophthalmology evaluation for vision changes\n3. Ergonomic workplace assessment\n4. BP monitoring - continue lisinopril\n5. Weight management referral\n\nFOLLOW-UP VISIT - September 20, 2018\nStable symptoms. Minor improvement in headaches with prescribed medications.\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - March 12, 2019\nReports improved work performance with ergonomic adjustments.\nMRI: Stable\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - March 5, 2020\nMild progression of visual symptoms.\nMRI: Minimal growth (2.9cm)\nContinuing conservative approach with increased monitoring.\nKPS: 75 | ECOG: 1\n\nFOLLOW-UP VISIT - September 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. Working remotely has reduced fatigue.\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP VISIT - March 10, 2021\nMRI: Stable at 2.9cm\nNotable improvement in balance issues with prescribed PT.\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - March 8, 2022\nSome worsening of headaches.\nMRI: Slight increase to 3.1cm\nDiscussed surgical options but patient prefers continued observation.\nAdded prophylactic migraine medication.\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP VISIT - September 20, 2022\nImproved headache control with medications.\nWorking part-time with accommodations.\nKPS: 75 | ECOG: 1\n\nFOLLOW-UP VISIT - March 15, 2023\nMRI: Stable at 3.1cm\nSymptoms well-managed with current regimen.\nKPS: 80 | ECOG: 1\n\nMOST RECENT VISIT - January 10, 2024\nStable neurological exam.\nMRI: No significant change\nSuccessfully managing work-life balance with current accommodations.\nKPS: 85 | ECOG: 1\n\nCURRENT MANAGEMENT STRATEGY:\n1. Continue surveillance MRI every 6 months\n2. Maintain current medications\n3. Regular ophthalmology follow-up\n4. Occupational therapy as needed\n5. Lifestyle modifications:\n   - Reduced work hours\n   - Regular exercise program\n   - Stress management techniques\n\nKPS Score Range (2018-2024): 70-85\nECOG Score Range (2018-2024): 1-2\n\nNOTES ON SCORES:\n- Lowest KPS (70) during period of symptom exacerbation in 2022\n- Highest KPS (85) during periods of stable disease and good symptom control\n- Conservative management has maintained relatively stable functional status\n- Patient has maintained independence in ADLs throughout observation period"
      }
    },
    {
      "demographics": {
        "age": 44,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing fatigue and difficulty concentrating at work",
          "Reports occasional ringing in right ear",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Two episodes of loss of balance while standing in the past month"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes recent headaches are different in character",
          "Hypertension diagnosed 2 years ago - currently on lisinopril 10mg daily",
          "Surgical history: Cholecystectomy in 2018",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history significant for mother with breast cancer",
          "No history of radiation exposure",
          "Regular medication: Lisinopril 10mg daily, multivitamin"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F44-A-2016\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2016\nPRESENTING SYMPTOMS: 44-year-old female with progressive neurological symptoms including morning headaches, right-sided visual disturbance, and balance issues. Occupation as librarian/baker requires significant attention to detail and physical stamina.\n\nIMAGING: Initial MRI reveals 3.8cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe. Enhancement pattern suggestive of WHO Grade II meningioma.\n\nASSESSMENT: Given tumor size, symptom progression, and occupation requiring cognitive precision, immediate surgical intervention recommended.\nKPS: 80/100\nECOG: 1\n\nSURGICAL NOTE - April 2, 2016\nPROCEDURE: Left frontal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved. Tumor adherent to superior sagittal sinus.\nPATHOLOGY: WHO Grade II (Atypical) Meningioma\nPOST-OP KPS: 70/100\nECOG: 2\n\nFOLLOW-UP - July 15, 2016\nPatient completing adjuvant radiation therapy (60 Gy/30 fractions)\nHeadaches improved, vision stabilizing\nReturn to work planned for September\nKPS: 80/100\nECOG: 1\n\nFOLLOW-UP - January 10, 2017\nMRI shows no recurrence\nReturned to work part-time\nKPS: 90/100\nECOG: 1\n\nFOLLOW-UP - July 2018\nSurveillance MRI reveals small enhancement near resection cavity\nRecommend surgical re-exploration\nKPS: 85/100\nECOG: 1\n\nSECOND SURGERY - August 15, 2018\nComplete resection of recurrent tumor\nPathology confirms Grade II\nKPS post-op: 65/100\nECOG: 2\n\nFOLLOW-UP - February 2020\nCOVID-19 pandemic impact noted\nTelemedicine visit\nStable imaging\nKPS: 90/100\nECOG: 1\n\nFOLLOW-UP - March 2022\nNew enhancement on MRI\nPatient experiencing increased headaches\nStarted on dexamethasone\nKPS: 75/100\nECOG: 1\n\nTHIRD SURGERY - May 2022\nTumor progression with Grade III transformation\nAggressive resection performed\nPost-op complications with wound healing\nKPS: 50/100\nECOG: 2\n\nFOLLOW-UP - December 2023\nOn systemic therapy\nStable disease but reduced functional status\nUnable to return to work\nKPS: 60/100\nECOG: 2\n\nCURRENT STATUS (March 2024)\nMaintaining on targeted therapy\nRegular imaging surveillance\nLimited work capacity\nKPS: 70/100\nECOG: 1\n\nTREATMENT SUMMARY:\n- Multiple surgical interventions\n- Grade progression from II to III\n- Radiation therapy\n- Systemic therapy\n- Regular imaging surveillance\n\nKPS RANGE OVER TREATMENT COURSE: 50-90/100\nECOG RANGE: 1-2\n\nRECOMMENDATIONS:\n1. Continue q3 month MRI surveillance\n2. Monthly neurocognitive assessments\n3. Consider occupational therapy for work adaptation\n4. Regular monitoring of BMI and hypertension\n5. Quality of life assessments",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Diagnosis: Intracranial Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8 cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- Dural tail sign present\n- No evidence of brain invasion\n\nASSESSMENT:\n44-year-old female librarian/baker presenting with progressive neurological symptoms. Given tumor size and symptoms, conservative management with close monitoring is initially recommended. Occupation requires attention to detail and physical stamina, which may be impacted.\n\nPLAN:\n1. Serial MRI monitoring every 6 months\n2. Prophylactic anticonvulsants not indicated\n3. Headache management with sumatriptan PRN\n4. BP monitoring - continue lisinopril\n5. Lifestyle modifications recommended for obesity\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - March 20, 2019\nStable symptoms. MRI shows no significant growth.\nHeadaches improved with medication management.\nContinue current plan.\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - September 18, 2019\nMinor increase in headache frequency.\nMRI: Tumor stable at 2.9 cm\nAdded prophylactic topiramate for headache management.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nReports increased stress affecting symptoms.\nProvided stress management strategies.\nMRI deferred due to pandemic.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 22, 2020\nMRI: Tumor size 3.0 cm\nMild progression of symptoms\nDiscussing surgical options but patient prefers conservative approach\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 18, 2021\nSignificant worsening of vision and balance\nMRI: Tumor growth to 3.3 cm with increased edema\nReferred for radiation oncology consultation\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - September 25, 2021\nPost-SRS treatment (14 Gy single fraction)\nImprovement in symptoms\nMRI: Early signs of treatment response\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 20, 2022\nContinued improvement\nMRI: Tumor stability with decreased edema\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 15, 2023\nMaintained improvement\nMRI: Tumor reduction to 2.8 cm\nReturn to work full-time\nKPS: 85 ECOG: 1\n\nLATEST FOLLOW-UP - January 10, 2024\nStable symptoms\nMRI: Further tumor reduction to 2.6 cm\nMaintaining conservative approach successful\nAnnual follow-up recommended\nKPS: 90 ECOG: 1\n\nTREATMENT SUMMARY:\nConservative management with eventual SRS intervention proved successful. Patient maintained good functional status throughout treatment course, with temporary decline during period of tumor growth. Current status shows excellent response to treatment with good quality of life preservation.\n\nKPS Score Range: 70-90 throughout monitoring period\nECOG Score Range: 1-2 throughout monitoring period\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Continue BP management\n3. Regular ophthalmology check-ups\n4. Weight management program\n5. Occupational therapy as needed\n6. Stress management techniques"
      }
    },
    {
      "demographics": {
        "age": 57,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional episodes of nausea, subtle personality changes noted by family members including increased irritability, recent difficulty with concentration at work, one episode of loss of balance when standing from seated position, mild right-sided facial numbness"
        ],
        "medical_history": [
          "Hypertension diagnosed 5 years ago - controlled with lisinopril 10mg daily, BMI 33.2, previous migraine history but pattern changed in recent months, underwent total hysterectomy at age 45 for fibroids, family history of breast cancer (maternal aunt), no history of radiation exposure, seasonal allergies treated with OTC antihistamines, mild osteoarthritis in right knee, completed menopause at age 51 with no hormone replacement therapy"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F57-A-2018\nWHO Grade: II (confirmed post-resection)\n\nPRESENTING EVALUATION:\n57-year-old female researcher presenting with progressive neurological symptoms. Initial MRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema and mass effect on adjacent frontal lobe. Enhancement pattern suggests possible WHO Grade II features.\n\nIMAGING:\n- MRI with/without contrast shows heterogeneous enhancement\n- Evidence of dural tail sign\n- Moderate vasogenic edema\n- Compression of right frontal lobe\n- No significant calcification\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention given:\n1. Tumor size >3cm\n2. Progressive symptomatology\n3. Impact on professional cognitive function\n4. Risk of further neurological deterioration\n\nKPS Score: 80\nECOG: 1\n\n-------------------\n\nSURGICAL NOTE - March 28, 2018\nSimpson Grade II resection performed. Subtotal resection achieved due to venous sinus involvement.\nPathology confirms WHO Grade II meningioma.\nPost-op MRI shows small residual tumor (0.8cm).\n\n-------------------\n\nFOLLOW-UP - June 15, 2018\nPost-operative adjuvant radiotherapy completed (54 Gy in 30 fractions).\nSymptoms improving.\nKPS Score: 70\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - December 20, 2018\nSix-month surveillance MRI shows stable residual disease.\nPatient has returned to work part-time.\nKPS Score: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - June 18, 2019\nSurveillance MRI stable. Minor headaches persisting.\nKPS Score: 90\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - January 10, 2020\nEvidence of small progression in residual tumor (now 1.2cm).\nRecommend stereotactic radiosurgery to residual.\nKPS Score: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - July 15, 2020\nPost-SRS MRI shows good response.\nPatient maintaining full-time work schedule.\nKPS Score: 90\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - January 20, 2021\nMRI stable. No new symptoms.\nKPS Score: 95\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - February 5, 2022\nNew enhancement noted on MRI (1.5cm).\nRecurrent headaches reported.\nPlan for repeat surgical intervention.\nKPS Score: 75\nECOG: 1\n\n-------------------\n\nSURGICAL NOTE - March 1, 2022\nSecond resection performed.\nSimpson Grade I achieved.\nPathology confirms recurrent WHO Grade II.\n\n-------------------\n\nFOLLOW-UP - September 15, 2022\nPost-operative course uncomplicated.\nReturn to work achieved.\nKPS Score: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 10, 2023\nSurveillance MRI stable.\nMaintaining good functional status.\nKPS Score: 90\nECOG: 0\n\n-------------------\n\nLATEST FOLLOW-UP - January 15, 2024\nNo evidence of recurrence.\nPatient fully functional at work.\nContinue bi-annual MRI surveillance.\nKPS Score: 95\nECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- KPS ranged from 70 (post-initial treatment) to 95 (current)\n- ECOG ranged from 0-1 throughout treatment course\n- Overall positive trajectory with temporary declines during treatment periods\n- Current status indicates excellent functional recovery\n\nONGOING RECOMMENDATIONS:\n1. Bi-annual MRI surveillance\n2. Regular neurocognitive assessment\n3. Blood pressure monitoring\n4. Weight management program\n5. Occupational stress management",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nDemographics: 57-year-old female, Blood Type A\nOccupation: Research scientist\nBMI: 33.2\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms but tumor size and location allow for initial conservative management. Given patient's professional cognitive demands, careful monitoring of cognitive function is essential.\n\nPLAN:\n1. Conservative management with close monitoring\n2. MRI surveillance every 4 months initially\n3. Dexamethasone 4mg BID for symptom management\n4. Neurocognitive testing baseline\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - January 12, 2019\nSymptoms slightly improved with steroid therapy\nMRI: No significant change\nPlan: Continue current management\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 20, 2019\nHeadaches better controlled\nCognitive function stable\nMRI: Stable\nPlan: Extend MRI interval to 6 months\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - December 15, 2019\nSome return of morning headaches\nMRI: Minimal growth (0.2cm)\nPlan: Continue monitoring, adjust work schedule to reduce stress\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - December 10, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nVirtual cognitive assessment satisfactory\nPlan: Continue monitoring\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - June 15, 2021\nMRI: Stable\nImproved symptom control\nWorking from home has reduced stress\nPlan: Continue conservative management\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - June 30, 2022\nMinor progression of visual symptoms\nMRI: Growth to 3.1cm\nDISCUSSION: Reviewed surgical options, patient prefers continued conservative approach\nPlan: Increase monitoring frequency\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - December 15, 2022\nIncreasing headaches\nMRI: 3.3cm with moderate edema\nPlan: Consider radiation therapy options\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - March 20, 2023\nPost-radiation therapy assessment\nSymptoms improving\nMRI: Stable with decreased edema\nPlan: Continue monitoring\nKPS: 80 ECOG: 1\n\nLATEST FOLLOW-UP - January 10, 2024\nGood symptom control\nMRI: Stable post-radiation\nCognitive function preserved\nWorking part-time successfully\nPlan: Continue 6-monthly MRI\nKPS: 85 ECOG: 1\n\nTREATMENT SUMMARY:\n- Successfully managed conservatively for 4+ years\n- Radiation therapy initiated only when necessary\n- Preserved cognitive function and work capability\n- Quality of life maintained throughout\n\nCURRENT STATUS:\nKPS Score: 85 - Able to carry on normal activity with minor symptoms\nECOG Score: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PLAN:\n1. MRI every 6 months\n2. Cognitive assessment annually\n3. Quality of life questionnaire every visit\n4. Occupational therapy assessment as needed\n\nNote: KPS scores ranged from 70-90 throughout treatment period, reflecting the conservative management approach's success in maintaining functional status while managing disease progression."
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty concentrating at work",
          "Subtle personality changes noted by family members",
          "Occasional balance issues when walking",
          "Mild right-sided facial numbness",
          "Increased fatigue and drowsiness during daytime"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Sleep apnea diagnosed 3 years ago, uses CPAP",
          "Hyperlipidemia - managed with atorvastatin",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M63-DS-B\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\nASSESSMENT: High-risk features present. Immediate intervention recommended.\nPLAN: Schedule surgical resection within 2 weeks\nKPS: 70 | ECOG: 1\n\nSURGICAL NOTE - September 28, 2018\nPROCEDURE: Right frontal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: WHO Grade II atypical meningioma\nPOST-OP STATUS: Stable\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - December 15, 2018\nSTATUS: Improving neurological symptoms\nIMAGING: Post-op MRI shows small residual tumor\nPLAN: Initiate adjuvant radiation therapy\nKPS: 80 | ECOG: 1\n\nRADIATION ONCOLOGY NOTE - January-March 2019\nTREATMENT: Completed 30 fractions, total 60 Gy\nTOLERANCE: Well-tolerated with minimal side effects\nKPS: 85 | ECOG: 1\n\n6-MONTH FOLLOW-UP - July 2019\nIMAGING: Stable residual disease\nSYMPTOMS: Improved vision and cognition\nPLAN: Continue q6month monitoring\nKPS: 90 | ECOG: 0\n\n2-YEAR FOLLOW-UP - September 2020\nCONCERN: New nodular enhancement at resection margin\nPLAN: Gamma Knife radiosurgery to recurrence\nKPS: 80 | ECOG: 1\n\n3-YEAR FOLLOW-UP - October 2021\nIMAGING: Post-radiosurgery stability\nSYMPTOMS: Well-controlled\nOCCUPATIONAL STATUS: Returned to full-time work\nKPS: 90 | ECOG: 0\n\n4-YEAR FOLLOW-UP - November 2022\nIMAGING: No progression\nSYMPTOMS: Stable\nPLAN: Continue surveillance\nKPS: 90 | ECOG: 0\n\n5-YEAR FOLLOW-UP - December 2023\nCONCERN: New satellite lesion identified\nSYMPTOMS: Mild recurrence of right-sided facial numbness\nPLAN: Surgical resection of new lesion scheduled\nKPS: 75 | ECOG: 1\n\nCURRENT STATUS - March 2024\nPOST-SECOND SURGERY: Stable\nPATHOLOGY: Confirmed WHO Grade II\nPLAN: \n- Monthly cognitive assessment\n- Quarterly MRI surveillance\n- Consider systemic therapy if progression\n- Occupational therapy for work adaptation\nKPS: 85 | ECOG: 1\n\nTREATMENT RATIONALE:\nGiven patient's:\n1. Professional cognitive demands as Data Scientist\n2. History of radiation exposure\n3. Obesity complicating factors\n4. Progressive neurological symptoms\nAggressive early intervention was warranted with close monitoring.\n\nOVERALL KPS/ECOG TREND:\n- Lowest KPS: 60 (immediate post-op)\n- Highest KPS: 90 (during stable periods)\n- Current KPS: 85\n- ECOG range: 0-2 (currently 1)",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M63-DS-B\nPrimary Diagnosis: Intracranial Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - March 15, 2016\nMRI Findings:\n- 2.8cm left frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- Dural tail sign present\nKPS: 90 | ECOG: 1\n\nAssessment & Plan:\nGiven patient's history of prior radiation exposure and current symptoms, recommending conservative management with close monitoring. Occupation as data scientist requires high cognitive function - symptoms affecting work performance noted.\n\nRecommendations:\n1. MRI surveillance every 4 months initially\n2. Neurocognitive assessment baseline\n3. Optimize blood pressure control\n4. CPAP compliance essential\n5. Weight management referral\n\nFOLLOW-UP - July 20, 2016\nTumor stable. Headaches improved with prophylactic topiramate.\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - November 15, 2016\nMinor tumor growth (0.2cm). Vision stable.\nKPS: 85 | ECOG: 1\n\nANNUAL REVIEW - March 10, 2017\nTumor stable. Patient adapted work schedule to manage fatigue.\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - March 5, 2018\nSlight progression (3.1cm). Discussing surgical options but maintaining conservative approach.\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - February 28, 2019\nStable disease. Managing work with accommodations.\nKPS: 75 | ECOG: 2\n\nCRITICAL ASSESSMENT - September 15, 2020\nTumor growth to 3.4cm. Increased symptoms.\nRecommended stereotactic radiosurgery (SRS).\nKPS: 70 | ECOG: 2\n\nPOST-SRS FOLLOW-UP - March 10, 2021\nGood response to SRS. Symptoms improving.\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - April 5, 2022\nStable disease. Working part-time with accommodations.\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - May 12, 2023\nContinued stability. Quality of life improved.\nKPS: 90 | ECOG: 1\n\nRECENT FOLLOW-UP - January 15, 2024\nTumor stable at 3.2cm. Patient maintaining good functional status.\nKPS: 90 | ECOG: 1\n\nManagement Summary:\n- Successfully maintained conservative approach for 4+ years\n- SRS implemented only when necessary\n- Preserved cognitive function for work\n- Maintained quality of life through careful symptom management\n- Regular monitoring allowed timely intervention when needed\n\nCurrent Status:\n- Stable disease\n- Working with accommodations\n- Well-managed symptoms\n- Good functional status\n\nKPS Range Over Treatment Period: 70-90\nECOG Range Over Treatment Period: 1-2\n\nNext Follow-up: Scheduled for July 2024\nContinue biannual MRI surveillance"
      }
    },
    {
      "demographics": {
        "age": 69,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Data generation failed"
        ],
        "medical_history": [
          "Data generation failed"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nInitial Visit - March 15, 2015\nPatient: 69F, Blood Type A\nOccupation: Software Developer\nStatus: Pregnant (2nd trimester)\nPresenting Condition: Incidental finding during routine MRI\nWHO Grade: I\n\nIMAGING:\n- MRI reveals 2.8cm left frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on adjacent structures\n- T1 with contrast shows homogeneous enhancement\n\nASSESSMENT:\nGiven patient's pregnancy status, occupation requiring cognitive precision, and tumor location, recommending close monitoring with potential intervention post-delivery.\n\nPLAN:\n1. Monthly MRI surveillance during pregnancy\n2. Neurocognitive testing baseline\n3. Reassess post-delivery for surgical intervention\nKPS: 90 ECOG: 1\n\nFollow-up - September 20, 2015\nPost-delivery status\nTumor size increased to 3.2cm\nRecommending surgical resection\nSimpson Grade I resection scheduled\nKPS: 85 ECOG: 1\n\nSurgery Note - October 15, 2015\nComplete resection achieved\nPathology confirms WHO Grade I\nKPS: 70 ECOG: 2\n\nFollow-up - January 10, 2016\nExcellent recovery\nReturned to work\nNo residual deficit\nKPS: 95 ECOG: 0\n\nAnnual Follow-up - March 2017\nNo recurrence\nMaintaining work schedule\nAnnual MRI scheduled\nKPS: 100 ECOG: 0\n\nAnnual Follow-up - March 2018\nSmall recurrence noted (1.1cm)\nRecommending SRS\nKPS: 90 ECOG: 1\n\nPost-SRS Follow-up - September 2018\nGood response to treatment\nTumor stable\nKPS: 85 ECOG: 1\n\nAnnual Follow-up - March 2020\nCOVID-19 Telemedicine visit\nStable imaging\nMinor headaches reported\nKPS: 80 ECOG: 1\n\nFollow-up - March 2022\nNo progression\nContinues full-time work\nKPS: 90 ECOG: 0\n\nLatest Follow-up - January 2024\nStable disease\nNo new symptoms\nMaintaining biennial monitoring\nKPS: 95 ECOG: 0\n\nTreatment Summary:\n- Initial surgical resection (2015)\n- SRS for small recurrence (2018)\n- Current status: Stable disease with excellent functional status\n- Regular monitoring continues\n\nOverall KPS trend: 70-100 (lowest post-surgery, highest during stable periods)\nCurrent Status: Excellent functional status with successful disease control",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\n69-year-old female, Blood Type A\nOccupation: Software Developer\nStatus: Pregnant (High-risk pregnancy due to advanced maternal age)\n\nINITIAL VISIT - March 15, 2015\nIncidental finding of right frontal convexity meningioma on MRI (2.1cm)\nWHO Grade I (presumptive based on imaging characteristics)\nAsymptomatic\nKPS: 90 ECOG: 0\n\nASSESSMENT & PLAN:\nGiven pregnancy status and asymptomatic presentation, recommending conservative management with close monitoring. Discussed risks/benefits with patient and multidisciplinary team including high-risk OB.\n\nFOLLOW-UP VISITS:\n\nSeptember 15, 2015\nPost-partum follow-up\nTumor stable at 2.1cm\nNo new symptoms\nContinuing conservative approach\nKPS: 90 ECOG: 0\n\nMarch 20, 2016\nAnnual follow-up\nMinimal growth (2.2cm)\nReports occasional headaches, likely related to extended computer use\nErgonomic workplace modifications recommended\nKPS: 85 ECOG: 1\n\nMarch 15, 2017\nTumor stable\nManaging work-related eye strain with blue light filters\nNo concerning symptoms\nKPS: 90 ECOG: 0\n\nApril 2, 2018\nSlight growth noted (2.4cm)\nStill asymptomatic\nDiscussed radiation options but patient prefers continued observation\nKPS: 85 ECOG: 1\n\nMay 10, 2019\nTumor stable\nReports improved work-life balance after reducing screen time\nNo new symptoms\nKPS: 90 ECOG: 0\n\nJune 15, 2020\nVirtual visit (COVID-19)\nNo reported changes\nManaging well with remote work\nKPS: 90 ECOG: 0\n\nJuly 1, 2021\nTumor shows minimal growth (2.5cm)\nSome reported fatigue\nRecommended workplace accommodations\nKPS: 80 ECOG: 1\n\nAugust 15, 2022\nStable disease\nBetter energy levels with modified work schedule\nKPS: 85 ECOG: 1\n\nSeptember 20, 2023\nTumor stable\nWell-adapted to hybrid work model\nNo new symptoms\nKPS: 90 ECOG: 0\n\nFebruary 1, 2024 (Most Recent)\nTumor stable at 2.5cm\nMaintaining good quality of life\nContinuing annual MRI surveillance\nKPS: 90 ECOG: 0\n\nMANAGEMENT SUMMARY:\n- Successfully managed with watchful waiting approach for 9 years\n- Total growth: 0.4cm over 9 years\n- Maintained high functional status\n- Well-adapted to work environment with ergonomic modifications\n- Pregnancy completed without complications\n- Annual MRI surveillance to continue\n\nCURRENT STATUS:\nKPS Score: 90 - Able to carry on normal activity with minor signs/symptoms of disease\nECOG Score: 0 - Fully active, able to carry on all pre-disease performance without restriction\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain ergonomic workplace modifications\n3. Regular breaks during computer work\n4. Follow-up in 12 months barring new symptoms\n5. Patient to contact if new/worsening symptoms develop"
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Reports mild balance issues when walking",
          "Two episodes of focal seizures affecting right arm in past month"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 3 years ago, controlled with lisinopril 10mg daily",
          "Concussion from sports injury 15 years ago, fully recovered",
          "Appendectomy at age 12",
          "No history of cancer",
          "No family history of brain tumors",
          "Non-smoker",
          "Social alcohol use",
          "No regular medications except lisinopril"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 45-year-old male, Blood Type O\nChief Complaint: Progressive neurological symptoms\n\nMRI Findings:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of superior sagittal sinus\n\nAssessment:\nWHO Grade: Suspected Grade II\nKPS Score: 80\nECOG: 1\n\nPlan:\n- Urgent surgical intervention recommended due to size, symptoms, and location\n- Pre-operative embolization scheduled\n- Craniotomy with goal of complete resection planned\n\nFollow-up Visit - April 2, 2018 (Post-operative)\nSurgical Outcome:\n- Simpson Grade II resection achieved\n- Pathology confirmed WHO Grade II atypical meningioma\n- Post-op MRI shows small residual enhancement\nKPS Score: 70\nECOG: 2\n\nFollow-up Visit - July 15, 2018\n- Completed adjuvant radiation therapy (60 Gy/30 fractions)\n- Improvement in visual symptoms\n- Headaches resolved\nKPS Score: 85\nECOG: 1\n\n6-Month Follow-up - October 10, 2018\n- MRI stable\n- Return to work full-time\n- Seizure-free on levetiracetam\nKPS Score: 90\nECOG: 0\n\nAnnual Follow-up - March 20, 2019\n- Surveillance MRI shows no recurrence\n- Maintaining normal activities\nKPS Score: 95\nECOG: 0\n\n18-Month Follow-up - September 15, 2019\n- New small enhancement noted on MRI\n- Recommending stereotactic radiosurgery for focal area\nKPS Score: 90\nECOG: 0\n\n2-Year Follow-up - March 10, 2020\n- Post-SRS MRI shows good response\n- Continued surveillance recommended\nKPS Score: 95\nECOG: 0\n\n3-Year Follow-up - March 5, 2021\n- MRI stable\n- Annual monitoring continued\nKPS Score: 95\nECOG: 0\n\n4-Year Follow-up - March 15, 2022\n- Small area of recurrence noted\n- Second surgery recommended\nKPS Score: 85\nECOG: 1\n\nPost-second Surgery - May 20, 2022\n- Complete resection achieved\n- Started on hydroxyurea\nKPS Score: 75\nECOG: 1\n\n5-Year Follow-up - March 10, 2023\n- Stable imaging\n- Continued medical therapy\nKPS Score: 85\nECOG: 1\n\nRecent Follow-up - February 15, 2024\n- MRI stable\n- Maintaining good quality of life\n- Continue current treatment plan\nKPS Score: 90\nECOG: 0\n\nTreatment Summary:\n- Initial presentation with WHO Grade II meningioma\n- Two surgical interventions\n- Adjuvant radiation therapy and SRS\n- Current status: Stable disease with good functional status\n\nOverall KPS Range: 70-95\nOverall ECOG Range: 0-2\n\nPrognosis: Guarded but favorable with continued aggressive monitoring and intervention as needed. Patient has maintained good functional status despite multiple treatments.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 45-year-old male, Blood Type O\nChief Complaint: Progressive neurological symptoms\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm left frontal convexity meningioma with moderate peritumoral edema. No significant mass effect on critical structures. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nDespite symptomatic presentation, patient expresses strong preference for conservative management. Given tumor size and location, watchful waiting approach with close monitoring is acceptable.\n\nPLAN:\n1. MRI surveillance every 4 months initially\n2. Anti-epileptic medication: Levetiracetam 500mg BID\n3. Dexamethasone 4mg daily for edema management\n4. Continue lisinopril 10mg daily\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - July 20, 2018\nMild improvement in symptoms with medical management. No new seizures.\nImaging shows stable tumor size.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - February 12, 2019\nPatient reports improved concentration at work. Headaches less frequent.\nMRI shows minimal growth (0.2cm).\nContinuing conservative management.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 15, 2020\nSome worsening of visual symptoms.\nMRI shows tumor growth to 3.2cm.\nDiscussed surgical options, patient still prefers conservative approach.\nStarted on higher dose of dexamethasone.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - December 10, 2020\nCOVID-19 telehealth visit\nStable symptoms. Managing work from home.\nContinued monitoring.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 8, 2021\nSignificant increase in headaches and visual disturbance.\nMRI shows tumor growth to 3.5cm with increased edema.\nStrongly recommended surgical intervention.\nPatient agrees to consider radiation therapy as compromise.\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - January 20, 2022\nPost-radiation therapy assessment\nCompleted fractionated RT (54 Gy/30 fractions)\nImprovement in symptoms\nMRI shows slight decrease in tumor size and edema\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 15, 2023\nStable disease post-radiation\nManaging well at work\nMinimal symptoms\nAnnual MRI shows no progression\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - February 1, 2024\nMaintaining good quality of life\nNo significant symptoms\nMRI stable\nContinuing annual monitoring\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Conservative management with medical therapy 2018-2021\n- Fractionated RT in late 2021\n- Successful symptom control and tumor stability achieved\n- Patient maintained employment throughout treatment\n- Quality of life preserved with minimal intervention approach\n\nKPS Score Range: 70-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medications\n3. Regular monitoring of vision and neurological status\n4. Return to clinic if new symptoms develop"
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding correct words",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly noticeable in past 6 weeks",
          "Increased fatigue and drowsiness during daytime",
          "One episode of nausea and vomiting last week"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily for past 8 years",
          "Osteoporosis - diagnosed 3 years ago, taking alendronate weekly",
          "Partial hysterectomy at age 45 for uterine fibroids",
          "History of migraines in 30s-40s, resolved spontaneously",
          "No prior neurological conditions",
          "No history of cancer",
          "No significant head trauma",
          "Family history notable for mother with breast cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-A-LIB\nInitial Visit: March 15, 2016\n\nINITIAL CONSULTATION\nChief Complaint: Progressive neurological symptoms with headaches and visual disturbance\nAssessment: 65-year-old female librarian presenting with concerning neurological symptoms suggestive of intracranial mass.\n\nIMAGING\nMRI with/without contrast reveals:\n- 4.2 cm parasagittal meningioma in right frontal region\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- WHO Grade II features suspected\nKPS: 80/100\nECOG: 1\n\nTREATMENT PLAN:\n1. Urgent surgical intervention recommended due to:\n   - Size >3cm\n   - Progressive symptoms\n   - Critical location\n   - Impact on daily function\n2. Pre-operative optimization of blood pressure\n3. Scheduled for craniotomy within 2 weeks\n\n-------------------\n\nSURGICAL NOTE - March 30, 2016\nProcedure: Right frontal craniotomy for tumor resection\nFindings: \n- Simpson Grade II resection achieved\n- Confirmed WHO Grade II meningioma\n- Some residual attachment to superior sagittal sinus\nKPS: 70/100\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - June 15, 2016 (2.5 months post-op)\nPatient reports:\n- Improved headaches\n- Resolving visual symptoms\n- Mild fatigue\nMRI: Small residual tumor (7mm)\nPlan: Adjuvant radiotherapy recommended\nKPS: 85/100\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - December 20, 2016 (Post-radiation)\nCompleted 30 fractions of radiation (54 Gy)\nSymptoms:\n- Minimal residual symptoms\n- Returned to work part-time\nMRI: Stable residual disease\nKPS: 90/100\nECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 15, 2017\nMRI: No progression\nSymptoms: Well-controlled\nPlan: Continue q6month monitoring\nKPS: 95/100\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - September 10, 2018\nMRI: Small increase in residual tumor (now 12mm)\nNew symptoms: Mild right-sided headaches\nPlan: Increased monitoring frequency\nKPS: 85/100\nECOG: 1\n\n-------------------\n\nURGENT VISIT - February 3, 2019\nPresenting with increased headaches and new onset seizure\nMRI: Tumor progression (2.1cm)\nPlan: Second surgical intervention scheduled\nKPS: 70/100\nECOG: 2\n\n-------------------\n\nPOST-SECOND SURGERY - February 20, 2019\nProcedure: Repeat craniotomy\nFindings: WHO Grade II-III features\nPlan: Aggressive adjuvant therapy\nKPS: 60/100\nECOG: 2\n\n-------------------\n\nFOLLOW-UP - January 15, 2020\nPost-completion of second round radiation\nStatus: Stable disease\nSymptoms: Well-managed with anticonvulsants\nKPS: 80/100\nECOG: 1\n\n-------------------\n\nCURRENT STATUS - March 2024\nEight-year follow-up\n- Stable disease on MRI\n- Maintained part-time work as librarian\n- Regular monitoring continues\n- On anticonvulsant therapy\nKPS: 85/100\nECOG: 1\n\nOVERALL DISEASE COURSE:\n- Initial presentation: WHO Grade II\n- Two surgical interventions\n- Two courses of radiation therapy\n- Current status: Stable disease with good functional status\n\nFinal KPS: 85/100\nFinal ECOG: 1\n\nTreatment approach focused on aggressive early intervention with close monitoring, which has resulted in good disease control despite initial concerning features and subsequent progression requiring additional intervention.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 65-year-old female, Blood Type A\nOccupation: Librarian\nWHO Grade: I (based on imaging characteristics)\n\nPRESENTING SYMPTOMS & FINDINGS:\n- Progressive headaches (4 months duration)\n- Visual disturbances (right eye)\n- Cognitive symptoms (word-finding difficulty)\n- Right facial numbness\n- Gait instability\n- Fatigue and drowsiness\n- Recent episode of nausea/vomiting\n\nIMAGING:\nMRI reveals 2.8cm right frontal convexity meningioma with minimal surrounding edema. No significant mass effect on adjacent structures. T2 sequence shows moderate signal intensity.\n\nINITIAL MANAGEMENT PLAN:\nGiven patient's stable employment and desire to maintain work capabilities, recommending close observation with serial imaging rather than immediate surgical intervention.\n\nKPS Score: 80\nECOG Score: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2018 (6 months)\nSymptoms slightly improved with dexamethasone 4mg daily.\nMRI: No significant change in tumor size.\nPlan: Continue conservative management\nMedications adjusted: Dexamethasone tapered to 2mg daily\n\nKPS Score: 85\nECOG Score: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2019 (1 year)\nPatient reports improved headaches but persistent mild visual symptoms.\nMRI: Stable lesion size\nPlan: Continue monitoring\nAdded: Vitamin D supplementation for osteoporosis management\n\nKPS Score: 85\nECOG Score: 1\n\n-------------------\n\nFOLLOW-UP - March 20, 2020 (2 years)\nCOVID-19 Telehealth Visit\nReports increased headaches\nMRI: Slight increase in peritumoral edema\nPlan: Increased dexamethasone temporarily\nModified work schedule recommended\n\nKPS Score: 75\nECOG Score: 2\n\n-------------------\n\nFOLLOW-UP - March 18, 2021 (3 years)\nSymptoms stabilized\nMRI: No significant change\nPlan: Continue conservative management\nOccupational therapy referral for balance exercises\n\nKPS Score: 80\nECOG Score: 1\n\n-------------------\n\nFOLLOW-UP - April 5, 2022 (4 years)\nNotable fatigue increase\nMRI: 3.0cm tumor (slight growth)\nPlan: Discussed radiation therapy options but patient prefers continued observation\nAdded: Sleep study referral\n\nKPS Score: 70\nECOG Score: 2\n\n-------------------\n\nFOLLOW-UP - March 30, 2023 (5 years)\nSymptoms stable with some quality of life improvements\nMRI: Stable at 3.0cm\nPlan: Continue conservative management\nModified work schedule maintaining part-time library duties\n\nKPS Score: 75\nECOG Score: 1\n\n-------------------\n\nCURRENT VISIT - February 15, 2024 (Nearly 6 years)\nPatient maintaining stable neurological status\nMRI: No significant change\nPlan: Continue biannual monitoring\nMaintaining part-time work schedule\n\nKPS Score: 80\nECOG Score: 1\n\nOVERALL KPS RANGE: 70-85\nOVERALL ECOG RANGE: 1-2\n\nSUMMARY OF CONSERVATIVE MANAGEMENT APPROACH:\n- Regular MRI monitoring\n- Symptom management with minimal steroid use\n- Lifestyle modifications\n- Occupational adjustments\n- Balance between quality of life and tumor control\n- Patient education and support\n- Regular assessment of cognitive function\n- Coordination with primary care for hypertension and osteoporosis management"
      }
    },
    {
      "demographics": {
        "age": 50,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Wine Taster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, particularly in the morning; Recent changes in sense of smell affecting wine-tasting ability; Intermittent blurred vision in right eye; Occasional episodes of nausea without vomiting; Subtle personality changes noted by coworkers (increased irritability); Difficulty concentrating during data analysis tasks that used to be routine; Two episodes of brief loss of balance in past month"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 2 years ago, managed with lifestyle modifications; Concussion from skiing accident 15 years ago with full recovery; Family history of migraines (mother); History of occasional tension headaches responding well to OTC medications; No history of seizures; No prior neurological conditions; Annual eye exams normal until 6 months ago showing slight right optic disc edema; No history of cancer; Non-smoker; Moderate alcohol consumption due to profession"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M50-O-2018\nPrimary: Dr. Sarah Chen, MD, PhD\n----------------------------------\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right frontal meningioma with significant mass effect\n- Moderate peritumoral edema\n- Compression of olfactory groove and partial compression of right optic nerve\n- No calcification visible\nWHO Grade: II (confirmed post-surgery)\n\nASSESSMENT:\nPatient's occupational requirements as data scientist and wine taster demand optimal cognitive and sensory function. Symptoms significantly impacting quality of life and work performance. High-risk features on imaging warrant immediate intervention.\n\nPLAN:\n- Scheduled for aggressive surgical resection within 2 weeks\n- Simpson Grade I resection planned\n- Pre-operative steroid therapy initiated\nKPS: 70 ECOG: 1\n\n----------------------------------\n\nPOST-OP FOLLOW-UP - April 12, 2018\n- Successful gross total resection achieved\n- Minimal residual enhancement at tumor bed\n- Pathology confirms WHO Grade II meningioma\n- Initiated adjuvant radiation therapy (60 Gy/30fx)\nKPS: 60 ECOG: 2\n\n----------------------------------\n\n6-MONTH FOLLOW-UP - October 5, 2018\n- Significant improvement in headaches and visual symptoms\n- Returning to work part-time\n- MRI shows no evidence of recurrence\n- Olfactory function improving\nKPS: 80 ECOG: 1\n\n----------------------------------\n\n1-YEAR FOLLOW-UP - March 20, 2019\n- Full return to work\n- Wine-tasting abilities restored\n- MRI stable\n- Cognitive testing normal\nKPS: 90 ECOG: 0\n\n----------------------------------\n\n2-YEAR FOLLOW-UP - April 15, 2020\nCONCERN:\nSmall enhancement noted on follow-up MRI\nPLAN:\n- Increased monitoring frequency\n- Monthly cognitive assessments\nKPS: 85 ECOG: 1\n\n----------------------------------\n\n3-YEAR FOLLOW-UP - March 30, 2021\n- Stable enhancement\n- No new symptoms\n- Maintaining professional activities\nKPS: 90 ECOG: 0\n\n----------------------------------\n\n4-YEAR FOLLOW-UP - April 10, 2022\nCONCERN:\nNew 1.2cm nodular enhancement\nPLAN:\n- Stereotactic radiosurgery (SRS) to new lesion\n- 16 Gy single fraction\nKPS: 80 ECOG: 1\n\n----------------------------------\n\n5-YEAR FOLLOW-UP - March 25, 2023\n- Post-SRS imaging shows good response\n- Maintained professional activities\n- No new neurological symptoms\nKPS: 90 ECOG: 0\n\n----------------------------------\n\n6-YEAR FOLLOW-UP - February 15, 2024\n- Stable disease\n- Annual MRI surveillance to continue\n- Maintaining full professional and personal activities\nKPS: 95 ECOG: 0\n\n----------------------------------\n\nTREATMENT SUMMARY:\n- Initial aggressive surgical resection\n- Adjuvant radiation therapy\n- Salvage SRS for small recurrence\n- Maintained high functional status throughout treatment course\n- Successful preservation of professional capabilities\n\nFINAL STATUS:\nKPS: 95 (Excellent functional status)\nECOG: 0 (Fully active)\n\nMONITORING PLAN:\n- Continue bi-annual MRI surveillance\n- Annual neuropsychological testing\n- Quarterly clinical assessments\n- Particular attention to olfactory function given profession",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M50-O-2018\nOccupation: Data Scientist/Professional Wine Taster\n\nINITIAL VISIT - March 15, 2018\nPresenting Complaint: Progressive neurological symptoms affecting professional function\nMRI Findings: 2.4cm right frontal meningioma, minimal peritumoral edema, no mass effect\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nAssessment & Plan:\nGiven tumor size <3cm and patient's professional requirements, recommending conservative management with close monitoring. Occupational considerations particularly important due to wine-tasting career requiring intact olfactory function.\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nInterval MRI: No significant change in tumor size\nSymptoms: Moderate improvement in headaches with prescribed medications\nNew Management: Started on low-dose propranolol for headache prophylaxis\nKPS: 90 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2019\nInterval MRI: Stable lesion\nSymptoms: Better headache control, improved work performance\nKPS: 95 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 18, 2020\nInterval MRI: Minimal growth (0.2mm), not clinically significant\nSymptoms: Well-controlled with current regimen\nNote: Maintaining professional activities with minor accommodations\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 5, 2021\nInterval MRI: Stable disease\nSymptoms: Reported increased stress affecting wine-tasting ability\nPlan: Added stress management referral\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 22, 2022\nInterval MRI: No significant change\nNotable: Successfully implemented workplace accommodations\nSymptoms: Stable with current management\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2023\nInterval MRI: Slight increase in peritumoral edema\nSymptoms: Temporary decline in olfactory discrimination\nTreatment: Short course dexamethasone\nKPS: 80 ECOG: 1\n\n-------------------\n\nRECENT FOLLOW-UP - February 20, 2024\nInterval MRI: Stable compared to previous\nSymptoms: Improved following steroid course\nCurrent Status: Maintaining professional activities with modifications\nKPS: 85 ECOG: 1\n\nSUMMARY OF MANAGEMENT APPROACH:\n- Conservative watchful waiting strategy successful over 6-year period\n- Preserved professional functionality through targeted symptom management\n- Regular MRI surveillance maintaining safety\n- Quality of life preservation prioritized\n- Occupational adaptations successful\n\nCURRENT RECOMMENDATIONS:\n1. Continue biannual MRI surveillance\n2. Maintain headache prophylaxis\n3. Regular neuro-ophthalmological monitoring\n4. Stress management continuation\n5. Workplace ergonomic modifications\n\nKPS Score Range Over Treatment Period: 80-95\nECOG Score Range: 0-1\n\nThe conservative management approach has proven successful in maintaining patient's quality of life and professional capabilities while ensuring adequate monitoring of the meningioma."
      }
    },
    {
      "demographics": {
        "age": 48,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in morning, intermittent blurred vision in right eye, occasional episodes of nausea, subtle personality changes noted by family members including increased irritability, recent difficulty with concentration while coding, two episodes of stumbling while walking in past month, reports mild right-sided facial numbness"
        ],
        "medical_history": [
          "Migraine headaches (well-controlled until recent changes), mild hypertension diagnosed 2 years ago - managed with lisinopril 10mg daily, history of mild asthma as child (resolved), tonsillectomy at age 12, family history notable for father with brain tumor (type unknown), no history of seizures or neurological disorders, no prior surgeries except tonsillectomy, non-smoker, occasional alcohol use (2-3 drinks/week), exposure to coffee roasting fumes for past 5 years in secondary job"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 48-year-old male, software developer/coffee roaster\nChief Complaint: Progressive headaches, visual changes, neurological symptoms\n\nIMAGING:\nInitial MRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nKPS: 80\nECOG: 1\n\nPLAN:\n- Urgent surgical intervention recommended due to size, symptoms, and occupation requiring cognitive precision\n- Pre-operative optimization with dexamethasone 4mg QID\n- Schedule craniotomy within 2 weeks\n- Occupational exposure to coffee roasting fumes noted as potential concern\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to venous sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- Post-op KPS: 70\n\nFOLLOW-UP - June 15, 2018\nPost-operative recovery progressing well\nAdjuvant radiation therapy initiated\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - December 20, 2018\nCompleted radiation therapy\nMRI shows no residual growth\nReturn to work approved with modifications\nKPS: 90\n\nFOLLOW-UP - June 18, 2019\nSurveillance MRI stable\nMinor headaches managed with medication\nKPS: 95\n\nFOLLOW-UP - December 12, 2019\nNew 8mm nodule noted at resection margin\nKPS: 90\nPlan: Increased monitoring frequency\n\nFOLLOW-UP - March 15, 2020\nNodule growth to 12mm\nDecision for focused SRS\nKPS: 85\n\nFOLLOW-UP - September 20, 2020\nPost-SRS response favorable\nNo new symptoms\nKPS: 90\n\nFOLLOW-UP - March 10, 2021\nStable imaging\nReturn to full work duties\nKPS: 95\n\nFOLLOW-UP - March 5, 2022\nRoutine surveillance\nNo evidence of recurrence\nKPS: 100\n\nFOLLOW-UP - September 15, 2023\nNew concerning changes on MRI\nMultiple small nodules along surgical tract\nKPS: 75\nPlan: Consider repeat surgical intervention\n\nCURRENT VISIT - February 20, 2024\nProgressive symptoms returning\nMRI shows multiple recurrent lesions\nKPS: 65\nECOG: 2\nPlan: Scheduled for second craniotomy with possible systemic therapy\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial: KPS 80/ECOG 1\n- Lowest: KPS 65/ECOG 2 (current)\n- Highest: KPS 100/ECOG 0 (2022)\n\nTreatment approach has been consistently aggressive given:\n1. WHO Grade II status\n2. Cognitive demands of software development work\n3. Young age at presentation\n4. Family history of brain tumor\n5. Occupational exposures\n\nContinuing close surveillance with imaging every 3 months and consideration of clinical trial enrollment for recurrent disease.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\n48-year-old male, Blood Type O\nOccupation: Software Developer & Coffee Roaster\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches (3-month duration), right eye blurred vision, nausea, personality changes, concentration difficulties, gait instability, right facial numbness.\nMRI Findings: 2.8cm left frontal parasagittal meningioma, minimal surrounding edema, WHO Grade I\nKPS: 90 ECOG: 1\n\nAssessment & Plan:\n- Given tumor size <3cm and minimal edema, recommending conservative management\n- Discussed risks/benefits of immediate intervention vs. watchful waiting\n- Occupational considerations: Coffee roasting fumes exposure - recommended improved ventilation/PPE\n- Prescribed: Dexamethasone 4mg BID for symptom management\nFollow-up: 3 months with repeat MRI\n\nFOLLOW-UP - June 20, 2018\nStable symptoms, minimal headache improvement\nMRI: No significant change in tumor size\nKPS: 85 ECOG: 1\nPlan: Continue conservative management, reduce dexamethasone to 2mg BID\n\nANNUAL FOLLOW-UP - March 12, 2019\nImproved headaches, stable vision\nMRI: Stable tumor size\nKPS: 90 ECOG: 0\nPlan: Annual monitoring, discontinued dexamethasone\n\nANNUAL FOLLOW-UP - March 10, 2020\nMinor symptom progression\nMRI: 3.0cm tumor, minimal growth\nKPS: 80 ECOG: 1\nPlan: Increase monitoring frequency to 6-monthly\n\nFOLLOW-UP - September 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nKPS: 80 ECOG: 1\nPlan: Continue monitoring\n\nANNUAL FOLLOW-UP - March 8, 2021\nWorsening headaches\nMRI: 3.2cm tumor\nKPS: 70 ECOG: 2\nPlan: Discussed surgical options, patient prefers continued conservative management\n\nFOLLOW-UP - September 14, 2021\nSignificant symptom progression\nMRI: 3.4cm tumor, moderate edema\nKPS: 60 ECOG: 2\nPlan: Referred for radiation oncology consultation\n\nFOLLOW-UP - March 22, 2022\nPost-radiation treatment (54 Gy/30fx)\nImproved symptoms\nKPS: 80 ECOG: 1\nPlan: Continue monitoring\n\nANNUAL FOLLOW-UP - March 14, 2023\nStable condition\nMRI: Slight tumor shrinkage (3.1cm)\nKPS: 90 ECOG: 1\nPlan: Annual monitoring\n\nRECENT FOLLOW-UP - February 20, 2024\nMaintained improvement\nMRI: Stable tumor size\nKPS: 95 ECOG: 0\nPlan: Continue annual monitoring\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial (2018): KPS 90/ECOG 1\n- Lowest (2021): KPS 60/ECOG 2 (during symptom progression)\n- Current (2024): KPS 95/ECOG 0 (post-radiation, stable disease)\n\nTreatment Strategy Summary:\n- Successfully maintained conservative management for 3+ years\n- Transitioned to radiation therapy when clinically indicated\n- Preserved occupational function with appropriate accommodations\n- Achieved excellent outcome with minimal intervention"
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually",
          "Balance issues when walking, particularly noticeable in past 2 months"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "Migraine headaches since age 40, but pattern has changed recently",
          "BMI 33.2 - Class I Obesity",
          "Surgical history: Cholecystectomy (2010)",
          "Hormone replacement therapy for 5 years post-menopause (stopped 3 years ago)",
          "Family history of breast cancer (mother)",
          "No history of smoking or significant alcohol use",
          "Regular mammograms, last one normal 8 months ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 63, Female, Blood Type: O\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, nausea, personality changes, concentration difficulties, right facial numbness, balance issues.\nInitial MRI Findings:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\nWHO Grade: II (confirmed post-surgery)\nKPS Score: 70\nECOG: 2\n\nTreatment Plan:\nRecommended immediate surgical intervention due to size, symptoms, and occupation requiring visual focus.\n\nSURGICAL INTERVENTION - March 28, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade: II\nComplications: None\nPost-op KPS: 60\nECOG: 2\n\nFOLLOW-UP - June 15, 2018 (2.5 months post-op)\nSymptoms: Improving\nMRI: No residual tumor\nStarted adjuvant radiotherapy\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - December 20, 2018 (9 months post-op)\nCompleted radiotherapy\nReturn to work part-time\nMRI: Stable\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - June 18, 2019\nMRI: Small enhancement at surgical site\nIncreased monitoring frequency\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - December 15, 2019\nMRI: Growth of enhancement\nSecond Surgery Recommended\nKPS Score: 75\nECOG: 1\n\nSECOND SURGERY - January 10, 2020\nProcedure: Revision craniotomy\nWHO Grade: Still II\nKPS Score: 65\nECOG: 2\n\nFOLLOW-UP - July 2020\nPost-radiation therapy complete\nMRI: Stable\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - January 2021\nMRI: Stable\nReturn to full-time work\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - January 2022\nMRI: Stable\nMaintaining work schedule\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - January 2023\nMRI: Small recurrence noted\nRecommended SRS\nKPS Score: 85\nECOG: 1\n\nLATEST FOLLOW-UP - January 2024\nPost-SRS follow-up\nMRI: Stable\nKPS Score: 85\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial surgical resection (2018)\n- Adjuvant radiotherapy\n- Second surgery (2020)\n- SRS for recurrence (2023)\n\nCURRENT STATUS:\nPatient maintains regular follow-up with quarterly MRI scans. Continues working with accommodations. Symptoms well-controlled.\n\nKPS Score Range Throughout Treatment: 60-90\nECOG Score Range: 0-2\n\nMONITORING RECOMMENDATIONS:\n1. Quarterly MRI scans\n2. Monthly neurology evaluations\n3. Cognitive function assessments every 3 months\n4. Visual field testing every 6 months\n5. Regular occupational therapy evaluations\n\nNote: Aggressive treatment approach justified by:\n- Patient's relatively young age\n- Cognitive demands of occupation\n- Initial tumor size and location\n- WHO Grade II classification\n- Presence of significant symptoms affecting daily function",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n63-year-old female with meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect on critical structures\nWHO Grade: I (presumptive radiological diagnosis)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation as software developer and presenting symptoms affecting vision/computer work, conservative management initially recommended. Symptoms warrant close monitoring.\n\nRECOMMENDATIONS:\n1. Monthly neurological evaluations for first 3 months\n2. Ergonomic workplace assessment\n3. Start Dexamethasone 4mg BID for edema management\n4. Regular ophthalmological evaluations\n5. Consider reduced screen time/frequent breaks\n\nFOLLOW-UP VISIT - December 20, 2018\nSymptoms partially improved with steroid therapy\nKPS: 85 | ECOG: 1\n- Headaches reduced in frequency\n- Vision stabilized\n- Continue current management\n- Taper dexamethasone to 2mg BID\n\nANNUAL FOLLOW-UP - September 2019\nMRI shows stable tumor size\nKPS: 90 | ECOG: 0\n- Maintaining work schedule with accommodations\n- Continue monitoring\n\nINTERIM VISIT - March 2020\nCOVID-19 considerations discussed\nKPS: 85 | ECOG: 1\n- Telemedicine follow-ups implemented\n- Working remotely beneficial for symptom management\n\nANNUAL FOLLOW-UP - September 2020\nMRI shows minimal growth (0.2cm)\nKPS: 75 | ECOG: 1\n- Increased headaches\n- Adjust medication regime\n- Consider radiation therapy if symptoms worsen\n\nFOLLOW-UP - March 2021\nKPS: 70 | ECOG: 2\n- Declining function\n- Increased work difficulties\n- Discussed potential for SRS if further decline\n\nANNUAL FOLLOW-UP - September 2021\nMRI stable\nKPS: 80 | ECOG: 1\n- Improved with medication adjustments\n- Continue conservative management\n\nFOLLOW-UP - September 2022\nStable disease\nKPS: 85 | ECOG: 1\n- Maintaining work with accommodations\n- Annual MRI schedule maintained\n\nANNUAL FOLLOW-UP - September 2023\nMRI shows no progression\nKPS: 90 | ECOG: 0\n- Well-maintained on conservative approach\n- Continue current management\n\nRECENT FOLLOW-UP - February 2024\nKPS: 85 | ECOG: 1\n- Stable symptoms\n- Maintaining quality of life\n- Continue conservative management\n\nMANAGEMENT SUMMARY 2018-2024:\n- Successfully managed with conservative approach\n- No surgical intervention required\n- Maintained employment with accommodations\n- Quality of life preserved\n- Regular monitoring effective\n\nKPS Range: 70-90 (lowest during 2021 exacerbation)\nECOG Range: 0-2\n\nONGOING RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Regular ophthalmological monitoring\n3. Maintain ergonomic workplace modifications\n4. Monitor hypertension management\n5. Weight management program referral\n6. Regular cognitive assessments\n7. Quality of life questionnaires at each visit\n\nNext scheduled follow-up: August 2024\nImaging: Annual MRI unless new symptoms develop"
      }
    },
    {
      "demographics": {
        "age": 42,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues",
          "Occasional nausea without vomiting",
          "Right-sided facial numbness that developed gradually over 2 months",
          "Increased fatigue and difficulty concentrating at work"
        ],
        "medical_history": [
          "Migraine headaches since age 25, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (maternal aunt)",
          "No history of radiation exposure",
          "Regular mammograms, last one normal 8 months ago",
          "No prior neurological conditions",
          "Currently taking oral contraceptives for 10+ years",
          "No significant head trauma"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F42-A\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of compression of optic apparatus\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms indicating aggressive tumor growth. Given size, location, and symptom progression, immediate surgical intervention recommended.\nWHO Grade: II (preliminary radiological assessment)\nKPS: 80\nECOG: 1\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative imaging protocol: MRI with volumetric analysis, CT angiogram\n3. Neuropsychological evaluation\n4. Discontinue oral contraceptives immediately\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to cavernous sinus involvement\n- Minimal blood loss: 300cc\n- No immediate complications\nPathology confirms WHO Grade II meningioma\nKPS: 70\nECOG: 2\n\nFOLLOW-UP - June 15, 2018\n- Post-operative radiation therapy completed (54 Gy/30 fractions)\n- Improvement in visual symptoms\n- Residual facial numbness\n- MRI shows no tumor progression\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - December 20, 2018\n- Stable imaging\n- Return to work part-time\n- Mild fatigue persists\nKPS: 90\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2019\n- MRI shows small enhancement at surgical site\n- Watchful waiting approach\n- Continuing biannual monitoring\nKPS: 90\nECOG: 1\n\nURGENT VISIT - September 2020\n- New onset seizures\n- MRI shows tumor recurrence (2.1cm)\n- Decision for repeat surgery\nKPS: 75\nECOG: 2\n\nSECOND SURGERY - October 2020\n- Complete resection achieved\n- Started anti-epileptic medication\nKPS: 65\nECOG: 2\n\nFOLLOW-UP - April 2021\n- Stable imaging\n- No seizures\n- Improved energy levels\nKPS: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2022\n- Continued stability\n- Maintaining work schedule\n- No new symptoms\nKPS: 95\nECOG: 0\n\nFOLLOW-UP - March 2023\n- Minor enhancement on MRI\n- Prophylactic SRS considered\nKPS: 90\nECOG: 1\n\nLATEST FOLLOW-UP - January 2024\n- Stable disease\n- Maintaining regular activities\n- Continue monitoring every 6 months\nKPS: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical interventions\n- Complete course of radiation therapy\n- Current status: Stable disease with good functional status\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nONGOING RECOMMENDATIONS:\n1. Biannual MRI surveillance\n2. Annual neuropsychological assessment\n3. Regular ophthalmological monitoring\n4. Maintain anticonvulsant therapy\n5. Consider prophylactic SRS if progression noted",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F42-A\nChief Complaint: Progressive neurological symptoms\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. WHO Grade I characteristics. No significant mass effect on adjacent structures.\n\nASSESSMENT:\n42-year-old female presenting with progressive neurological symptoms. Given tumor size and location, conservative management initially recommended with close monitoring.\nKPS: 80/100\nECOG: 1\n\nPLAN:\n1. MRI surveillance every 6 months\n2. Prophylactic anticonvulsants not indicated\n3. Discontinue oral contraceptives due to potential hormone sensitivity\n4. Headache management optimization with neurologist\n5. Occupational therapy referral for balance assessment\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nMinimal tumor growth (2.9cm). Symptoms stable.\nVision unchanged. Balance improved with therapy.\nKPS: 85/100\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nTumor stable at 2.9cm. Patient reports improved headache control.\nStarted on prophylactic calcium/vitamin D supplementation.\nKPS: 90/100\nECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 5, 2020\nSlight tumor growth to 3.1cm. Increased headache frequency.\nDecision point discussed regarding surgical intervention vs. continued observation.\nPatient prefers conservative approach.\nKPS: 75/100\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 15, 2020\nTumor stable. COVID-19 telehealth visit.\nManaging work-from-home adjustments well.\nKPS: 80/100\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 10, 2021\nTumor size 3.2cm. Mild progression of visual symptoms.\nReferred to neuro-ophthalmology.\nDiscussing potential for future SRS if progression continues.\nKPS: 70/100\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 8, 2022\nStable disease. Vision stabilized with prescribed prism glasses.\nMaintaining full-time work with accommodations.\nKPS: 75/100\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 14, 2023\nTumor growth to 3.4cm. Increased symptoms.\nPatient now considering SRS as next step.\nKPS: 65/100\nECOG: 2\n\n-------------------\n\nCURRENT VISIT - February 20, 2024\nScheduled for SRS next month due to progressive growth and symptoms.\nPre-procedure evaluation completed.\nKPS: 70/100\nECOG: 1\n\nTREATMENT SUMMARY:\n- Conservative management maintained for 6 years\n- Regular MRI surveillance\n- Symptom management prioritized\n- Quality of life focus maintained\n- Transition to SRS planned due to gradual progression\n\nKPS Score Range: 65-90/100\nECOG Score Range: 0-2\n\nRECOMMENDATIONS:\n1. Continue 6-monthly MRI post-SRS\n2. Maintain balance therapy\n3. Regular neuro-ophthalmology follow-up\n4. Consider work accommodations as needed\n5. Continue headache prophylaxis"
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when reviewing financial documents",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in last 2 months"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s, resolved spontaneously",
          "Surgical history: Cholecystectomy (2010)",
          "Hormone replacement therapy for 3 years post-menopause (discontinued 2019)",
          "Family history: Mother with breast cancer",
          "No history of smoking",
          "Occasional alcohol use (2-3 glasses of wine per week)",
          "Regular mammograms, last one normal (6 months ago)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F58-O-2016\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\nWHO Grade: II (atypical features noted)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven size >3cm, significant edema, and occupation requiring high cognitive function, immediate surgical intervention recommended. Started on Dexamethasone 4mg QID for edema management.\n\nFOLLOW-UP - April 2, 2016\nPre-operative evaluation completed. Surgery scheduled for April 15.\n\nSURGICAL NOTE - April 15, 2016\nProcedure: Left frontal craniotomy with Simpson Grade II resection\nComplications: None\nKPS: 70 | ECOG: 2\n\nPOST-OP FOLLOW-UP - May 30, 2016\nPathology confirmed WHO Grade II meningioma\nStarted adjuvant radiation therapy: 60 Gy in 30 fractions\nKPS: 75 | ECOG: 1\n\n6-MONTH FOLLOW-UP - October 15, 2016\nMRI shows no residual tumor\nReturned to work part-time\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - April 15, 2017\nStable imaging\nFull return to work\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - October 15, 2017\nNew 1.2 cm nodule at resection margin\nRecommended stereotactic radiosurgery (SRS)\nKPS: 85 | ECOG: 1\n\nSRS FOLLOW-UP - January 15, 2018\nCompleted SRS treatment\nKPS: 80 | ECOG: 1\n\nANNUAL FOLLOW-UP - January 15, 2019\nStable imaging\nMinor radiation changes\nKPS: 85 | ECOG: 1\n\nURGENT VISIT - March 30, 2020\nNew onset seizures\nMRI shows tumor recurrence (2.8 cm)\nKPS: 60 | ECOG: 2\n\nSECOND SURGERY - April 15, 2020\nSimpson Grade I resection\nPathology: WHO Grade II\nKPS: 50 | ECOG: 3\n\nPOST-OP FOLLOW-UP - June 1, 2020\nStarted on anticonvulsants\nRehabilitation program initiated\nKPS: 65 | ECOG: 2\n\nFOLLOW-UP - December 15, 2020\nImproved function\nNo seizures\nKPS: 75 | ECOG: 1\n\nANNUAL FOLLOW-UP - December 15, 2021\nStable imaging\nMaintained work schedule\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - December 15, 2022\nNo evidence of recurrence\nKPS: 90 | ECOG: 0\n\nLATEST FOLLOW-UP - December 15, 2023\nContinued stability\nMaintained full work schedule\nRegular cognitive assessments normal\nKPS: 95 | ECOG: 0\n\nCURRENT STATUS (2024):\n- Disease-free interval: 3.5 years\n- Regular MRI surveillance every 6 months\n- Maintaining full-time work\n- No cognitive deficits\n- Current KPS: 95 | ECOG: 0\n\nTreatment approach prioritized early intervention due to:\n1. Occupation requiring high cognitive function\n2. Size and location of tumor\n3. WHO Grade II classification\n4. Progressive neurological symptoms\n\nMonitoring Protocol:\n- MRI with contrast every 6 months\n- Quarterly neurological examinations\n- Annual neuropsychological testing\n- Regular cognitive function assessments related to work performance",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 58-year-old female, Financial Analyst\nMRI Findings: 2.4cm left frontal parasagittal meningioma with minimal surrounding edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nAssessment & Plan:\nGiven the patient's stable professional career and moderate symptom progression, recommending close monitoring initially. Symptoms appear manageable with medical therapy. Location and size permit conservative approach.\n\nRecommendations:\n1. Dexamethasone 4mg BID for 2 weeks, then taper\n2. Follow-up MRI in 3 months\n3. Neurocognitive assessment baseline\n4. Continue current medications\n5. Occupational therapy referral for workplace adaptations\n\nFollow-up Visit - June 20, 2018\nImaging: Stable tumor size\nSymptoms: Improved headaches, persistent visual symptoms\nKPS: 85 ECOG: 1\nPlan: Continue conservative management, MRI every 4 months\n\nAnnual Review - March 12, 2019\nTumor stable at 2.4cm\nSymptoms well-controlled with medical management\nKPS: 90 ECOG: 1\nAdded prophylactic anticonvulsant (Levetiracetam 500mg BID)\nMaintaining work schedule with accommodations\n\nFollow-up - February 28, 2020\nSlight tumor growth to 2.6cm\nIncreased headache frequency\nKPS: 80 ECOG: 1\nPlan: Increase monitoring frequency, consider radiation if growth continues\n\nCritical Assessment - September 15, 2020\nTumor: 2.8cm with moderate edema\nDeclining work performance noted\nKPS: 70 ECOG: 2\nDecision Point: Offered stereotactic radiosurgery (SRS)\nPatient opted to continue observation\n\nFollow-up - March 10, 2021\nPost-SRS (patient accepted treatment in November 2020)\nTumor stable, reduced edema\nKPS: 85 ECOG: 1\nImproved symptom control\n\nAnnual Review - April 5, 2022\nStable disease, good response to SRS\nReturn to full work capacity\nKPS: 90 ECOG: 0\nContinued monitoring plan\n\nFollow-up - May 12, 2023\nMaintained stability\nMinor residual symptoms\nKPS: 95 ECOG: 0\nAnnual MRI schedule implemented\n\nLatest Visit - January 15, 2024\nLong-term stable disease\nFully functional at work\nKPS: 95 ECOG: 0\nPlan: Continue annual monitoring\n\nTreatment Summary:\n- Conservative management 2018-2020\n- SRS in November 2020\n- Successful symptom control and tumor stability\n- Preserved occupational function\n- Quality of life maintained\n\nKPS Score Range: 70-95 throughout course\nECOG Score Range: 0-2 throughout course\n\nNote: Conservative approach initially chosen based on:\n1. Tumor size <3cm\n2. Patient's professional demands\n3. Initially manageable symptoms\n4. Good response to medical management\n5. Patient preference for non-surgical intervention\n\nLong-term outcome validates conservative approach with timely intervention when needed. Patient maintains high functional status and career continuation."
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Occasional ringing in right ear",
          "Reports feeling more clumsy lately, dropping items while baking",
          "Mild right-sided facial numbness noticed in past 2 weeks"
        ],
        "medical_history": [
          "Migraine headaches since age 30, but notes current headaches feel different",
          "Myopia, corrected with glasses (-2.0 diopters both eyes)",
          "Tonsillectomy at age 12",
          "No history of cancer",
          "No previous head trauma or neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "No family history of brain tumors",
          "Currently taking oral contraceptives (10+ years)",
          "No significant radiation exposure history"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-2016\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2016\nPRESENTING SYMPTOMS: Progressive headaches, right-sided visual disturbance, facial numbness, and coordination issues affecting work performance. Symptoms suggest possible mass effect with cranial nerve involvement.\n\nIMAGING:\nInitial MRI reveals 3.8cm right sphenoid wing meningioma with significant peritumoral edema. Mass effect on temporal lobe and compression of optic nerve. T2 sequence shows hyperintense signal. No calcification noted.\nWHO Grade: II (atypical features noted)\nKPS Score: 80\nECOG: 1\n\nTREATMENT PLAN:\nGiven size, location, and symptom progression, recommend immediate surgical intervention. Occupation requires precise visual and cognitive function. Schedule for craniotomy within 2 weeks.\n\nSURGICAL NOTE - March 30, 2016\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade: II resection\nFindings: Firm, well-circumscribed tumor with dural attachment\nPost-op KPS: 70\nECOG: 2\n\nFOLLOW-UP - June 15, 2016\nPatient recovering well. Visual symptoms improving. Returned to work part-time.\nAdjuvant radiotherapy initiated: 60 Gy in 30 fractions\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - December 20, 2016\nMRI shows no recurrence. Symptoms resolved.\nKPS: 90\nECOG: 0\n\nANNUAL FOLLOW-UP - March 2017\nStable imaging. Full return to work.\nKPS: 95\nECOG: 0\n\nFOLLOW-UP - September 2018\nSmall enhancement noted on MRI. Close monitoring warranted.\nKPS: 90\nECOG: 0\n\nURGENT VISIT - February 2019\nNew onset headaches. MRI shows tumor recurrence (2.1cm)\nKPS: 75\nECOG: 1\n\nSECOND SURGERY - March 2019\nComplete resection achieved\nPost-op KPS: 65\nECOG: 2\n\nFOLLOW-UP - September 2019\nRecovery progressing well. No evidence of recurrence.\nKPS: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2020\nStable imaging. Maintained work schedule.\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - March 2021\nNo evidence of recurrence. Annual monitoring continued.\nKPS: 95\nECOG: 0\n\nFOLLOW-UP - March 2022\nStable imaging. Patient fully functional.\nKPS: 95\nECOG: 0\n\nFOLLOW-UP - March 2023\nSmall enhancement noted, requiring closer monitoring.\nKPS: 90\nECOG: 0\n\nLATEST FOLLOW-UP - January 2024\nImaging stable. Continue surveillance.\nCurrent KPS: 95\nCurrent ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical interventions (2016, 2019)\n- Complete adjuvant radiotherapy\n- Current status: Stable disease with good functional status\n- Occupation maintained with accommodations\n- Regular MRI surveillance ongoing\n\nKPS Score Range: 65-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nMONITORING PLAN:\nContinue bi-annual MRI surveillance\nRegular ophthalmological assessments\nCognitive function monitoring\nQuality of life assessments",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 45-year-old female, Data Scientist/Baker\nMRI Findings: 2.4cm right sphenoid wing meningioma with minimal peritumoral edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nAssessment:\nRight sphenoid wing meningioma presenting with progressive neurological symptoms. Location and symptomatology warrant close monitoring, though size favors initial conservative management.\n\nPlan:\n- Watchful waiting with serial imaging\n- Dexamethasone 4mg BID for symptom management\n- Occupational modifications recommended\n- Follow-up MRI in 3 months\n\n-------------------\n\nFollow-up - June 20, 2018\nImaging: Stable tumor size\nSymptoms: Moderate improvement in headaches with steroids\nKPS: 90 ECOG: 1\n\nPlan:\n- Continue conservative management\n- Taper dexamethasone to 2mg BID\n- Workplace ergonomic assessment recommended\n- Next MRI in 6 months\n\n-------------------\n\nFollow-up - December 12, 2018\nImaging: No significant growth\nSymptoms: Stable with occasional headaches\nKPS: 95 ECOG: 0\n\nPlan:\n- Further steroid taper\n- Continue monitoring\n- Annual MRI schedule initiated\n\n-------------------\n\nAnnual Follow-up - December 15, 2019\nImaging: Minimal growth (0.2cm)\nSymptoms: Well-controlled\nKPS: 90 ECOG: 1\n\nPlan:\n- Maintain conservative approach\n- Continue annual imaging\n\n-------------------\n\nAnnual Follow-up - December 10, 2020\nImaging: Stable disease\nNote: Patient reports COVID-19 recovery\nKPS: 85 ECOG: 1\n\nPlan:\n- Continue observation\n- Added telemedicine options for follow-up\n\n-------------------\n\nAnnual Follow-up - December 8, 2021\nImaging: 2.8cm tumor (slight growth)\nSymptoms: Increased headaches\nKPS: 80 ECOG: 1\n\nPlan:\n- Consider radiation therapy options\n- Increase monitoring frequency\n- MRI in 6 months\n\n-------------------\n\nFollow-up - June 15, 2022\nImaging: Stable at 2.8cm\nSymptoms: Improved with medication adjustment\nKPS: 85 ECOG: 1\n\nPlan:\n- Continue conservative management\n- Resume annual imaging\n\n-------------------\n\nAnnual Follow-up - June 20, 2023\nImaging: No significant changes\nSymptoms: Well-managed\nKPS: 90 ECOG: 1\n\nPlan:\n- Maintain current approach\n- Annual MRI continuation\n\n-------------------\n\nRecent Follow-up - January 15, 2024\nImaging: Stable disease\nSymptoms: Well-controlled\nKPS: 95 ECOG: 0\n\nOverall Course Summary:\nPatient has maintained good functional status with conservative management over 6-year period. Minimal tumor growth observed. Successful symptom management achieved through medication adjustments and lifestyle modifications.\n\nKPS Range Over Treatment Course: 80-95\nECOG Range: 0-1\n\nOccupational Considerations:\n- Modified computer screen usage patterns\n- Ergonomic workplace adjustments\n- Maintained both professional roles with accommodations\n\nQuality of Life Outcomes:\n- Preserved cognitive function\n- Maintained independence\n- Continued professional activities\n- Good symptom control\n\nLong-term Recommendations:\n- Continue annual MRI surveillance\n- Maintain current lifestyle modifications\n- Regular neurological assessments\n- Consider radiation therapy only if significant progression occurs"
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Reports subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Mild balance issues when walking, especially when turning quickly"
        ],
        "medical_history": [
          "Migraine headaches since age 25, well-controlled with sumatriptan",
          "Myopia, corrected with glasses since childhood",
          "Tonsillectomy at age 12",
          "No history of cancer",
          "No previous neurological conditions",
          "No family history of brain tumors",
          "Regular annual check-ups with normal findings",
          "No significant trauma history",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F40-O-2016\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nSymptomatic left frontal meningioma with concerning features warranting immediate intervention. Occupation requires high cognitive function; symptoms significantly impacting work performance.\nPLAN:\n- Scheduled for surgical resection within 2 weeks\n- Pre-operative optimization\n- Dexamethasone 4mg QID for edema\nKPS: 70 | ECOG: 1\n\nSURGICAL NOTE - March 30, 2016\n- Simpson Grade II resection achieved\n- Subtotal removal due to sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate complications\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - June 15, 2016\n- Improved headaches\n- Residual visual symptoms\n- Started adjuvant radiotherapy\n- MRI shows small residual tumor\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - December 20, 2016\n- Completed RT (54 Gy/30 fractions)\n- Improved neurological symptoms\n- Returned to work part-time\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - June 18, 2017\n- Stable imaging\n- Full-time work resumed\n- Minor fatigue\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - December 15, 2018\n- MRI shows small progression of residual tumor\n- New onset headaches\n- Recommended second surgery\nKPS: 80 | ECOG: 1\n\nSURGICAL NOTE - January 30, 2019\n- Second resection performed\n- Simpson Grade I achieved\n- Pathology confirms recurrent Grade II\nKPS: 70 | ECOG: 1\n\nFOLLOW-UP - June 15, 2020\n- Post-radiation changes stable\n- No evidence of progression\n- Maintained work schedule\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - July 10, 2021\n- MRI stable\n- Excellent functional status\n- Annual monitoring continued\nKPS: 100 | ECOG: 0\n\nFOLLOW-UP - August 5, 2022\n- New small satellite lesion identified\n- Gamma Knife radiosurgery planned\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - February 15, 2023\n- Post-radiosurgery changes as expected\n- Maintained cognitive function\n- Continues full-time work\nKPS: 90 | ECOG: 0\n\nCURRENT VISIT - January 20, 2024\n- Stable disease\n- Excellent functional status\n- Continues semi-annual monitoring\nKPS: 90 | ECOG: 0\n\nTREATMENT SUMMARY 2016-2024:\n- Two surgical resections\n- Conventional radiotherapy\n- Gamma Knife radiosurgery\n- Aggressive monitoring protocol maintained\n- Overall excellent outcome with maintained occupational function\n\nKPS Score Range: 60-100 (Currently 90)\nECOG Score Range: 0-2 (Currently 0)\n\nMONITORING PLAN:\n- Continue semi-annual MRI\n- Neuropsychological testing annually\n- Regular ophthalmological evaluation\n- Consider prophylactic anticonvulsants",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 40F, Blood Type O\nOccupation: Librarian\nWHO Grade: I (confirmed by imaging characteristics)\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (4-month duration)\n- Right eye visual disturbance\n- Concentration difficulties affecting work\n- Right facial paresthesia\n- Mild ataxia\n- Personality changes\n\nIMAGING FINDINGS:\nMRI reveals 2.3cm right frontal convexity meningioma, minimal perilesional edema, no mass effect on critical structures. T2 sequence shows moderate signal intensity.\n\nASSESSMENT & PLAN:\nGiven tumor size <3cm and patient's age, recommending conservative management with close monitoring. Discussed benefits/risks of watchful waiting approach versus immediate intervention.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months initially\n2. Headache management optimization with neurologist\n3. Occupational adjustments: ergonomic workspace assessment, regular breaks\n4. Continue current medications\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nMinimal symptom progression. Headaches better controlled with adjusted medication regimen.\nMRI: No significant change in tumor size or characteristics\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nReports improved concentration at work. Vision stable.\nMRI: Stable findings\nKPS: 95 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. Managing work-from-home transition well.\nPrevious MRI comparison: No progression\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 10, 2021\nNotes increased headache frequency\nMRI: Minimal growth (2.5cm), slight increase in edema\nPLAN: Increased monitoring frequency, initiated dexamethasone\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - October 15, 2021\nSymptoms stabilized with steroids\nMRI: Stable compared to previous\nPLAN: Steroid taper, continue monitoring\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 20, 2022\nExperiencing increased visual symptoms\nMRI: Tumor growth to 2.8cm\nDISCUSSION: Reviewing surgical options while maintaining conservative approach\nKPS: 75 ECOG: 2\n\n-------------------\n\nFOLLOW-UP - October 25, 2022\nOpted for stereotactic radiosurgery (SRS)\nPost-treatment response favorable\nKPS: 70 ECOG: 2\n\n-------------------\n\nFOLLOW-UP - April 15, 2023\nPost-SRS improvement in symptoms\nMRI: Early signs of tumor response\nReturn to work part-time\nKPS: 80 ECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - February 20, 2024\nSignificant improvement in all symptoms\nMRI: Tumor reduction to 2.4cm\nFull return to work\nPLAN: Continue annual MRI surveillance\nKPS: 90 ECOG: 1\n\nOVERALL COURSE SUMMARY:\nPatient managed successfully with conservative approach for 4 years before requiring SRS. Post-treatment showing favorable outcome with good quality of life preservation and continued employment. Regular monitoring allowed for timely intervention when needed.\n\nFINAL KPS: 90\nFINAL ECOG: 1\n\nTreatment approach prioritized minimal intervention while maintaining close surveillance, particularly appropriate given patient's occupation requiring cognitive focus and stable lifestyle factors."
      }
    },
    {
      "demographics": {
        "age": 52,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Increasing difficulty concentrating at work on financial reports",
          "Occasional nausea without vomiting",
          "Reports feeling more clumsy when typing",
          "Mild balance issues when walking, particularly noticeable when wearing heels"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 3 years post-hysterectomy",
          "Mild hypertension diagnosed 2 years ago, managed with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "Non-smoker",
          "Occasional alcohol use (1-2 glasses of wine per week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F52-A-FA\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on superior frontal gyrus\n- Dural tail sign present\nWHO Grade: II (atypical features on imaging)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's cognitive-demanding occupation and progressive neurological symptoms, recommend aggressive surgical intervention. Patient's symptoms significantly impact work performance. Schedule for craniotomy within 2 weeks.\n\nSURGICAL NOTE - October 1, 2018\n- Simpson Grade II resection achieved\n- Minimal residual tumor along superior sagittal sinus\n- Pathology confirms WHO Grade II meningioma\nKPS: 70 | ECOG: 2\n\nPOST-OP FOLLOW-UP - December 15, 2018\n- Improved vision and headaches\n- Starting adjuvant radiation therapy\n- 54 Gy in 30 fractions planned\nKPS: 85 | ECOG: 1\n\n6-MONTH FOLLOW-UP - April 10, 2019\n- Completed radiation therapy\n- Minimal residual enhancement\n- Return to work part-time\nKPS: 90 | ECOG: 1\n\n1-YEAR FOLLOW-UP - October 5, 2019\n- Full-time work resumed\n- No new neurological symptoms\n- Surveillance MRI stable\nKPS: 95 | ECOG: 0\n\n2-YEAR FOLLOW-UP - October 12, 2020\n- Small focus of enhancement noted\n- Watchful waiting approach\nKPS: 90 | ECOG: 1\n\n3-YEAR FOLLOW-UP - September 30, 2021\n- Enhancement progression\n- New mild headaches\n- Recommend repeat surgery\nKPS: 85 | ECOG: 1\n\nSECOND SURGERY - November 15, 2021\n- Complete resection achieved\n- Pathology shows transformation to WHO Grade III\nKPS: 60 | ECOG: 2\n\nPOST-SECOND SURGERY - February 1, 2022\n- Started on systemic therapy\n- Significant fatigue\n- Unable to work\nKPS: 50 | ECOG: 3\n\n1-YEAR POST SECOND SURGERY - November 20, 2022\n- Improved tolerance to treatment\n- Partial return to work\n- Stable imaging\nKPS: 75 | ECOG: 1\n\nRECENT FOLLOW-UP - December 15, 2023\n- Working full-time\n- Quarterly MRI surveillance\n- No evidence of recurrence\nKPS: 90 | ECOG: 1\n\nLATEST VISIT - March 1, 2024\n- Maintaining good functional status\n- Continues quarterly imaging\n- Consider extending to biannual surveillance if stable\nKPS: 95 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial WHO Grade II meningioma\n- Two surgical interventions\n- Progression to Grade III\n- Complete course of radiation therapy\n- Systemic therapy\n- Current status: Stable disease with good functional recovery\n\nKPS Score Range: 50-95 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 52-year-old female, Financial Analyst\nMRI FINDINGS: 2.8cm left frontal convexity meningioma with minimal surrounding edema, WHO Grade I\nKPS: 90 | ECOG: 1\n\nASSESSMENT:\nLeft frontal convexity meningioma presenting with progressive neurological symptoms. Given size (<3cm) and WHO Grade I status, recommending close monitoring with consideration for conservative management.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Neurology referral for headache management\n3. Occupational therapy evaluation for typing difficulties\n4. Continue current blood pressure management\n5. Discuss potential workplace accommodations\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nMinimal tumor growth (2.9cm)\nSymptoms stable with improved headache control\nKPS: 90 | ECOG: 1\n\nPLAN:\nContinue surveillance\nPrescribed blue light filtering glasses for computer work\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nNo significant growth\nVision symptoms improved with glasses\nKPS: 95 | ECOG: 0\n\nPLAN:\nMaintain current management approach\nExtended MRI interval to annual\n\n-------------------\n\nANNUAL FOLLOW-UP - March 15, 2020\nTumor stable at 2.9cm\nCOVID-19 considerations discussed\nKPS: 90 | ECOG: 1\n\nPLAN:\nTelemedicine follow-ups when appropriate\nStress management techniques recommended\n\n-------------------\n\nANNUAL FOLLOW-UP - March 18, 2021\nSlight growth noted (3.1cm)\nIncreased headache frequency\nKPS: 85 | ECOG: 1\n\nPLAN:\nReturn to 6-month MRI surveillance\nHeadache diary implementation\nConsider radiation therapy if symptoms worsen\n\n-------------------\n\nFOLLOW-UP - September 22, 2021\nTumor stable\nHeadaches improved with medication adjustment\nKPS: 90 | ECOG: 1\n\nPLAN:\nContinue current management\nMaintain work modifications\n\n-------------------\n\nANNUAL FOLLOW-UP - March 15, 2022\nNo growth\nQuality of life improved\nKPS: 95 | ECOG: 0\n\nPLAN:\nReturn to annual surveillance\nContinue workplace accommodations\n\n-------------------\n\nANNUAL FOLLOW-UP - March 20, 2023\nMinimal growth (3.2cm)\nSome visual symptoms returning\nKPS: 80 | ECOG: 1\n\nPLAN:\nOphthalmology consultation\nDiscuss radiation therapy options\nMaintain conservative approach unless symptoms worsen\n\n-------------------\n\nRECENT FOLLOW-UP - January 15, 2024\nTumor stable\nVision stable after medication adjustment\nKPS: 85 | ECOG: 1\n\nTREATMENT SUMMARY:\nSuccessfully managed with conservative approach over 6 years\nMaintained professional activities with accommodations\nQuality of life preserved through non-surgical interventions\n\nKPS Score Range Over Treatment Period: 80-95\nECOG Score Range: 0-1\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain workplace ergonomic modifications\n3. Regular ophthalmology follow-up\n4. Monitor for any new neurological symptoms\n5. Consider SRS if significant progression occurs\n\nNote: Patient has maintained relatively high functional status throughout observation period, with temporary decreases during periods of symptom exacerbation. Conservative management approach has proven effective in maintaining quality of life while avoiding surgical risks."
      }
    },
    {
      "demographics": {
        "age": 50,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work on computer screens",
          "Subtle personality changes noted by family - more irritable than usual",
          "Mild right-sided facial numbness that began 2 months ago",
          "Reports feeling more fatigued than usual despite adequate sleep"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 3 years post-hysterectomy",
          "No prior neurological conditions",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Regular vision checks with last exam 1 year ago showing normal results",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\nPatient ID: F50-O-DS\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION\nChief Complaint: Progressive neurological symptoms including headaches, visual disturbance, and cognitive changes.\n\nIMAGING FINDINGS:\nMRI reveals a 3.8cm right sphenoid wing meningioma with significant peritumoral edema. Mass effect on adjacent temporal lobe. T2 sequence shows hyperintensity. Minimal calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nKPS: 80\nECOG: 1\n\nTREATMENT PLAN:\nGiven patient's occupation requiring high cognitive function and progressive symptoms, recommend early surgical intervention. Schedule for right frontotemporal craniotomy with image-guided resection.\n\n-------------------\n\nPOST-OPERATIVE NOTE\nDate: April 2, 2018\n\nProcedure: Right frontotemporal craniotomy with Simpson Grade II resection\nFindings: Firm, well-circumscribed tumor with some dural invasion\nPathology: Confirmed WHO Grade II meningioma\nKPS: 70\nECOG: 2\n\n-------------------\n\nFOLLOW-UP VISIT\nDate: October 15, 2018\n\nPatient reports improvement in headaches and vision. Continuing physical therapy.\nMRI shows small residual enhancement along dural attachment.\nRecommended adjuvant radiation therapy.\nKPS: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP VISIT\nDate: April 20, 2019\n\nPost-radiation assessment\nComplete course of IMRT (60 Gy in 30 fractions)\nMinimal treatment-related fatigue\nMRI stable\nKPS: 90\nECOG: 1\n\n-------------------\n\nSURVEILLANCE VISIT\nDate: March 10, 2020\n\nPatient back to work full-time\nNo new neurological symptoms\nMRI shows no evidence of progression\nKPS: 95\nECOG: 0\n\n-------------------\n\nURGENT VISIT\nDate: September 15, 2021\n\nNew onset seizures\nMRI shows tumor recurrence (2.2cm)\nRecommend repeat surgical intervention\nKPS: 60\nECOG: 2\n\n-------------------\n\nPOST-SECOND SURGERY\nDate: October 30, 2021\n\nSimpson Grade I resection achieved\nStarted on anticonvulsants\nKPS: 75\nECOG: 1\n\n-------------------\n\nFOLLOW-UP VISIT\nDate: April 15, 2022\n\nStable neurologically\nNo seizures\nMRI clear\nConsider stereotactic radiosurgery for prophylaxis\nKPS: 85\nECOG: 1\n\n-------------------\n\nROUTINE SURVEILLANCE\nDate: March 20, 2023\n\nMaintaining good function\nWorking full-time\nMRI stable\nKPS: 90\nECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP\nDate: January 15, 2024\n\nSix-year post-initial diagnosis\nNo evidence of recurrence\nCognitively intact\nContinues regular computer work\nMRI stable\nKPS: 95\nECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial: KPS 80/ECOG 1\n- Lowest: KPS 60/ECOG 2 (during recurrence)\n- Current: KPS 95/ECOG 0 (excellent recovery)\n\nONGOING RECOMMENDATIONS:\n1. Biannual MRI surveillance\n2. Annual neuropsychological testing\n3. Continue anticonvulsant therapy\n4. Regular ophthalmological monitoring\n5. Return to clinic immediately for any new symptoms",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 50F, Blood Type O\nOccupation: Data Scientist\n\nPRESENTING SYMPTOMS:\nProgressive headaches, right-sided visual disturbance, concentration difficulties, and facial numbness. Symptoms significantly impacting work performance with computer screens.\n\nIMAGING:\nMRI reveals 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. WHO Grade I characteristics.\n\nASSESSMENT:\nGiven tumor size, location, and patient's stable neurological status, recommending close observation over immediate surgical intervention.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Ophthalmology referral for baseline visual field testing\n3. Prophylactic anticonvulsants not indicated\n4. Occupational therapy consultation for workplace ergonomics\n5. Continue current migraine management\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nMinimal symptom progression. Visual symptoms stable.\nMRI: No significant change in tumor size.\nImplemented workplace modifications with success.\nContinue conservative management.\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nReports improved headache control.\nMRI: Stable lesion size.\nAdded blue light filtering glasses for computer work.\nKPS: 95 ECOG: 0\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable symptoms. Managing well with remote work setup.\nPrevious MRI comparison shows no progression.\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 10, 2021\nReports increased headache frequency.\nMRI: Minimal growth (0.2cm over 3 years).\nAdjusted migraine medication.\nConsider radiation therapy if symptoms worsen.\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - May 5, 2022\nExperiencing more frequent visual symptoms.\nMRI: Tumor size 3.1cm with moderate edema.\nDiscussing radiation therapy options while maintaining conservative approach.\nStarted dexamethasone for edema management.\nKPS: 75 ECOG: 2\n\n-------------------\n\nFOLLOW-UP - June 15, 2023\nPost-radiation therapy assessment (completed focused RT).\nSignificant improvement in visual symptoms.\nMRI: Decreased edema, stable tumor size.\nGradually tapering dexamethasone.\nKPS: 85 ECOG: 1\n\n-------------------\n\nRECENT FOLLOW-UP - January 10, 2024\nMaintained improvement post-radiation.\nMRI: Stable disease, no progression.\nSuccessfully returned to full-time work.\nContinue annual monitoring.\nKPS: 90 ECOG: 1\n\nTREATMENT SUMMARY:\nConservative management successfully maintained for 4+ years before requiring radiation therapy. Patient maintained high functional status throughout treatment course with minimal intervention.\n\nKPS Score Range: 75-95\nECOG Score Range: 0-2\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Regular ophthalmology follow-up\n3. Maintain ergonomic workplace modifications\n4. Continue migraine management\n5. Quality of life monitoring\n6. Cognitive function assessment annually"
      }
    },
    {
      "demographics": {
        "age": 57,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion while coding at work",
          "Mild right-sided facial numbness",
          "Reports difficulty concentrating during long meetings",
          "Two episodes of stumbling while walking in past month",
          "Gradual personality changes noted by coworkers - more irritable than usual"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "Hypertension - on Lisinopril 10mg daily",
          "Migraine headaches since age 40 - previously well-controlled with sumatriptan",
          "Mild obesity (BMI 31)",
          "Laser eye surgery (LASIK) 12 years ago",
          "No history of cancer",
          "No significant head trauma",
          "Family history: Father had stroke at age 65"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M57-O-SD\nPrimary Diagnosis: Meningioma\n==================================\n\nINITIAL VISIT - September 15, 2018\n---------------------------------\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Compression of superior sagittal sinus\nWHO Grade: II (Atypical features noted)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's cognitive symptoms affecting work performance, size >3cm, and significant edema, immediate surgical intervention recommended. Patient's occupation requires high cognitive function; delays could impact professional capabilities.\n\nSURGICAL PLANNING - October 1, 2018\n----------------------------------\nPre-op Assessment:\n- Dexamethasone 4mg QID started\n- Surgical approach: Right frontal craniotomy\n- Simpson Grade II resection planned\nKPS: 75 | ECOG: 1\n\nSURGERY - October 15, 2018\n-------------------------\nProcedure: Right frontal craniotomy with Simpson Grade II resection\nFindings: Firm, well-circumscribed tumor with dural attachment\nPathology: WHO Grade II meningioma\nPost-op Status: Stable\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - January 15, 2019 (3 months post-op)\n----------------------------------------------\n- Improved headaches\n- Vision normalized\n- Return to work part-time\n- Started adjuvant radiotherapy\nKPS: 70 | ECOG: 1\n\nFOLLOW-UP - July 15, 2019 (9 months post-op)\n-------------------------------------------\n- Completed RT (54 Gy in 30 fractions)\n- Full return to work\n- No new neurological symptoms\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - October 15, 2020\n----------------------------------\nMRI: Small enhancement at resection site\nSymptoms: None\nWork Status: Full-time, performing well\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - April 15, 2021\n--------------------------\nMRI: Stable post-surgical changes\nNew symptoms: Mild intermittent headaches\nKPS: 85 | ECOG: 1\n\nURGENT VISIT - January 10, 2022\n------------------------------\nMRI: 1.5cm recurrence at original site\nSymptoms: Return of visual symptoms\nPlan: SRS scheduled\nKPS: 70 | ECOG: 1\n\nPOST-SRS FOLLOW-UP - July 15, 2022\n---------------------------------\nResponse: Good tumor control\nSymptoms: Improving\nKPS: 80 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 15, 2023\n--------------------------------\nMRI: Stable disease\nWork Status: Maintained full-time employment\nKPS: 85 | ECOG: 1\n\nRECENT FOLLOW-UP - January 10, 2024\n----------------------------------\nMRI: No evidence of progression\nSymptoms: Well-controlled\nWork Status: Considering part-time consulting\nKPS: 80 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection (2018)\n- Adjuvant RT completed (2019)\n- SRS for recurrence (2022)\n- Regular MRI surveillance q6 months\n\nCURRENT STATUS:\n- Disease stable\n- Maintained cognitive function\n- Continues professional work\n- Regular monitoring ongoing\n\nFinal KPS/ECOG Trend:\n- Lowest KPS: 60 (immediate post-op)\n- Highest KPS: 90 (2020)\n- Current KPS: 80\n- Current ECOG: 1",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M57-O-SD\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- WHO Grade I (likely)\nKPS: 90 | ECOG: 1\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting work performance. Given tumor size and location, conservative management initially preferred. Cognitive symptoms likely impacting software development work.\n\nPLAN:\n1. Close monitoring with serial imaging\n2. Optimize diabetes management\n3. Neurocognitive assessment\n4. Consider work accommodations\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nStable symptoms. Minor improvement in headaches with medication adjustment.\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nReports increased difficulty with computer work\nMRI: Minimal growth (0.2cm)\nImplemented reduced screen time and ergonomic adjustments\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - January 15, 2020\nWorsening symptoms\nMRI: Growth to 3.2cm with increased edema\nDECISION POINT: Discussing surgical options while maintaining conservative approach\nKPS: 70 | ECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 10, 2020\nStarted on dexamethasone for edema management\nWorking remotely due to COVID-19 - helping with symptom management\nKPS: 75 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - February 18, 2021\nStable symptoms with steroid management\nMRI: No further growth\nImplementing cognitive rehabilitation\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 5, 2022\nImproved work performance with accommodations\nMRI: Stable\nReduced steroid dosage\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - April 12, 2023\nMinor symptom progression\nMRI: Minimal growth (3.3cm)\nMaintaining conservative approach with close monitoring\nKPS: 80 | ECOG: 1\n\n-------------------\n\nCURRENT VISIT - January 20, 2024\nStable symptoms with occasional headaches\nMRI: No significant change\nContinuing conservative management\nKPS: 85 | ECOG: 1\n\nMANAGEMENT SUMMARY:\n- Successfully maintained conservative approach over 6 years\n- KPS range: 70-90 (lowest during 2020, improved with management)\n- ECOG range: 1-2\n- Work accommodations and lifestyle modifications key to management\n- Regular monitoring continues to be appropriate\n\nCURRENT RECOMMENDATIONS:\n1. Continue MRI monitoring every 6 months\n2. Maintain work modifications\n3. Regular diabetes management\n4. Cognitive assessment every 6 months\n5. Quality of life assessments ongoing\n\nWHO Grade: I (stable)\nCurrent KPS: 85\nCurrent ECOG: 1"
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Increasing difficulty with balance when walking",
          "Episodes of confusion and difficulty finding correct words",
          "Right-sided facial numbness",
          "Occasional nausea without vomiting",
          "Fatigue and drowsiness"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 12 years ago - managed with metformin",
          "High-risk pregnancy at age 67 (extremely rare/unusual case)",
          "Hypertension - controlled with methyldopa due to pregnancy",
          "History of migraine headaches, but pattern changed recently",
          "Mild obesity (BMI 31)",
          "Cataract surgery left eye 3 years ago",
          "Family history of breast cancer (mother)",
          "No prior history of cancer",
          "No previous neurological conditions",
          "Currently in second trimester of pregnancy (high-risk)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n67-year-old female, Blood Type A\nOccupation: Librarian\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\n- Compression of right optic tract\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms and high-risk factors:\n- Advanced age\n- High-risk pregnancy (second trimester)\n- Diabetes\n- Progressive neurological symptoms\nKPS Score: 70\nECOG: 2\n\nTREATMENT PLAN:\nUrgent surgical intervention recommended due to:\n1. Tumor size >3cm\n2. Progressive symptoms\n3. Optic tract compression\n4. Pregnancy considerations\n\n-------------------\n\nSURGICAL NOTE - September 20, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II meningioma\nComplications: None\nKPS Score: 60\nECOG: 2\n\n-------------------\n\nPOST-OP FOLLOW-UP - October 15, 2018\n- Improved vision\n- Residual facial numbness\n- Pregnancy progressing normally\nStarted fractionated RT (54 Gy/30fx)\nKPS Score: 65\nECOG: 2\n\n-------------------\n\n6-MONTH FOLLOW-UP - March 2019\n- Successful delivery of healthy baby\n- MRI shows no recurrence\n- Improved neurological symptoms\nKPS Score: 80\nECOG: 1\n\n-------------------\n\n1-YEAR FOLLOW-UP - September 2019\nMRI: Small enhancement at resection margin\nSymptoms: Mild headaches\nKPS Score: 85\nECOG: 1\n\n-------------------\n\n2-YEAR FOLLOW-UP - September 2020\nMRI: Progressive enhancement\nNew symptoms: Visual disturbances\nDecision: Second surgery recommended\nKPS Score: 75\nECOG: 1\n\n-------------------\n\nSECOND SURGERY - October 2020\nSimpson Grade I resection\nPathology: WHO Grade II with focal Grade III features\nPost-op RT initiated\nKPS Score: 55\nECOG: 2\n\n-------------------\n\n3-YEAR FOLLOW-UP - September 2021\nMRI: No recurrence\nSymptoms: Well-controlled\nStarted systemic therapy\nKPS Score: 70\nECOG: 1\n\n-------------------\n\n5-YEAR FOLLOW-UP - September 2023\nMRI: Stable\nMinor cognitive issues affecting library work\nRegular rehabilitation\nKPS Score: 75\nECOG: 1\n\n-------------------\n\nCURRENT STATUS - March 2024\n- Stable disease\n- Retired from library work\n- Regular q3-month MRI surveillance\n- Maintained on systemic therapy\nKPS Score: 80\nECOG: 1\n\nTREATMENT SUMMARY 2018-2024:\n- Two surgical resections\n- Two courses of radiation therapy\n- Ongoing systemic therapy\n- Regular cognitive rehabilitation\n\nKPS Score Range: 55-85\nECOG Score Range: 1-2\n\nMONITORING PROTOCOL:\n- Q3-month MRI\n- Monthly neurological examinations\n- Quarterly cognitive assessments\n- Regular diabetes management\n- Quality of life assessments",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n67-year-old female, Blood Type A\nOccupation: Librarian\nWHO Grade II Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8 cm right frontal parasagittal meningioma\n- Moderate peritumoral edema\n- Mass effect on superior sagittal sinus\n- No hydrocephalus\n\nASSESSMENT:\nComplex case given high-risk pregnancy (second trimester), diabetes, and age. Symptoms concerning but must balance risks carefully.\nKPS: 70\nECOG: 2\n\nPLAN:\n1. Conservative management during pregnancy\n2. Dexamethasone 4mg BID for edema\n3. Weekly neurological monitoring\n4. Monthly MRI with limited contrast protocol\n5. Coordinate with high-risk OB team\n\nFOLLOW-UP - July 20, 2018\nPost-successful C-section delivery\nTumor stable\nSymptoms partially improved with steroids\nKPS: 75\nECOG: 1\nPlan: Continue monitoring, gradual steroid taper\n\nFOLLOW-UP - January 15, 2019\nMRI shows minimal growth (2.9 cm)\nSymptoms stable\nDiscussing treatment options\nKPS: 80\nECOG: 1\nPlan: Continue conservative management with quarterly MRI\n\nFOLLOW-UP - December 10, 2019\nTumor stable\nVision symptoms improved\nBalance issues persistent\nKPS: 85\nECOG: 1\nPlan: Maintain current approach\n\nANNUAL REVIEW - March 5, 2020\nStable disease\nPatient managing work duties with modifications\nKPS: 80\nECOG: 1\nPlan: Continue monitoring, extend MRI interval to 6 months\n\nFOLLOW-UP - April 12, 2021\nSlight tumor progression (3.1 cm)\nNew onset headaches\nKPS: 70\nECOG: 2\nPlan: Consider stereotactic radiosurgery\n\nFOLLOW-UP - October 8, 2022\nPost-radiosurgery (15 Gy single fraction)\nGood response, tumor stable\nSymptoms improving\nKPS: 85\nECOG: 1\nPlan: Continue monitoring\n\nLATEST FOLLOW-UP - February 15, 2024\nTumor stable post-treatment\nManaging well at work with accommodations\nMinor residual symptoms\nKPS: 90\nECOG: 1\n\nMANAGEMENT SUMMARY:\n- Conservative approach successful\n- Workplace accommodations: reduced hours, ergonomic adjustments\n- Quality of life preserved\n- Regular monitoring continues\n- Diabetes well-controlled throughout\n\nCURRENT RECOMMENDATIONS:\n1. Biannual MRI\n2. Annual neuropsychological assessment\n3. Continue diabetes management\n4. Maintain modified work schedule\n5. Regular balance/gait assessment\n\nFinal KPS Trend: 70 \u2192 90\nFinal ECOG Trend: 2 \u2192 1\n\nNote: Patient's occupation as librarian allowed for workplace modifications and relatively low physical demands, supporting conservative management approach."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Wine Taster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, particularly in the morning; Right-sided facial numbness; Gradual decline in sense of smell affecting wine tasting work; Recent episodes of difficulty finding correct words while speaking; Occasional balance issues when reaching for books on high shelves; Mild nausea without vomiting; Increasing fatigue over past 2 months"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily; Mild hearing loss in left ear diagnosed 5 years ago; History of concussion from bicycle accident 15 years ago with full recovery; Occasional migraines in 40s that resolved; Successful cataract surgery right eye 2 years ago; Family history of father with stroke at age 70; No history of seizures or other neurological conditions; No prior cancer history"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 62-year-old male, Blood Type O\nOccupation: Librarian and Professional Wine Taster\n\nPRESENTING SYMPTOMS:\n- Progressive morning headaches (3-month duration)\n- Right-sided facial numbness\n- Anosmia affecting professional wine tasting ability\n- Word-finding difficulties\n- Balance issues\n- Mild nausea\n- Progressive fatigue\n\nIMAGING:\nMRI reveals 3.8cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on frontal lobe with midline shift of 5mm. T2 hyperintense with heterogeneous enhancement.\n\nASSESSMENT:\nWHO Grade II meningioma suspected due to irregular borders and significant edema. Given patient's occupation requiring fine olfactory discrimination and cognitive function, immediate intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Preoperative dexamethasone 4mg QID\n3. Anticonvulsant prophylaxis\nKPS: 80 ECOG: 1\n\n-------------------\n\nPOST-OPERATIVE VISIT - April 2, 2018\nSimpson Grade II resection achieved. Pathology confirms WHO Grade II meningioma.\nMinimal residual tumor at skull base attachment.\nRecommended adjuvant radiation therapy.\nKPS: 70 ECOG: 2\n\n-------------------\n\nFOLLOW-UP - July 15, 2018\nPost-radiation assessment\nCompleted 54 Gy in 30 fractions\nImproved symptoms, minimal residual facial numbness\nMRI shows no progression\nKPS: 85 ECOG: 1\n\n-------------------\n\n6-MONTH FOLLOW-UP - January 10, 2019\nStable imaging\nReturned to work with accommodations\nPartial recovery of olfactory function\nKPS: 90 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - March 20, 2020\nMRI shows small enhancement at surgical site\nWatchful waiting approach\nNo new symptoms\nKPS: 90 ECOG: 1\n\n-------------------\n\n18-MONTH FOLLOW-UP - September 15, 2021\nEvidence of tumor progression (1.2cm growth)\nNew onset headaches\nRecommended repeat surgical intervention\nKPS: 75 ECOG: 1\n\n-------------------\n\nPOST-SECOND SURGERY - November 1, 2021\nComplete resection achieved\nPathology confirms recurrent WHO Grade II\nStarted on temozolomide\nKPS: 65 ECOG: 2\n\n-------------------\n\nFOLLOW-UP - March 15, 2022\nGood response to treatment\nNo evidence of recurrence\nReturned to modified work schedule\nKPS: 85 ECOG: 1\n\n-------------------\n\nANNUAL FOLLOW-UP - April 10, 2023\nStable imaging\nMaintaining work activities\nMinor balance issues persist\nKPS: 90 ECOG: 1\n\n-------------------\n\nRECENT FOLLOW-UP - February 20, 2024\nMRI stable\nNo new symptoms\nContinues modified work schedule\nRegular monitoring to continue\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\nPatient underwent aggressive initial intervention due to occupation-critical symptoms. Two surgical resections with adjuvant radiation and chemotherapy have resulted in good disease control. Current status shows excellent recovery with minimal functional limitations.\n\nKPS Range during treatment: 65-95\nECOG Range during treatment: 0-2\n\nMONITORING PROTOCOL:\n- MRI every 3 months for first 2 years, then biannually\n- Quarterly neurological examinations\n- Annual neuropsychological testing\n- Regular olfactory function assessment due to occupation",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\nBlood Type: O\nOccupation: Librarian/Wine Taster\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 2.1cm left frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\nKPS: 90 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven tumor size <3cm, minimal edema, and stable employment requiring cognitive/sensory acuity, recommending conservative management with close monitoring. Occupational considerations particularly important given wine tasting profession requiring preserved olfactory function.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months initially\n2. Blood pressure monitoring\n3. Continue lisinopril 10mg daily\n4. Occupational therapy assessment for balance issues\n5. Speech therapy consultation for word-finding difficulties\n\nFOLLOW-UP VISIT - September 20, 2016\nTumor stable at 2.1cm. Headaches improved with prophylactic medication.\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP VISIT - March 14, 2017\nMinimal growth to 2.2cm. Maintaining conservative approach.\nImplemented workplace modifications for reaching high shelves.\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - March 20, 2018\nTumor stable. Olfactory function slightly declined but managing professional duties.\nStarted balance exercises with physical therapy.\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - April 15, 2019\nGrowth to 2.4cm noted. Increased headache frequency.\nAdded preventive migraine medication.\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP VISIT - May 10, 2020\nCOVID-19 Telehealth visit\nStable symptoms. Continuing conservative management.\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP VISIT - June 8, 2021\nTumor size 2.5cm. Increased word-finding difficulties.\nSpeech therapy intensified. Considering reduced work hours.\nKPS: 75 | ECOG: 2\n\nFOLLOW-UP VISIT - July 12, 2022\nStable tumor size. Quality of life maintained with adaptations.\nModified wine tasting techniques implemented.\nKPS: 75 | ECOG: 2\n\nFOLLOW-UP VISIT - August 15, 2023\nTumor growth to 2.7cm. Discussing potential radiation therapy if symptoms worsen.\nKPS: 70 | ECOG: 2\n\nCURRENT VISIT - January 10, 2024\nMaintaining watchful waiting approach. Patient adapted well to workplace modifications.\nRegular monitoring continues.\nKPS: 70 | ECOG: 2\n\nMANAGEMENT SUMMARY:\n- Successfully maintained conservative approach for 8 years\n- Preserved occupational function through adaptive strategies\n- Slow tumor progression with acceptable symptom management\n- Quality of life prioritized while monitoring for intervention triggers\n\nONGOING RECOMMENDATIONS:\n1. Continue MRI surveillance every 6 months\n2. Maintain balance and speech therapy\n3. Regular blood pressure monitoring\n4. Occupational adaptations as needed\n5. Consider radiation therapy if significant progression occurs\n\nKPS Score Range: 70-90 throughout monitoring period\nECOG Score Range: 1-2 throughout monitoring period"
      }
    },
    {
      "demographics": {
        "age": 48,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Gradual onset of persistent headaches over 3 months, worse in morning; intermittent blurred vision in right eye; occasional episodes of nausea; recent difficulty concentrating at work; mild right-sided facial numbness; reports increased clumsiness when typing, particularly with right hand; mild personality changes noted by spouse (more irritable than usual)"
        ],
        "medical_history": [
          "Migraine headaches (diagnosed 10 years ago, well-controlled with sumatriptan until recent changes); mild hypertension (diagnosed 2 years ago, managed with lifestyle modifications); concussion from sports injury in college (fully recovered); family history of stroke (father); occasional neck pain from prolonged computer use; no history of seizures or neurological disorders; no prior surgeries; non-smoker; moderate alcohol consumption (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M48-SD-A\nPrimary: Dr. [Neurosurgeon Name]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: Progressive neurological symptoms including right-sided headaches, visual disturbances, and upper extremity coordination issues. Occupational impact noted.\nIMAGING: Initial MRI reveals 3.2cm right frontal convexity meningioma with moderate peritumoral edema. Mass effect on adjacent motor cortex. Enhancement pattern consistent with WHO Grade II meningioma.\nASSESSMENT: Given size >3cm, location, and symptomatic presentation, immediate surgical intervention recommended.\nPLAN: Schedule craniotomy within 2 weeks. Pre-operative optimization initiated.\nKPS: 80 | ECOG: 1\n\nSURGICAL NOTE - March 29, 2018\nPROCEDURE: Right frontal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved. Some adherence to superior sagittal sinus noted.\nPATHOLOGY: WHO Grade II atypical meningioma\nPOST-OP COURSE: Uncomplicated\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - June 15, 2018\nSTATUS: Good recovery. Minimal residual right hand weakness. Returned to modified work schedule.\nIMAGING: Post-op MRI shows small residual enhancement\nPLAN: Initiate adjuvant radiation therapy\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - December 20, 2018\nSTATUS: Completed radiation therapy. Improvement in symptoms.\nIMAGING: Stable residual disease\nPLAN: Continue q6month surveillance\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - June 18, 2019\nSTATUS: Maintaining work schedule. Minor fatigue.\nIMAGING: No progression\nKPS: 90 | ECOG: 1\n\nURGENT VISIT - March 5, 2020\nSTATUS: New onset seizures\nIMAGING: MRI shows tumor progression\nPLAN: Surgical re-exploration scheduled\nKPS: 60 | ECOG: 2\n\nSECOND SURGERY - March 20, 2020\nPROCEDURE: Repeat craniotomy\nFINDINGS: More aggressive tumor characteristics\nPATHOLOGY: WHO Grade III progression\nKPS: 50 | ECOG: 3\n\nFOLLOW-UP - September 15, 2020\nSTATUS: Post-radiation therapy. Started on systemic therapy.\nIMAGING: Post-treatment changes\nKPS: 70 | ECOG: 2\n\nFOLLOW-UP - March 10, 2021\nSTATUS: Stable disease. Working remotely.\nIMAGING: No progression\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - March 15, 2022\nSTATUS: Maintained stability. Full-time remote work.\nIMAGING: Stable disease\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - April 10, 2023\nSTATUS: Continued stability. Good quality of life.\nIMAGING: No progression\nKPS: 90 | ECOG: 1\n\nCURRENT VISIT - January 15, 2024\nSTATUS: Maintains stable neurological status. Successfully adapted work environment.\nIMAGING: No evidence of progression\nPLAN: Continue q3month MRI surveillance\nCurrent KPS: 90 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Progression to Grade III in 2020\n- Two surgical interventions\n- Multiple courses of radiation therapy\n- Systemic therapy\n- Successful occupational adaptation\n- Current status: Stable disease\n\nKPS Score Range: 50-90 throughout treatment course\nECOG Score Range: 1-3 throughout treatment course",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 48-year-old male software developer\nWHO Grade: I (suspected based on imaging characteristics)\n\nIMAGING:\nMRI reveals a 2.1cm right frontal convexity meningioma, minimal peritumoral edema. T2 sequence shows moderate signal intensity. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nGiven tumor size <3cm, minimal edema, and stable employment requiring cognitive function, conservative management is recommended. Symptoms suggest mild mass effect but patient maintains high functional status.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Headache management optimization with neurology referral\n3. Ergonomic workplace assessment\n4. BP monitoring\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nInterval MRI shows stable tumor size. Headaches improved with adjusted migraine medication and ergonomic modifications at work.\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nTumor stable. Vision symptoms improved with prescribed computer glasses. Maintaining full work schedule.\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 10, 2020\nSlight tumor growth to 2.3cm. Patient reports increased headache frequency during COVID-19 remote work transition. Recommended additional ergonomic adjustments.\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 15, 2020\nTumor stable. Symptoms improved with adjusted work setup and stress management techniques.\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 18, 2021\nMinimal growth to 2.4cm. New onset occasional balance issues. Maintaining work performance but requiring more frequent breaks.\nKPS: 80 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 21, 2021\nNo further growth. Balance improved with physical therapy. Continuing conservative management.\nKPS: 85 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 15, 2022\nStable imaging. Patient adapted well to hybrid work schedule. Symptoms well-controlled.\nKPS: 90 ECOG: 1\n\n-------------------\n\nFOLLOW-UP - March 14, 2023\nGrowth to 2.7cm with moderate edema. Increased headaches and right-hand coordination issues affecting typing speed. Discussing potential treatment options while maintaining conservative approach.\nKPS: 75 ECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - January 10, 2024\nTumor stable at 2.7cm. Patient utilizing voice-recognition software at work. Symptoms managed with medication adjustments.\n\nCURRENT MANAGEMENT:\n1. Continuing observation with bi-annual MRI\n2. Regular neurology follow-up\n3. Occupational therapy for hand coordination\n4. Stress management techniques\n5. Regular BP monitoring\n\nKPS: 80 ECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Highest KPS: 90 (2018-2019, 2020, 2022)\n- Lowest KPS: 75 (2023 during period of tumor growth)\n- ECOG maintained at 1 throughout\n- Current status: Stable with adaptations\n\nTreatment approach remains conservative given patient's stable functional status and successful workplace adaptations, despite modest tumor growth over 6 years."
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty finding correct words while speaking",
          "Mild right-sided facial numbness",
          "Occasional balance issues when walking",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches (different from current headaches) - managed with sumatriptan PRN",
          "Menopause at age 52",
          "Osteoporosis diagnosed 2 years ago - taking calcium and vitamin D supplements",
          "Cholecystectomy in 2010",
          "No history of cancer",
          "No family history of brain tumors",
          "No prior radiation exposure to head/neck",
          "Regular mammograms and colonoscopy screenings up to date"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n66-year-old female, Blood Type A\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of cortical invasion\n\nASSESSMENT:\nGiven patient's occupation requiring high cognitive function and presenting symptoms indicating rapid progression, immediate surgical intervention recommended. WHO Grade II suspected based on imaging characteristics.\n\nTREATMENT PLAN:\n1. Schedule urgent surgical resection within 2 weeks\n2. Simpson Grade I resection targeted\n3. Pre-operative functional MRI and DTI for surgical planning\nKPS Score: 70\nECOG: 1\n\n-------------------\n\nPOST-OPERATIVE FOLLOW-UP - April 12, 2018\nPROCEDURE: Left frontal craniotomy with gross total resection\nPATHOLOGY: Confirmed WHO Grade II atypical meningioma\nPOST-OP COURSE:\n- Minimal residual edema\n- Improvement in headaches and vision\n- Speech therapy initiated\nPLAN:\n- Adjuvant radiation therapy (60 Gy/30 fractions)\nKPS Score: 60\nECOG: 2\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 15, 2018\n- Completed radiation therapy\n- Significant improvement in symptoms\n- Returned to work part-time\nMRI: No evidence of recurrence\nKPS Score: 80\nECOG: 1\n\n-------------------\n\n1-YEAR FOLLOW-UP - April 2019\n- Full-time work resumed\n- Minor fatigue persists\n- Cognitive function improved\nMRI: Stable post-treatment changes\nKPS Score: 90\nECOG: 0\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 2020\nCONCERN: Small enhancement at surgical margin\nPLAN: Increased monitoring frequency\nKPS Score: 85\nECOG: 1\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 2021\nMRI: Progressive enhancement\nDECISION: Second surgery performed\nPATHOLOGY: Recurrent WHO Grade II\nKPS Score: 65\nECOG: 2\n\n-------------------\n\n4-YEAR FOLLOW-UP - April 2022\n- Post-second surgery recovery\n- Stereotactic radiosurgery completed\n- Working remotely\nKPS Score: 75\nECOG: 1\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 2023\n- Stable disease\n- Maintained cognitive function\n- Continues remote work\nKPS Score: 85\nECOG: 1\n\n-------------------\n\nCURRENT VISIT - February 2024\nSTATUS: Stable disease\nIMAGING: No evidence of recurrence\nOCCUPATION: Semi-retired, consulting work\nPLAN: Continue bi-annual MRI surveillance\nKPS Score: 80\nECOG: 1\n\nOVERALL KPS/ECOG PROGRESSION:\n- Initial Presentation: KPS 70/ECOG 1\n- Lowest Post-op: KPS 60/ECOG 2\n- Best Recovery: KPS 90/ECOG 0\n- Current: KPS 80/ECOG 1\n\nTREATMENT SUMMARY:\n- Two surgical resections (2018, 2021)\n- Adjuvant radiation therapy\n- Stereotactic radiosurgery\n- Continuous monitoring\n- Successful maintenance of professional activities with modifications",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 66-year-old female software developer\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect on critical structures\n- WHO Grade I characteristics on imaging\n\nASSESSMENT:\nDespite presenting symptoms suggesting progression, tumor size and location allow for initial conservative management. Patient's cognitive demands as software developer considered in treatment planning.\n\nPLAN:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema management\n3. Monthly clinical monitoring\n4. Follow-up MRI in 3 months\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2018\nSymptoms improved with medical management:\n- Headaches reduced\n- Vision stabilized\n- Cognitive function adequate for work\nMRI: No significant growth\nPLAN: Continue current management\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 12, 2019\nStable symptoms\nMRI: Minimal growth (0.2cm)\nPLAN: Maintain conservative approach\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nStable condition\nVirtual cognitive assessment satisfactory\nKPS: 85 ECOG: 1\n\nURGENT VISIT - September 10, 2020\nIncreased headaches and visual symptoms\nMRI: Tumor growth to 3.2cm\nPLAN: \n- Increased dexamethasone\n- Neurosurgical intervention discussed but patient prefers conservative approach\n- Consider stereotactic radiosurgery if symptoms worsen\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - March 18, 2021\nPost-stereotactic radiosurgery (15 Gy single fraction)\nImprovement in symptoms\nMRI: Early signs of treatment response\nKPS: 75 ECOG: 1\n\nANNUAL FOLLOW-UP - March 15, 2022\nStable condition\nWorking part-time with accommodations\nMRI: Tumor stability post-radiation\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 20, 2023\nMaintained stability\nContinuing part-time work\nMRI: No progression\nKPS: 85 ECOG: 1\n\nRECENT FOLLOW-UP - January 15, 2024\nWell-controlled symptoms\nSuccessfully managing work-life balance\nMRI: Stable disease\nPLAN: Continue annual monitoring\nKPS: 90 ECOG: 0\n\nTREATMENT SUMMARY (2018-2024):\n- Successfully managed with conservative approach initially\n- Required SRS intervention in 2021\n- Maintained good functional status\n- Preserved cognitive function for professional work\n- Current WHO Grade: I\n\nKPS Score Range: 70-90 (lowest during progression, highest during stable periods)\nECOG Score Range: 0-2 (correlating with KPS changes)\n\nCURRENT RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain anti-epileptic medication\n3. Regular cognitive assessments\n4. Ergonomic workplace modifications\n5. Quality of life monitoring"
      }
    },
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Intermittent blurred vision in right eye; Recent onset of clumsiness in left hand when cooking; Occasional nausea without vomiting; Reports difficulty concentrating at work; Mild personality changes noted by coworkers (more irritable than usual); Two episodes of focal seizures affecting left arm in past month"
        ],
        "medical_history": [
          "BMI 33.2; Hypertension diagnosed 2 years ago, managed with lisinopril 10mg daily; Migraine headaches since age 30 (previously well-controlled with sumatriptan); Surgical history: Cholecystectomy 2018; Family history: Mother with breast cancer; No prior neurological conditions; No history of head trauma; Current medications: Lisinopril 10mg daily, Sumatriptan as needed; No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-2016\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2016\nPRESENTING SYMPTOMS: 46-year-old female researcher/chef with progressive neurological symptoms.\nIMAGING: Initial MRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema.\nWHO Grade: II (atypical features on imaging)\nASSESSMENT: Symptomatic meningioma requiring urgent intervention due to:\n- Size >3cm with mass effect\n- Progressive neurological symptoms\n- Occupation requiring fine motor skills\nKPS: 80 ECOG: 1\n\nSURGICAL INTERVENTION - April 2, 2016\nPROCEDURE: Right frontal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: Confirmed WHO Grade II meningioma\nPOST-OP KPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2016\nSTATUS: Improving neurological symptoms\nIMAGING: Post-op MRI shows small residual tumor\nPLAN: Adjuvant radiotherapy initiated\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - January 10, 2017\nSTATUS: Completed RT, improved symptoms\nIMAGING: Stable residual disease\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - July 2018\nSTATUS: Minor headaches, working part-time\nIMAGING: No progression\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - January 2020\nSTATUS: New onset seizures\nIMAGING: Small recurrence at surgical margin\nPLAN: SRS to recurrent focus\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - June 2021\nSTATUS: Post-SRS, seizure-free on levetiracetam\nIMAGING: Reduced tumor volume\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - December 2022\nSTATUS: Mild fatigue, working full-time\nIMAGING: Stable disease\nKPS: 90 ECOG: 0\n\nLATEST FOLLOW-UP - October 2024\nSTATUS: Maintaining good function, occasional headaches\nIMAGING: No progression\nCurrent KPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection\n- Adjuvant RT\n- Salvage SRS for recurrence\n- Regular imaging surveillance\n\nCURRENT RECOMMENDATIONS:\n1. Continue q6month MRI surveillance\n2. Maintain anticonvulsant therapy\n3. Regular neurocognitive assessment\n4. Weight management program\n5. Occupational therapy for fine motor skills\n\nPROGNOSIS:\nFavorable with continued monitoring. Patient has maintained professional activities with appropriate accommodations.\n\nFinal KPS: 95\nFinal ECOG: 0\n\nNote: KPS scores fluctuated between 70-95 throughout treatment course, reflecting treatment effects and recovery periods. Current high scores indicate successful management strategy.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n46-year-old female, Chef/Researcher\nWHO Grade II Meningioma\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Moderate peritumoral edema\n- Mass effect on adjacent frontal lobe\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation requiring fine motor skills and cognitive function, recommending close monitoring with conservative management initially. Symptoms warrant attention but allow for measured approach.\n\nTREATMENT DECISIONS:\n1. Anti-epileptic: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema control\n3. Monthly neurological assessments\n4. Occupational therapy referral\n5. BP monitoring - continue lisinopril\n\n-------------------\n\nFOLLOW-UP - September 20, 2016\nTumor stable. Headaches improved with steroids.\nSeizures controlled on levetiracetam.\nKPS: 85 | ECOG: 1\n\n-------------------\n\nANNUAL REVIEW - March 10, 2017\nSlight tumor growth (3.0cm)\nLeft hand function improved with OT\nKPS: 80 | ECOG: 1\n\n-------------------\n\nURGENT VISIT - November 5, 2017\nIncreased seizure frequency\nMRI shows increased edema\nDecision made for surgical intervention\nKPS: 70 | ECOG: 2\n\n-------------------\n\nPOST-SURGERY - December 15, 2017\nSubtotal resection achieved\nPathology confirms WHO Grade II\nKPS: 60 | ECOG: 2\n\n-------------------\n\nRECOVERY - March 2018\nGood recovery from surgery\nReturning to work part-time\nKPS: 75 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 2018\nStable imaging\nResumed full work duties\nKPS: 85 | ECOG: 1\n\n-------------------\n\nANNUAL REVIEW - March 2019-2024\nSix-monthly MRI surveillance\nNo recurrence\nMaintaining work activities\nLatest KPS: 90 | ECOG: 0\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified kitchen duties to reduce injury risk\n- Ergonomic workplace assessment\n- Regular breaks recommended\n- Cognitive rest periods during research work\n\nQUALITY OF LIFE MEASURES:\n- Maintaining independence\n- Working full-time\n- Good social support\n- Managing stress through counseling\n\nMONITORING PROTOCOL:\n1. MRI every 6 months\n2. Monthly neurological assessments\n3. Quarterly cognitive function tests\n4. Regular BP monitoring\n5. Annual ophthalmological review\n\nKPS/ECOG PROGRESSION:\nLowest: KPS 60 (post-surgery)\nHighest: KPS 90 (current)\nCurrent ECOG: 0\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue anticonvulsant therapy\n2. Regular cognitive assessment\n3. Maintain healthy weight program\n4. Stress management\n5. Sleep hygiene protocol"
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by spouse - increased irritability",
          "Balance difficulties when walking, particularly in dim lighting",
          "Intermittent right-sided facial numbness",
          "Mild nausea without vomiting"
        ],
        "medical_history": [
          "Cranial radiation therapy 30 years ago for childhood retinoblastoma",
          "Hypertension - controlled with lisinopril 10mg daily",
          "Hypercholesterolemia - managed with atorvastatin 20mg daily",
          "Appendectomy (1985)",
          "No history of seizures",
          "No prior intracranial surgeries",
          "Family history negative for brain tumors",
          "20-pack year smoking history, quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M63-O-2016\nOccupation: Financial Analyst\n\nInitial Visit - March 15, 2016\nPRESENTING SYMPTOMS: Progressive neurological symptoms including morning headaches, right eye visual disturbance, cognitive changes, and balance issues. Concerning for space-occupying lesion.\n\nIMAGING: MRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement.\n\nASSESSMENT: WHO Grade II Meningioma (suspected based on imaging characteristics)\nPLAN: Recommend urgent surgical resection given size, symptoms, and prior radiation exposure history.\nKPS: 80 ECOG: 1\n\n-------------------\n\nPost-Op Visit - April 2, 2016\nPROCEDURE: Left frontal craniotomy with gross total resection\nPATHOLOGY: Confirmed WHO Grade II atypical meningioma\nCOMPLICATIONS: None\nPLAN: Initiate adjuvant radiation therapy\nKPS: 70 ECOG: 1\n\n-------------------\n\nFollow-up - October 15, 2016\nSTATUS: Completed 60 Gy/30fx radiation therapy\nSYMPTOMS: Improved vision and headaches. Mild fatigue persists.\nIMAGING: Post-treatment MRI shows no residual tumor\nPLAN: Continue q4 month surveillance\nKPS: 85 ECOG: 1\n\n-------------------\n\nAnnual Review - March 20, 2017\nSYMPTOMS: Generally stable. Minor memory complaints.\nIMAGING: No evidence of recurrence\nPLAN: Continue surveillance\nKPS: 90 ECOG: 0\n\n-------------------\n\nFollow-up - February 12, 2019\nSYMPTOMS: New onset intermittent headaches\nIMAGING: Small 1.2cm recurrence at original site\nPLAN: Stereotactic radiosurgery (SRS) scheduled\nKPS: 85 ECOG: 1\n\n-------------------\n\nPost-SRS Review - June 15, 2019\nTREATMENT: Completed SRS (16 Gy single fraction)\nSYMPTOMS: Stable\nPLAN: Continue q4 month monitoring\nKPS: 80 ECOG: 1\n\n-------------------\n\nFollow-up - March 10, 2021\nSYMPTOMS: Progressive right-sided weakness\nIMAGING: Multiple new lesions, largest 2.3cm\nPLAN: Second craniotomy scheduled\nKPS: 60 ECOG: 2\n\n-------------------\n\nPost-Op Review - April 30, 2021\nPROCEDURE: Repeat left frontal craniotomy\nPATHOLOGY: WHO Grade III progression\nCOMPLICATIONS: Post-op speech deficit\nPLAN: Initiate temozolomide chemotherapy\nKPS: 50 ECOG: 2\n\n-------------------\n\nFinal Note - January 15, 2024\nSTATUS: Multiple recurrences despite aggressive treatment\nSYMPTOMS: Significant functional decline, requiring assistance\nPLAN: Palliative care consultation\nKPS: 40 ECOG: 3\n\nTREATMENT SUMMARY 2016-2024:\n- Initial craniotomy with GTR (2016)\n- Adjuvant radiation therapy\n- SRS for first recurrence (2019)\n- Second craniotomy (2021)\n- Systemic therapy\n- Progressive disease despite aggressive intervention\n\nKPS Score Range: 40-90\nECOG Score Range: 0-3\n\nNote: Patient's occupation as Financial Analyst initially influenced aggressive treatment approach to preserve cognitive function. Prior radiation exposure history likely contributed to higher grade and more aggressive disease course.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M63-O-2016\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No mass effect on critical structures\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nGiven patient's history of prior radiation exposure and current symptomatology, careful monitoring is warranted. Symptoms suggest progressive nature, but tumor size allows for initial conservative approach.\n\nPLAN:\n1. MRI surveillance every 3 months initially\n2. Dexamethasone 4mg BID for edema management\n3. Prophylactic levetiracetam 500mg BID\n4. Regular cognitive assessments\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - June 20, 2016\nSymptoms slightly improved with steroids. Vision stable.\nMRI: No significant change in tumor size\nPLAN: Continue current management\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - December 5, 2016\nHeadaches well-controlled. Working full-time with accommodations.\nMRI: Stable\nPLAN: Extend monitoring interval to 6 months\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - June 15, 2017\nMinor progression of visual symptoms\nMRI: 3.0cm tumor, increased edema\nPLAN: Increase dexamethasone to 4mg TID\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - January 10, 2018\nDeclining functional status, considering early retirement\nMRI: 3.2cm tumor\nPLAN: Discuss surgical options vs. radiation\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - July 20, 2018\nPatient opted for fractionated RT\nPost-treatment MRI: Stable disease\nPLAN: Continue monitoring\nKPS: 65 ECOG: 2\n\nFOLLOW-UP - February 12, 2019\nPost-radiation improvement in symptoms\nWorking part-time\nMRI: Slight decrease in tumor size\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 5, 2020\nStable symptoms\nMRI: No progression\nPLAN: Annual monitoring\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - April 15, 2021\nMaintained stability\nMinor balance issues persist\nMRI: Stable\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - May 10, 2022\nGood functional status\nRetired but active\nMRI: No progression\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - June 8, 2023\nContinued stability\nMRI: Stable disease\nPLAN: Continue annual monitoring\nKPS: 85 ECOG: 1\n\nLATEST FOLLOW-UP - January 15, 2024\nWell-maintained functional status\nMinor residual symptoms\nMRI: Stable disease\nPLAN: Continue annual monitoring\nKPS: 85 ECOG: 1\n\nTREATMENT SUMMARY:\nConservative management with radiation therapy when progression occurred. Patient maintained good functional status throughout most of the monitoring period. Occupation as Financial Analyst initially impacted by cognitive symptoms but managed with workplace accommodations until retirement.\n\nCURRENT STATUS:\n- Stable disease\n- Good quality of life\n- Independent in daily activities\n- Regular monitoring continues\n\nFinal KPS: 85\nFinal ECOG: 1"
      }
    },
    {
      "demographics": {
        "age": 41,
        "gender": "Female",
        "blood_type": "AB",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches increasing in frequency over past 4 months, typically worse in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Difficulty concentrating at work, especially when looking at computer screens for long periods",
          "Occasional ringing in right ear starting 2 months ago",
          "Mild balance issues noted when walking, particularly when tired",
          "Reports increased fatigue and irritability"
        ],
        "medical_history": [
          "Migraine headaches since age 25, but notes current headaches feel different",
          "Lasik surgery 8 years ago with good results",
          "History of oral contraceptive use for 15 years",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "Occasional tension headaches managed with OTC pain relievers",
          "Normal annual physical examinations",
          "No history of head trauma or radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F41-AB-DS\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION\nChief Complaints: Progressive headaches, right-sided visual disturbance, balance issues\nWHO Grade: Grade II (confirmed post-resection)\n\nIMAGING FINDINGS:\nMRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema\nEnhancement pattern suggests aggressive features\nMass effect on adjacent frontal lobe with 5mm midline shift\nEvidence of dural tail sign\n\nTREATMENT PLAN:\nGiven size, symptoms, and occupation requiring detailed cognitive function, recommend immediate surgical intervention\nScheduled for gross total resection within 2 weeks\nPre-operative functional MRI to map eloquent areas\nKPS: 80 ECOG: 1\n\n-------------------\n\nPOST-OPERATIVE FOLLOW-UP: April 12, 2018\nSuccessful gross total resection achieved\nMinimal residual enhancement at tumor bed\nPatient alert and oriented\nInitial symptoms showing improvement\nKPS: 70 ECOG: 2\n\n-------------------\n\n6-MONTH FOLLOW-UP: October 15, 2018\nMRI shows no evidence of recurrence\nVision fully restored\nReturned to work part-time\nProphylactic radiation therapy recommended\nKPS: 85 ECOG: 1\n\n-------------------\n\n1-YEAR FOLLOW-UP: April 18, 2019\nCompleted radiation therapy (54 Gy in 30 fractions)\nNo evidence of recurrence\nFull-time work resumed\nMinor fatigue persists\nKPS: 90 ECOG: 1\n\n-------------------\n\n2-YEAR FOLLOW-UP: May 20, 2020\nSmall enhancement noted on follow-up MRI\nWatchful waiting approach\nIncreased monitoring frequency\nKPS: 85 ECOG: 1\n\n-------------------\n\n3-YEAR FOLLOW-UP: June 15, 2021\nEnhancement stable\nNo new symptoms\nMaintaining work performance\nKPS: 90 ECOG: 0\n\n-------------------\n\n4-YEAR FOLLOW-UP: July 10, 2022\nNew 1.2cm nodule adjacent to resection cavity\nRecommend stereotactic radiosurgery\nKPS: 80 ECOG: 1\n\n-------------------\n\n4.5-YEAR FOLLOW-UP: December 5, 2022\nPost-SRS imaging shows good response\nMinimal radiation changes\nKPS: 75 ECOG: 1\n\n-------------------\n\n5-YEAR FOLLOW-UP: June 20, 2023\nStable disease\nNo new neurological symptoms\nMaintaining full work schedule\nKPS: 85 ECOG: 1\n\n-------------------\n\nCURRENT VISIT: January 15, 2024\nComplete imaging workup shows stable disease\nNo evidence of progression\nCognitive function preserved\nContinue monitoring every 6 months\nKPS: 90 ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial surgical resection (2018)\n- Adjuvant radiation therapy (2018-2019)\n- Salvage SRS for recurrence (2022)\n- Maintained high functional status throughout treatment course\n\nKPS Score Range: 70-90 (lowest post-surgery, highest during stable periods)\nECOG Score Range: 0-2 (highest post-surgery, lowest during stable periods)\n\nONGOING RECOMMENDATIONS:\n1. Bi-annual MRI surveillance\n2. Regular cognitive function assessment\n3. Occupational therapy as needed\n4. Continued monitoring of computer screen tolerance\n5. Regular ophthalmological evaluations",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F41-AB-DS\nPrimary Diagnosis: Intracranial Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - September 15, 2018\nMRI findings: 2.4cm right frontal convexity meningioma, minimal peritumoral edema\nKPS: 90 | ECOG: 1\n\nAssessment:\n- Symptomatic right frontal meningioma\n- Symptoms affecting work performance but patient maintains independence\n- Occupation requires significant screen time and cognitive focus\n\nPlan:\n- Conservative management with close monitoring\n- Prescribed Dexamethasone 4mg daily for edema management\n- Ergonomic workplace assessment recommended\n- Follow-up MRI in 3 months\n\nFOLLOW-UP - December 20, 2018\nMRI: No significant change in tumor size\nKPS: 85 | ECOG: 1\n- Headaches improved with steroid therapy\n- Implementing regular breaks during computer work\n- Continue current management\n- Next MRI in 6 months\n\nFOLLOW-UP - June 18, 2019\nMRI: Stable lesion size\nKPS: 90 | ECOG: 1\n- Successfully weaned off steroids\n- Started prophylactic topiramate for headache management\n- Maintaining work schedule with accommodations\n- Annual MRI recommended\n\nANNUAL REVIEW - June 22, 2020\nMRI: Minimal growth (0.2cm)\nKPS: 85 | ECOG: 1\n- Vision symptoms stable\n- Continuing topiramate\n- Added vestibular therapy for balance issues\n- Continue annual monitoring\n\nANNUAL REVIEW - July 15, 2021\nMRI: No significant change\nKPS: 95 | ECOG: 0\n- Marked improvement in symptoms\n- Successfully implemented workplace modifications\n- Maintaining full-time work schedule\n- Continue annual monitoring\n\nURGENT VISIT - March 10, 2022\nMRI: Increased peritumoral edema\nKPS: 70 | ECOG: 2\n- Worsening headaches and vision changes\n- Temporary medical leave from work\n- Resumed dexamethasone\n- Scheduled for follow-up in 3 months\n\nFOLLOW-UP - June 12, 2022\nMRI: Edema improved, tumor stable\nKPS: 85 | ECOG: 1\n- Returned to work part-time\n- Maintaining on reduced steroid dose\n- Continue close monitoring\n\nANNUAL REVIEW - July 8, 2023\nMRI: Stable findings\nKPS: 90 | ECOG: 1\n- Working full-time with accommodations\n- Well-controlled symptoms\n- Maintaining quality of life\n- Continue annual monitoring\n\nRECENT FOLLOW-UP - January 15, 2024\nMRI: No significant changes\nKPS: 95 | ECOG: 0\n- Excellent symptom control\n- Full work capacity\n- Successfully managing work-life balance\n- Next review scheduled for January 2025\n\nMANAGEMENT SUMMARY:\n- Conservative approach successful over 5+ years\n- Maintained high functional status despite initial symptoms\n- Workplace accommodations key to management success\n- Quality of life preserved through non-surgical intervention\n- Regular monitoring effective in tracking disease progression\n\nKPS Range During Treatment: 70-95\nECOG Range During Treatment: 0-2\n\nRecommendations:\n1. Continue annual MRI surveillance\n2. Maintain workplace ergonomic modifications\n3. Regular ophthalmological assessments\n4. Stress management and lifestyle counseling\n5. Consider surgical intervention only if significant progression"
      }
    },
    {
      "demographics": {
        "age": 41,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness and tingling; Occasional blurred vision in right eye; Recent changes in taste perception affecting work performance; Mild balance issues when walking; Increased irritability noted by family members"
        ],
        "medical_history": [
          "Type 2 diabetes diagnosed 6 years ago, managed with metformin; Hypertension diagnosed 4 years ago, controlled with lisinopril; History of migraine headaches but notes current headaches are different in character; Had sinus surgery 8 years ago for chronic sinusitis; Family history of stroke (father); BMI 31; Current medications: Metformin 1000mg BID, Lisinopril 10mg daily, Vitamin D supplement"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M41-B-FC\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches (3 months), right facial paresthesia, visual disturbances, taste alterations, gait instability, mood changes.\nInitial MRI Findings: 3.8cm right sphenoid wing meningioma with significant mass effect and peritumoral edema. Enhancement pattern suggestive of WHO Grade II.\nKPS: 80 ECOG: 1\n\nTreatment Plan:\n- Urgent surgical intervention recommended due to size, location, and occupation-related impact\n- Pre-operative optimization of diabetes management\n- Dexamethasone 4mg QID for edema\nNext Visit: 2 weeks for pre-surgical planning\n\nSURGICAL NOTE - April 3, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op KPS: 70 ECOG: 2\n\nFOLLOW-UP - May 1, 2018\nStatus: Improving neurological symptoms\nPlan: Adjuvant radiation therapy recommended\nKPS: 75 ECOG: 1\n\nRADIATION ONCOLOGY - June-July 2018\nTreatment: Completed 30 fractions, total 60 Gy\nTolerance: Moderate fatigue, minimal side effects\nKPS: 80 ECOG: 1\n\n6-MONTH FOLLOW-UP - October 15, 2018\nMRI: No evidence of recurrence\nSymptoms: Significant improvement in headaches and vision\nWork Status: Gradually returning to food critic duties\nKPS: 90 ECOG: 0\n\nANNUAL FOLLOW-UP - April 2019\nMRI: Stable post-surgical changes\nSymptoms: Fully resolved\nKPS: 95 ECOG: 0\n\n18-MONTH FOLLOW-UP - October 2019\nMRI: Small enhancement noted at surgical margin\nPlan: Increased monitoring frequency\nKPS: 90 ECOG: 0\n\n2-YEAR FOLLOW-UP - April 2020\nMRI: Progressive enhancement\nPlan: Stereotactic radiosurgery to residual tumor\nKPS: 85 ECOG: 1\n\nPOST-SRS FOLLOW-UP - October 2020\nResponse: Good tumor control\nKPS: 90 ECOG: 0\n\n3-YEAR FOLLOW-UP - April 2021\nStatus: Stable disease\nKPS: 95 ECOG: 0\n\n4-YEAR FOLLOW-UP - April 2022\nMRI: New satellite lesion identified\nPlan: Surgical resection of recurrence\nKPS: 80 ECOG: 1\n\nPOST-SECOND SURGERY - June 2022\nOutcome: Complete resection achieved\nPathology: Confirmed WHO Grade II\nKPS: 70 ECOG: 2\n\n5-YEAR FOLLOW-UP - April 2023\nStatus: Stable disease, maintaining work activities\nKPS: 85 ECOG: 1\n\nCURRENT STATUS - January 2024\nMRI: No evidence of recurrence\nSymptoms: Well-controlled\nOccupation: Fully resumed food critic duties\nKPS: 90 ECOG: 0\n\nTreatment Summary:\n- Initial Simpson Grade II resection (2018)\n- Adjuvant radiation therapy (2018)\n- SRS for residual tumor (2020)\n- Second surgery for satellite lesion (2022)\n\nCurrent Monitoring Protocol:\n- MRI every 4 months\n- Quarterly neurological assessments\n- Regular diabetes management\n- Quality of life assessments\n\nKPS Score Range: 70-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M41-B-FC\nPrimary Diagnosis: Right Sphenoid Wing Meningioma\nWHO Grade: I\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- Dural tail sign present\nKPS: 90 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation as food critic and symptoms affecting taste perception, conservative management initially recommended. Tumor size and location warrant close monitoring. Patient educated about treatment options and agrees to watchful waiting approach.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months\n2. Neurology referral for headache management\n3. Ophthalmology evaluation for visual symptoms\n4. Diabetes management optimization\n5. Weight management program referral\n\nFOLLOW-UP VISIT - September 20, 2018\nStable symptoms. MRI shows no tumor growth.\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP VISIT - March 12, 2019\nMinor improvement in headaches with prescribed medications.\nMRI: No significant changes\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP VISIT - September 18, 2019\nReports increased work difficulties due to taste alterations.\nMRI: Minimal growth (0.2cm)\nKPS: 80 | ECOG: 1\n\nCRITICAL VISIT - March 15, 2020\nSignificant symptom progression\nMRI: Tumor growth to 3.2cm with increased edema\nDECISION POINT: Discussed treatment options\nKPS: 70 | ECOG: 2\n\nTREATMENT INITIATION - April 2020\nOpted for Fractionated RT (54 Gy/30 fractions)\nKPS: 65 | ECOG: 2\n\nPOST-TREATMENT FOLLOW-UP - October 2020\nImprovement in symptoms\nMRI: Stable disease\nKPS: 75 | ECOG: 1\n\nANNUAL FOLLOW-UP - October 2021\nContinued improvement\nReturn to work with accommodations\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - October 2022\nStable disease\nImproved taste perception\nKPS: 90 | ECOG: 1\n\nRECENT FOLLOW-UP - October 2023\nMaintained stability\nFull return to work activities\nKPS: 95 | ECOG: 0\n\nCURRENT STATUS - February 2024\nPatient maintains good quality of life\nStable disease on imaging\nSuccessfully managing work responsibilities\nKPS: 95 | ECOG: 0\n\nMANAGEMENT SUMMARY:\n- Conservative approach initially chosen\n- Transition to RT when progression noted\n- Successful outcome with preserved quality of life\n- Occupation-specific considerations maintained throughout\n- Diabetes remains well-controlled\n\nKPS Range During Treatment Period: 65-95\nECOG Range During Treatment Period: 0-2\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Regular diabetes monitoring\n3. Continued weight management\n4. Annual ophthalmology check\n5. Quality of life assessments\n6. Occupational therapy as needed"
      }
    },
    {
      "demographics": {
        "age": 68,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, particularly in the morning; Recent onset of right-sided weakness affecting arm and leg; Increasing difficulty with balance when walking; Occasional episodes of confusion and word-finding difficulties; Visual changes including intermittent double vision; Personality changes noted by family members including increased irritability"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily; Underwent surgery for benign prostate hyperplasia 5 years ago; History of mild hearing loss in left ear; Previous MRI for headaches 10 years ago was unremarkable; Family history of stroke (father); No history of seizures or neurological disorders; Former smoker - quit 15 years ago; Takes daily aspirin 81mg for cardiovascular prevention"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY SERVICE\nPrimary Diagnosis: Meningioma\nPatient: 68-year-old male, Blood Type O\nOccupation: Researcher/Baker\n\nInitial Visit - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm parasagittal meningioma in right frontal region\n- Significant perilesional edema\n- Mass effect with 6mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\nWHO Grade: II (preliminary radiological assessment)\nKPS: 70\nECOG: 2\n\nASSESSMENT & PLAN:\nGiven patient's progressive neurological symptoms and imaging findings, recommend immediate surgical intervention. Occupational demands require fine motor skills and cognitive clarity. Current symptoms significantly impacting quality of life and work capacity.\n\nSurgical Intervention - April 2, 2018\nPROCEDURE: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op KPS: 60\nECOG: 2\n\nFollow-up Visit - July 15, 2018\nPost-operative MRI shows small residual tumor\nAdjuvant radiotherapy initiated: 54 Gy in 30 fractions\nKPS improved to 80\nECOG: 1\n\n6-Month Follow-up - October 2, 2018\nImproved right-sided strength\nMinor word-finding difficulties persist\nMRI shows stable residual disease\nKPS: 85\nECOG: 1\n\n1-Year Follow-up - April 15, 2019\nMaintaining good functional status\nNo new neurological deficits\nMRI stable\nKPS: 90\nECOG: 1\n\n2-Year Follow-up - May 10, 2020\nMRI shows small area of enhancement\nDecision for gamma knife radiosurgery to residual tumor\nKPS: 85\nECOG: 1\n\n3-Year Follow-up - June 1, 2021\nPost-radiosurgery imaging shows good response\nMinor fatigue reported\nKPS: 80\nECOG: 1\n\n4-Year Follow-up - July 12, 2022\nNew enhancement noted on MRI\nRecurrent headaches\nDecision for repeat surgical intervention\nKPS: 70\nECOG: 2\n\nSecond Surgery - August 30, 2022\nComplete resection achieved\nPathology confirms recurrent WHO Grade II\nPost-op KPS: 65\nECOG: 2\n\n5-Year Follow-up - September 15, 2023\nGood recovery from second surgery\nMaintaining independent function\nRegular MRI surveillance continued\nKPS: 85\nECOG: 1\n\nRecent Follow-up - January 20, 2024\nStable imaging findings\nReturned to modified work schedule\nMinor residual right-sided weakness\nKPS: 80\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson Grade II resection (2018)\n- Adjuvant radiotherapy completed\n- Gamma knife radiosurgery to residual tumor (2020)\n- Second surgical intervention (2022)\n- Continued surveillance with q6month MRI\n\nKPS Score Range: 60-90 throughout treatment course\nECOG Score Range: 1-2 throughout treatment course\n\nCURRENT STATUS:\nPatient maintains good functional status with minor deficits. Continues modified work schedule with accommodations for reduced physical demands. Regular imaging surveillance ongoing.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 68-year-old male, Blood Type O\nOccupation: Researcher/Baker\nKPS: 70 | ECOG: 2\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (3 months)\n- Right-sided weakness\n- Balance difficulties\n- Cognitive changes\n- Visual disturbances\n- Personality changes\n\nIMAGING:\nMRI reveals 2.8cm left frontal convexity meningioma with moderate peritumoral edema. WHO Grade I suspected based on imaging characteristics.\n\nASSESSMENT & PLAN:\nGiven patient's age and occupation requiring fine motor skills (baking), recommending close monitoring initially. Will start with dexamethasone 4mg BID to manage edema and symptoms.\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nKPS: 80 | ECOG: 1\n\nImprovement in headaches and visual symptoms with steroid therapy. Maintaining conservative approach. Reduced dexamethasone to 2mg BID.\n\nPLAN: \n- MRI in 3 months\n- Continue current medications\n- Physical therapy referral for balance training\n\n-------------------\n\nFOLLOW-UP - December 5, 2018\nKPS: 85 | ECOG: 1\n\nStable symptoms. MRI shows no significant tumor growth.\nSuccessfully weaned off dexamethasone.\n\nPLAN:\n- Continue monitoring\n- MRI every 6 months\n- Occupational therapy for work adaptations\n\n-------------------\n\nFOLLOW-UP - June 15, 2019\nKPS: 75 | ECOG: 1\n\nMild increase in headaches. MRI shows minimal increase in peritumoral edema.\n\nPLAN:\n- Low-dose dexamethasone (1mg daily)\n- Continue monitoring\n- Consider radiation therapy if symptoms worsen\n\n-------------------\n\nANNUAL REVIEW - March 10, 2020\nKPS: 65 | ECOG: 2\n\nCOVID-19 Telehealth Visit\nReporting increased fatigue and balance issues.\nMRI shows stable tumor size but increased edema.\n\nPLAN:\n- Increase dexamethasone to 2mg daily\n- Virtual PT sessions\n- Monthly telehealth check-ins\n\n-------------------\n\nFOLLOW-UP - September 8, 2021\nKPS: 80 | ECOG: 1\n\nImprovement in symptoms with medication adjustment.\nHas modified work schedule (reduced baking hours).\nMRI stable.\n\nPLAN:\n- Continue current management\n- Annual MRI if stable\n- Regular BP monitoring\n\n-------------------\n\nFOLLOW-UP - October 15, 2022\nKPS: 75 | ECOG: 1\n\nStable symptoms. Working part-time.\nMRI shows no progression.\n\nPLAN:\n- Maintain current approach\n- Consider reducing steroid dose\n- Continue regular monitoring\n\n-------------------\n\nRECENT FOLLOW-UP - January 20, 2024\nKPS: 70 | ECOG: 2\n\nSome decline in functional status but maintaining independence.\nMRI stable over 6 years of monitoring.\n\nCURRENT MANAGEMENT:\n- Low-dose dexamethasone (1mg daily)\n- Regular PT/OT\n- Modified work schedule\n- Regular monitoring of BP and steroid side effects\n\nOVERALL PROGRESS SUMMARY:\nPatient has maintained relatively stable disease course over 6 years with conservative management. While experiencing some functional decline, quality of life has been preserved through medication management and lifestyle modifications. Watchful waiting approach has proven appropriate for this case.\n\nFinal KPS/ECOG Trend:\n- Initial (2018): KPS 70/ECOG 2\n- Peak (2018-2019): KPS 85/ECOG 1\n- Current (2024): KPS 70/ECOG 2"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work for past 2-3 months",
          "Mild right-sided facial numbness",
          "Reports feeling off-balance when walking"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "Mild hypertension managed with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Regular mammograms and health screenings, all normal",
          "No prior head injuries or neurological disorders"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-O-2018\nOccupation: Research Scientist\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggestive of WHO Grade II\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nGiven patient's cognitive-demanding occupation and progressive neurological symptoms, immediate surgical intervention recommended. High-risk features include size >3cm, peritumoral edema, and venous sinus involvement.\nKPS: 80 ECOG: 1\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative functional MRI and DTI tractography\n3. Steroid therapy initiated (Dexamethasone 4mg QID)\n\nSURGICAL NOTE - April 2, 2018\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II atypical meningioma\n- Minor residual tumor at sinus interface\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - July 15, 2018\nPost-operative MRI shows minimal residual tumor\nAdjuvant radiation therapy initiated: 60 Gy in 30 fractions\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - January 10, 2019\nComplete radiation course completed\nImproved symptoms\nMRI stable\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - July 2019, January 2020, July 2020\nBi-annual MRIs show stable disease\nPatient returned to work full-time\nKPS: 95 ECOG: 0\n\nURGENT VISIT - February 15, 2021\nNew onset seizures\nMRI shows tumor progression\nKPS: 60 ECOG: 2\n\nSECOND SURGERY - March 1, 2021\n- Re-resection performed\n- Simpson Grade III\n- Pathology confirms progression to WHO Grade III\nKPS: 50 ECOG: 3\n\nFOLLOW-UP - June 2021\nStarted on systemic therapy\nTemozolomide initiated\nKPS: 70 ECOG: 2\n\n2022-2023: Quarterly follow-ups\nVariable response to treatment\nMultiple medication adjustments\nKPS ranging 65-85 ECOG: 1-2\n\nCURRENT STATUS (January 2024):\n- Stable disease on modified chemotherapy protocol\n- Maintaining part-time work schedule\n- Regular MRI surveillance continues\n- Managing seizures with levetiracetam\nKPS: 80 ECOG: 1\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Complete course of radiation therapy\n- Ongoing systemic therapy\n- Regular imaging surveillance\n\nKPS Score Range: 50-95 throughout treatment course\nECOG Score Range: 0-3 throughout treatment course\n\nMONITORING PLAN:\n- Quarterly MRI with volumetric analysis\n- Monthly neurological assessments\n- Cognitive function testing every 3 months\n- Quality of life assessments\n- Occupational therapy evaluation as needed",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 53-year-old female researcher\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, balance issues, cognitive changes\nMRI Findings: 2.4cm left frontal convexity meningioma, minimal surrounding edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 80 ECOG: 1\n\nAssessment & Plan:\nGiven size <3cm and minimal edema, recommending conservative management with close monitoring. Patient's cognitive symptoms warrant attention due to occupation demands. Discussed watchful waiting approach with patient.\n\nRecommendations:\n- MRI surveillance every 6 months initially\n- Neurocognitive assessment baseline\n- Continue current migraine management\n- BP monitoring\n- Consider reducing work hours temporarily\n\nFOLLOW-UP - September 20, 2018\nInterval MRI shows stable tumor size\nSymptoms: Mild improvement in headaches with medication adjustment\nKPS: 85 ECOG: 1\nPlan: Continue monitoring\n\nFOLLOW-UP - March 12, 2019\nTumor stable\nSymptoms: Better concentration, headaches controlled\nKPS: 90 ECOG: 0\nPlan: Extend MRI interval to annual if next scan stable\n\nANNUAL FOLLOW-UP - March 15, 2020\nMinimal tumor growth (0.2mm)\nCOVID-19 considerations discussed\nKPS: 85 ECOG: 1\nPlan: Continue annual monitoring, telehealth options offered\n\nANNUAL FOLLOW-UP - March 18, 2021\nStable disease\nReports good work performance\nMinor balance issues persist\nKPS: 90 ECOG: 0\nPlan: Maintain current approach\n\nANNUAL FOLLOW-UP - March 22, 2022\nSlight increase in tumor size (2.7cm)\nNew intermittent headaches\nKPS: 75 ECOG: 1\nPlan: Increase monitoring frequency to 6-monthly\nAdded prophylactic anticonvulsant\n\nFOLLOW-UP - September 15, 2022\nStable compared to March\nImproved headache control\nKPS: 85 ECOG: 1\nPlan: Continue current management\n\nANNUAL FOLLOW-UP - March 20, 2023\nTumor stable at 2.7cm\nWell-adapted to work modifications\nKPS: 90 ECOG: 0\nPlan: Continue annual monitoring\n\nRECENT FOLLOW-UP - January 15, 2024\nStable disease\nMaintaining good quality of life\nSuccessfully managing work responsibilities\nKPS: 95 ECOG: 0\nPlan: Continue annual imaging\n\nOverall Course Summary:\n- Successfully managed conservatively over 6-year period\n- Minimal tumor growth\n- Maintained high functional status\n- Preserved work capability\n- Quality of life prioritized\n\nKPS Range: 75-95 throughout monitoring period\nECOG Range: 0-1\n\nRecommendations for Ongoing Care:\n1. Annual MRI surveillance\n2. Regular neurocognitive assessments\n3. Maintain work-life balance\n4. Continue BP monitoring\n5. Annual ophthalmological exams\n6. Regular quality of life assessments\n\nThe conservative approach has proven successful in this case, with the patient maintaining high functionality and career engagement while avoiding surgical intervention."
      }
    },
    {
      "demographics": {
        "age": 68,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding right words",
          "Subtle personality changes noted by family - increased irritability",
          "Mild right-sided weakness when typing at work",
          "Balance issues when standing for long periods while baking",
          "Two episodes of focal seizures affecting right arm in past month"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Mild hearing loss in left ear - diagnosed 5 years ago",
          "Cholesterol managed with atorvastatin 20mg daily",
          "History of migraine headaches in 30s-40s, resolved spontaneously",
          "Appendectomy at age 23",
          "No history of cancer",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nPrimary Occupation: Software Developer/Baker\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of left motor cortex\n\nASSESSMENT:\nSymptomatic left frontal meningioma with concerning features warranting immediate intervention. WHO Grade II suspected based on imaging characteristics.\nKPS: 70\nECOG: 2\n\nTREATMENT PLAN:\n1. Surgical resection recommended within 2 weeks\n2. Preoperative optimization of blood pressure\n3. Dexamethasone 4mg QID for edema\n4. Anti-epileptic prophylaxis with Levetiracetam 500mg BID\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Estimated blood loss: 400cc\n- No complications\nPathology: WHO Grade II (Atypical) Meningioma\nKi-67: 12%\n\nPOST-OP FOLLOW-UP - April 15, 2018\n- Improved right-sided weakness\n- Minimal speech difficulties\n- Wound healing well\nKPS: 60\nECOG: 2\nPlan: Adjuvant radiation therapy scheduled\n\nRADIATION ONCOLOGY - May-June 2018\n- Completed 60 Gy in 30 fractions\n- Well-tolerated with minimal side effects\n\n6-MONTH FOLLOW-UP - September 2018\n- Improved neurological status\n- Returned to modified work schedule\n- MRI: No evidence of recurrence\nKPS: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - March 2019\n- Stable neurological exam\n- Working full-time\n- MRI: Stable post-treatment changes\nKPS: 90\nECOG: 1\n\n18-MONTH FOLLOW-UP - September 2019\n- New onset headaches\n- MRI: Small enhancement at resection margin\n- Decision for SRS boost to concerning area\nKPS: 85\nECOG: 1\n\n2-YEAR FOLLOW-UP - March 2020\n- Post-SRS boost\n- Improved symptoms\n- MRI: Stable disease\nKPS: 90\nECOG: 1\n\n3-YEAR FOLLOW-UP - March 2021\n- Focal seizure recurrence\n- MRI: Progressive enhancement\n- Second surgery recommended\nKPS: 75\nECOG: 1\n\nSECOND SURGERY - April 2021\n- Simpson Grade III resection\n- Pathology confirms recurrent WHO Grade II\nKPS: 65\nECOG: 2\n\n4-YEAR FOLLOW-UP - March 2022\n- Good recovery from second surgery\n- Working part-time\n- MRI: Stable post-operative changes\nKPS: 80\nECOG: 1\n\n5-YEAR FOLLOW-UP - March 2023\n- Maintained neurological status\n- MRI: No evidence of progression\nKPS: 85\nECOG: 1\n\nCURRENT VISIT - January 2024\n- Stable symptoms\n- Continues modified work schedule\n- MRI: Stable disease\nKPS: 85\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection (2018)\n- Adjuvant radiation therapy\n- SRS boost for early progression (2019)\n- Second surgery for recurrence (2021)\n- Currently stable on surveillance\n\nMONITORING PROTOCOL:\n- MRI every 4 months\n- Neurological assessment quarterly\n- Seizure diary maintenance\n- Regular cognitive assessment\n\nFinal KPS: 85/100\nFinal ECOG: 1\n\nThe patient's course reflects aggressive initial management with close monitoring and prompt intervention for recurrence, considering occupational demands requiring fine motor skills (software development) and physical stamina (baking).",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 68-year-old male, software developer/baker\nMRI FINDINGS: 2.8cm left frontal convexity meningioma with minimal surrounding edema\nWHO Grade: I (presumptive based on imaging characteristics)\nKPS: 90 ECOG: 1\n\nASSESSMENT & PLAN:\nGiven the patient's multiple neurological symptoms and tumor location, conservative intervention is warranted. However, considering his dual occupation requiring both cognitive and physical stamina, we'll proceed cautiously.\n\nRECOMMENDATIONS:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID with taper over 2 weeks\n3. Monthly neurological monitoring initially\n4. Occupational therapy evaluation for workplace adaptations\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nSymptoms improved with medical management\nMRI: Stable tumor size\nKPS: 85 ECOG: 1\nPlan: Continue current management, decrease monitoring to quarterly\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2019\nMild symptom progression\nMRI: Minimal growth (3.0cm)\nKPS: 80 ECOG: 1\nPlan: Increase steroid dose temporarily, continue monitoring\n\n-------------------\n\nFOLLOW-UP - March 10, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nKPS: 75 ECOG: 2\nPlan: Virtual monitoring monthly due to pandemic\n\n-------------------\n\nFOLLOW-UP - April 15, 2021\nNotable decline in work performance\nMRI: Growth to 3.3cm with moderate edema\nKPS: 65 ECOG: 2\nPlan: Discussion of surgical options vs. radiation therapy\nDecision: Patient opted for fractionated RT\n\n-------------------\n\nPOST-RT FOLLOW-UP - September 20, 2021\nCompleted RT (54 Gy in 30 fractions)\nImproved symptoms\nKPS: 75 ECOG: 1\nPlan: Continue quarterly monitoring\n\n-------------------\n\nANNUAL FOLLOW-UP - September 15, 2022\nStable disease\nMRI: Slight decrease in tumor size (3.1cm)\nKPS: 80 ECOG: 1\nPlan: Continue monitoring, reduced to semi-annual\n\n-------------------\n\nFOLLOW-UP - March 10, 2023\nMaintaining part-time work schedule\nMRI: Stable\nKPS: 85 ECOG: 1\nPlan: Continue current management\n\n-------------------\n\nRECENT FOLLOW-UP - February 15, 2024\nWell-controlled symptoms\nMRI: Further decrease in size (2.9cm)\nKPS: 90 ECOG: 1\nPlan: Annual monitoring if remains stable\n\nOVERALL KPS/ECOG TRAJECTORY:\n- Highest KPS: 90 (Initial visit and recent follow-up)\n- Lowest KPS: 65 (Pre-radiation therapy)\n- Current KPS: 90\n- ECOG range: 1-2\n\nTREATMENT SUMMARY:\nConservative management with radiation therapy when necessary has resulted in good tumor control and symptom management while maintaining quality of life and allowing continued participation in work activities, though at a modified level."
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of dizziness when changing positions",
          "Increased difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually over past 2 months",
          "Reports of recent personality changes noted by family - more irritable than usual",
          "Two episodes of nausea and vomiting in past month, unrelated to food or illness"
        ],
        "medical_history": [
          "Hypertension diagnosed 3 years ago, well-controlled with lisinopril 10mg daily",
          "Migraine headaches since age 35, but notes current headaches are different in nature",
          "Surgical removal of ovarian cyst in 2010",
          "Mother diagnosed with breast cancer at age 62",
          "No history of head trauma or neurological conditions",
          "Regular eye exams, last one 18 months ago was normal",
          "No significant radiation exposure history",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-O-SD\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2018\nChief Complaints: Progressive headaches, right-sided visual disturbance, cognitive changes\nKPS: 80 | ECOG: 1\n\nIMAGING:\nMRI reveals a 4.2cm right sphenoid wing meningioma with significant mass effect and perilesional edema. Enhancement pattern consistent with WHO Grade II meningioma. Evidence of compression of the right optic nerve.\n\nASSESSMENT & PLAN:\nGiven tumor size, location, and symptomatic presentation, immediate surgical intervention recommended. Occupation requires sustained visual focus and cognitive function, making aggressive treatment crucial.\n\nSURGICAL INTERVENTION - October 3, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II (Atypical) Meningioma\nKPS: 70 | ECOG: 2\n\nPOST-OP FOLLOW-UP - December 15, 2018\nPatient recovering well. Minor residual facial numbness.\nAdjuvant radiation therapy initiated\nKPS: 75 | ECOG: 1\n\n6-MONTH FOLLOW-UP - April 8, 2019\nMRI shows no recurrence\nVisual symptoms improved\nReturned to work part-time\nKPS: 85 | ECOG: 1\n\n1-YEAR FOLLOW-UP - October 12, 2019\nStable imaging\nFull return to work\nMaintaining quarterly MRI surveillance\nKPS: 90 | ECOG: 0\n\n2-YEAR FOLLOW-UP - October 15, 2020\nSmall focus of enhancement noted on MRI\nDecision made for gamma knife radiosurgery\nKPS: 85 | ECOG: 1\n\n3-YEAR FOLLOW-UP - September 30, 2021\nPost-radiation imaging stable\nMild radiation-related changes\nKPS: 80 | ECOG: 1\n\n4-YEAR FOLLOW-UP - October 5, 2022\nNew satellite lesion identified\nSecond surgical intervention recommended\nKPS: 75 | ECOG: 1\n\nSECOND SURGERY - November 12, 2022\nComplete resection of recurrence\nPathology confirms WHO Grade II\nKPS: 65 | ECOG: 2\n\n5-YEAR FOLLOW-UP - October 3, 2023\nPost-second surgery recovery satisfactory\nMaintained on 3-monthly MRI surveillance\nKPS: 80 | ECOG: 1\n\nCURRENT STATUS - March 15, 2024\nStable disease control\nContinuing regular monitoring\nWorking full-time with accommodations\nKPS: 85 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Adjuvant radiation therapy\n- Gamma knife radiosurgery for recurrence\n- Regular MRI surveillance\n- Occupational therapy support\n\nMONITORING PROTOCOL:\n- MRI every 3 months\n- Ophthalmological evaluation every 6 months\n- Neuropsychological assessment annually\n- Regular quality of life assessments\n\nKPS Score Range: 65-90 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nPROGNOSIS:\nGuarded but stable with aggressive multimodal treatment approach. Continued close monitoring essential due to WHO Grade II status and history of recurrence.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-O-SD\nPrimary Diagnosis: Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- Dural tail sign present\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's occupation as software developer and presenting symptoms affecting vision/concentration, conservative management initially recommended. Symptoms warrant close monitoring but tumor size and characteristics allow for non-surgical approach.\n\nFOLLOW-UP SCHEDULE:\n- MRI every 4 months for first year\n- Neurocognitive assessment quarterly\n- Monthly ophthalmology evaluations\n\nRECOMMENDATIONS:\n1. Ergonomic workplace assessment\n2. Blue light filtering glasses\n3. Regular work breaks (20/20/20 rule)\n4. Dexamethasone 4mg daily for edema management\n\n-------------------\n\nFOLLOW-UP - July 20, 2018\nStable symptoms. Minor improvement in headaches.\nMRI: No significant change\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - December 5, 2018\nImproved concentration at work\nVision symptoms stable\nMRI: No growth\nKPS: 90 | ECOG: 0\n\n-------------------\n\nFOLLOW-UP - June 15, 2019\nSome increase in headache frequency\nMRI: Minimal growth (0.2cm)\nKPS: 75 | ECOG: 1\nPlan: Increased dexamethasone to 6mg daily\n\n-------------------\n\nANNUAL REVIEW - March 10, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nPrevious MRI reviewed\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - September 30, 2020\nWorsening symptoms\nMRI: Growth to 3.2cm\nKPS: 60 | ECOG: 2\nDiscussion of surgical options - patient prefers continued conservative management\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nStabilization of symptoms with adjusted medication\nMRI: No further growth\nKPS: 70 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - February 28, 2022\nImproved symptom control\nMRI: Stable\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - January 15, 2023\nMaintaining work schedule with accommodations\nMRI: No progression\nKPS: 90 | ECOG: 0\n\n-------------------\n\nLATEST FOLLOW-UP - December 5, 2024\nLong-term stable disease\nMRI: No significant change from 2022\nKPS: 85 | ECOG: 1\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Highest KPS: 90 (2023)\n- Lowest KPS: 60 (2020)\n- Current KPS: 85\n- ECOG range: 0-2\n\nMANAGEMENT SUCCESS FACTORS:\n1. Patient's strong compliance with monitoring\n2. Workplace adaptations\n3. Effective symptom management\n4. Regular interdisciplinary coordination\n\nLONG-TERM RECOMMENDATIONS:\n- Continue biannual MRI monitoring\n- Maintain current medication regimen\n- Regular neurocognitive assessments\n- Annual ophthalmology evaluations\n- Ongoing workplace ergonomic adjustments"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work on computer screens",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly in dimly lit areas"
        ],
        "medical_history": [
          "Migraine headaches since age 35, previously well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of mild depression treated with sertraline 50mg daily",
          "No prior neurological conditions",
          "No history of cancer",
          "No radiation exposure",
          "Regular eye exams, last one 18 months ago was normal",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-B-DS\nPrimary Diagnosis: Meningioma\nInitial Visit: March 15, 2018\n\nINITIAL CONSULTATION (03/15/2018)\nPresenting Symptoms: Progressive neurological symptoms including headaches, visual disturbance, and balance issues suggesting possible mass effect. Occupational impact noted with difficulty focusing on computer screens - particularly concerning given patient's role as Data Scientist.\n\nInitial MRI Findings:\n- 3.8cm left frontal parasagittal meningioma\n- Moderate peritumoral edema\n- Mass effect on superior sagittal sinus\n- Enhancement pattern consistent with WHO Grade II meningioma\nWHO Grade: II (preliminary radiological assessment)\nKPS Score: 80\nECOG: 1\n\nSURGICAL INTERVENTION (04/02/2018)\nProcedure: Left frontal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPost-op WHO Grade: Confirmed Grade II\nComplications: None\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP VISIT (07/15/2018)\nStatus: Good recovery from surgery\nAdjuvant Treatment: Initiated fractionated RT (54 Gy/30fx)\nSymptoms: Improving vision, reduced headaches\nKPS Score: 85\nECOG: 1\n\n6-MONTH FOLLOW-UP (10/02/2018)\nMRI: No evidence of recurrence\nSymptoms: Significantly improved\nReturn to Work: Cleared for part-time work\nKPS Score: 90\nECOG: 1\n\n1-YEAR FOLLOW-UP (04/15/2019)\nMRI: Stable post-surgical changes\nOccupational Status: Full-time work resumed\nKPS Score: 95\nECOG: 0\n\n2-YEAR FOLLOW-UP (04/20/2020)\nMRI: Small enhancement noted at surgical margin\nRecommendation: Increased monitoring frequency\nKPS Score: 90\nECOG: 1\n\n3-YEAR FOLLOW-UP (05/10/2021)\nMRI: Progressive enhancement\nDecision: Second surgical intervention performed\nPost-op WHO Grade: Still Grade II\nKPS Score: 75\nECOG: 1\n\n4-YEAR FOLLOW-UP (06/15/2022)\nStatus: Post second surgery recovery\nTreatment: Additional RT course completed\nKPS Score: 85\nECOG: 1\n\n5-YEAR FOLLOW-UP (07/20/2023)\nMRI: Stable disease\nSymptoms: Well-controlled\nOccupational Status: Maintained full-time work\nKPS Score: 90\nECOG: 0\n\nCURRENT VISIT (01/15/2024)\nMRI: No evidence of progression\nLong-term Outlook: Favorable\nCurrent Medications: Levetiracetam 500mg BID\nKPS Score: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Two surgical interventions (2018, 2021)\n- Two courses of radiation therapy\n- Regular MRI surveillance every 6 months\n- Maintained high functional status throughout treatment\n- Successful occupational rehabilitation\n\nCURRENT STATUS:\nKPS Score: 95 (Able to carry on normal activity; minor symptoms)\nECOG Performance Status: 0 (Fully active)\n\nMONITORING PLAN:\n- Continue bi-annual MRI surveillance\n- Quarterly neurological examinations\n- Annual neuropsychological assessment\n- Ongoing occupational therapy assessment\n- Regular ophthalmological monitoring\n\nNote: Patient's high-functioning occupation as Data Scientist influenced aggressive treatment approach to preserve cognitive function and visual acuity. Treatment success reflected in maintained ability to perform complex computational tasks.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 53-year-old female, Data Scientist\nMRI FINDINGS: 2.8cm left frontal parasagittal meningioma with minimal surrounding edema. WHO Grade I suspected.\nKPS: 90 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven tumor size <3cm and patient's cognitive-demanding occupation, recommending initial conservative management with close monitoring. Symptoms warrant attention but may be partially related to underlying migraine condition.\n\nRECOMMENDATIONS:\n1. Follow-up MRI in 3 months\n2. Optimization of migraine management\n3. Occupational therapy evaluation for computer screen modifications\n4. Increase sertraline to 75mg daily for mood symptoms\n5. Balance assessment by physical therapy\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nMinimal tumor growth (2.9cm). Vision symptoms stable.\nKPS: 85 | ECOG: 1\nPLAN: Continue monitoring. Prescribed blue-light filtering glasses for computer work.\n\n-------------------\n\nFOLLOW-UP - December 5, 2018\nTumor stable at 2.9cm. Headaches improved with migraine management optimization.\nKPS: 90 | ECOG: 1\nPLAN: Extended MRI interval to 6 months.\n\n-------------------\n\nFOLLOW-UP - June 15, 2019\nSlight tumor growth to 3.1cm. Increased perilesional edema.\nKPS: 80 | ECOG: 1\nPLAN: Started dexamethasone 4mg daily. Discussed surgical options but patient prefers conservative approach.\n\n-------------------\n\nFOLLOW-UP - December 10, 2019\nStable tumor size. Edema decreased with steroids.\nKPS: 85 | ECOG: 1\nPLAN: Taper dexamethasone. Continue monitoring.\n\n-------------------\n\nFOLLOW-UP - June 30, 2020\nCOVID-19 Telehealth visit. Stable symptoms.\nKPS: 85 | ECOG: 1\nPLAN: Remote work accommodations discussed. MRI deferred 2 months due to pandemic.\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nTumor growth to 3.3cm. Worsening symptoms.\nKPS: 70 | ECOG: 2\nPLAN: Recommended stereotactic radiosurgery (SRS) given growth pattern.\n\n-------------------\n\nFOLLOW-UP - September 20, 2021\nPost-SRS follow-up. Initial tumor response.\nKPS: 75 | ECOG: 1\nPLAN: Continue monitoring. Gradual return to full-time work.\n\n-------------------\n\nFOLLOW-UP - March 10, 2022\nTumor reduction to 3.0cm. Improved symptoms.\nKPS: 85 | ECOG: 1\nPLAN: Annual MRI surveillance.\n\n-------------------\n\nFOLLOW-UP - April 5, 2023\nStable disease. Working full-time with accommodations.\nKPS: 90 | ECOG: 0\nPLAN: Continue annual monitoring.\n\n-------------------\n\nLATEST FOLLOW-UP - February 20, 2024\nTumor stable at 3.0cm. Well-maintained quality of life.\nKPS: 90 | ECOG: 0\nPLAN: Continue annual MRI. Maintain current accommodations at work.\n\nOVERALL KPS/ECOG TREND:\n- Highest KPS: 90 (Initial visit, 2023-2024)\n- Lowest KPS: 70 (March 2021, pre-SRS)\n- Current KPS: 90\n- Current ECOG: 0\n\nConservative management with eventual SRS proved successful in maintaining patient's professional functionality and quality of life. Regular monitoring and supportive care enabled appropriate timing of intervention."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "AB",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty finding words during meetings",
          "Subtle right-sided facial numbness",
          "Occasional balance issues when walking",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraines in 30s-40s, resolved spontaneously",
          "Osteoarthritis in both knees",
          "Cholecystectomy in 2010",
          "Family history of breast cancer (mother)",
          "No history of smoking",
          "Occasional alcohol use (1-2 drinks/week)",
          "Regular mammograms, last one normal 8 months ago",
          "No previous neurological conditions"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n65-year-old female with meningioma\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on left frontal lobe with 6mm midline shift\n- Enhancement pattern consistent with WHO Grade II meningioma\nASSESSMENT: Symptomatic large meningioma requiring urgent intervention\nPLAN: Scheduled for surgical resection within 2 weeks\nKPS: 70 | ECOG: 1\n\nSURGICAL NOTE - September 28, 2018\nPROCEDURE: Left frontal craniotomy for tumor resection\nFINDINGS: Simpson Grade II resection achieved\nPATHOLOGY: WHO Grade II atypical meningioma\nPOST-OP STATUS: Stable\nKPS: 60 | ECOG: 2\n\nFOLLOW-UP - December 15, 2018\nSTATUS: Improving neurological symptoms\nIMAGING: Post-op MRI shows small residual tumor (7mm)\nPLAN: Initiate adjuvant radiotherapy\nKPS: 80 | ECOG: 1\n\nRADIATION ONCOLOGY NOTE - January-March 2019\nTREATMENT: Completed 60 Gy/30 fractions\nTOLERANCE: Well-tolerated with minimal side effects\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - September 2019\nSTATUS: Improved cognitive function, returned to work part-time\nIMAGING: Stable residual disease\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - March 2020\nSTATUS: New onset seizures\nIMAGING: Progressive disease at surgical margins\nPLAN: Initiated levetiracetam, scheduled for gamma knife\nKPS: 75 | ECOG: 1\n\nGAMMA KNIFE NOTE - April 2020\nPROCEDURE: SRS to progressive areas\nDOSE: 14 Gy to margin\nKPS: 70 | ECOG: 1\n\nFOLLOW-UP - October 2020\nSTATUS: Seizure-free, stable symptoms\nIMAGING: Decreased enhancement post-SRS\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - September 2021\nSTATUS: Maintaining work schedule, mild fatigue\nIMAGING: Stable disease\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - March 2022\nSTATUS: New headaches, mild right-sided weakness\nIMAGING: Small area of progression\nPLAN: Increased monitoring frequency\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - September 2022\nSTATUS: Symptoms stabilized with medical management\nIMAGING: Stable disease\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - September 2023\nSTATUS: Maintaining function, occasional headaches\nIMAGING: No progression\nKPS: 90 | ECOG: 0\n\nRECENT FOLLOW-UP - February 2024\nSTATUS: Stable neurologically, working full-time\nIMAGING: No evidence of progression\nPLAN: Continue q6month MRI surveillance\nCurrent KPS: 95 | ECOG: 0\n\nTREATMENT SUMMARY:\n- Initial surgical resection (WHO Grade II)\n- Adjuvant radiotherapy\n- Salvage gamma knife for progression\n- Regular imaging surveillance\n- Successful return to work\n- Overall positive outcome with aggressive multimodal approach\n\nKPS Range Throughout Treatment: 60-95\nECOG Range Throughout Treatment: 0-2\n\nNote: Patient's occupation as Financial Analyst influenced aggressive treatment approach to preserve cognitive function. Obesity was considered in surgical planning but did not significantly impact treatment outcomes.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient ID: F65-AB\nChief Complaint: Progressive neurological symptoms with headaches\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm left frontal convexity meningioma with minimal surrounding edema. No significant mass effect on adjacent structures. WHO Grade I characteristics.\n\nASSESSMENT:\n65-year-old female financial analyst presenting with concerning neurological symptoms. Given tumor size and symptoms, conservative intervention warranted.\nKPS: 80\nECOG: 1\n\nPLAN:\n1. Start Dexamethasone 4mg BID for symptom management\n2. Anti-epileptic (Levetiracetam 500mg BID)\n3. Monthly clinical monitoring\n4. Workplace accommodations recommended\n5. Follow-up MRI in 3 months\n\n-------------------\n\nFOLLOW-UP - June 20, 2018\nSymptoms partially improved with medical management. Headaches reduced.\nMRI: Stable tumor size\nKPS: 85\nECOG: 1\n\nPLAN:\n1. Continue current medications\n2. Reduce Dexamethasone to 2mg BID\n3. Next MRI in 6 months\n\n-------------------\n\nFOLLOW-UP - January 10, 2019\nReports improved work performance. Minor visual symptoms persist.\nMRI: No significant change\nKPS: 90\nECOG: 0\n\nPLAN:\n1. Further reduce Dexamethasone\n2. Maintain anti-epileptic\n3. Annual MRI schedule\n\n-------------------\n\nANNUAL REVIEW - January 15, 2020\nStable symptoms. Managing work well with accommodations.\nMRI: Minimal growth (0.2cm)\nKPS: 85\nECOG: 1\n\nPLAN:\n1. Continue conservative management\n2. Regular cognitive assessments\n3. Next MRI in 12 months\n\n-------------------\n\nURGENT VISIT - September 5, 2021\nIncreased headaches and visual symptoms\nMRI: Tumor growth to 3.2cm with moderate edema\nKPS: 70\nECOG: 2\n\nPLAN:\n1. Increase Dexamethasone\n2. Consider radiation therapy options\n3. Short-term disability leave recommended\n\n-------------------\n\nFOLLOW-UP - December 10, 2021\nPost-radiation therapy assessment (completed fractionated RT)\nSymptoms improving\nKPS: 75\nECOG: 1\n\n-------------------\n\nANNUAL REVIEW - January 20, 2022\nGood response to radiation therapy\nMRI: Tumor reduction to 2.9cm\nKPS: 85\nECOG: 1\n\n-------------------\n\nFOLLOW-UP - February 15, 2023\nMaintaining stable condition\nMRI: No progression\nKPS: 90\nECOG: 0\n\n-------------------\n\nLATEST FOLLOW-UP - January 10, 2024\nWell-controlled symptoms\nWorking part-time with accommodations\nMRI: Stable disease\nKPS: 85\nECOG: 1\n\nOVERALL COURSE:\nPatient managed successfully with conservative approach, requiring radiation therapy only when progression occurred. Maintained good quality of life and continued modified work schedule.\n\nKPS Range over treatment course: 70-90\nECOG Range: 0-2\n\nRECOMMENDATIONS:\n1. Continue biannual MRI monitoring\n2. Maintain current medication regimen\n3. Regular cognitive assessments\n4. Ergonomic workplace modifications\n5. Stress management and lifestyle counseling"
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness; Occasional balance issues when walking; Increasing difficulty concentrating at work; Mild personality changes noted by family; Two episodes of nausea/vomiting in past month; Recent vision changes - blurring in right peripheral field"
        ],
        "medical_history": [
          "Type 2 diabetes diagnosed 12 years ago, managed with metformin; Hypertension controlled with lisinopril; Total hysterectomy at age 48; History of migraine headaches but pattern changed recently; Osteoarthritis in left knee; Family history of breast cancer (mother); No prior neurological conditions; No history of cancer; Regular mammograms with last one clear 8 months ago; Current medications: metformin 1000mg BID, lisinopril 10mg daily, calcium/vitamin D supplement"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-O-2018\nPrimary: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: 65F researcher presents with progressive neurological symptoms including morning headaches, right facial numbness, gait instability, cognitive changes, and right peripheral vision changes. Symptoms significantly impacting work performance.\n\nIMAGING: Initial MRI reveals 4.2cm right sphenoid wing meningioma with significant mass effect and peritumoral edema. Enhancement pattern consistent with WHO Grade II meningioma. Compression of right optic nerve noted.\n\nASSESSMENT: Given size, location, and progressive symptoms, immediate surgical intervention recommended. Patient's occupation requires high cognitive function; delay could impact professional capabilities.\n\nPLAN: \n- Scheduled for aggressive surgical resection within 2 weeks\n- Pre-op optimization of diabetes management\n- Baseline neuropsychological testing\nKPS: 70 | ECOG: 1\n\n-------------------\n\nPOST-OP VISIT - April 12, 2018\nPROCEDURE: Complete surgical resection achieved. Simpson Grade II.\nPATHOLOGY: WHO Grade II atypical meningioma\nCURRENT STATUS: Good recovery, minimal residual facial numbness\nPLAN: \n- Adjuvant radiotherapy recommended\n- Start 6-week course of IMRT (60 Gy/30fx)\nKPS: 80 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - October 15, 2018\nPOST-RT STATUS: Completed radiation therapy with good tolerance\nIMAGING: Post-treatment MRI shows no residual/recurrent disease\nSYMPTOMS: Improved vision, resolved headaches\nPLAN: \n- Q4 month MRI surveillance\n- Continue diabetes management\nKPS: 90 | ECOG: 0\n\n-------------------\n\nANNUAL REVIEW - April 20, 2019\nIMAGING: Stable post-treatment changes\nSYMPTOMS: Maintaining good functional status, returned to research work\nPLAN: Continue surveillance\nKPS: 95 | ECOG: 0\n\n-------------------\n\nSURVEILLANCE - March 10, 2020\nIMAGING: New 1.2cm nodule at surgical margin\nPLAN: \n- SRS to nodular recurrence\n- Increase monitoring frequency\nKPS: 90 | ECOG: 0\n\n-------------------\n\nPOST-SRS - September 15, 2020\nRESPONSE: Good local control of recurrence\nSYMPTOMS: Stable\nKPS: 85 | ECOG: 1\n\n-------------------\n\nFOLLOW-UP - June 12, 2021\nCOMPLICATIONS: Radiation necrosis suspected\nSYMPTOMS: Increased fatigue, mild cognitive decline\nPLAN: \n- Started dexamethasone\n- Hyperbaric oxygen therapy considered\nKPS: 60 | ECOG: 2\n\n-------------------\n\nPROGRESS NOTE - January 20, 2022\nIMPROVEMENT: Radiation changes stabilized\nSYMPTOMS: Improved energy levels\nPLAN: Continue monitoring\nKPS: 75 | ECOG: 1\n\n-------------------\n\nANNUAL REVIEW - March 15, 2023\nSTATUS: Stable disease control\nIMAGING: No new lesions\nOCCUPATION: Semi-retired but maintains part-time research\nKPS: 80 | ECOG: 1\n\n-------------------\n\nLATEST FOLLOW-UP - January 10, 2024\nLONG-TERM STATUS: \n- Maintained good disease control\n- Cognitive function stable\n- Continues modified work schedule\nPLAN: \n- Continue biannual MRI\n- Annual neuropsychological testing\nKPS: 85 | ECOG: 1\n\nOVERALL DISEASE COURSE:\nPatient demonstrated typical progression for WHO Grade II meningioma with one episode of local recurrence successfully managed with SRS. KPS scores ranged from 60-95, reflecting treatment effects and recovery periods. Current status shows good functional outcome with appropriate early aggressive intervention strategy.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\n65-year-old female researcher with T2DM\nBlood Type: O+\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nSYMPTOMS/PRESENTATION:\n- Progressive headaches (3 months)\n- Right facial numbness\n- Balance disturbance\n- Cognitive changes affecting work\n- Visual changes (right peripheral field)\n- Morning nausea/vomiting\n\nASSESSMENT & PLAN:\nGiven tumor size <3cm and patient's comorbidities (T2DM, HTN), recommending conservative management with close monitoring. Will start dexamethasone 4mg BID for symptom management.\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - June 20, 2018 (3 months)\n- Improvement in headaches with dexamethasone\n- Stable visual symptoms\n- MRI: No significant change\n- Reducing dexamethasone to 2mg BID\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - December 12, 2018 (6 months)\n- Successfully weaned off dexamethasone\n- Mild residual symptoms\n- MRI: Stable\nKPS Score: 90\nECOG: 0\n\nANNUAL FOLLOW-UP - January 15, 2019\n- Maintaining work schedule with accommodations\n- MRI: No growth\n- Continue observation\nKPS Score: 90\nECOG: 0\n\nANNUAL FOLLOW-UP - February 3, 2020\n- New onset headaches\n- MRI: 1mm growth, not clinically significant\n- Started prophylactic topiramate 50mg daily\nKPS Score: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - March 10, 2021\n- Good symptom control\n- MRI: Stable\n- Maintaining research work with modifications\nKPS Score: 85\nECOG: 1\n\nINTERIM VISIT - September 15, 2021\n- Acute worsening of symptoms\n- MRI: Increased peritumoral edema\n- Resumed dexamethasone 4mg BID\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - January 20, 2022\n- Improved symptoms\n- Successfully tapered dexamethasone\n- MRI: Decreased edema\nKPS Score: 80\nECOG: 1\n\nANNUAL FOLLOW-UP - February 8, 2023\n- Stable symptoms\n- Working part-time\n- MRI: No progression\nKPS Score: 85\nECOG: 1\n\nRECENT FOLLOW-UP - January 15, 2024\n- Well-controlled symptoms\n- Maintaining quality of life\n- MRI: Stable disease\n- Continue annual monitoring\nKPS Score: 90\nECOG: 0\n\nMANAGEMENT SUMMARY:\n- Conservative approach successful\n- Symptom management with intermittent steroids\n- Preserved work capability with modifications\n- Regular MRI surveillance\n- Focus on quality of life maintenance\n\nKPS Score Range: 70-90 throughout monitoring period\nECOG Score Range: 0-2 throughout monitoring period\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Regular diabetes monitoring\n3. Occupational therapy for work adaptations\n4. Monthly BP monitoring\n5. Regular cognitive assessments\n6. Vision testing every 6 months"
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Gradually worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work on computer screens",
          "Subtle personality changes noted by spouse - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Reports feeling off-balance when walking in past 2 weeks"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - diagnosed 3 years ago, managed with lisinopril",
          "BMI 33.2 - classified as Class I Obesity",
          "Sleep apnea diagnosed 2 years ago, uses CPAP",
          "Migraine headaches (infrequent) managed with sumatriptan PRN",
          "No history of seizures or neurological disorders",
          "No significant family history of brain tumors or cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M56-B-DS\nPrimary Diagnosis: Meningioma\nWHO Grade: Initially Grade II, progressing to Grade III\n\nINITIAL VISIT - March 15, 2018\nMRI Findings:\n- 4.2cm parasagittal meningioma in right frontal region\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Evidence of brain parenchyma compression\nAssessment: High-risk presentation given size, location, and patient's history of radiation exposure\nKPS: 80 | ECOG: 1\n\nSURGICAL INTERVENTION - April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II meningioma\nPost-op KPS: 70 | ECOG: 2\n\nFOLLOW-UP - July 15, 2018\n- Good recovery from surgery\n- Improvement in headaches and vision\n- Started adjuvant radiation therapy\n- Return to work planned for September\nKPS: 85 | ECOG: 1\n\n6-MONTH FOLLOW-UP - October 2, 2018\nMRI: No evidence of recurrence\nSymptoms: Significantly improved\nRecommendation: Continue q3month monitoring\nKPS: 90 | ECOG: 0\n\nANNUAL REVIEW - April 15, 2019\nMRI: Small enhancement noted at surgical margin\nPlan: Increased monitoring frequency\nKPS: 85 | ECOG: 1\n\nURGENT ASSESSMENT - January 10, 2020\nPresenting with renewed symptoms\nMRI: Tumor recurrence 2.8cm\nPlan: Second surgical intervention\nKPS: 70 | ECOG: 2\n\nSECOND SURGERY - February 1, 2020\nFindings: Aggressive regrowth\nPathology: Progression to WHO Grade III\nPost-op KPS: 60 | ECOG: 2\n\nFOLLOW-UP - May 15, 2020\nStarted on systemic therapy\nSignificant fatigue reported\nKPS: 50 | ECOG: 3\n\n2021 QUARTERLY REVIEWS:\nQ1: Stable disease | KPS: 65 | ECOG: 2\nQ2: Minor progression | KPS: 60 | ECOG: 2\nQ3: Started alternative chemotherapy | KPS: 55 | ECOG: 3\nQ4: Mixed response | KPS: 50 | ECOG: 3\n\n2022 MONITORING:\n- February: Disease stabilization | KPS: 70 | ECOG: 2\n- June: Improvement noted | KPS: 75 | ECOG: 2\n- October: Maintained stability | KPS: 80 | ECOG: 1\n\n2023 ASSESSMENT:\n- March: Continued stability | KPS: 85 | ECOG: 1\n- September: Minor progression | KPS: 75 | ECOG: 2\n\nCURRENT STATUS (2024):\n- Regular monitoring continues\n- Managing work with accommodations\n- Maintained on current therapy\nCurrent KPS: 70 | ECOG: 2\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified work schedule implemented\n- Ergonomic adjustments for computer work\n- Regular breaks recommended for vision strain\n- Cognitive rehabilitation ongoing\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Complete course of radiation therapy\n- Multiple rounds of systemic therapy\n- Regular imaging surveillance\n- Comprehensive supportive care\n\nKPS Range Throughout Treatment: 50-90\nECOG Range Throughout Treatment: 0-3",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nInitial Visit - March 15, 2018\nPatient: 56-year-old male data scientist\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nMRI Findings:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nAssessment:\nGiven patient's history of prior radiation exposure and current symptomatology, careful monitoring is warranted. Occupation requires significant screen time and cognitive focus, which may be impacted by current symptoms.\n\nPlan:\n1. Conservative management with close monitoring\n2. Medications:\n   - Dexamethasone 4mg BID for edema control\n   - Continue current lisinopril\n3. Monthly follow-up initially\nKPS: 80 ECOG: 1\n\nFollow-up - June 20, 2018\nSymptoms slightly improved with steroid therapy. Visual symptoms stable.\nMRI: No significant change in tumor size\nPlan: Gradual steroid taper\nKPS: 85 ECOG: 1\n\nDecember 12, 2018\nPatient reports improved concentration at work\nMRI: Stable lesion size\nPlan: Continue monitoring\nKPS: 90 ECOG: 0\n\nJune 15, 2019\nMild headache recurrence\nMRI: Minimal growth (0.2cm)\nPlan: Resume low-dose dexamethasone\nKPS: 75 ECOG: 1\n\nJanuary 10, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nContinue current management\nKPS: 80 ECOG: 1\n\nAugust 23, 2020\nMRI shows 3.1cm tumor size\nIncreased edema\nDiscussing surgical options but patient prefers conservative approach\nPlan: Increase steroid dose\nKPS: 70 ECOG: 2\n\nMarch 15, 2021\nWorsening symptoms\nMRI: 3.3cm tumor\nRecommended surgical consultation\nPatient still preferring conservative management\nKPS: 65 ECOG: 2\n\nSeptember 30, 2021\nAgreed to gamma knife radiosurgery after worsening symptoms\nPost-treatment plan established\nKPS: 60 ECOG: 2\n\nFebruary 15, 2022\nPost-radiation follow-up\nImprovement in symptoms\nMRI: Stable tumor size with decreased edema\nKPS: 75 ECOG: 1\n\nAugust 20, 2022\nContinued improvement\nReturn to work full-time\nMRI: Minor tumor shrinkage\nKPS: 85 ECOG: 1\n\nMarch 10, 2023\nMaintaining stable condition\nAnnual MRI: No progression\nKPS: 90 ECOG: 0\n\nJanuary 15, 2024\nLatest follow-up\nStable disease\nContinue annual monitoring\nKPS: 95 ECOG: 0\n\nTreatment Summary:\n- Conservative management initially successful\n- Transition to radiation therapy when necessary\n- Overall good outcome with preserved quality of life\n- Patient able to maintain employment throughout treatment\n\nFinal KPS: 95\nFinal ECOG: 0\n\nNote: KPS scores ranged from 60-95 throughout treatment course, reflecting periods of symptom exacerbation and improvement. The patient's eventual positive response to radiation therapy and return to baseline functionality is reflected in the final high KPS score."
      }
    },
    {
      "demographics": {
        "age": 60,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when cataloging books",
          "Mild right-sided facial numbness that developed gradually",
          "Reports feeling unsteady when climbing library stairs",
          "Intermittent tinnitus in right ear"
        ],
        "medical_history": [
          "Hysterectomy at age 45 for uterine fibroids",
          "Migraine headaches since age 30, but pattern has changed recently",
          "Treated for hypertension for past 8 years - well controlled on lisinopril",
          "History of benign breast cysts - last mammogram normal 6 months ago",
          "Osteoarthritis in both knees",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history significant for mother with breast cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F60-O-MEN\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of optic nerve noted\n\nASSESSMENT:\nGiven size, location, and symptomatic presentation, immediate surgical intervention recommended. Occupation requires fine visual acuity and cognitive function, currently compromised.\nWHO Grade: II (preliminary)\nKPS: 70\nECOG: 1\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative imaging protocol including functional MRI\n3. Steroid therapy initiated: Dexamethasone 4mg QID\n4. Anti-seizure prophylaxis: Levetiracetam 500mg BID\n\nSURGERY - April 2, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to cavernous sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate complications\nKPS: 60\nECOG: 2\n\nPOST-OP FOLLOW-UP - May 15, 2018\n- Improved visual symptoms\n- Residual facial numbness\n- Started adjuvant radiation therapy\nKPS: 75\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 2, 2018\n- Completed radiation therapy\n- MRI shows no progression\n- Returned to work part-time\nKPS: 85\nECOG: 1\n\nANNUAL FOLLOW-UP - April 15, 2019\n- Stable imaging\n- Minor cognitive complaints\n- Maintaining work schedule\nKPS: 90\nECOG: 0\n\n18-MONTH FOLLOW-UP - October 10, 2019\n- Small area of enhancement noted\n- Watchful waiting approach\nKPS: 85\nECOG: 1\n\n2-YEAR FOLLOW-UP - April 2020\n- Growth of residual tumor\n- Second surgery recommended\nKPS: 80\nECOG: 1\n\nSECOND SURGERY - June 15, 2020\n- Further debulking achieved\n- Gamma Knife to residual\nKPS: 65\nECOG: 2\n\n3-YEAR FOLLOW-UP - April 2021\n- Stable disease\n- Full return to work\nKPS: 90\nECOG: 0\n\n4-YEAR FOLLOW-UP - April 2022\n- No progression\n- Maintaining function\nKPS: 95\nECOG: 0\n\n5-YEAR FOLLOW-UP - April 2023\n- Stable imaging\n- Excellent functional status\nKPS: 95\nECOG: 0\n\nCURRENT STATUS - January 2024\n- Continues surveillance MRI q6 months\n- Maintains full-time work\n- No significant neurological deficits\nKPS: 90\nECOG: 0\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Complete course of radiation therapy\n- Gamma Knife to residual\n- Regular imaging surveillance\n- Successful maintenance of occupational function\n\nKPS Score Range: 60-95 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nPROGNOSIS:\nFavorable with continued close monitoring. Patient has maintained high functional status despite aggressive treatment approach, supporting the decision for early intervention.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 60-year-old female librarian\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\n\nIMAGING:\nInitial MRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. WHO Grade I suspected based on imaging characteristics.\n\nASSESSMENT:\nGiven patient's stable employment, well-controlled comorbidities, and relatively small tumor size, recommending conservative management with close monitoring. Symptoms, while concerning, do not indicate immediate surgical necessity.\n\nPLAN:\n1. Serial MRI monitoring every 6 months initially\n2. Dexamethasone 4mg daily for symptom management\n3. Neurology referral for headache management\n4. Occupational therapy evaluation for balance/mobility\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nMinimal tumor growth (2.9cm). Headaches improved with medical management.\nMaintaining conservative approach.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 12, 2019\nStable tumor size. Patient reports improved concentration at work after medication adjustments.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 10, 2020\nTumor stable at 2.9cm. COVID-19 considerations discussed. Transitioning to annual MRI.\nPatient working remotely - reduced physical demands.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 15, 2021\nSlight tumor growth to 3.1cm. Increased headaches.\nModified treatment plan:\n1. Increased dexamethasone to 6mg daily\n2. Monthly neuro-ophthalmology monitoring\n3. Consider radiation therapy if symptoms worsen\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - September 10, 2021\nTumor stable but symptoms progressing. Discussing radiation therapy options.\nPatient took medical leave from work.\nKPS: 70 ECOG: 2\n\nFOLLOW-UP - March 8, 2022\nPost-radiation therapy (54 Gy/30 fractions)\nTumor showing minor shrinkage (2.9cm)\nGradual symptom improvement\nReturning to work part-time\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 14, 2023\nStable disease. Working full-time with accommodations.\nMaintaining annual MRI schedule.\nKPS: 85 ECOG: 1\n\nCURRENT VISIT - February 20, 2024\nTumor stable at 2.9cm. Patient well-adapted to current situation.\nContinuing conservative management.\nRegular monitoring plan:\n1. Annual MRI\n2. Quarterly neurology visits\n3. Biannual neuro-ophthalmology checks\n4. Continued occupational therapy as needed\nKPS: 90 ECOG: 0\n\nSUMMARY OF KPS/ECOG PROGRESSION:\n- Initial presentation: KPS 80/ECOG 1\n- Best status: KPS 90/ECOG 0\n- Lowest point: KPS 70/ECOG 2 (pre-radiation)\n- Current status: KPS 90/ECOG 0\n\nConservative management with eventual radiation therapy has proven successful for this patient, allowing her to maintain employment and quality of life. Will continue current monitoring schedule unless symptoms change.\n\nWHO Grade: I (based on imaging characteristics and clinical course)"
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Perfumer",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty concentrating at work",
          "Subtle personality changes noted by family members",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly in dimly lit areas",
          "Increased fatigue and drowsiness during daytime"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches since age 40 - previously managed with sumatriptan PRN",
          "Menopause at age 52",
          "Osteoporosis diagnosed at age 60 - on calcium and vitamin D supplements",
          "Previous surgery for carpal tunnel syndrome (right wrist) in 2018",
          "Family history of breast cancer (mother)",
          "No history of smoking or significant alcohol use",
          "Regular mammograms and health screenings up to date"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-A-2016\nOccupation: Data Scientist/Perfumer\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 4.2 cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\nKPS: 70 | ECOG: 1\n\nASSESSMENT:\nGiven patient's cognitive symptoms and occupation requiring high-level data analysis, immediate intervention recommended. Tumor location and size concerning for progression.\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization of hypertension\n3. Neuropsychological evaluation\n4. Occupational therapy assessment\n\nPOST-OPERATIVE VISIT - April 12, 2016\nPROCEDURE: Simpson Grade II resection\nPATHOLOGY: WHO Grade II atypical meningioma\nKPS: 60 | ECOG: 2\n- Initiated post-operative radiation therapy (60 Gy/30 fractions)\n\n6-MONTH FOLLOW-UP - October 15, 2016\n- Improved cognitive function\n- Returned to work part-time\n- MRI shows no residual tumor\nKPS: 80 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 20, 2017\n- Full-time work resumed\n- Minor residual facial numbness\nKPS: 90 | ECOG: 0\n\n2-YEAR FOLLOW-UP - April 15, 2018\n- New 1.2 cm nodule at resection margin\n- Recommended stereotactic radiosurgery\nKPS: 85 | ECOG: 1\n\n3-YEAR FOLLOW-UP - May 10, 2019\n- Post-SRS imaging stable\n- Maintaining work performance\nKPS: 90 | ECOG: 0\n\n4-YEAR FOLLOW-UP - June 5, 2020\n- Multiple small recurrent nodules\n- Declined performance at work\nKPS: 70 | ECOG: 1\n- Initiated temozolomide therapy\n\n5-YEAR FOLLOW-UP - July 15, 2021\n- Disease progression despite therapy\n- Medical leave from work\nKPS: 50 | ECOG: 2\n\n6-YEAR FOLLOW-UP - August 20, 2022\n- Second surgery performed\n- WHO Grade III progression\nKPS: 40 | ECOG: 3\n\n7-YEAR FOLLOW-UP - September 12, 2023\n- Responding to aggressive therapy\n- Limited work from home\nKPS: 60 | ECOG: 2\n\nCURRENT STATUS - February 15, 2024\n- Stable disease on imaging\n- Partial return to work activities\nKPS: 70 | ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection (2016)\n- Adjuvant radiation therapy\n- Salvage SRS (2018)\n- Chemotherapy (2020)\n- Second surgery (2022)\n- Ongoing surveillance\n\nKPS Score Range: 40-90\nECOG Score Range: 0-3\n\nOCCUPATIONAL CONSIDERATIONS:\n1. Cognitive demands of data science role necessitated aggressive initial treatment\n2. Chemical exposure in perfumery work monitored for potential interactions\n3. Modified work arrangements implemented throughout treatment course",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\nBlood Type: A\nOccupation: Data Scientist/Perfumer\n\nINITIAL VISIT - September 15, 2016\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\nKPS: 80 | ECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's age, tumor size <3cm, and stable employment requiring cognitive function, recommending conservative management with close monitoring. Occupational considerations include cognitive demands of data science role and olfactory sensitivity required for perfume work.\n\nRECOMMENDATIONS:\n1. Serial MRI monitoring\n2. Prophylactic anticonvulsants not indicated\n3. Dexamethasone 4mg BID for symptom management\n4. Continue current medications\n5. Occupational therapy evaluation\n\nFOLLOW-UP - March 20, 2017\nStable symptoms. MRI shows no significant change.\nKPS: 85 | ECOG: 1\nPlan: Continue monitoring, reduce dexamethasone to 2mg BID\n\nANNUAL FOLLOW-UP - April 5, 2018\nMinor tumor growth (0.2cm). Patient maintaining work schedule with accommodations.\nKPS: 75 | ECOG: 1\nPlan: Increase monitoring frequency to 6-monthly\n\nFOLLOW-UP - October 12, 2018\nSymptoms stable. Vision complaints improved with prescription adjustment.\nKPS: 80 | ECOG: 1\nPlan: Continue current management\n\nFOLLOW-UP - May 3, 2019\nTumor stable. Patient reports improved concentration with cognitive exercises.\nKPS: 85 | ECOG: 1\nPlan: Maintain current approach\n\nCRITICAL EPISODE - January 15, 2020\nIncreased headache severity. MRI shows increased peritumoral edema.\nKPS: 60 | ECOG: 2\nPlan: Increase dexamethasone, consider radiation if symptoms persist\n\nFOLLOW-UP - July 20, 2020\nImprovement after medication adjustment. Working part-time.\nKPS: 70 | ECOG: 1\nPlan: Continue current management\n\nANNUAL FOLLOW-UP - August 5, 2021\nStable disease. Patient adapted well to hybrid work arrangement.\nKPS: 80 | ECOG: 1\nPlan: Maintain conservative approach\n\nFOLLOW-UP - September 10, 2022\nMinor progression noted. Patient managing well with accommodations.\nKPS: 75 | ECOG: 1\nPlan: Continue monitoring, discuss radiation options if progression continues\n\nCURRENT VISIT - March 15, 2024\nStable disease. Patient maintaining good quality of life.\nKPS: 80 | ECOG: 1\n\nOVERALL DISEASE COURSE:\n- KPS Range: 60-85\n- ECOG Range: 1-2\n- Successfully maintained conservative management\n- Patient adapted work environment to accommodate symptoms\n- Preserved olfactory function critical for perfume work\n- Cognitive function adequate for data science tasks\n\nCURRENT RECOMMENDATIONS:\n1. Continue biannual MRI monitoring\n2. Maintain current medication regimen\n3. Regular cognitive assessments\n4. Occupational therapy as needed\n5. Consider radiation therapy only if significant progression\n\nThe conservative approach has allowed patient to maintain professional activities while managing symptoms effectively. Quality of life remains good with current management strategy."
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Perfumer",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 6 months, worse in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of dizziness and loss of balance",
          "Increased fatigue and difficulty concentrating at work",
          "Subtle personality changes noted by coworkers",
          "Mild right-sided facial numbness developing over past 3 months",
          "Reported decreased sense of smell affecting work as perfumer"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood thyroid condition at age 12",
          "BMI 33.2 (Obesity Class I)",
          "Hypertension diagnosed 3 years ago, controlled with lisinopril",
          "Migraine headaches since age 30, but notes recent change in pattern",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Regular computer use with extended screen time in software development role",
          "Recent eye examination 2 months ago showing slight papilledema"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F56-B-MEN\nPrimary Diagnosis: Meningioma\nOccupation: Software Developer/Perfumer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on frontal lobe with 5mm midline shift\n- Enhancement pattern suggestive of WHO Grade II\n- Proximity to olfactory groove and superior sagittal sinus\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant edema\n- Critical location\n- Symptomatic presentation\n- Occupational impact (affecting smell discrimination required for work)\nKPS Score: 80\nECOG: 1\n\nPLAN:\nRecommend immediate surgical intervention due to:\n1. Progressive symptoms\n2. Size and location\n3. Occupational implications\n4. History of radiation exposure increasing risk\n\nFOLLOW-UP VISIT - April 2, 2018\nPre-operative Assessment\n- Completed functional MRI\n- DTI tractography\n- Volumetric analysis\n- Surgical planning completed\nKPS Score: 75\nECOG: 1\n\nSURGICAL NOTE - April 15, 2018\n- Simpson Grade II resection achieved\n- WHO Grade II confirmed\n- Minor residual along superior sagittal sinus\nKPS Score: 60\nECOG: 2\n\nPOST-OP VISIT - May 30, 2018\n- Good recovery\n- Initiated adjuvant radiation therapy\n- 54 Gy in 30 fractions\nKPS Score: 70\nECOG: 1\n\n6-MONTH FOLLOW-UP - October 15, 2018\n- Improved vision\n- Partial recovery of olfactory function\n- Return to work part-time\nKPS Score: 85\nECOG: 1\n\n1-YEAR FOLLOW-UP - April 15, 2019\n- Stable MRI\n- Full-time work resumed\n- Minimal residual symptoms\nKPS Score: 90\nECOG: 0\n\n2-YEAR FOLLOW-UP - April 20, 2020\n- Small area of enhancement noted\n- Watchful waiting approach\nKPS Score: 85\nECOG: 1\n\n3-YEAR FOLLOW-UP - May 1, 2021\n- Progressive growth of residual tumor\n- New symptoms emerging\n- Second surgery recommended\nKPS Score: 75\nECOG: 1\n\nSECOND SURGERY - June 15, 2021\n- Complete resection achieved\n- WHO Grade II confirmed\nKPS Score: 55\nECOG: 2\n\n4-YEAR FOLLOW-UP - April 10, 2022\n- Excellent recovery\n- No evidence of recurrence\nKPS Score: 95\nECOG: 0\n\n5-YEAR FOLLOW-UP - March 30, 2023\n- Stable imaging\n- Full functional recovery\n- Continues perfumer work successfully\nKPS Score: 100\nECOG: 0\n\nCURRENT VISIT - February 15, 2024\n- Maintained stability\n- Regular monitoring continues\n- No evidence of recurrence\nKPS Score: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Two surgical interventions\n- Complete adjuvant radiation therapy\n- Regular MRI surveillance\n- Successful occupational rehabilitation\n\nKPS Score Range: 55-100 throughout treatment course\nECOG Score Range: 0-2 throughout treatment course\n\nMONITORING PROTOCOL:\n- MRI every 3 months for first year post-surgery\n- Then every 6 months for 5 years\n- Annual thereafter if stable\n- Immediate imaging if new symptoms develop",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 56\nGender: Female\nOccupation: Software Developer/Perfumer\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right eye blurred vision, dizziness, fatigue, concentration issues, personality changes, right facial numbness, decreased olfactory function.\n\nMRI Findings:\n- 2.8cm right sphenoid wing meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nAssessment:\nGiven patient's complex symptom profile and occupation-specific concerns (olfactory function critical for perfumer role), recommending conservative management with close monitoring. Tumor size and location warrant careful observation rather than immediate surgical intervention.\n\nPlan:\n1. MRI surveillance every 6 months\n2. Ophthalmology follow-up for vision monitoring\n3. Prescribed Dexamethasone 4mg BID for edema management\n4. Ergonomic workplace assessment recommended\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - September 20, 2018\nSymptoms stable. Vision slightly improved with steroid therapy.\nMRI: No significant change in tumor size\nPlan: Continue current management\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - March 12, 2019\nReports improved headache control\nMRI: Stable lesion\nReduced steroid dosage to 2mg BID\nKPS Score: 90\nECOG: 0\n\nFOLLOW-UP - March 10, 2020\nCOVID-19 Telehealth Visit\nStable symptoms\nContinue current management\nKPS Score: 85\nECOG: 1\n\nFOLLOW-UP - September 15, 2020\nMRI shows minimal growth (0.2cm)\nIncreased headaches\nAdjusted medications\nConsider radiation therapy if progression continues\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - March 18, 2021\nSymptoms worsening\nMRI: Growth to 3.2cm\nDiscussed treatment options\nReferred for Gamma Knife consultation\nKPS Score: 70\nECOG: 2\n\nFOLLOW-UP - September 20, 2021\nPost-Gamma Knife (performed July 2021)\nInitial response positive\nHeadaches improving\nKPS Score: 75\nECOG: 1\n\nFOLLOW-UP - March 15, 2022\nMRI shows tumor stability\nImproved symptoms\nReturned to work part-time\nKPS Score: 80\nECOG: 1\n\nFOLLOW-UP - March 14, 2023\nContinued stability\nWorking full-time\nOlfactory function partially recovered\nKPS Score: 90\nECOG: 0\n\nLATEST FOLLOW-UP - January 10, 2024\nMRI: Stable disease\nMinimal symptoms\nMaintaining work-life balance\nAnnual follow-up recommended\nKPS Score: 95\nECOG: 0\n\nTREATMENT SUMMARY:\n- Conservative management initially successful\n- Gamma Knife intervention required after progression\n- Overall positive outcome with preserved quality of life\n- Occupational adaptation successful\n\nCURRENT STATUS:\n- Stable disease\n- Good functional status\n- Regular monitoring continues\n- Patient maintains professional activities with accommodations\n\nFinal KPS Score: 95\nFinal ECOG Score: 0"
      }
    },
    {
      "demographics": {
        "age": 44,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional episodes of nausea, recent onset of clumsiness in left hand when typing, difficulty concentrating during work hours, one episode of focal seizure affecting left arm two weeks ago"
        ],
        "medical_history": [
          "Migraine headaches since age 35 (previously well-controlled with sumatriptan), mild hypertension diagnosed 2 years ago (managed with lifestyle modifications), concussion from sports injury at age 22 with full recovery, family history of brain tumor in maternal aunt, no history of cancer, non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M44-SD-2016\nBlood Type: A\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2016\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No calcification noted\nWHO Grade: II (confirmed post-surgery)\nKPS: 80\nECOG: 1\n\nASSESSMENT & PLAN:\nGiven patient's age, occupation requiring fine motor skills, and progressive neurological symptoms, immediate surgical intervention recommended. Location and size of tumor causing concerning mass effect. Occupation requires high cognitive function and manual dexterity.\n\nSURGICAL INTERVENTION - April 2, 2016\n- Simpson Grade II resection performed\n- Subtotal resection due to venous sinus involvement\n- Post-op MRI shows small residual (0.5cm)\nKPS: 70\nECOG: 2\n\nFOLLOW-UP - July 15, 2016\nPost-radiation therapy completion (60 Gy/30 fractions)\nSymptoms improving\nReturned to work part-time\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - January 10, 2017\nMRI stable\nResumed full-time work\nMinor fatigue reported\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - July 2017, January 2018, July 2018\nQuarterly MRIs: No progression\nMaintaining work schedule\nKPS: 90-95\nECOG: 0\n\nCONCERNING VISIT - March 15, 2019\nMRI shows small growth in residual tumor\nNew onset headaches\nKPS: 75\nECOG: 1\n\nSECOND SURGERY - May 1, 2019\n- Gamma Knife radiosurgery to residual tumor\n- Well-tolerated\nKPS: 70\nECOG: 2\n\nRECOVERY PERIOD - 2020-2021\nBiannual MRIs: Stable disease\nReturned to both occupations\nKPS: 85-90\nECOG: 0-1\n\nFOLLOW-UP - 2022-2023\nAnnual MRIs: No progression\nFully functional\nKPS: 95\nECOG: 0\n\nLATEST VISIT - January 2024\nStable disease\nWorking full-time\nNo neurological deficits\nKPS: 100\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial aggressive surgical resection\n- Adjuvant radiation therapy\n- Gamma Knife for residual\n- Regular imaging surveillance\n- Excellent functional outcome\n\nFinal Status:\nKPS: 100 - Fully functional, no evidence of disease\nECOG: 0 - Fully active\n\nThe patient's case demonstrates successful aggressive management of a WHO Grade II meningioma with excellent functional recovery, allowing return to demanding dual occupations requiring both cognitive and manual dexterity skills.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M44-SD-2016\nBlood Type: A\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2016\nPresenting Symptoms: Progressive headaches (3 months), morning severity, right eye blurred vision, nausea, left hand coordination issues, work concentration difficulties, recent left arm focal seizure.\n\nMRI Findings:\n- 2.8cm right frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\n\nAssessment:\nGiven tumor size <3cm, minimal edema, and stable neurological status, recommending conservative management with close monitoring. Occupation requires fine motor skills and cognitive focus - essential to preserve function.\n\nPlan:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg daily for edema control\n3. Quarterly MRI surveillance\n4. Occupational therapy referral\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2016\nSymptoms improved with medical management. Headaches reduced.\nMRI: Stable tumor size\nPlan: Continue current management\nKPS: 85 ECOG: 1\n\nANNUAL REVIEW - March 14, 2017\nMinimal symptom progression\nMRI: No significant growth\nPlan: Extend to bi-annual MRI\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - March 10, 2019\nReports increased headaches\nMRI: 3.0cm tumor, slight growth\nPlan: Maintain conservative approach, increase steroid dose\nKPS: 75 ECOG: 1\n\nURGENT VISIT - November 15, 2020\nAcute seizure episode\nMRI: 3.2cm tumor, moderate edema\nPlan: Adjust anti-epileptics, consider surgical consultation\nKPS: 60 ECOG: 2\n\nFOLLOW-UP - February 20, 2021\nImproved seizure control\nMRI: Stable\nPlan: Continue conservative management\nKPS: 70 ECOG: 1\n\nANNUAL REVIEW - March 15, 2022\nStable symptoms\nMRI: No progression\nPlan: Maintain current approach\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 10, 2023\nWell-controlled symptoms\nMRI: Stable disease\nPlan: Continue monitoring\nKPS: 85 ECOG: 1\n\nLATEST REVIEW - January 15, 2024\nMaintaining work activities\nMinor visual symptoms\nMRI: Stable at 3.2cm\nPlan: Continue conservative management\nKPS: 90 ECOG: 0\n\nTREATMENT SUMMARY (2016-2024):\nSuccessfully managed with conservative approach\n- Avoided surgical intervention\n- Maintained occupational function\n- Quality of life preserved\n- Stable disease control\n\nCurrent Status:\n- KPS: 90 (High functioning)\n- ECOG: 0 (Fully active)\n- WHO Grade: I\n- Regular monitoring continues\n\nNote: KPS scores fluctuated between 60-90 throughout treatment period, with lowest during 2020 seizure episode and highest during stable periods. Conservative management strategy proved effective in maintaining patient's quality of life and occupational functionality."
      }
    },
    {
      "demographics": {
        "age": 60,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional balance difficulties when walking, subtle personality changes noted by spouse including increased irritability, one episode of focal seizure affecting left hand 2 weeks ago, mild confusion with word-finding difficulties"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily, migraine headaches in 30s that resolved, surgical removal of appendix in 1985, family history of father with lung cancer, no prior neurological conditions, no history of head trauma, non-smoker, occasional alcohol use (2-3 drinks/week), occupational exposure to laboratory chemicals as researcher but uses appropriate PPE, annual physicals all normal until current symptoms began"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 60-year-old male researcher\nChief Complaint: Progressive headaches, visual disturbances, balance issues\n\nIMAGING:\nInitial MRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nKPS: 80\nECOG: 1\n\nPLAN:\nUrgent surgical intervention recommended due to:\n- Size >3cm\n- Symptomatic presentation\n- Occupation requiring high cognitive function\n- Risk of further neurological deterioration\n\n-------------------\n\nSURGICAL NOTE - March 28, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 300cc\nNo complications\nPathology confirms WHO Grade II meningioma\n\n-------------------\n\nPOST-OP FOLLOW-UP - April 15, 2018\nPatient recovering well\nHeadaches improved\nVision stabilizing\nKPS: 70\nECOG: 1\nPlan: Adjuvant radiation therapy recommended\n\n-------------------\n\nRADIATION ONCOLOGY NOTE - May-June 2018\nCompleted fractionated RT\n60 Gy in 30 fractions\nWell tolerated\n\n-------------------\n\n6-MONTH FOLLOW-UP - September 2018\nMRI: No evidence of recurrence\nSymptoms resolved\nReturned to work part-time\nKPS: 90\nECOG: 0\n\n-------------------\n\n1-YEAR FOLLOW-UP - March 2019\nMRI: Stable post-surgical changes\nFull-time work resumed\nKPS: 95\nECOG: 0\n\n-------------------\n\n2-YEAR FOLLOW-UP - March 2020\nMRI: Small enhancement at surgical margin\nNew mild headaches\nKPS: 85\nECOG: 1\nPlan: Increased monitoring frequency\n\n-------------------\n\n2.5-YEAR FOLLOW-UP - September 2020\nMRI: Progressive enhancement\nRecurrent symptoms\nKPS: 75\nECOG: 1\nPlan: Surgical re-intervention recommended\n\n-------------------\n\nSECOND SURGERY - October 2020\nComplete resection of recurrence\nSimpson Grade I\nPathology: WHO Grade II\n\n-------------------\n\n3-YEAR FOLLOW-UP - March 2021\nPost-second surgery\nStable imaging\nKPS: 85\nECOG: 1\n\n-------------------\n\n5-YEAR FOLLOW-UP - March 2023\nMRI: No evidence of recurrence\nFully functional\nMinor fatigue\nKPS: 90\nECOG: 0\n\n-------------------\n\nCURRENT VISIT - January 2024\nMRI: Stable\nAsymptomatic\nContinues research work\nKPS: 95\nECOG: 0\n\nMONITORING PLAN:\n- Continue q6month MRI\n- Neuropsychological testing annually\n- Monthly blood pressure monitoring\n- Regular cognitive assessments given occupation\n\nOverall KPS Range: 70-95\nOverall ECOG Range: 0-1\n\nTreatment approach focused on maintaining cognitive function critical for research work. Early intervention and aggressive monitoring proved beneficial for occupational continuity and quality of life.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n60-year-old male, Blood Type: O\nOccupation: Research Scientist\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, balance issues, personality changes, recent focal seizure (left hand), word-finding difficulties.\nMRI Findings: 2.8cm left frontal convexity meningioma with moderate peritumoral edema\nWHO Grade: I (presumptive based on imaging characteristics)\nManagement Plan: Given size <3cm but symptomatic presentation, recommending conservative management with close monitoring.\nInitial KPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nSymptoms: Moderate improvement in headaches with dexamethasone 4mg daily\nImaging: Stable tumor size\nManagement: Continue steroids with slow taper\nAdded levetiracetam 500mg BID for seizure prophylaxis\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 12, 2019\nSymptoms: Well-controlled with reduced steroid dose\nImaging: No tumor growth\nManagement: Continue current regimen\nKPS: 90 ECOG: 0\n\nINTERIM VISIT - December 5, 2019\nSymptoms: Increased headaches\nImaging: Minimal growth (0.2cm)\nManagement: Optimize medical management\nAdjusted work schedule recommended\nKPS: 75 ECOG: 1\n\nANNUAL FOLLOW-UP - March 18, 2020\nSymptoms: Stable with medication adjustments\nImaging: No further growth\nManagement: Continue conservative approach\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 15, 2021\nSymptoms: Well-controlled\nImaging: Stable\nManagement: Maintain current approach\nConsider reducing MRI frequency to 18-month intervals\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - September 10, 2022\nSymptoms: Mild visual complaints\nImaging: No significant changes\nManagement: Ophthalmology consultation added\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 20, 2023\nSymptoms: Stable\nImaging: No progression\nManagement: Continue conservative approach\nPatient maintaining research work with accommodations\nKPS: 90 ECOG: 0\n\nRECENT FOLLOW-UP - January 15, 2024\nSymptoms: Well-controlled\nImaging: Stable disease\nManagement: Continue current regimen\nPatient successfully adapted work routine\nKPS: 95 ECOG: 0\n\nTREATMENT SUMMARY:\n- Conservative management successful over 6-year period\n- Regular MRI surveillance\n- Medical management with:\n  * PRN dexamethasone for edema\n  * Levetiracetam for seizure prophylaxis\n  * Regular blood pressure monitoring\n- Occupational adjustments implemented\n- Quality of life maintained with minimal intervention\n\nKPS Range Over Treatment Period: 75-95\nECOG Range: 0-1\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular neurocognitive assessments\n4. Periodic ophthalmology follow-up\n5. Consider workplace chemical exposure assessment\n6. Continue current lifestyle modifications\n\nThe conservative approach has proven successful, with the patient maintaining professional activities and good quality of life. Will continue monitoring with low threshold for intervention if progression occurs."
      }
    }
  ],
  "metadata": {
    "total_cases": 100,
    "data_version": "1.0"
  }
}